cell_line_id,drug_id,response
SNU-308,439501,-2.437759024379206
SNU-407,5460769,0.640220508180195
KMRC-2,11485656,3.489579667056433
HEC-59,9903786,2.2541518083702172
SNU-685,54618164,4.365952533334999
HCC44,9927531,3.2754168004895328
TYK-nu,12003241,-2.574649573149326
SU-DHL-1,409805,5.150132871505728
OVCAR-5,439501,-2.798423639950905
Hs 578T,3689413,-0.3709013801718254
NCI-H1944,409805,5.441201830264429
OCI-AML-2,135398744,6.3440072866172965
NCI-H1666,44491742,3.401457772249809
CML-T1,73707440,4.384977554594534
SR,54618164,4.32790577490103
Hs 888.Lu,selumetinib-GDC-0941 (4-1 mol-mol),2.177806274579951
PE/CA-PJ15,439501,-2.069757641280327
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277
Mino,44491742,3.5991371763887616
Tm87-16,11485656,2.0934920623366784
OCI-AML-2,44493528,3.8960180300608345
MV4-11,44491742,3.928114355026535
OV-90,6505803,-3.2294324705329576
P3HR-1,5460769,3.3454995233869957
LAMA-84,148198,-3.5414595786059886
Hs 611.T,26596,-1.6290206215335707
BxPC-3,6505803,-3.0514917868960767
Hs 940.T,409805,3.704694505958849
LS180,135875424,4.384751932486372
BT 159,54618164,4.278849354727367
TE-14,44491742,4.678720015809428
Namalwa,148198,-5.5603375502023
SNU-878,107985,-2.055146714055888
HCC1500,44491742,3.6723474636183537
BT 359,9936388,-7.804167889982691
ESS-1,36462,-0.1255368808432747
LAMA-84,439501,-2.4301107765097525
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
NCI-H2405,6505803,-2.525065037693204
LCLC-97TM1,135875424,3.9585615026829823
SNU-1076,44491742,5.119632622149795
MDA-MB-157,26596,-2.8480155125253623
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
OCI-Ly3,148198,-4.419938902375586
U-BLC1,36462,2.690560707412892
23132/87,12003241,-0.6974968916735146
P-STS,6610216,4.215676656862813
MDA-MB-435S,54618164,4.082989583633613
OE21,9927531,4.992848693668257
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
SNU-1196,5460769,1.0482928300242556
JM-1,11485656,1.6613246077420758
Hs 294T,10296883,4.084911728329476
RKN,11485656,2.343665915939472
HuP-T3,148198,-3.5090934063696153
NCI-H2196,10296883,4.157958831010532
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
LCLC-103H,107985,-2.4603139026976213
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
BL-70,44491742,3.343909693711406
HPB-ALL,439501,-2.479146853758179
SNU-503,3689413,0.9941235992839832
CAL-78,6610216,4.387261995734319
TF-1,44491742,3.716758320980523
KMS-18,10296883,2.8324410966365985
CCF-STTG1,168313200,3.710540265594596
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
COLO 684,107985,-4.706181112932697
MOLM-13,9903786,0.7109980532390177
JHH-4,24180125,3.2145727224704412
CAL-85-1,409805,3.2736432155675983
SF539,148198,-6.422680321892083
KYSE-140,11485656,2.138414918607982
HCC-56,148124,-1.9552943365805164
BT 179,6610216,4.238536269357804
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
Mono-Mac-1,107985,-4.510683187416183
SUP-HD1,46943432,3.007835920740822
LS180,5460769,0.3293841533128088
Fu97,6610216,2.939108753023632
EB1,26596,-3.5599614403908264
KYM-1,5460769,0.1657624677468328
RKO,6505803,-0.9276151073099124
Ki-JK,49836020,-3.31096865556518
SNU-738,6610216,4.938178948183777
TF-1,24180125,3.3571261304067326
SW579,409805,3.672611404001125
SNU-410,6610216,4.607565323971714
Caki-1,3689413,-2.406735628687606
UACC-257,9903786,4.920300978966239
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
Aska-SS,JQ-1-carboplatin (1-1 mol-mol),-0.8718657257645913
ME-1 [Human leukemia],9936388,1.383892450807597
KMS-27,135875424,3.062949478876591
TF-1,10296883,3.653157078260328
IGROV-1,9903786,1.7387584479757865
GB-1,6610216,4.739230652843282
NCI-H841,6610216,4.086730283804729
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
647V,44493528,4.175577269384225
NCI-H2171,11485656,1.3701169509015756
TE-10,9903786,3.070607136357089
NCI-H2023,24180125,3.7677499946881743
KG-1-C,9903786,3.898193715125589
NCI-H929,46943432,-0.7846111801119194
COLO 829,3689413,0.7694296944480054
SNU-761,159324,2.4588772330633115
MIA PaCa-2,3689413,-2.455927464924985
COR-L95,107985,-2.989419812710682
U-CH1,6610216,3.8100359260465617
Kasumi-2,168313200,3.5619242662151342
MV4-11,3689413,-0.1876256430889787
MCAS,11485656,2.57416789640687
Tm87-16,6610216,4.349326509918039
PE/CA-PJ15,8515,2.421663775633471
SNU-899,3689413,3.063297937380225
ONCO-DG-1,24180125,3.4172871528516677
CFPAC-1,107985,-2.993539279710045
HCC1195,135875424,2.5037417223701572
NCI-H1793,6610216,3.8790622627793225
TE-14,54618164,4.303760954268937
NCI-H1581,44493528,4.36885070157506
BDCM,36462,-1.2940643345656602
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
MSTO-211H,26596,-0.5653018529577997
NCI-H146,3689413,0.5626872136369616
GSS,9877608,3.923769598981982
SNU-1,24180125,3.3252406480350065
JHUEM-7,3689413,-2.2301251225415255
HOS,44491742,4.672695647178855
OUMS-23,36462,4.217798151185395
SET-2,12003241,-1.37504024910663
KMRC-1,24180125,3.3952911821821052
RPMI-8402,26596,-2.3009998991377274
Rh18,159324,2.379884885928139
KALS-1,148198,-1.8271090842643645
NCI-H1944,10296883,4.093574875483821
EHEB,36462,-0.01305148556103
MIA PaCa-2,439501,-4.331404793236993
Hs 936.T,11485656,2.4154558200874803
DAN-G,54618164,3.977352758546573
DU4475,135423438,2.3536121101855096
LOX-IMVI,439501,-2.207275092585139
EM-2,44493528,3.698991403338848
GP2d,107985,-4.252296994603502
MC116,9903786,4.909292458120856
SaOS-2,44491742,4.263847553999534
NCI-H1734,6610216,4.006473100907771
KMRC-2,3689413,-1.0505298927618916
HT-1080,36462,-0.5040503669915217
SNU-475,135875424,5.230711078177573
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
697,439501,-3.82474204489092
CAL-120,135398744,6.432645448228996
UACC-257,10296883,3.905415192758359
AML-193,36462,0.2235615608129252
NCI-H2452,6505803,0.3706171048891257
SK-N-DZ,54618164,3.925658631288567
HeLa,8515,1.8792207243719483
MOLT-3,JQ-1-carboplatin (1-1 mol-mol),-0.167608830947713
YD-8,44493528,4.2998537557563346
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
HCT 15,26596,-1.5306161018190547
BT 359,439501,-2.266223118686084
NCI-H838,10296883,4.165878010219483
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
Hs 839.T,439501,-1.1818140450451011
KYSE-180,9936388,-5.3897473887689
RVH-421,135875424,4.136589484266176
RPMI-6666,107985,-4.274541908591321
HT-144,168313200,2.154847170471374
HCC1500,8515,5.3989297102528715
SNU-601,54618164,4.367725876257716
LS1034,107985,-4.1764612715233325
SNU-685,JQ-1-carboplatin (1-1 mol-mol),2.807780609987689
HCC15,44491742,4.47716804785037
SK-HEP-1,148124,3.734435411699081
MCF-7,54618164,4.236362509172509
HCT 116,409805,6.026395844071452
SBC-5,148198,-1.371938553790338
SUP-T11,9927531,4.66163575559017
KCL-22,9903786,2.593050827774072
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
SNU-387,135875424,4.7667426399208965
NU-DUL-1,148198,-2.450510583541313
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
Kelly,439501,-0.837700217244781
Aska-SS,5460769,3.7674682150871552
KMS-26,6610216,3.996132091239896
NCI-H2170,135423438,3.656006227697759
HCC2935,12003241,-0.8324751754872037
KP-N-SI9s,54618164,3.938128772569179
253J,JQ-1-carboplatin (1-1 mol-mol),2.6243340273130733
H-STS,5460769,1.2422964505231244
IGR-1,6505803,1.3637597658923408
TTC-709,12003241,-2.491438610606954
NCI-H1734,36462,-0.544254253022864
SHP-77,24180125,3.776210546228356
NCI-H2085,159324,3.0275398658525785
NB1,54618164,3.8017135330145377
NCI-H1944,selumetinib-GDC-0941 (4-1 mol-mol),0.8132454381958738
Mino,148198,-4.997781998015961
Namalwa,148124,-8.376959890675789
SUP-HD1,36462,-0.9379934382543692
HSC-2,5460769,0.0073733744403826
BT 482,6505803,-0.931790010731935
JL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.640014576160969
SK-ES-1,9903786,1.417242629772361
TE-1,36462,2.941259846710762
HCC95,54618164,4.312739423514147
SUP-M2,8515,2.7865906060972647
COLO 668,107985,-4.1866229688434
HSC-2,6505803,-0.2270434612108878
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
HEC-1-B,12003241,-1.9447585975595445
MOLT-13,148198,-2.9272995134597157
MEC-1,46943432,0.6531344978892847
HCC78,409805,5.666316394079404
BT 333,135875424,3.156129563480943
KMS-26,44491742,3.93722038391691
OCI-AML-5,6505803,-0.3064133467102931
NCI-H1355,12003241,-2.4294292569102436
OUMS-23,148198,-2.1659685214591664
Daudi,135875424,2.734623655159311
BT 359,107985,-0.9981088796808636
LCLC-103H,135875424,4.227127244707997
OE21,44491742,3.708692446594154
Peer,44491742,1.9885349932687044
OCI-AML-5,8515,3.17727630785645
PSN1,44491742,3.787418780270154
Hs 766T,46943432,3.2125671025540536
C2BBe1,3689413,0.1296061414739377
NCI-H1341,10296883,3.7188145345884407
KO52,9903786,1.3206822748757847
COLO 829,6610216,4.231441240568813
PK-59,409805,4.129578188717334
NU-DUL-1,6505803,-0.4706315127513403
COV644,107985,-3.1393219510283186
UM-UC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.98446738693651
SK-BR-3,49836020,6.022467534114696
TE-9,3689413,4.927394449121957
WM88,36462,2.778591866824928
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
CA46,36462,0.0715644321871689
NCI-H69,12003241,2.7316245717871572
NCI-H1155,12003241,0.5053452290511842
EFE-184,10296883,3.6509562081155167
TM-31,10296883,4.091171590398709
SNU-449,12003241,0.2005365129445947
OCI-Ly10,9927531,5.366378866921267
NCI-H1184,12003241,-1.9901297280698445
5637,54618164,3.894901401799729
A-375,9936388,-2.2482939434629223
HuH-6,24180125,2.007302619499647
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
SNU-61,439501,-1.3808373898758073
DMS 454,439501,-2.8107075635854866
DMS 53,8515,3.81092171327107
SNU-175,24180125,-0.5173296686160461
SNU-899,148198,-1.9308055104707893
DB,409805,3.899652839809395
COLO 320,9927531,3.3062100750903594
UM-UC-3,8515,5.210153711549927
SCC-9,8515,4.77911141452934
SNU-503,409805,5.9383917645195075
BT 179,36462,3.422327002990244
NCI-H446,44491742,5.101744314169451
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
SK-MEL-1,12003241,-1.7363712573149035
MDST8,439501,-2.351670240427255
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
THP-1,10296883,3.2356206516906765
CAL-33,135398744,6.573384587063474
NCI-H1915,24180125,3.781606905137401
COV644,148198,-3.8315909355374607
KMS-20,439501,-3.5751856752548985
SNU-601,3689413,0.8443240779543064
ME-1 [Human leukemia],168313200,1.6367692901213335
MDA-MB-468,135875424,4.133730456333857
SNU-61,107985,-3.1587785808489297
SNU-1066,54618164,4.288929864034331
VCaP,44493528,4.161690845377168
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
BT 231,6505803,0.1418659460842767
NU-DHL-1,135875424,2.8057790902603665
MKN7,54618164,4.012076431058733
Hs 852.T,6505803,-1.3832996341384214
SR,36462,-0.3109859295977757
PLC/PRF/5,54618164,4.054681529600222
SK-N-MC,6610216,3.936381871517216
SUP-T11,159324,0.229109625943877
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
Ri-1,6505803,0.1421500129584279
GMS-10,9936388,1.763954811977491
HEL 92.1.7,JQ-1-carboplatin (1-1 mol-mol),0.0305344247994576
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
LS180,148198,-2.644013472885731
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172
PC-3,6505803,3.983075773464378
CHP-126,5460769,0.9651768958989126
HEC-6,46943432,3.440165677285934
BICR 6,49836020,4.408429630205201
KMS-18,8515,4.2274985612472715
LAMA-84,3689413,-1.3009180368872624
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
Kuramochi,54618164,4.340040712483917
FTC-238,148198,-4.9024101761285435
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
Rh30,36462,1.3156470813708137
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
TE-1,107985,-2.1441864894921587
SK-UT-1,24180125,3.450035886510637
Panc 10.05,8515,4.8938327251250335
A2780,54618164,3.641335469190071
ONCO-DG-1,135875424,3.8536123048292175
NCI-H1581,8515,3.165024241321023
HCC1419,selumetinib-GDC-0941 (4-1 mol-mol),1.9715069787616553
MOR/CPR,107985,-3.2493016535307073
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
SUIT-2,6610216,4.902807448612422
HCC95,6610216,4.197174673248092
SNU-16,3689413,-2.4569670929316656
Hs 746.T,24180125,3.39079368613673
TT2609-C02,5460769,3.053476613598646
NCI-H1650,409805,5.641915285745506
SNU-387,10296883,4.167941134769786
COLO 668,54618164,3.5292451402005818
SNU-668,439501,-0.7901558289045547
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
SU.86.86,10296883,4.023388867710504
U-118MG,26596,0.614033451908362
MDA-MB-468,5460769,3.9216030050456023
HCT 15,6505803,0.2162599595018707
SNU-213,24180125,3.139959624084286
BT 359,24180125,3.227467986452967
LNCaP clone FGC,6505803,-1.5170131166658098
HCT 15,5460769,3.425383237869742
GB-1,135875424,3.7799523392029593
IGROV-1,9936388,2.10108466287406
ECC10,12003241,-2.873030940363692
EHEB,26596,-2.0876334457911727
OV56,6505803,0.8040031173297286
Daudi,54618164,3.154466747848232
NCI-H889,26596,-2.687353168028847
NCI-H441,6610216,4.273182904143366
KMS-12-BM,6610216,3.741234433073347
SNU-182,5460769,4.45196550133433
BT 147,135875424,2.90044056464114
Daudi,9903786,1.3988461789185107
KP-4,8515,3.507883744965969
A-204,JQ-1-carboplatin (1-1 mol-mol),0.2793211134785925
KCL-22,135875424,3.663318576460465
Li-7,6610216,3.269081187832887
OE19,409805,5.918872403397379
Panc 10.05,44491742,3.75595275347319
DU4475,54618164,3.720163464604322
SW1783,409805,4.510325829942446
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
NCI-H520,439501,-2.5978412941351405
NCI-H841,11485656,1.425453258199406
TYK-nu,107985,-3.986066902554295
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
PaTu 8902,9936388,2.1491039356268966
TE-8,135875424,3.858903579459316
IMR-32,439501,-2.4799025778743884
BFTC-905,24180125,2.4151686868886557
REC-1,44491742,3.8136752597353953
Hs 839.T,107985,-2.4712975807156403
VMRC-RCZ,JQ-1-carboplatin (1-1 mol-mol),3.747713311192417
KE-39,409805,5.860910954246773
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
G-402,8515,4.197979847393778
NCI-H446,11485656,1.965301254432185
SNU-449,135875424,4.841371934548395
TT2609-C02,9936388,3.168099243698234
KU-19-19,107985,-2.420790531142743
HCC78,5460769,-0.5347925527973022
FaDu,148124,3.760375102860639
SNU-1214,107985,-3.75427796779674
KE-39,44493528,4.79040409668691
HCC2108,5460769,1.78766929460534
BICR 56,9936388,-4.960855402776582
ZR-75-1,36462,3.527244858285703
AM-38,26596,-1.378118107802664
Hs 940.T,439501,-3.345771956263442
OV7,36462,2.3597249794920785
NCI-H1838,6610216,4.831533607411558
NCI-H526,12003241,1.2765702668014436
LOX-IMVI,44493528,4.127526604228942
SK-N-MC,49836020,5.673841333096494
RL,9903786,3.83184195533614
HCT 15,46943432,4.414742739807934
KATO III,409805,6.010441126415053
JHUEM-1,26596,-1.2940313289426515
HuP-T4,159324,3.287131354646656
EBC-1,54618164,3.221465025886113
P31/FUJ,8515,2.4023085754769133
LS1034,9903786,3.887461634575776
HCC-56,9927531,5.667739973718857
JMSU-1,26596,-1.1755063311173417
JVM-3,9936388,-6.226344313547517
ChaGo-K-1,36462,1.940737547002896
JHH-2,3689413,-2.478608277030538
KATO III,54618164,4.165114309874091
OVCAR-5,6610216,3.967689851217868
BICR 18,409805,5.834842902034196
AU565,11485656,2.0156354686346174
KMS-28BM,159324,2.1754109137768327
NCI-H1651,26596,-1.4213694669265446
Ci-1,26596,-1.6175201482887698
QGP-1,107985,-2.5717210871655203
KMS-11,107985,-4.8759119142247
JURL-MK1,5460769,3.622430112813927
Rh41,439501,-3.728538784636516
Hs 940.T,44491742,4.308619589326881
MM1.S,439501,-1.8322200924082088
HOS,168313200,3.7801043003963217
NCI-H1341,135875424,1.697371790785142
OVCAR-4,6610216,5.074160315502063
SNU-1033,12003241,-0.6294445516416565
SK-MES-1,148198,-4.042000221520934
KYM-1,135875424,2.5463366788137427
GP2d,36462,0.7877061806446254
NCI-H1869,6610216,4.465976467686126
TE-11,5460769,-1.6571855134906777
NCI-H1703,36462,0.3978809635850562
NCC-StC-K140,148198,-5.392485338723143
OCI-M1,10296883,3.5292915322873255
SNU-840,54618164,4.366346173630273
Fu97,selumetinib-GDC-0941 (4-1 mol-mol),0.7041233813460074
Kasumi-2,8515,3.2781378887974775
EFM-192A,148124,-4.4565215369603814
KCL-22,6610216,3.733041732556284
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
NCI-H2196,3689413,-2.371911217935783
JHH-1,36462,3.4742558280841536
SNU-410,11485656,3.512018724098686
IGR-37,135423438,1.6806022412705843
SR,5460769,1.487017062685354
KMS-21-BM,9936388,-8.048894686182319
NCI-H524,135875424,1.583285673103297
SK-BR-3,148124,-5.1305926925012235
HCC2218,26596,-0.1880453521462128
HPB-ALL,9936388,-8.275368871773662
NCI-H1915,9936388,2.519208351388662
COLO 205,54618164,4.3534025935886955
OVISE,159324,4.206537691518507
KE-39,54618164,4.766262408385177
HMC-1-8,6505803,-1.2276193463288383
UACC-257,9927531,4.918712273550195
NCI-H2106,9903786,3.304741679115025
SaOS-2,135875424,3.0421388786055727
IGROV-1,26596,2.910298792762654
SH-4,selumetinib-GDC-0941 (4-1 mol-mol),-0.2287581368829222
HCC-56,selumetinib-GDC-0941 (4-1 mol-mol),-0.1385009392783674
BICR 31,8515,4.104799625743522
HOP-62,36462,1.2556592517294145
KATO III,12003241,-4.840637368540689
KNS-81,6610216,4.677287397778329
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
LCLC-97TM1,135423438,1.8911988038183152
A-673,148198,-7.755828732328633
NCI-H508,26596,-1.5060721880179218
SET-2,10296883,3.6220267482667943
BICR 18,26596,-0.934766780366006
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
LS180,3689413,1.3392854552239355
8305C,24180125,2.6212256046987052
EBC-1,148198,-1.529856681948531
GSU,6505803,-1.4354147992291242
SNU-C1,107985,-3.980380328262601
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
Malme-3M,JQ-1-carboplatin (1-1 mol-mol),-0.4541728562567664
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
A-375,54618164,4.173421291280232
JHOM-1,168313200,3.938698311360986
HCC1438,148198,-4.23267201662653
NCI-H2081,107985,-4.4331361775732905
KCL-22,24180125,3.6923950741905074
TC-71,24180125,3.7432821305045545
NCI-H211,8515,3.6048650203419457
LMSU,8515,4.269991680871031
8305C,107985,-3.674181215647319
CHP-126,439501,-0.4236570710914729
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
647V,36462,0.4218876333700403
T84,11485656,2.016527723529138
SF126,135423438,1.5830794600000448
K-562,148124,-7.41486725283878
FTC-238,12003241,-0.6060695245587711
SK-N-FI,148198,-6.001619008319419
SW1783,10296883,3.940377993774996
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
LS513,8515,3.476923089541429
COLO 792,9903786,2.6845883070851277
IM95,11485656,1.1906630822338928
NCI-H647,24180125,3.804113444039596
SNG-M,5460769,2.9987935080013695
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
CCF-STTG1,11485656,3.67410233042364
OCI-Ly3,135398744,6.408015135669225
8505C,409805,5.335927763220102
BHT-101,6505803,-0.1519656140432062
Karpas-620,9903786,4.2683089971609265
SNU-1,135875424,2.684613740830041
KNS-60,107985,-3.3035021977330947
TE-14,8515,4.691290159599005
HCC15,135875424,4.57405525423842
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
HCC1438,135875424,4.418316451963679
ONCO-DG-1,9903786,3.737117521186133
BICR 6,9927531,3.2709369283144674
A3/Kawakami,6505803,-0.1184666814431136
647V,148198,-4.071650146213555
Ki-JK,JQ-1-carboplatin (1-1 mol-mol),-0.8899338497944629
SUP-HD1,44491742,5.1977387021810255
KYSE-140,9903786,2.4605743135261653
ALL-SIL,46943432,1.7359798293614472
A-549,54618164,4.216271974260082
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
NCI-H1703,6610216,3.962286374366853
JHH-2,11485656,3.3849117399649513
NCI-H1703,148198,-3.5169860092327587
LCLC-97TM1,148198,-1.8422045751990368
UACC-257,54618164,4.3515064934854095
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
Hs 611.T,44491742,3.458740390209698
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
SW1783,8515,3.491142478274941
Sq-1,409805,5.517276398336014
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
HCC1833,54618164,3.937517250635008
Lu-99,26596,-1.1176086778994336
NCI-H747,24180125,2.088918009184693
ChaGo-K-1,54618164,3.816944034787713
VMRC-LCD,44493528,5.517080304343614
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
COR-L105,8515,4.561371818511258
HCC1419,168313200,2.3751078129153025
Mel JuSo,8515,4.331675363159847
Becker,439501,-2.817437349005285
NCI-H2110,9903786,2.318107893964858
PC-14,9903786,1.3474672632704163
FaDu,5460769,4.852166639687207
SNU-738,9927531,4.827507825762818
SW1271,107985,-2.924919788256343
NCI-H1395,54618164,4.0783729987601225
NCI-H1915,12003241,-2.138789855422618
KYSE-30,9903786,5.462463083669851
IPC-298,10296883,3.818121747972668
Capan-2,3689413,2.633842483871067
OV56,9903786,4.181691762553772
COLO 829,148124,-4.326485260562876
HOP-62,6610216,4.033430969864694
SU-DHL-10,26596,-1.8221428143230487
SR,6610216,4.010987064969844
BFTC-909,44493528,4.370300807083883
NCI-H1339,24180125,3.3577258152264635
KMS-26,54618164,3.749169095828711
SNU-16,168313200,1.665996336027964
BT-474,409805,3.72373361463483
SNU-175,26596,-1.9837379159345812
NCI-H441,159324,3.2801227887174
OPM-2,135423438,0.9866001177758746
IGROV-1,135875424,3.3275053166921347
Lu-65,135875424,4.016301544047221
KE-39,24180125,2.8951506389407053
NCI-H647,168313200,2.222361802043905
RMG-I,107985,-3.282472145872261
OVCAR-8,36462,3.6790944167016097
NCO2,9936388,-6.28064659559562
MDA-MB-468,11485656,1.4404367152008126
L-540,148198,-2.923933345267779
Hep-G2,148198,-2.3541136469085493
BICR 16,24180125,3.1205694926325034
IA-LM,54618164,4.43488746250501
IMR-32,107985,-5.071647837163832
KALS-1,135875424,3.665008490823154
HCC1395,107985,-4.4491862214991595
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
LC-1/sq-SF,10296883,4.166838405657319
OVCAR-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.7048742493039822
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
BHT-101,9903786,3.039821260092269
HT-55,11485656,1.9068584581515573
HCT 8,12003241,1.3953140594908418
OCI-Ly19,135875424,3.926549898319096
MPP 89,12003241,-0.4822573033051652
BT 147,selumetinib-GDC-0941 (4-1 mol-mol),1.4700877243858868
NCI-H1623,24180125,3.727544824819635
WM793,135875424,3.1604105075223656
HCC366,26596,-1.6336746121015082
BT 216,168313200,1.9085884214210995
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
KO52,6610216,4.150836928578526
HH [Human lymphoma],12003241,0.3736289232405389
HSC-2,selumetinib-GDC-0941 (4-1 mol-mol),0.8174688254253049
TE-4,44493528,4.301636360206761
RERF-LC-Ad2,148198,-4.2716837580451825
NCI-H226,107985,-3.130066790773439
NCI-H2110,3689413,0.5131338822863976
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
CCF-STTG1,11485656,3.67410233042364
Raji,159324,2.512472945563818
HCC1171,selumetinib-GDC-0941 (4-1 mol-mol),-0.4155569356036221
TE-5,148124,-6.926392091129738
Hep-G2,12003241,-0.7040118985216451
CAL-12T,5460769,3.2968044881057734
OVSAHO,36462,4.07027674269764
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
HT-1080,24180125,3.242600087423989
F-36P,6505803,-0.1070428944453584
NCI-H211,439501,-3.5479428279050955
ME-1 [Human leukemia],44493528,4.9966517088046345
JeKo-1,439501,-6.227788271417287
JHUEM-2,JQ-1-carboplatin (1-1 mol-mol),1.384634873843588
Calu-1,11485656,3.860482320905327
KG-1-C,3689413,-1.7465014908016088
OC 314,JQ-1-carboplatin (1-1 mol-mol),-0.0943346801193366
U-937,8515,3.244318926695943
NCI-N87,36462,0.3600781388020123
HT-1080,54618164,4.264830967692318
BT 482,409805,5.470910874160514
BC-3C,11485656,2.025268186046356
BT 416,36462,1.1914496621950696
Kelly,36462,0.235895154836424
BT 245,12003241,-0.4272477548788383
Mono-Mac-1,8515,3.2918667240053643
YD-15,159324,3.5154662615579486
Mel Ho,3689413,0.6432726542837045
BICR 56,5460769,-1.0977162863448868
J82,JQ-1-carboplatin (1-1 mol-mol),4.923162890410876
BV-173,159324,-1.7619985937899936
TUHR10TKB,24180125,2.8782335603201665
NCI-H510A,11485656,1.795372186053248
JHUEM-3,5460769,0.399281620663996
HT-1197,6505803,0.6995636823670472
SNU-899,9877608,7.308498444418231
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
EPLC-272H,44491742,4.296380741364786
SF268,6505803,-0.4080835752334602
MKN7,168313200,3.0639752304620274
HCT 116,159324,3.5390690046327573
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
MOLT-3,135423438,2.3622071216207594
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
SCC-25,3689413,-0.8116745291609476
DU145,9927531,4.922928089289864
A4/Fukuda,107985,-4.34456564276242
TE-15,10296883,4.422841947508094
SUIT-2,3689413,0.4029780891432681
SJSA-1,9903786,3.6249544402257863
NCI-H1155,148198,-4.37557893691535
PL-21,168313200,3.805742072358513
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
Mel JuSo,159324,1.5841553738768115
SNU-407,9903786,2.2079678485918977
COLO 699,135875424,3.78821155380287
NCI-H2029,24180125,2.5610139497172257
RPMI-8402,9936388,-6.946099895647247
FU-OV-1,24180125,2.037807307003979
TCC-Pan2,36462,3.2804805767376197
PC-3,6610216,4.524675902616183
NCI-H1092,9927531,3.406213307022425
SNU-216,135423438,1.816422149531831
HCC1954,26596,-1.6295363665710343
EBC-1,135875424,4.611810630126507
RCH-ACV,54618164,3.616633396112511
NCI-H2196,135875424,2.980052195607556
KMS-28BM,selumetinib-GDC-0941 (4-1 mol-mol),1.2761888843371896
NCI-H1568,26596,-1.690126811671561
EN,107985,-3.693718586943453
5637,6505803,-0.9891177489911248
EFM-192A,9903786,5.377742197319564
KMRC-3,3689413,-1.603340065722176
RCH-ACV,135875424,3.077448855642363
HD-MY-Z,168313200,2.256800856387925
Hs 934.T,44491742,4.305764247310721
U2OS,148198,-3.483181142521373
TE-11,6610216,4.289491420470742
ST486,11485656,1.65014245999224
RERF-LC-MS,148124,-5.592640359076286
Ci-1,107985,-3.0068407615661537
PE/CA-PJ49,24180125,3.249476496714235
HCC4006,54618164,4.128566350429528
NCI-H1693,24180125,1.2211030322641976
MDA-MB-435S,JQ-1-carboplatin (1-1 mol-mol),5.894688800138277
RT-112,36462,2.29619659218897
HMC-1-8,36462,2.02540653166462
NCI-H889,409805,5.162454720252358
HCC1395,9877608,6.36391605144629
EC-GI-10,135875424,4.9830420551116985
WM115,9936388,-1.175666523167262
KCL-22,3689413,0.1679864473503304
EPLC-272H,135875424,3.5284269616389943
Lu-99,107985,-3.777908529109632
JHUEM-7,135398744,6.411220982649173
BT-20,54618164,4.2305342335962175
EFO-21,9927531,5.470218663007946
Hs 578T,107985,-4.43048214511299
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
Capan-1,148198,-2.3520537722391075
OVCAR-4,9903786,4.586941705699431
BT 286,107985,-3.490112295441736
LOX-IMVI,6610216,4.50475887239393
EB1,46943432,5.750857255240241
SW1417,6610216,4.3263936017007225
FaDu,168313200,2.388529084723483
SNU-61,44491742,3.859456688826312
DMS 53,107985,-3.9095415440862458
LK-2,12003241,-1.6123297720888603
BT 239,26596,-0.3538471097190154
COLO 678,439501,-1.1365168855313783
8505C,8515,4.351335582705761
UM-UC-3,36462,1.2074051726105934
COLO 668,JQ-1-carboplatin (1-1 mol-mol),3.106273678335465
NB4,12003241,-0.9132683604987908
MDA-MB-468,8515,4.214689901867794
SUP-M2,46943432,0.7437665955481163
Tm87-16,36462,3.553446684320628
Caov-3,3689413,1.9135377903432256
NCI-H526,6505803,0.072926475224881
LS411N,44491742,5.693616041532359
IM95,5460769,5.308865140220459
SNU-1214,54618164,3.4998200252029257
NCI-H2286,5460769,0.0147592339119179
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
BT 359,135875424,3.201120817115183
JeKo-1,11485656,1.8076114759672557
NCI-H520,148198,-5.585206831860286
KLE,36462,1.5319564725809691
HEC-6,135875424,4.1138725556721685
GDM-1,107985,-3.5655662654697284
NCI-H1568,9903786,2.4011050725962115
MDST8,6505803,-0.0816923181525763
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
EBC-1,26596,-2.071625704215017
Pfeiffer,11485656,1.3826588653804326
KATO III,11485656,1.9735561216219804
VM-CUB-1,9903786,3.0676048433352268
RERF-LC-MS,168313200,3.896073258981905
KE-97,148198,-2.582378915330286
SNU-245,54618164,4.324549531674931
SW579,6610216,4.132063529234779
VMRC-LCD,439501,-2.2001056287042715
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
Ki-JK,24180125,2.224495261698477
B-CPAP,44493528,4.579013970980452
KMS-11,135423438,-0.4348123575852698
SU-DHL-8,selumetinib-GDC-0941 (4-1 mol-mol),1.9311696765253152
HCC1438,6505803,-2.462970464658383
SW1990,107985,-4.22199587403486
MDA-MB-157,439501,-3.062684000428755
KALS-1,10296883,4.367875954814542
SK-N-BE(2),12003241,-2.145069511983118
WM266-4,36462,0.1003965458983716
SNU-449,9903786,3.696408358539977
U-251MG,selumetinib-GDC-0941 (4-1 mol-mol),1.876710388033308
PF-382,12003241,-3.7051147214471114
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994
SNU-1105,3689413,0.7210916116253745
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
SYO-1,409805,3.616112790347393
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
SNU-1214,5460769,-0.9519860634538546
DEL,135875424,3.00477413293185
HuG1-N,12003241,-0.7398422629882291
TE-5,54618164,4.06864256728215
KMH-2,36462,-0.642209166172259
NCI-H1651,6505803,-0.3819158515130707
LOX-IMVI,148198,-2.445772941232649
F-36P,107985,-4.433418239536547
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
SCC-9,3689413,-0.5284639903905319
SNU-1077,148198,-1.03431054543621
HeLa,168313200,4.248438421303553
PaTu 8988s,409805,3.706044847536148
COR-L95,439501,-1.1523844892623298
YD-8,9927531,5.007831795650313
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266
HuH-1,36462,2.248539187241854
SK-MEL-5,5460769,5.96903783579764
NCI-H647,10296883,4.213615092820639
Aska-SS,6610216,4.460274887229386
VMRC-RCW,409805,5.902795568168737
HCC15,6505803,-2.813846830430111
MCAS,9903786,3.9207216019302007
WM983B,107985,-4.2173502785895245
SK-N-MC,8515,2.9723089928083577
SUP-B15,11485656,1.8615959467984833
SK-N-FI,9903786,1.217997719739724
Pfeiffer,26596,-3.7585498657816414
SU-DHL-8,5460769,1.8345696055083096
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
SNU-1,44491742,4.0790825455255195
LS1034,439501,-2.506043270280418
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
SW982,135875424,6.1479470083270735
CML-T1,11485656,1.9899616795432975
KYSE-510,6505803,-1.66043256037682
SNU-869,36462,3.1715816266138
SNU-C5,439501,-1.612847853644416
F-36P,8515,2.752757057086389
DAN-G,9927531,4.82875872277198
L-428,135875424,2.6389964210598937
CAL-62,6505803,1.4700941326099095
HOS,9927531,4.717123870748892
DMS 114,44491742,4.749496559747659
P3HR-1,409805,3.946032344990011
BT 139,12003241,-0.7824976089919207
YD-10B,3689413,2.253033530854965
DBTRG-05MG,selumetinib-GDC-0941 (4-1 mol-mol),1.9211216865971592
MOLT-13,159324,-1.1866760000541376
MCAS,6505803,-1.4160035963714128
COLO 320,107985,-3.942895993457312
NCI-H1869,36462,3.1749992742870923
KO52,26596,-3.758446698642679
HLF,9903786,4.061487019079308
TE-1,148198,-2.725381459547287
U-251MG,409805,5.498064419607069
L-1236,3689413,-0.1223462388223707
NB1,159324,3.048958177907293
KMS-21-BM,9903786,1.778157023990249
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
JHUEM-3,9927531,4.734556698770441
TYK-nu,JQ-1-carboplatin (1-1 mol-mol),2.875539349540035
NCI-H1792,135398744,6.377997167001959
JVM-2,36462,-2.228443710611506
JK-1,159324,-0.6912677372060566
SNU-1066,3689413,-0.3741974458844401
OCI-AML-2,9903786,1.7653976313293729
NCI-H1651,24180125,3.395099452634416
TALL-1 [Human adult T-ALL],8515,3.885007345208586
IGR-1,44491742,3.995353370886831
IM95,24180125,2.4219347351026643
KYO-1,44493528,4.460522325437717
G-402,107985,-3.5863491011783517
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
SNU-601,12003241,-1.174156148938379
MOLT-16,168313200,3.8656491063755207
DU145,11485656,2.5427151524786993
CAL-85-1,9903786,2.154153676778314
LP-1,11485656,1.1058923195648849
LAMA-84,135423438,-1.4093443238275885
KE-97,selumetinib-GDC-0941 (4-1 mol-mol),2.3217302036143295
ME-1 [Human leukemia],10296883,3.2444666645650675
TE-11,148198,-3.0538183571053183
Hs 895.T,12003241,-1.2157135831587602
BT 422,44491742,4.87231922177064
BHT-101,54618164,4.746159131791783
KHM-1B,409805,3.6418621708763945
OV-90,439501,-0.6322605477357213
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
769-P,12003241,-0.850847726914325
EN,148198,-4.716132059388744
SK-N-MC,3689413,-2.3816652298923873
SK-MES-1,6505803,-1.6452904236752195
MKN74,409805,5.7612246650948356
PE/CA-PJ41 (clone D2),409805,5.090011413594482
OCI-AML-3,54618164,3.7553618842798726
TE-8,159324,3.1716058711532833
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
TCCSUP,24180125,2.590806345958597
IGR-37,8515,3.3809165095861236
KU-19-19,11485656,2.7576201496249264
YAPC,24180125,3.806846010722946
HCC2935,135875424,5.111767291831502
DMS 273,9927531,4.953960158421894
NCI-H1299,135875424,3.7950147310792257
HOS,36462,1.2276704607974214
SNU-398,9936388,-6.365933460277143
Panc 03.27,409805,5.782459205310856
BT 328,6610216,4.43822058219873
WM115,44491742,3.78432787650886
HuT 78,46943432,0.3707901357093127
Namalwa,46943432,0.650701651867592
JHH-5,9903786,3.1481910076888684
Ku812,24180125,2.3184854542342217
Calu-3,44493528,4.337619480836725
MOLP-2,5460769,4.105160520991768
NCI-H1385,11485656,1.967780346674157
CAL-33,3689413,0.5447147166063717
BT 112,168313200,1.7991755506997456
SNU-668,148198,-1.6951870968907452
BICR 31,439501,-2.4499261286992007
JURL-MK1,3689413,0.8778438710921479
MJ,439501,-3.472446137047906
SNU-C4,148124,-1.7954485275356942
SK-BR-3,36462,-0.4893529517615315
Rh30,9903786,2.553175737800522
WM266-4,9936388,1.925680740660873
RERF-LC-Ad2,6610216,4.489268569667584
H-STS,26596,-2.569417697964928
SNU-182,selumetinib-GDC-0941 (4-1 mol-mol),-0.56211795944893
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
KM12,5460769,1.9442092441204395
CHP-212,8515,1.882954928641981
SK-HEP-1,12003241,-1.7510835313415607
OV7,6610216,4.457826030978553
MOTN-1,6505803,1.224860499211516
HCC2218,11485656,1.6045404853234653
MOLT-3,168313200,1.915492137335788
SNU-61,11485656,2.115016827038527
Daudi,148198,-7.679285276133229
ZR-75-30,409805,3.93258642245537
SK-MEL-5,9903786,4.335376265950657
NCI-H2023,107985,-3.2164871324415816
SNU-1272,11485656,2.6947903691441795
TE-11,44493528,4.3195742716631615
Kelly,46943432,3.8381762571789926
SCaBER,3689413,-2.276836963642964
WT2-iPS,12003241,-2.3723982156624057
KYSE-140,3689413,0.0626395685413909
NCI-H522,9903786,3.9217135447784783
MHH-CALL-4,24180125,2.4020121607744653
AsPC-1,54618164,4.187549957668634
22Rv1,107985,-3.2649317078671984
DV-90,168313200,1.844250299013333
KYO-1,135875424,2.9941253538881925
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
DMS 53,148124,-2.0065392154646537
CHP-212,107985,-3.762512577622678
KYSE-450,6610216,4.803414401111398
EoL-1,26596,-3.796383365572035
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
COV644,9936388,-1.581655589979093
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
SET-2,44491742,3.5989743077742387
ACC-MESO-1,439501,-2.1177142805540163
BT-549,9936388,-4.888200161073446
SK-N-AS,6610216,4.189892588331561
BICR 22,6610216,4.672862717569176
IGROV-1,135875424,3.3275053166921347
Hs 578T,49836020,0.6847429303234678
VMRC-LCD,3689413,-0.1897073669297062
NCI-H524,10296883,3.65691401974992
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
Hs 852.T,54618164,3.172900105103994
Mel Ho,159324,3.173943708119276
HCC1438,9927531,4.9957520851932955
LK-2,26596,-1.655987263184575
IGROV-1,49836020,5.658436828096057
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
LCLC-97TM1,54618164,4.1848187977728
JURL-MK1,9903786,1.1530539492536125
KYSE-450,10296883,4.225795837642371
Daudi,8515,3.193004700442435
HCC1954,148198,-1.209657619864023
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
BT 164,439501,-4.366983118458045
HuP-T4,3689413,-0.6711491165828569
SNU-201,3689413,-1.5340531054377644
OC 314,6505803,-0.2710007878606607
G-401,54618164,3.8592700204433807
Ku812,26596,-2.18380806647072
GaMG,12003241,-1.1621616673389346
SEM,26596,-3.506968001766276
PC-14,6505803,-1.6585666949761726
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
PLC/PRF/5,148198,-2.947936464140587
A-375,135398744,6.486116496095493
BICR 6,6505803,-0.317492661903071
ChaGo-K-1,44493528,4.285653924871417
OCI-M1,JQ-1-carboplatin (1-1 mol-mol),0.7435952415619963
Caov-3,6610216,4.139176998976753
Hep 3B2.1-7,439501,-1.9738642324779276
NCI-H2405,159324,2.074483405739434
TE-5,36462,0.7154443377977948
MOTN-1,3689413,-2.530735206047899
HCC827,36462,2.605539354003478
NCI-H727,24180125,3.0565666249941015
CAS-1,9936388,1.0698428320732736
PL-21,148198,-2.77177529672749
TM-31,3689413,-2.3957166593643104
Granta-519,6610216,4.381057854502396
COV434,26596,-1.4572205446145876
SW1990,9903786,3.346032701157222
NCI-H929,49836020,2.30560189930029
NCI-H2171,3689413,-2.7117222930063867
HPAC,54618164,3.204433172015927
SNU-216,148198,-4.857755213358989
IGROV-1,5460769,1.6083174601829917
OAW28,5460769,4.044755256654475
NCO2,107985,-5.5165771909272046
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
Rh30,9936388,1.7390836835977532
SK-N-SH,JQ-1-carboplatin (1-1 mol-mol),2.4267481661369734
SK-N-SH,26596,-3.7665654883669664
TM-31,12003241,-1.3961411648113156
BT 248,54618164,4.1848059637542585
NCI-H1869,439501,-1.575584272947446
Sq-1,135875424,4.0365326385362055
ECC10,JQ-1-carboplatin (1-1 mol-mol),0.0523843610498873
MSTO-211H,10296883,3.6762481855456985
KMS-12-BM,409805,3.008136654369979
CAL-54,9927531,5.326263652959217
HCC44,26596,-2.4855427767458735
EN,24180125,3.337760459599765
BT 159,3689413,0.7549791540054046
MOLT-3,9927531,3.2112573350362372
KMRC-20,3689413,-2.0293333018936877
BT 216,6610216,3.705448664684853
HEC-50B,439501,-2.0612919893622084
NCI-H747,46943432,3.1532320742185553
PK-45H,11485656,3.836496845860948
Calu-3,11485656,1.9769247449011944
A-253,49836020,4.493346426084629
ZR-75-30,10296883,3.903831871588827
SNU-213,159324,3.5982392765945344
KP-4,26596,-2.006035898797214
HCC1500,9903786,4.21203406645071
HGC-27,44491742,3.7914350891371114
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
DK-MG,409805,3.8694402600406206
SNU-620,24180125,2.1071422943866405
Karpas-299,selumetinib-GDC-0941 (4-1 mol-mol),2.273668184734746
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
RMG-I,JQ-1-carboplatin (1-1 mol-mol),2.4287881260338584
BT 482,135423438,1.5025223732344029
CAL-78,JQ-1-carboplatin (1-1 mol-mol),0.9735097666189562
Mono-Mac-1,159324,1.4923395471491
RKO,12003241,-0.2410566552434749
T3M-10,12003241,-1.1759997048612671
MDA-MB-468,44491742,4.175044772115959
U-251MG,3689413,0.7299892089467567
DB,135423438,1.7960303918163716
KNS-60,409805,3.248100992650401
Panc 10.05,409805,4.8204171361213906
HL-60,3689413,0.2723590351268871
GP2d,54618164,4.277742817183889
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
NCI-H1734,159324,1.6131666092145154
NCI-H1563,135875424,2.353629734666018
SNU-61,8515,5.6731171982359365
Ci-1,148198,-4.220925638162102
TE-6,selumetinib-GDC-0941 (4-1 mol-mol),3.56930262529698
Calu-3,26596,0.6204289833771246
Mono-Mac-1,36462,0.1065012305215149
A-375,10296883,4.364928139092641
KNS-62,6505803,0.1679251813007588
NCI-H838,selumetinib-GDC-0941 (4-1 mol-mol),1.9940738428957552
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
5637,36462,0.8736544346483371
ONS-76,5460769,1.8809234095271896
HCC15,9927531,3.758901572486559
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
RERF-LC-Ad2,10296883,4.240676300513298
L-363,159324,3.0592398872090123
DEL,439501,-2.407341543091591
CAL-62,JQ-1-carboplatin (1-1 mol-mol),1.017398941700892
HLF,6505803,-1.0701085003041886
HPB-ALL,selumetinib-GDC-0941 (4-1 mol-mol),3.2361225802608593
MDA-MB-231,6505803,0.6630652134402967
U-937,439501,-2.545607636797326
P12-Ichikawa,135875424,3.359554329425199
MHH-CALL-3,44491742,4.228181381617403
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
SK-N-DZ,148198,-7.727965978529101
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
HEC-1-A,54618164,4.25244148271506
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
NCI-H838,44491742,4.734730430776703
HuP-T3,6610216,4.722811341582641
HSC-3,159324,3.228445723809223
COR-L47,9936388,-7.709676320407029
KMH-2,6505803,-1.1271558599433815
SU-DHL-10,3689413,-0.1067642786236739
NCI-H526,9903786,2.628275304590264
NCI-H1694,10296883,3.5236508455835116
COLO 684,44491742,3.593536773011693
DMS 79,24180125,1.5282453938940843
HSC-4,44491742,4.173988284907792
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
NCI-H1435,3689413,0.9860334604053864
KMS-26,159324,-4.353423626038214
NCI-H2405,6610216,4.7475909326553705
639V,selumetinib-GDC-0941 (4-1 mol-mol),4.596668684568556
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
EB1,5460769,0.545957183213574
KYM-1,11485656,2.085980626190086
GSS,11485656,1.8292349527382337
A-204,12003241,-1.8688427044932845
CAL-78,46943432,3.7521594850871822
CCK-81,5460769,-0.0536611992608542
ZR-75-30,148124,3.761125086824371
COLO 699,9936388,-4.155221111232459
COLO 668,10296883,4.05500534274126
NCI-H28,12003241,-0.6704965456124867
NCI-H661,168313200,3.81404568417466
BT 228,6610216,4.129545438534938
HuP-T4,46943432,0.958551174490495
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
Peer,9936388,-7.0845020379788375
Hs 294T,107985,-3.5780163636392768
LP-1,36462,3.92598939536504
COV362,3689413,0.2449279899544521
G-401,46943432,1.6295589064479152
DMS 53,168313200,1.6369614504907055
UM-UC-3,3689413,2.922700003558909
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
HT-1080,11485656,1.905187358604855
TE 441.T,5460769,2.227250069350157
DAN-G,148198,-3.4486802184893386
NH-6,148198,-5.967790177292145
SK-MEL-24,3689413,0.3993824056710978
ZR-75-1,107985,-2.8555700274021176
BT 179,168313200,2.3040060201960073
Hs 683,36462,2.0938427707720786
EBC-1,44491742,3.57682955784604
SCC-9,135875424,4.9754653396039314
KMS-28BM,JQ-1-carboplatin (1-1 mol-mol),-0.0604179663950409
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
SNU-1196,11485656,2.2971817788007183
RD,439501,-3.401030731559912
PLC/PRF/5,JQ-1-carboplatin (1-1 mol-mol),5.5351057973107505
Ki-JK,5460769,-2.8439091816710707
NCI-H2444,9903786,4.235157669098579
OAW42,12003241,1.2884936123543242
NCI-H1869,107985,-2.86385536497776
LC-1/sq-SF,107985,-4.128895444338486
EHEB,439501,-2.4217048608799097
LUDLU-1,168313200,3.000777530927683
NH-6,5460769,1.427769870137193
NCI-H2085,9903786,1.6610112484663062
CAL-29,9936388,1.3417151621152168
Panc 04.03,3689413,0.3957464459941977
AML-193,10296883,0.366102504312359
CAL-12T,11485656,1.8742108242710025
HEC-1-A,135875424,2.7872654410751148
NCI-H810,10296883,3.337359136658117
NCI-H747,36462,3.2601408904256757
SK-N-SH,9903786,1.912941590488841
HCC2935,36462,4.359275755872679
NCI-H2009,6610216,3.953101400309774
SK-LU-1,49836020,-1.7403396635124715
SNU-387,409805,3.771748093437339
Rh18,135875424,2.011591688646641
Reh,107985,-3.632720091318157
NU-DUL-1,26596,-3.721309412327892
CA46,6610216,4.017162804005507
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
BICR 16,9903786,3.9167102075651785
H-STS,135875424,3.212810522479317
TE 441.T,10296883,4.028933328577424
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
A-673,135875424,2.9734448822107886
SK-MEL-3,168313200,3.813993293038376
M059K,72199289,4.467934336193957
BICR 18,11485656,2.3253115987118114
HCC1419,54618164,4.916120867107994
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331
MIA PaCa-2,107985,-4.172242964909647
SNU-1079,6610216,3.35756036881602
HCC2279,26596,-1.3902688555824585
TT,148198,-1.9923096051392415
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
SK-HEP-1,6610216,4.694225049802747
AsPC-1,439501,-1.6009280184427317
SNU-1041,11485656,2.4138197522707383
DU145,107985,-2.6553199343257483
CAL-51,6610216,4.7761200098267365
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
Calu-3,3689413,-2.218147351051095
MOLP-8,46943432,-0.8980695552897974
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
SK-OV-3,107985,-2.353051363092625
BT-20,107985,-2.620430033405692
UM-UC-1,148198,-3.090298410357246
HPB-ALL,JQ-1-carboplatin (1-1 mol-mol),1.026609404352011
SF126,6610216,4.855449805426185
DMS 53,36462,1.5723952514738209
OCI-AML-3,9936388,-8.90406813186184
NCI-H441,168313200,4.136932083688696
KMS-34,54618164,2.8126038622481717
JHH-5,3689413,-2.062402723839909
A-253,135875424,3.168681324917889
Hs 852.T,159324,3.244112139278481
Hs 611.T,6610216,4.160309523547129
SNU-478,6505803,-0.3330598781077968
PE/CA-PJ49,12003241,-1.496755728928347
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
TE-8,JQ-1-carboplatin (1-1 mol-mol),3.3318874034400885
786-O,26596,-1.1841737668988108
NCI-H2286,8515,5.248584846283366
J82,10296883,4.03825923249178
IPC-298,6610216,4.490869221617785
HEC-59,439501,-0.4694388725326887
SNU-840,11485656,2.295014349130572
NCI-H1184,9903786,1.9169497440885477
SK-N-DZ,24180125,1.1528831396239576
EPLC-272H,159324,3.9545582528533982
OCI-Ly10,439501,-3.3893615276573783
BDCM,12003241,-3.7863516552935415
BT 164,11485656,1.7708908189678425
HCC1500,135875424,3.5744445956281483
22Rv1,9936388,-6.447034824270601
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
NCI-H446,selumetinib-GDC-0941 (4-1 mol-mol),2.0638797586373263
SK-LU-1,36462,1.0548894968192253
A2780,159324,-2.166969557176003
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
HD-MY-Z,24180125,4.121222391282799
HOP-92,11485656,3.011235199919159
GDM-1,6610216,3.672528817791422
SNU-216,148124,-4.152128230067924
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
HCT 15,11485656,1.8077127542489733
CAL-54,8515,3.577845304599322
ZR-75-30,44493528,5.463168492919208
MSTO-211H,9903786,1.212702371904443
IGROV-1,54618164,4.2184521751950115
SHP-77,9936388,-4.866558294975543
HH [Human lymphoma],46943432,-1.3973827152305456
IGR-39,135875424,6.243999816524794
AML-193,46943432,2.338266793436764
SBC-5,135398744,6.447254342428179
CMK,46943432,0.8826851376858325
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
KMS-26,12003241,-3.93647753580664
CAL-27,54618164,3.951252505952405
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
Toledo,9927531,3.803347409887559
SH-10-TC,36462,3.008828443008953
OVCAR-4,54618164,3.9627314558285818
EFM-192A,11485656,2.8514070088200527
HT,9903786,3.804202680432086
BICR 22,12003241,-0.4808187565312439
NCI-H747,10296883,1.2461857502958518
DB,439501,-2.823022710491889
JVM-2,6505803,-0.473368143486524
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
MDA-MB-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.5607130395634891
42-MG-BA,12003241,-1.3085155086024562
SEM,49836020,0.2207243584754971
NCI-H1299,159324,2.855064979130342
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
THP-1,3689413,0.1739337887776562
COLO 678,9927531,4.922936078042476
P3HR-1,6610216,4.758792166812945
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
SK-N-DZ,49836020,4.282357500475809
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
OPM-2,46943432,-1.735277326796896
MDA-MB-361,135423438,1.6675255620633262
NCI-H1341,44493528,3.962775176370478
HT-29,11485656,2.2620864353624786
RERF-LC-MS,11485656,1.5190166417661397
OE21,JQ-1-carboplatin (1-1 mol-mol),0.5069290847889931
ONS-76,44493528,4.396938069944904
JK-1,439501,-2.3094568759097265
HL-60,selumetinib-GDC-0941 (4-1 mol-mol),-2.2086507819126213
JeKo-1,135875424,3.073704073284497
JHH-4,44491742,4.756848275600054
CAL-78,3689413,1.0903536033822472
OVK18,159324,1.778528017414363
DU145,148198,-3.066698935751989
NCI-H520,3689413,0.9100551461140616
CAS-1,135875424,5.317066072752183
MPP 89,24180125,2.9094571122086723
NCI-H1435,135398744,6.3008870427516115
Tm87-16,107985,-4.232752042376738
KO52,9927531,4.721929704585103
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924
HT-1080,6505803,0.5678766317067223
GCT,selumetinib-GDC-0941 (4-1 mol-mol),2.439679750854635
SNU-601,168313200,3.891936151492726
SW1271,49836020,-1.4027167140646708
DU145,36462,1.0541002135373008
NCI-H2081,148198,-5.584711698479823
T3M-10,10296883,4.278304655632823
L-363,44493528,5.083298031137833
SW1710,selumetinib-GDC-0941 (4-1 mol-mol),2.8555583802472277
YKG-1,24180125,3.6126357196897496
MDA-MB-468,439501,-1.8794738155702295
OVK18,10296883,4.168587177693041
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
OCI-Ly3,26596,-3.73515804460265
SEM,12003241,-3.075217153076431
ONCO-DG-1,148198,-3.7879992500612407
MDA-MB-453,24180125,2.9500133631526477
CAL-120,36462,3.5842555256529436
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
HCC-56,6610216,4.543261999492176
UACC-812,148198,-2.7739066615342236
CJM [Human melanoma],439501,-2.3505582983790076
WM1799,439501,-0.7778279608408036
P12-Ichikawa,24180125,2.4423636001480156
MOLM-13,409805,3.504188648592109
Daoy,409805,5.985033994430834
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
P12-Ichikawa,selumetinib-GDC-0941 (4-1 mol-mol),1.616010765024319
IGR-37,11485656,2.5244768295786697
SW948,11485656,1.7814283284456571
Granta-519,54618164,3.794628352719798
HEL,3689413,-2.191477482826257
SNU-5,9903786,3.415136592873371
PK-1,439501,-1.8745947720441176
JK-1,10296883,2.2916856247126263
SNU-81,107985,-4.076050447844214
TT2609-C02,8515,4.138677313481392
NCI-H460,159324,4.0462841352482855
EN,36462,2.8431128539945414
Hs 578T,148124,-8.012392121848073
NUGC-3,107985,-4.895591423275197
BT 333,24180125,2.910102236403659
MOLT-3,44491742,3.801093183463652
ST486,135398744,6.173673764709001
OVSAHO,6610216,4.836498712368914
T84,36462,3.2461268076235283
LS123,24180125,2.6195509654232665
5637,9936388,-5.346129703335208
GP2d,JQ-1-carboplatin (1-1 mol-mol),1.3751792778879013
SNG-M,6505803,0.0045720591705094
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
RD,107985,-3.493701313545662
A-375,409805,5.425302340535218
P12-Ichikawa,439501,-2.449202945881867
TC-71,3689413,0.4216372127873143
SNU-16,107985,-5.277922842237505
SUP-M2,409805,3.348024044810787
G-402,168313200,3.4717706784897224
TOV-21G,107985,-3.920988354702577
UM-UC-1,3689413,0.3078714826369425
BT 498,439501,-2.816531814980934
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
PSN1,JQ-1-carboplatin (1-1 mol-mol),4.6221791431053845
PC-3,10296883,5.2902434892598365
Hs 729.T,148198,-2.5851950903835834
IGROV-1,36462,2.313632721410001
KMS-27,11485656,2.096815262793708
SK-N-BE(2),26596,-1.6881701599106194
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
HSC-4,159324,3.192829599869501
MOR/CPR,148198,-2.5838099224586
SW1990,44491742,4.13198674266079
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
Capan-1,168313200,2.9993325450618022
NCI-H322,3689413,3.1405279208224086
LC-1/sq-SF,11485656,2.9810268276277267
BICR 31,168313200,4.293337148285007
HuNS1,439501,-3.2381997907918447
Hs 936.T,9936388,-4.507745146359587
Detroit 562,9903786,2.622976915424344
Hs 822.T,24180125,2.973161880999435
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
KP-3,6610216,4.430226203729176
BICR 22,36462,0.4717839486114671
Karpas-620,selumetinib-GDC-0941 (4-1 mol-mol),4.598341067647778
HCC38,148124,-4.841006043756389
NCI-H209,9927531,3.5477571143466156
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
Hs 944.T,11485656,2.842031194485269
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
NCI-H146,36462,-0.9223549938225544
Hs 578T,26596,-0.9561374383661984
OCI-Ly19,9927531,5.466722325400782
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
HMCB,6505803,-1.40903466994972
MKN74,6610216,4.33380428824605
JK-1,12003241,-7.790720782549377
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
MHH-ES-1,3689413,-2.44734032949193
RCC10RGB,135423438,4.4299924289236055
SK-LU-1,6505803,-1.477995420791017
BT 328,9936388,2.1535847087745386
KNS-42,44493528,4.291598351645838
U266B1,36462,0.6350126648002399
Mel JuSo,selumetinib-GDC-0941 (4-1 mol-mol),1.489805359284141
NCI-H446,9903786,1.878824600883621
HuH-28,159324,2.8746957838350062
HT-29,36462,3.3861916836102983
NCI-H1703,9903786,2.5255687748265903
NCI-H1092,148124,4.484868615111272
L-363,6505803,-2.0442344992040837
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
SUP-M2,135423438,1.6419066239176594
BT 482,9936388,1.0428737774764048
L3.3,159324,3.32597872906173
NCI-H2085,168313200,2.9031279315038954
BT 224,135398744,6.495060752655371
HEC-251,409805,6.031835667467917
LNCaP clone FGC,44491742,3.7255423914895776
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
Caov-3,JQ-1-carboplatin (1-1 mol-mol),0.7058210563631089
MOLP-8,409805,3.552664043240888
VMRC-RCW,54618164,4.1951410650073235
SF268,11485656,2.1720991191644994
KYSE-30,148198,-4.331453900167214
LN-18,5460769,0.9939611818756712
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
BT 131,9927531,5.2651806903181235
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
HEY A8,6505803,-1.5335181028470497
MES-SA,6610216,4.191241749527869
SiMa,selumetinib-GDC-0941 (4-1 mol-mol),0.1893088365447134
RERF-LC-Ad2,6505803,1.9541445598040723
Hs 611.T,148198,-3.7604102025742345
RMG-I,9903786,4.466562574504816
CAL-85-1,46943432,3.269339830266358
MHH-ES-1,409805,3.617894256902542
M-07e,6505803,0.1015429750426806
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978
SK-HEP-1,3689413,-2.4602386660304143
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
HMCB,36462,1.7096647665785494
U-BLC1,9927531,5.132450103816796
DEL,JQ-1-carboplatin (1-1 mol-mol),1.3960837973555382
DK-MG,44493528,4.356107772315373
RL,107985,-3.9156198451425857
KYM-1,6505803,-2.3943028473817005
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
SK-LMS-1,54618164,4.255927554001473
NCI-H747,3689413,-2.2954703648292605
SNU-840,148198,-2.353488885952442
BCP-1,46943432,1.2230336269713535
PF-382,9927531,5.462558018035092
JHUEM-3,6505803,0.6198707712073951
HCC827,selumetinib-GDC-0941 (4-1 mol-mol),0.5704009597174646
G-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.129609857983409
Hs 888.Lu,12003241,-2.029150250693523
OCI-Ly19,6505803,0.7102258486981511
SW1088,5460769,2.7590684048589025
CAL-27,24180125,2.5723395665723285
SNU-407,107985,-4.40126942216499
Li-7,26596,-1.7379173085827686
RVH-421,26596,1.0810327973270226
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
MKN1,148198,-2.187340578141158
MPP 89,148124,-4.406901923278282
OAW42,9927531,5.261343543721406
KMH-2,73707440,5.915660341573708
NCI-H2291,107985,-3.367463815189516
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
MFE-296,409805,5.9865001584823405
Daudi,44491742,3.5549145676591314
WT2-iPS,9903786,4.00311264543886
JVM-3,JQ-1-carboplatin (1-1 mol-mol),-1.4584140934293672
Panc 05.04,9903786,4.601199939689659
DV-90,49836020,4.269422045712615
DND-41,5460769,0.7297318325246287
MDA-MB-453,439501,-3.002845657836036
HT-1376,54618164,4.43635672332215
K-562,49836020,4.414855158615189
DOV13,44493528,4.286577642766648
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
VM-CUB-1,9936388,-1.2208910173981742
KMS-18,46943432,0.7335709559336779
JJN-3,3689413,0.1640237934246712
PE/CA-PJ49,54618164,4.029217614638186
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
BT 271,10296883,4.284017476819925
BT 271,6505803,-3.278165748164475
HT-1376,409805,6.134546024517547
IGR-1,107985,-3.302323947887529
HCC1954,409805,3.5221605615273095
TALL-1 [Human adult T-ALL],24180125,1.9711647389605609
TE-15,49836020,0.684840592082847
CCK-81,168313200,3.592391454207574
UACC-62,9927531,5.07743176976165
Li-7,36462,1.2712954059342498
HT-55,JQ-1-carboplatin (1-1 mol-mol),3.678098211673295
WSU-DLCL2,46943432,0.1082975695214752
Panc 08.13,24180125,3.7393311414493944
HOP-92,107985,-1.5945194541124064
MOLT-16,9903786,1.2441798518109255
MDST8,11485656,2.867381561993162
KG-1-C,135875424,3.0761511771820573
VMRC-RCW,JQ-1-carboplatin (1-1 mol-mol),1.9272630806826467
SNU-216,135875424,3.0610068784934885
LS513,26596,-1.0957721063054122
JHOM-1,3689413,0.7537035675764964
DB,46943432,1.5920279886281368
F-36P,12003241,-0.4333234421592413
769-P,9936388,1.480470549487973
LoVo,8515,2.0502092932288543
NCI-H1581,11485656,1.8332307875240343
PSN1,135423438,3.9890178070104927
CAL-12T,9903786,2.474655504914218
BT-12,135398744,6.373256605371206
HT-144,135423438,3.7063212476270144
SNU-1105,9936388,-0.2458072651641521
Hs 729.T,148124,-4.36637329405652
OAW28,12003241,-0.542287488877267
NCI-H1734,9936388,-4.869160721724045
SH-10-TC,11485656,3.549629960388959
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
SF126,6505803,1.4927738710676783
OAW42,24180125,3.18113812065638
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
THP-1,409805,3.587964257219881
GOS-3,3689413,-2.185831490776692
SF126,9903786,3.79320485000813
HEC-251,439501,-2.223367930628925
ESS-1,409805,3.6702401515474135
BICR 18,44491742,4.057400353675569
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
JHH-4,12003241,-1.7562385090138668
NCI-H2029,8515,4.558047697955578
HuH-1,selumetinib-GDC-0941 (4-1 mol-mol),1.7373904451201925
P31/FUJ,36462,-0.6599401629031103
SK-N-DZ,9903786,2.0344840639265787
SCC-4,439501,-2.9533139403217397
YD-10B,409805,3.5619928536153775
PL-21,6610216,4.06640166284154
EJM,10296883,2.9448984253361057
NCI-H1703,10296883,3.9122809054247054
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
Tm87-16,409805,3.644885872826904
BT 504,8515,3.6274381992503786
HCT 8,11485656,2.552597628159539
NUGC-4,6610216,4.097960293460252
NCI-H23,6505803,-3.94863940408712
SK-LMS-1,5460769,5.744937264039862
SH-10-TC,26596,-1.1215294696679303
Daoy,54618164,4.1710348513042
SW579,JQ-1-carboplatin (1-1 mol-mol),2.4764812172650905
RPMI-8402,11485656,1.7497353972694758
NCI-H522,409805,3.737006742854017
HCC78,6505803,3.403944957250862
8505C,11485656,2.524843425328081
OCUM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2423134599079573
OVK18,9936388,-8.646346484628276
TE-5,135423438,3.0033799425211405
AGS,5460769,2.317513443937506
DMS 454,36462,2.270934530908605
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
NCI-H23,46943432,1.7147765418067102
DU4475,JQ-1-carboplatin (1-1 mol-mol),0.3822189062446061
COR-L88,JQ-1-carboplatin (1-1 mol-mol),1.7692891259412051
NCI-H292,9927531,4.942242070848643
HCC1569,JQ-1-carboplatin (1-1 mol-mol),1.570304655964314
AN3-CA,11485656,-0.8274044857319752
NCI-H1105,8515,4.559359227152753
BICR 56,3689413,1.5922116280396923
RKN,159324,4.081844329649501
MHH-CALL-4,159324,2.2712057532386254
WM983B,9936388,-0.2926482048121987
G-292 clone A141B1,8515,4.326693177509201
HDLM-2,135875424,3.7112298908511017
KCL-22,73707440,5.760609737483316
PaTu 8988s,168313200,2.2085646036836786
NCI-H1395,44493528,4.373197971838804
MFE-296,11485656,2.443705584915375
OS-RC-2,107985,-2.111710402162911
J82,12003241,-0.1407716325694316
KE-37,8515,3.0439645130974906
NCI-H1435,135875424,4.380789148010153
HH [Human lymphoma],148124,-7.407928701983839
KP-4,3689413,-2.736369445880075
NCI-H2228,6610216,4.4838321019833
RPMI-8402,6505803,1.0273996849455458
OVSAHO,135875424,4.354044130900052
PaTu 8988s,107985,-3.719022802572999
G-292 clone A141B1,135398744,6.65861915049708
NCI-H1435,5460769,2.24942337838163
NCI-H2106,135875424,3.1880464092319105
HDQ-P1,11485656,2.7842616734423116
J82,439501,-1.5072353700594
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
SKM-1,168313200,4.186901063511942
SEM,107985,-4.245084684067336
NUGC-3,135875424,3.4631977650642396
MIA PaCa-2,12003241,-0.7993036743010778
KMS-11,6610216,3.796053268478964
ECC12,9936388,-4.873950021290679
Panc 02.03,409805,5.9877775932277615
RVH-421,409805,3.9378453682817858
BT 131,168313200,1.7184330352004986
JHH-1,44491742,4.550943997135646
VMRC-RCZ,439501,0.1982663120150432
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
HLF,12003241,-1.5273612308967348
KE-39,135875424,3.891762591841876
COLO 668,148198,-4.3418041773017135
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
DV-90,44491742,3.389036842154366
TE-15,409805,5.7286558076606955
MOLP-8,9903786,1.299688823902182
Kasumi-1,135423438,-3.561696471128374
NCI-H1573,9903786,2.787588976876453
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
SJSA-1,10296883,3.777259880045869
U-87MG ATCC,135875424,4.458869499205082
NCI-H1975,9903786,1.3990648437170825
MJ,107985,-2.8858164405295015
HCT 15,107985,-3.3789999307881344
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
NCI-H2029,9927531,4.454841105841318
CAL-62,24180125,3.2577032157820547
SW1116,JQ-1-carboplatin (1-1 mol-mol),-0.0144510957041741
OE33,11485656,2.057023759496841
IA-LM,36462,3.5803800151684384
CAL-54,36462,1.7881475166292906
HSC-2,12003241,-2.7433654243875214
BT 164,168313200,1.8126035324544545
KATO III,9927531,6.301212923475331
Daoy,5460769,2.932419907525853
COLO 668,9927531,4.694789725560254
EB1,6610216,3.5568648182048523
Karpas-299,107985,-4.724970996204854
MDA-MB-157,107985,-3.8805729202788304
DAN-G,11485656,1.7552086859966678
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
TE-6,6610216,4.258406467182382
Hs 294T,9927531,5.24007707651297
SK-LMS-1,26596,1.8216060443410544
786-O,439501,-3.5974319595711832
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
Hs 888.Lu,54618164,4.594107940900578
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
AN3-CA,3689413,0.1719288482065274
MOTN-1,9927531,4.434768269129304
DOV13,409805,5.824694231108339
SH-10-TC,148124,-4.410168498577838
MKN1,135875424,4.434731625885322
HCC1438,9936388,-5.250044991536538
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
JHOC-5,9936388,2.2786503857706593
HDLM-2,439501,-2.3355243460723747
DEL,3689413,-2.5284347391762583
CHP-212,6610216,3.760481483683652
MHH-CALL-3,135398744,6.205129646453742
NCI-H1755,JQ-1-carboplatin (1-1 mol-mol),0.9057830308904904
SF268,107985,-3.4740427748665073
SUP-T11,54618164,3.811166364183871
CAL-12T,159324,3.872891724538248
ONS-76,54618164,4.167815792355048
HEY A8,36462,2.5086693619029448
NUGC-4,9927531,4.1074548867853045
NCI-H838,54618164,4.282467198837469
LS180,26596,-1.3053249122689552
OPM-2,148124,-6.3849256320012575
LNCaP clone FGC,36462,0.9338803006106506
PaTu 8988t,6610216,5.064895456595333
SK-N-BE(2),135875424,2.863964710968437
MDA-MB-435S,11485656,2.972471846280711
NCI-H2122,168313200,3.523081981483709
NCI-H1395,6610216,4.652818435628847
SK-MES-1,135875424,4.094460625120135
SNU-1105,54618164,4.383989798122411
HCC1833,107985,-3.0980572813804352
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
DMS 273,10296883,4.130929131041443
SUP-T11,107985,-3.2197393672196477
Ku812,8515,2.860455557749638
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
PLC/PRF/5,36462,0.8167490272691379
Panc 03.27,5460769,1.9093660486325057
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987
Hs 611.T,5460769,0.2348324565646969
Granta-519,10296883,3.749738066673353
NCI-H1373,409805,5.070955449061009
L-540,6610216,3.6364714067937265
OCI-Ly10,409805,3.0484077961681773
OPM-2,8515,3.0418796641091226
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
Mel JuSo,11485656,2.451512427332153
SR,10296883,3.1802245137675533
MES-SA,9927531,4.955649444081026
BT 440,6505803,-2.620705612839711
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
EN,10296883,4.0657206853664345
BT 440,44491742,6.048012757107985
HCT 8,135875424,4.984268823368111
Granta-519,46943432,2.0409318821812477
NCI-H727,107985,-2.9799734550318204
TOV-21G,54618164,4.2128283407896685
Hs 683,135875424,4.08610069423659
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
GMS-10,36462,2.852515511149566
NCI-H1792,12003241,-0.2343490439085071
AN3-CA,12003241,-2.637522524679412
KMS-18,159324,2.2676031232884375
SCaBER,11485656,1.7418324422308689
NB4,9903786,1.7786072365174606
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
LNCaP clone FGC,9903786,4.486079979714403
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
TT,409805,5.07026702775905
ESS-1,107985,-4.436359650155883
SKM-1,9936388,-5.746280121163761
Hs 852.T,26596,-1.3645726938327003
NCI-H650,26596,-0.9939630725117288
OC 314,44491742,4.454392522958538
HT115,3689413,1.0252939168322983
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
YD-38,409805,3.7875636051814663
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
DMS 53,148198,-4.7992801457563665
NCI-H2196,168313200,1.6514605130076123
DoHH2,26596,-2.141975510207564
HOP-92,9927531,4.8467416959319625
SW1417,409805,5.014574040660532
HCC4006,12003241,-2.6394477245029355
HCC1419,135875424,4.5952897384359215
Panc 10.05,selumetinib-GDC-0941 (4-1 mol-mol),-0.0838909853180393
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
IPC-298,409805,5.061629156209871
NCI-H841,5460769,2.2001101436907984
MCF-7,9927531,5.854182634805009
SNU-119,9903786,3.393165032525661
EFE-184,11485656,3.681714040860518
SNU-1079,409805,6.036263178854899
JHOC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1101820766966832
DMS 273,44491742,3.7307306463602545
A2780,168313200,1.7543183926879495
SNU-899,6610216,4.41972312079981
AsPC-1,12003241,0.1897400127907629
OVSAHO,439501,-1.6237946984233838
BT-549,5460769,6.35928800843138
IMR-32,46943432,1.660440908421779
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
NCI-H1299,6505803,-0.2534280947368875
SNU-878,12003241,-0.6657900217683382
FTC-238,26596,-1.757502878688391
A-172,148198,-5.088269215681032
BT-16,11485656,2.0917795824799787
CHP-126,36462,0.1971543123326329
JHH-4,409805,6.082410201762188
SEM,409805,3.7048315559445575
DoHH2,439501,-2.792554896141067
SNU-1076,135875424,4.991306630113997
EPLC-272H,54618164,4.238029382952188
QGP-1,12003241,-0.3742156649429844
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
YD-10B,8515,0.95278205640322
Becker,26596,-2.013233579681989
SK-MEL-30,36462,3.2992643549134932
HuH-28,12003241,-1.746609784805712
NH-6,439501,-1.820365577971014
HOP-92,6610216,3.934588345083168
OCI-AML-5,135423438,1.842047430976123
MKN1,135423438,3.025317436009671
KYSE-410,6610216,4.091315961018864
HCC44,11485656,1.7726273089694435
SUP-HD1,49836020,4.390823916389519
BT 286,36462,-0.1751673749960541
TT,54618164,4.051891315692752
NCI-H2342,6505803,3.6269686653214497
HCC1171,3689413,-1.743559773321706
JHUEM-2,11485656,1.361181565006939
SK-CO-1,26596,-2.200264316257102
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
RT-4,148198,-0.8360848986797086
42-MG-BA,11485656,2.199214577741701
OV56,11485656,3.4702075496289018
MHH-CALL-3,439501,-2.5206189278952325
SU.86.86,36462,3.59253947895057
YD-10B,9927531,6.486218545334236
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
NCI-H929,9927531,5.740923779315927
NCI-H520,6610216,3.9954490147026647
MOLT-3,135875424,2.964820433196679
NCI-H650,selumetinib-GDC-0941 (4-1 mol-mol),1.2489714260088474
KE-39,11485656,2.227722528153515
SU-DHL-1,9936388,0.846879508636978
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
HGC-27,12003241,-2.439316929165163
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
LS180,439501,-1.9142457865624176
PSN1,24180125,3.947786415385254
SIG-M5,54618164,3.803874177030029
NCI-H2030,11485656,2.3036086259885526
Rh41,6505803,-0.6098068443145847
A-253,selumetinib-GDC-0941 (4-1 mol-mol),2.2204781544732284
CL-11,selumetinib-GDC-0941 (4-1 mol-mol),-0.9577137132947868
SNU-245,439501,-2.452660264273032
CMK,12003241,0.0052049395185332
NCI-H1793,3689413,2.3725709733273663
BT 498,6610216,4.077552585304459
HuH-6,409805,3.23994143121387
Tm87-16,148198,-4.741899128420961
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
SYO-1,6505803,-0.5697677300157696
HuG1-N,409805,3.876200248719346
WM115,9927531,5.125567810288171
C2BBe1,148124,1.383831912212665
NCI-H2444,3689413,-2.223418972852252
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
TE-1,44493528,5.0979019635900364
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
BT 440,54618164,4.177836021580234
TUHR4TKB,11485656,2.4946743864247467
8505C,3689413,-3.9181742012691143
SW579,148124,-6.414916163554543
42-MG-BA,9936388,2.1836082954328644
CAL-62,409805,3.837587991386787
TTC-709,11485656,2.1468859036039327
Ci-1,10296883,4.053173965998694
DEL,44493528,3.9686709959238833
LoVo,36462,0.97058855741136
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
SW948,409805,5.995103866916248
HCT 8,148198,-5.465944443336747
HuH-1,409805,5.845530039707077
TYK-nu,36462,1.613744136173373
UACC-812,9936388,-5.022392750910281
TE-5,selumetinib-GDC-0941 (4-1 mol-mol),0.92004648470689
NCI-H2106,JQ-1-carboplatin (1-1 mol-mol),3.821123323467481
KYSE-520,148124,0.6862121689494067
A-549,12003241,-1.903076073453771
NCI-H1395,9936388,2.8582059793440964
SNU-685,107985,-3.2050759373927953
Kasumi-2,49836020,6.151495097204233
MOTN-1,439501,-3.3199671011375913
JHOM-1,11485656,1.6870772577759805
FTC-238,JQ-1-carboplatin (1-1 mol-mol),3.2551841017728083
SNU-738,36462,3.2633116796246715
YKG-1,8515,4.7576372381485
L-540,54618164,3.5943387572444827
HEL,5460769,3.63888115942649
IPC-298,159324,2.329841695256939
OCI-AML-3,3689413,-2.4390268193517275
RERF-LC-A1,24180125,3.739716378366165
HCC44,24180125,3.500627575266525
HEC-1-A,168313200,1.7559556787527029
SYO-1,49836020,4.445841076102608
THP-1,107985,-4.6582793969870755
BICR 56,9903786,4.170821075739504
HCC1419,409805,4.912297202709663
MHH-CALL-4,11485656,2.372182753461333
NCI-H1869,10296883,4.447785026459559
BEN,11485656,2.522824701097711
Hs 895.T,135875424,4.928152538117819
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
SNU-685,12003241,-1.0976198055590074
COLO 829,10296883,3.971671939086983
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
NCI-H1341,168313200,1.5932831010867334
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
SUP-T1,135875424,3.316622158258836
MOLP-2,409805,3.4926626149278026
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
T24,12003241,-0.6434481559725229
NCI-H2110,12003241,-0.2811614102315782
GSS,54618164,3.355805594093071
HEC-59,9936388,2.590780507756847
MOTN-1,409805,3.656377954751396
OCI-AML-5,26596,-1.736130608355082
BICR 22,49836020,2.6142262300183305
L-428,5460769,3.644532278593977
SNU-685,6505803,1.7815345104431104
LOU-NH91,6610216,4.701575628194421
BT 428,12003241,-1.1639537703903158
OCI-AML-3,135875424,2.9827106176181735
PK-45H,12003241,-0.6609061403409452
Peer,54618164,2.8451441287771084
KE-39,168313200,1.6918255094583214
CAL-54,409805,5.955024791707747
NUGC-3,54618164,3.5634318473860658
Hs 746.T,12003241,0.0057336203254279
RPMI-6666,168313200,3.881794248847984
KYSE-410,439501,-2.4284024166032365
769-P,selumetinib-GDC-0941 (4-1 mol-mol),2.2458256114397788
C2BBe1,49836020,4.36863555932656
CGTH-W-1,JQ-1-carboplatin (1-1 mol-mol),2.382639318925406
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
SNU-503,9927531,6.946018069076572
NCI-H1105,148198,-5.386518056256114
OCUM-1,49836020,-0.6781383792077297
UO-31,6610216,3.3028377500780235
FTC-133,5460769,4.281031552964228
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
DMS 79,54618164,3.1024825189466005
T3M-10,11485656,3.630524872417795
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
TE-15,168313200,2.769784502897391
NCI-H1435,24180125,2.7176040628753357
LP-1,439501,-3.639573627473922
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
LS513,135875424,4.138794062430469
SK-MEL-31,9936388,2.306732151838548
IMR-32,36462,-1.733502190713641
MOLT-16,11485656,1.9305016234574737
IM95,54618164,3.6786593466115063
SNU-407,JQ-1-carboplatin (1-1 mol-mol),0.2520834241289693
F-36P,168313200,3.2109752739746886
TT2609-C02,9927531,6.514577910597335
Kasumi-1,26596,-2.5055411121240705
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
NCI-H647,JQ-1-carboplatin (1-1 mol-mol),2.369977920664563
KMS-34,44493528,3.6227585741611
NCI-H2196,24180125,2.6408442695810925
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
NB1,JQ-1-carboplatin (1-1 mol-mol),2.7630745664593426
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
SNU-1079,12003241,-2.81102043929997
SK-BR-3,JQ-1-carboplatin (1-1 mol-mol),3.127240758828175
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
GCT,6505803,2.0457782939841667
OCI-Ly19,10296883,3.222057904422062
GCT,9927531,4.599543435598106
RVH-421,148124,3.535615476070291
LCLC-103H,409805,5.797514940413998
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
SHP-77,selumetinib-GDC-0941 (4-1 mol-mol),3.697439866327475
Caki-2,409805,6.325494049989893
KNS-42,9936388,1.888318570516148
A101D,439501,-0.9695989482214274
A-498,3689413,-0.327867250415736
IGROV-1,46943432,4.105714883822214
CAMA-1,3689413,0.0263776901636627
CJM [Human melanoma],11485656,2.6899904123540037
SET-2,135875424,3.0388135878797833
DMS 454,12003241,-0.401739549188604
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
HT-144,9936388,0.7271233653710654
SNU-201,54618164,6.248621486824713
Granta-519,439501,-6.00499370561019
HSC-2,8515,3.770008719257322
OE21,409805,3.7550255149690943
Jurkat,selumetinib-GDC-0941 (4-1 mol-mol),2.512422287113006
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
KMS-18,135875424,3.1558215727233208
CAL-62,12003241,-1.1507806931187785
NCI-H1694,6505803,0.2523164939163045
PC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.4972652387658174
786-O,12003241,0.5866804436375384
JK-1,46943432,0.8611878663113326
NCI-H1105,9936388,-6.252003030821692
BT 172,9903786,4.891040343072455
SK-MES-1,148124,-3.591423335334301
Mino,12003241,-3.278689335869641
HT-144,6505803,-0.5901763284760635
SK-MEL-3,6505803,3.3435678878510817
HEC-1-A,9903786,5.533982095458378
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
SK-N-FI,6505803,0.5825551569342805
U-87MG ATCC,11485656,3.26618514793835
OVTOKO,54618164,4.681056230171988
Tm87-16,168313200,3.0949876712428224
Pfeiffer,selumetinib-GDC-0941 (4-1 mol-mol),-0.3312571594037772
HCC44,409805,3.740964566470102
G-401,409805,3.720272745750916
GSS,24180125,2.5429718088865503
LN-18,6505803,-2.139737100228386
EFO-21,selumetinib-GDC-0941 (4-1 mol-mol),2.070102563498296
HSC-3,6505803,-2.979370598270903
MM1.S,6610216,4.132453161575956
ECC12,6610216,4.8480732818751395
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
MG-63,6610216,5.0810751878936165
HT-144,148124,3.5563459138511595
CW-2,9927531,5.678325078717316
BT 187,6505803,-2.6159963341734613
COR-L51,3689413,-2.4511139859333526
Hs 895.T,54618164,6.120763798597076
BT 224,439501,-1.0305399865987015
KMS-11,46943432,0.5072871565715428
EHEB,159324,2.208250970812642
MKN7,9903786,5.918197098229428
COLO 320,9936388,-1.5439590773342686
ONCO-DG-1,9936388,-5.057642902396516
HCC78,36462,0.8922368228413601
SK-N-FI,26596,-3.6176410664455374
CCK-81,9903786,2.4008516567284848
SNU-423,148198,-4.2261536044419765
HCC366,6505803,3.392526655908561
MCAS,107985,-3.860765706660282
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
WT2-iPS,135423438,3.753455715800744
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
Hs 944.T,JQ-1-carboplatin (1-1 mol-mol),2.5361847784795715
KYSE-450,9936388,-0.9236320595886032
SF126,selumetinib-GDC-0941 (4-1 mol-mol),2.749668996319385
2004,11485656,0.272935055916473
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
HOS,26596,0.4724890056436647
TM-31,44491742,6.007028920174117
A4/Fukuda,148124,-6.6912736941139865
HCC366,6610216,4.78977524933946
Mel JuSo,12003241,-0.8749256028494242
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
AML-193,6610216,3.825540267355674
SU.86.86,107985,-3.2399662487956875
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577
KU-19-19,9936388,2.972521935644637
DU4475,168313200,1.634598375119855
Mono-Mac-1,10296883,2.780550097818586
HCC1395,26596,-1.834868374404667
EFO-27,135423438,3.7049046399150134
NCI-H2196,5460769,6.02637664184288
T98G,6610216,4.441401687083466
IGROV-1,8515,2.1861539315976053
BT 216,409805,5.658617795151575
Rh18,9903786,2.6471801174141625
P3HR-1,24180125,2.923923284516129
SNU-1066,12003241,-0.4993915951512702
IPC-298,5460769,5.755627361996784
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
DV-90,24180125,3.321191195126123
NCI-H2228,54618164,4.114234543064267
YD-8,6505803,-0.4521993512764767
COR-L51,10296883,3.6257769468740166
A2780,26596,-4.32263985415392
GaMG,26596,-1.3647461579215698
WT2-iPS,8515,4.500386586039305
COLO 699,107985,-3.919459078432389
DU4475,11485656,1.359840937957691
HEC-6,3689413,-0.7278233112149324
Ci-1,12003241,-0.8991759784993727
SK-MEL-5,54618164,3.941567949618183
SK-MEL-3,148124,3.772454869250104
SK-UT-1,9903786,5.78516391020833
SNU-878,9927531,4.662529833906493
L-540,6505803,-0.3168506234020811
HLF,3689413,-1.4235179966835771
GP2d,3689413,0.2049378471192219
BICR 6,10296883,4.111164180583034
KYO-1,44491742,4.154466430935869
HuP-T3,10296883,4.266239948990751
BT-549,107985,-4.157404914346088
HuH-6,11485656,2.2399247025675084
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
AGS,3689413,2.90749290772993
TYK-nu,439501,-2.468535707905716
RL,3689413,-2.4285945149334185
MHH-ES-1,49836020,5.438630069429388
Granta-519,135875424,2.983761714085865
ChaGo-K-1,439501,-4.217436880778372
IA-LM,6610216,4.173583896241699
MOR/CPR,selumetinib-GDC-0941 (4-1 mol-mol),2.600932232406458
TE 441.T,6610216,4.146097180963395
NCI-H1693,26596,0.3286565515580511
A-204,135423438,-4.574115498517721
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
Li-7,409805,6.263511622178945
NCI-H2081,36462,-1.2215520528836945
NCI-H508,8515,4.121757487402849
Hs 688(A).T,12003241,-0.4220829795676687
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
MKN74,439501,-1.7547166912858625
LN-18,3689413,-0.4753252169993508
C2BBe1,9903786,1.7742124050197758
NCI-H322,24180125,3.2183123555478703
NCI-H1650,159324,3.40496590407731
LS411N,36462,3.380504085081747
EoL-1,46943432,-1.6312084333642909
CA46,8515,3.648186715161825
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
NCI-H1339,107985,-2.3926548683095885
TALL-1 [Human adult T-ALL],107985,-3.66791594276573
NCI-H1869,6610216,4.465976467686126
NCI-H520,148198,-5.585206831860286
NCI-H1155,9903786,2.7353298872083984
SNU-216,44491742,4.347867819055225
SJSA-1,11485656,2.5808954348958797
LS513,9927531,6.189167828595346
NCI-H1734,46943432,1.3526453499379931
HL-60,439501,-2.5264411138407836
GI-1,44491742,3.8147677768435497
NCI-H28,9903786,3.2913179081195776
LXF 289,54618164,3.0378434141224617
BT 340,6505803,0.8782913115261707
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
NCI-H1623,107985,-2.7226564689550488
COLO 699,9903786,3.444453349709646
HCT 116,3689413,3.301731662910047
BICR 18,148198,-1.2308146568318987
Hs 688(A).T,439501,-2.959985011333181
EHEB,107985,-3.431566617096362
NCI-H1694,selumetinib-GDC-0941 (4-1 mol-mol),2.084938486650406
SCaBER,9936388,-6.596808157772059
MFE-296,107985,-4.0658320718780985
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
LK-2,107985,-3.2613767647283702
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
CAL-85-1,5460769,4.15135857015067
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
BT 231,JQ-1-carboplatin (1-1 mol-mol),2.3175217406535156
BT 139,11485656,3.131336333287838
NCI-H1666,409805,3.918123899724523
SNG-M,44491742,4.516771250419383
Toledo,6610216,4.001631927569148
G-401,148124,-6.018913106580182
BT 271,11485656,2.2293362300863016
BCP-1,11485656,1.531241298696853
DMS 79,107985,-3.6946025137175273
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
OVCAR-5,5460769,4.389197007102137
T3M-10,3689413,0.3494943823106689
OAW42,148198,-4.166593370065839
HT115,9903786,1.6808315283009525
LOX-IMVI,36462,2.305207758034576
BT 228,107985,-1.863382776783745
NCI-H2052,5460769,4.5383671359434254
A101D,9903786,4.417171452040311
KALS-1,409805,4.7781064352481835
KM12,135875424,3.0557052091310357
Raji,439501,-2.4044549184869872
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
KCL-22,159324,2.501491533347955
GDM-1,409805,4.531290163313776
LP-1,44491742,3.686326414227543
ChaGo-K-1,9936388,-4.876543253304364
BICR 22,44493528,4.288893884195869
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
RPMI-8402,44493528,4.185952710394156
JVM-2,selumetinib-GDC-0941 (4-1 mol-mol),-4.259839678662807
NCI-H508,6505803,-2.7126843112816927
BT 340,409805,5.754055033760214
SK-MEL-28,24180125,3.6660135560508142
MOTN-1,148124,-6.513897177118398
SW48,6610216,4.461301788418361
NCI-H446,409805,4.60093780948022
NCI-H838,12003241,-1.6819169768090954
SH-4,168313200,3.5127580598255026
BT-474,JQ-1-carboplatin (1-1 mol-mol),5.214986891454346
Hs 944.T,107985,-4.037293595068503
NCI-H1355,9903786,1.6922210610733373
Hs 683,5460769,1.3545224877290158
BT 131,10296883,4.294985704877121
NCI-H1793,49836020,4.8036601506688275
J82,9903786,4.0002373465355054
CAL-51,3689413,0.5709426612715743
ME-1 [Human leukemia],135875424,3.754856170927667
HCT 15,10296883,4.151348683553031
PE/CA-PJ15,12003241,-2.2005242909151668
KYSE-520,6505803,-2.015031116266543
TE-8,439501,-2.6420993562145925
G-402,44491742,3.86820580626592
KE-97,46943432,0.5632795363835643
BDCM,439501,-2.7334853290513497
RS4;11,24180125,2.423594456573407
SF126,107985,-2.3534932872641803
697,46943432,-0.4384533900138119
KG-1-C,JQ-1-carboplatin (1-1 mol-mol),1.591651516557658
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
EHEB,9903786,1.657877258917439
QGP-1,9903786,2.781324092534045
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
NCI-H1581,JQ-1-carboplatin (1-1 mol-mol),3.147849134537928
SNU-1,148198,-4.8344466851703425
KNS-42,168313200,2.6332995372243757
ES-2,135398744,8.06870751291861
SNG-M,135398744,7.8429611595155055
PK-1,107985,-2.929309788812076
SUP-B15,8515,4.235192067683924
JURL-MK1,JQ-1-carboplatin (1-1 mol-mol),0.6722664514176999
SU-DHL-8,26596,-2.3999944738407257
Panc 10.05,168313200,1.837879090184572
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
SCaBER,8515,2.2629448450847915
Panc 08.13,54618164,4.453700486080014
PC-3,8515,4.719538552927186
NCI-H526,439501,-2.4772740458578983
HCC38,5460769,2.8026336362460307
SNU-668,selumetinib-GDC-0941 (4-1 mol-mol),1.744810645163071
COLO 668,11485656,1.801054934064134
SK-MM-2,439501,-1.9347764023362728
SK-MEL-24,148198,-2.756155300346231
HT,8515,3.745952882940517
SUP-T1,159324,-0.7674662281240341
EJM,9903786,2.5710642236856818
LS513,49836020,4.383197758831643
OVCAR-4,49836020,-3.3998329005368833
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
NCI-H526,3689413,-2.6230284067277725
OE33,9936388,2.0912313369341287
SUP-M2,49836020,-3.0340639982218898
KYSE-180,409805,5.709174911109602
PLC/PRF/5,148124,-0.1119871124056631
NCI-H23,439501,-3.080706529891667
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
HCC202,135875424,3.830240155533794
LMSU,9936388,2.8786407463456656
JJN-3,11485656,1.9215217079086016
SEM,8515,3.1734533469366064
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
MOLP-2,9927531,5.358514182418203
Daoy,12003241,1.232177667394707
8305C,3689413,-2.5688983672154575
Sq-1,159324,2.5082178612561976
HMCB,107985,-2.41132307847832
HEC-59,44493528,4.437244076863349
COR-L95,3689413,-1.01311028513846
BICR 6,409805,3.8715471361387848
CAS-1,24180125,2.814372663438922
SUP-B15,9927531,5.1368052730530955
U-87MG ATCC,439501,-1.3147544227486891
A-253,11485656,0.5769754234687416
OPM-2,3689413,-4.501811354570108
BICR 31,409805,3.7719372874267982
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
639V,107985,-2.44668650004491
OVISE,107985,-3.603598955800668
EBC-1,9903786,3.237672392939453
MOLP-2,11485656,2.290738081221924
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
OCI-AML-2,6610216,3.58079476566594
BHT-101,26596,-0.678699585519716
NCI-H889,3689413,1.8557298697874456
BT 131,JQ-1-carboplatin (1-1 mol-mol),5.021524376247219
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
BICR 18,54618164,4.250023654949769
AsPC-1,6505803,-1.959385905579291
LoVo,10296883,3.831816674357036
HT,26596,-2.1592273986948394
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
IA-LM,3689413,-4.432004355370191
LP-1,6610216,3.563963398106019
LOX-IMVI,9903786,2.476339692878584
LS123,9936388,0.5461115096373947
Hs 822.T,8515,4.8347087726536815
BT 333,148198,-2.763261808909799
OVK18,26596,-0.4420601425641566
SNG-M,409805,5.670713500548849
MFE-296,12003241,-1.246731028560956
BT 187,36462,2.6435388163026023
COV362,439501,-2.4929175140704443
NCI-H522,6505803,-3.5272214952237344
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
BFTC-909,107985,-3.700699007813787
KATO III,135875424,4.043779267428047
MCAS,44491742,4.8173197109659
P3HR-1,5460769,3.3454995233869957
UM-UC-3,9936388,2.2420800599378325
MOLM-6,JQ-1-carboplatin (1-1 mol-mol),0.2604997389910982
COV434,selumetinib-GDC-0941 (4-1 mol-mol),1.0563079487833569
YD-8,24180125,3.6955333195671938
NCI-H1299,11485656,2.4848432250614843
HEC-1-B,54618164,4.194719040460806
HT-1080,107985,-3.5335184718289345
SNB-75,9936388,1.911669139874388
PF-382,148198,-4.947878541405711
NUGC-3,6610216,4.213897022791766
OC 314,24180125,1.1841173792860056
HCC15,11485656,2.480533785053976
BT 330,6505803,-1.6088860696930485
MDA-MB-453,6610216,3.7821562137745217
OV-90,44493528,4.327625554130725
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
Kelly,10296883,3.2053414181421265
SNU-16,49836020,4.5096990404507125
PK-1,5460769,3.319049240944118
JHH-2,9927531,4.777538001331337
COLO 699,439501,-0.4708312711011941
T24,135875424,4.724253336521634
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
VMRC-RCZ,8515,5.1867896592063545
2004,168313200,1.9308841671916883
M-07e,6610216,4.11023848384902
NCI-H520,8515,4.614929200779132
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079
BT 172,9936388,-4.290165173398555
HPB-ALL,26596,-2.8269771859665824
GCT,107985,-3.933588021223445
BL-41,44491742,3.779286328341323
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
HCT 15,8515,2.256673740803226
Raji,6610216,4.035753851614817
KO52,24180125,3.3572012584638613
BT 340,9936388,1.2186667237232216
MDA-MB-435S,9903786,3.3965750050470356
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
OV-90,JQ-1-carboplatin (1-1 mol-mol),2.6498991971281702
U-118MG,168313200,2.145334385054909
Hs 888.T,49836020,6.084092385452033
HH [Human lymphoma],36462,1.6399321018536528
WM1799,409805,4.869414940452359
Daoy,439501,-2.3347693323407195
CGTH-W-1,36462,1.432706505120937
BT 330,54618164,3.911280393833352
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
COLO 792,135875424,3.9911927217813385
HCC1395,3689413,-0.620515875859175
Capan-2,10296883,4.260435559241064
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
HuH-1,9903786,2.716851853041897
NCI-H1339,26596,-1.3893901381267089
T3M-10,5460769,3.3157316369773926
NCI-H2170,148124,2.714749959152977
MDA-MB-361,8515,6.307213158315527
SW620,135398744,6.387116600988426
U2OS,159324,4.284852110349447
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
JHH-4,selumetinib-GDC-0941 (4-1 mol-mol),1.975979663923368
ESS-1,54618164,4.192374601121606
KG-1-C,54618164,4.428583513385725
MKN74,107985,-2.988368566005849
COR-L105,409805,5.8843358134901775
Hs 934.T,11485656,3.91753732132253
SUP-HD1,selumetinib-GDC-0941 (4-1 mol-mol),2.188403523917611
Hs 944.T,6505803,-0.4446247220242906
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
A2058,12003241,1.9511247747481215
RPMI-7951,26596,-1.730558618097036
LN-229,135875424,3.7186537763136807
SR,49836020,-3.5786730229489603
RCH-ACV,159324,1.0284560082881151
SNU-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.1592396564326592
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
HCC2108,3689413,-1.830632797435868
P12-Ichikawa,54618164,3.774064824270636
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
DMS 114,6610216,4.687724609368201
Hs 578T,6610216,4.144845051199694
WT2-iPS,36462,0.0247559236952942
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
Namalwa,44491742,4.1395858329172235
AN3-CA,8515,3.3149085250291632
NCI-H716,168313200,3.967262456883907
Hs 944.T,36462,0.0692561534374343
K-562,12003241,-5.632155645383806
LAMA-84,selumetinib-GDC-0941 (4-1 mol-mol),-0.0298835136014615
MG-63,9903786,3.648237948966595
Li-7,9903786,1.4917500852360135
HCC1588,159324,2.919673795321196
Calu-1,12003241,-0.3445186674692038
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
NCI-H1105,54618164,3.971690507738235
KMRC-1,3689413,-1.8207429228817171
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
SW1990,54618164,4.162528357630221
BT 164,10296883,4.081572415093264
TC-71,148198,-5.123045083168725
DOV13,11485656,2.572121506597987
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
Panc 10.05,6505803,-0.9946511088404476
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
IGROV-1,159324,2.8766947154825044
KYSE-520,6610216,4.362727317650632
NCI-H1568,6610216,3.52063980115584
GB-1,12003241,-0.733058723008687
BT 112,135875424,2.6326015677965087
SYO-1,36462,-0.3821468106451705
YD-10B,selumetinib-GDC-0941 (4-1 mol-mol),-2.4124074693543887
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
BT 330,24180125,2.435960640097673
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
KMS-34,9936388,-7.578544661125487
NCI-H2087,148198,-2.1193068046896255
RPMI-8402,409805,3.6932223426421023
NB4,selumetinib-GDC-0941 (4-1 mol-mol),-0.8849476640562556
TE-11,12003241,-1.4991757511197057
EHEB,44491742,5.293750317448726
22Rv1,44493528,4.251423815919127
SaOS-2,26596,-1.8442798913702467
HeLa,159324,2.7422361867154654
SK-BR-3,12003241,-1.7425302549890949
SNU-423,26596,-1.230407332735001
LMSU,439501,-3.1304465735998153
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
YD-15,11485656,1.939430156438133
NCI-H1435,107985,-4.254574866171067
TE 441.T,135423438,2.5250342402764816
DND-41,9936388,0.9439294041019026
TE 617.T,8515,3.600809985804118
HCC2279,12003241,-1.0560673565017786
SNU-869,44491742,4.0762801195520675
BT 179,3689413,2.324623273227175
HuH-6,6610216,3.4772585756777357
FU-OV-1,159324,3.7929038817112746
HuT 78,44491742,3.833204810123411
OC 314,5460769,0.7455149919957782
WM88,168313200,2.778601670140009
NCI-H23,44491742,4.066691621644064
A-549,168313200,3.5389649746345815
SH-4,148198,-4.104582342720325
JVM-2,73707440,4.245846854009652
T84,9927531,3.2336753080400933
ChaGo-K-1,9927531,4.39504142130407
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
SW1783,148124,3.5822290901632545
HT-144,8515,5.322157375138796
G-361,159324,1.690399124036534
Panc 03.27,9903786,3.06546007586267
MOLT-16,44491742,3.707485326024471
COLO 800,148198,-3.6591761210846423
SK-N-BE(2),409805,6.030364994346273
NCI-H2122,439501,-2.460326379579743
YD-15,6505803,-2.549779097055298
SNU-1077,9903786,3.350516769184116
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
NCI-H2141,8515,4.27499486698666
HCC1588,44493528,4.903297648657414
HEY A8,159324,3.154250268026962
PF-382,24180125,1.6002910588088834
EN,54618164,4.025046535764669
Hs 746.T,148198,-2.6846160081126422
NCI-H1944,5460769,2.8815728712933533
MHH-NB-11,5460769,0.1822518013387546
Hs 852.T,148198,-2.877314307810341
AGS,439501,-2.3986338247622148
NCI-H2405,24180125,2.50085273368924
RL,JQ-1-carboplatin (1-1 mol-mol),-0.1816781364388249
SK-N-FI,148124,-5.991544192204867
MHH-ES-1,9936388,-6.403533054534267
LS123,409805,5.70006510405378
OCI-Ly10,36462,1.511328691216577
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
HCC202,selumetinib-GDC-0941 (4-1 mol-mol),2.1279074309941413
IM95,409805,3.0284859777571955
TYK-nu,6505803,-1.946353341465887
BICR 56,36462,3.0627573168213496
IGR-37,148124,-4.42288391393864
SJSA-1,12003241,-0.348535560110424
SNU-8,135875424,4.308406363333984
ECC12,36462,1.5469230001640613
A-549,409805,5.689640893560965
DMS 454,24180125,3.458274614597035
HOP-62,135875424,2.89405317867683
CAL-12T,135875424,4.193322146667977
NCI-H1944,6505803,-2.861840554451695
COR-L105,54618164,4.149947168538197
OCI-M1,46943432,1.475072626321256
OCUM-1,6505803,-2.038766132244714
PSN1,selumetinib-GDC-0941 (4-1 mol-mol),0.7617880642657375
NCI-H2405,9903786,2.53791171783736
RPMI-8402,9927531,3.4344708783390856
COLO 829,11485656,3.3013884087788794
OV-90,9903786,3.9551127291738424
SF539,409805,5.790114720226367
SR,9927531,3.5947665035551113
MHH-CALL-4,107985,-3.8831394707718294
GA-10,5460769,2.1295302547958976
JHH-5,439501,-1.654650544214748
A2058,3689413,3.023224690588694
HCC1143,107985,-3.4652614368177432
HEL,36462,0.8349109175120154
DB,9903786,1.8629742307315609
FTC-238,9927531,3.762159625160711
SW1271,135423438,1.1699634662635283
Ki-JK,12003241,-1.478318359413444
KYO-1,159324,1.12474085264908
BT 224,selumetinib-GDC-0941 (4-1 mol-mol),3.286346759744933
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
HGC-27,26596,-3.243081069551806
KM12,54618164,4.266874999580224
WSU-DLCL2,44491742,3.7672171779194983
NCI-H1568,439501,-2.6831567396736022
NCI-H2405,44493528,5.716888607372898
MOLT-13,439501,-2.4259548935745348
SNU-899,6505803,-0.0802623134971481
TE-14,JQ-1-carboplatin (1-1 mol-mol),0.3658378251951246
SK-MEL-3,36462,3.2398359693189622
WM793,54618164,4.258619603305177
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
Yamato-SS,107985,-3.415977953838454
SNU-1214,9903786,2.1258190574569955
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
TE 617.T,107985,-4.218073473743226
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
WSU-DLCL2,9903786,-0.2732990105431844
TF-1,26596,-1.8278178688424689
Tm87-16,3689413,-0.2220957395853978
LMSU,107985,-1.9062813049718328
NCI-H23,54618164,3.7047773278622778
A-204,5460769,1.2636887852465275
OVCAR-8,selumetinib-GDC-0941 (4-1 mol-mol),3.698487260127977
NCI-H1666,6505803,-3.0985953637534354
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
HT-29,9936388,1.7022736774811322
SNU-C5,3689413,0.7822461761518839
KMS-12-BM,54618164,3.5838118675433783
Hs 936.T,6610216,4.507566402989384
SW48,159324,-1.9628962598081805
KMS-27,9903786,2.0838522642379216
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
HCC366,11485656,2.823123661586525
NCI-H2196,148124,-1.1516038288442412
NCI-H1755,135875424,3.1335901028630393
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
A-673,107985,-4.827881226135439
GDM-1,9903786,1.637599474321908
BT 239,44491742,3.7318422225870753
TE-5,10296883,3.820447093434926
M059K,6505803,0.7247359369416212
OV7,107985,-3.6267899251905606
NCI-H1299,439501,-2.475221299124019
BT 216,6505803,-2.2402570422569905
253J,54618164,4.056107548266079
SK-N-AS,148124,-5.963448683076425
Rh41,JQ-1-carboplatin (1-1 mol-mol),-0.6167510986440503
Daudi,107985,-4.311158471957254
L-540,11485656,1.982100275891034
LoVo,26596,-4.043483931746528
Kasumi-1,JQ-1-carboplatin (1-1 mol-mol),-1.0248552118786003
RERF-LC-Ad2,11485656,2.920676874689175
NUGC-3,11485656,2.456489968727232
MEC-1,49836020,4.363121412189612
KYSE-70,135875424,3.720063911223788
SK-LU-1,9903786,1.4733207164642357
Hs 895.T,6505803,1.07500421429109
LOX-IMVI,36462,2.305207758034576
G-402,135423438,-0.2175800815480045
DMS 114,148198,-6.558131209279394
KHM-1B,44491742,4.066156285625521
SNU-620,44493528,3.907657594721087
OVCAR-5,135875424,2.7043210388951007
LOX-IMVI,54618164,3.986772519561911
NCI-H2009,439501,-2.087429471182781
HT-1197,148198,-3.334872937201218
COR-L47,439501,-2.8835443741058437
JHH-6,439501,-0.5793275995059294
EBC-1,8515,4.407730578981125
Hs 852.T,46943432,2.409734436943373
D283 Med,439501,-4.70695325279779
C2BBe1,5460769,5.889347981048802
GP2d,9903786,1.6186361299968774
UACC-62,44493528,4.51687103541405
G-292 clone A141B1,9903786,2.9519846446825277
G-401,9927531,4.9703255494446035
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
M-07e,148198,-7.025596172971479
Panc 04.03,8515,4.900392472396633
NCI-H522,54618164,3.979913879048498
OVCAR-4,135875424,4.627520209049134
PaTu 8988s,135875424,4.807406911194583
HCC15,9903786,1.5576741113339283
MHH-CALL-4,168313200,3.206527597863312
HCC1143,9936388,-6.988875343339418
OS-RC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8729257102095325
OAW42,JQ-1-carboplatin (1-1 mol-mol),4.198659850424817
HPAC,12003241,0.9185778330779416
SNU-C2A,6610216,4.343391029884027
NCI-H2029,3689413,-0.5548676180878093
SNU-1079,148198,-3.7175883561835295
Hs 729.T,9927531,5.3265551472820425
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
M059K,JQ-1-carboplatin (1-1 mol-mol),1.2153984105475986
Sq-1,10296883,4.026329905742616
SiMa,36462,0.1829414877953918
NCI-H2087,44491742,3.6695473170739583
LCLC-97TM1,6505803,0.2281876141434561
NCI-H2228,409805,5.240879679587451
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
OE19,3689413,2.2009145574363895
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
HT,46943432,1.075577820528673
SNU-8,409805,5.0276813202923325
DMS 273,9936388,3.4086707637717883
BT 359,selumetinib-GDC-0941 (4-1 mol-mol),2.125695165959512
DU145,9927531,4.922928089289864
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
CAS-1,9927531,5.442580925984542
JK-1,26596,-2.9056009254184247
HH [Human lymphoma],135423438,1.7493298511702722
LN-229,54618164,4.032684546454332
SNU-46,9936388,3.201545334866413
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
HCC1395,159324,2.879244601573153
VMRC-RCW,135875424,3.9669138059560063
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
SK-N-AS,439501,-3.01819280603901
SCC-25,107985,-3.48065127857335
MKN7,135875424,3.97567031740838
BCP-1,JQ-1-carboplatin (1-1 mol-mol),0.3849655191585445
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
CCF-STTG1,10296883,4.282837475963798
BT 239,36462,-0.612323435298888
COLO 829,9903786,4.931323632089431
Panc 10.05,11485656,2.563143068622914
SUP-T1,168313200,3.8217155223423
LK-2,36462,2.1867677758587405
Hep 3B2.1-7,9936388,1.3594944323688356
NCI-H1092,3689413,-0.2231155414175143
EFE-184,6610216,4.606537612273475
T84,6505803,-1.9695494266623712
T84,26596,-1.9747226822057509
WM115,5460769,2.9023963298546507
KP-4,9903786,1.7495953596701077
KMS-27,12003241,-0.3161890721272481
NCI-N87,12003241,-2.470820657410725
CL-34,12003241,-1.25604782594079
BT 286,54618164,4.321497968648174
769-P,JQ-1-carboplatin (1-1 mol-mol),2.198713761096946
NCI-H211,148198,-5.011927941581449
CAL-85-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1820592337314743
NCI-H520,8515,4.614929200779132
U266B1,148124,-5.9084465946358895
Hs 944.T,54618164,3.859613969928264
HSC-3,12003241,-1.4285198417789524
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
G-401,168313200,3.793890782777564
JHUEM-7,107985,-5.321387186988869
L-428,26596,-3.3648892390526144
TE-4,3689413,3.3768605304218036
TALL-1 [Human adult T-ALL],49836020,4.412561834618748
GSU,JQ-1-carboplatin (1-1 mol-mol),3.56440629696987
CAS-1,135423438,2.545447966463113
KE-37,6505803,-0.078936185166994
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
NCI-H1703,107985,-4.063268775801852
SK-MEL-30,107985,-2.8355953355058205
JMSU-1,36462,0.54359798251978
639V,439501,-2.2821025832606083
EPLC-272H,6505803,-1.0769896118510445
L-1236,9936388,2.483385835901907
JHUEM-7,12003241,-3.5765771521887246
HLF,107985,-3.9797994602354847
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654
BT 231,439501,-3.8677572824685913
DLD-1,107985,-3.352847665202384
NCI-H727,6610216,4.563405769903236
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
SNU-668,9927531,6.94205854979306
HPB-ALL,24180125,2.353985646096143
Karpas-299,5460769,1.8174425760442317
TE 441.T,9927531,5.546705362793043
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
KHM-1B,54618164,3.3281109403552795
L-363,5460769,3.1855297672006087
BFTC-905,11485656,2.1700639053341666
HuH-1,6505803,-0.939416670904982
SIG-M5,107985,-4.712250940257049
NCI-H1915,8515,4.43756010195983
BT 333,439501,-2.413365908020449
SNU-1076,12003241,-1.173823716137647
KMS-11,JQ-1-carboplatin (1-1 mol-mol),-1.3337682684641334
JHH-2,6610216,3.9742495338356263
SaOS-2,409805,5.764413924489168
SNU-840,135875424,4.211396947721992
ONCO-DG-1,6505803,-0.2819077176711598
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
NCI-H2122,44493528,4.295267332742467
Ki-JK,44493528,3.660755145624423
JK-1,JQ-1-carboplatin (1-1 mol-mol),0.4843297170939055
SF539,3689413,-2.2250008276513107
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
JHUEM-1,6505803,-0.0330531463180682
RCC10RGB,44491742,5.1484686760969645
TALL-1 [Human adult T-ALL],44493528,3.717855911159704
HCT 8,JQ-1-carboplatin (1-1 mol-mol),1.4638248293100051
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
JHOS-2,54618164,3.809859961366981
KALS-1,12003241,-0.678278256964916
T3M-10,409805,6.215786200217872
SK-MEL-2,3689413,2.4030655110444767
SNU-489,107985,-2.42677081085971
NCI-H1092,10296883,3.8260798051213376
Caki-1,148198,-2.50080081476661
KYM-1,6610216,3.835650941604875
OVISE,54618164,4.29678583267412
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
SNU-C1,135398744,6.35894151615267
DLD-1,JQ-1-carboplatin (1-1 mol-mol),2.485770842488409
SIG-M5,6505803,-0.1487060693646739
CAL-27,10296883,4.057207739356728
COLO 699,6610216,4.402616524797006
JM-1,12003241,0.2073989775302392
BICR 16,54618164,4.406569999060278
RD,135875424,4.367894980695875
8-MG-BA,3689413,0.0230588346989354
LNCaP clone FGC,135875424,3.855348592559951
JVM-3,5460769,-4.534057079586897
SNU-16,135875424,3.101421210140047
NCI-H28,6505803,-3.2149479697747534
U-CH1,10296883,4.147142232028317
HD-MY-Z,54618164,4.048037306322694
DAN-G,3689413,2.9814511815134943
MHH-NB-11,9903786,1.7813974868905205
NCI-H661,54618164,4.023349318575714
NCI-H1792,159324,5.06662867697722
Mino,24180125,1.2507747465119918
SK-MES-1,168313200,1.727184472049229
MOLP-2,selumetinib-GDC-0941 (4-1 mol-mol),2.6485727489944555
RS4;11,46943432,0.8873668364178348
SNU-719,439501,-0.6056911297010781
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
Toledo,168313200,1.788753632318655
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
NCO2,JQ-1-carboplatin (1-1 mol-mol),-0.8378761962661548
U-118MG,36462,3.4030913750354563
SU.86.86,439501,-1.025939576051134
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
LMSU,26596,2.3008598244356935
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
DU4475,6505803,-2.3168305657918156
NCI-H1355,24180125,4.622759020325423
Hs 895.T,selumetinib-GDC-0941 (4-1 mol-mol),2.3327892844393374
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
SF126,135398744,7.810596319596066
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
NCI-H226,selumetinib-GDC-0941 (4-1 mol-mol),3.612309653965627
SNU-1079,44491742,4.118848224044972
MHH-CALL-3,54618164,4.22349519380149
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
IGR-1,12003241,0.2975109917194724
NCI-H2110,44491742,4.139827167651669
OPM-2,5460769,4.223891374112808
Panc 03.27,135875424,4.313798765654786
TC-71,135875424,2.7755794314588105
H-STS,36462,-1.1706487337003968
MCAS,135398744,6.37399282177603
ST486,9927531,3.885019702146961
CGTH-W-1,3689413,-0.6568714259027654
COLO 205,3689413,0.2425510566398385
CW-2,9936388,-2.7633080589769885
DB,44491742,3.5309759894848747
SW1783,6610216,4.1970131352388265
MDA-MB-231,44493528,4.662027918960356
BICR 22,5460769,-1.4539525700949456
VM-CUB-1,3689413,3.0900699567187013
LN-18,11485656,1.656863008716467
KYSE-520,148198,-3.940360591916268
NCI-H1944,9927531,4.180597511578871
NCI-H747,JQ-1-carboplatin (1-1 mol-mol),-0.0686546754719674
MFE-296,135875424,3.004641901934104
SNU-1066,36462,2.955428142789315
ESS-1,49836020,-4.193111027878734
NCI-H1573,11485656,1.6192247576925332
NCI-H146,135875424,2.9115600315347057
CAL-148,46943432,1.3946805830156972
VMRC-RCW,135398744,6.359457324257638
Karpas-422,135875424,4.0020075582939
SR,selumetinib-GDC-0941 (4-1 mol-mol),2.945554798995567
NCI-H1694,11485656,1.9484050464829303
NCI-H508,168313200,3.8956929305723618
PC-3,36462,3.8990725123276215
OVK18,135875424,3.840132228822679
NCI-H1563,44491742,4.074873654245284
NCI-H1184,JQ-1-carboplatin (1-1 mol-mol),-0.5864173330660996
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
NCI-H929,148198,-3.717368743483661
DU4475,9927531,3.2558531780718507
DOV13,6610216,4.6419084541016415
HSC-2,6610216,4.150484676216286
NCI-H28,439501,-2.3815897212946333
HCC1171,6610216,4.662809555111892
CHP-126,44493528,4.776388586076308
T24,409805,6.178304218667183
BFTC-905,409805,3.630865153119702
RD,3689413,-1.0823038646320762
MCF-7,9936388,1.4763358152049189
THP-1,5460769,3.8427937277030497
Karpas-620,135423438,1.2661543285400736
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
WM266-4,135875424,3.043976656542822
OCI-Ly3,44493528,3.993360395088613
BxPC-3,5460769,-0.1362128387149436
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
OV-90,168313200,3.885761361931424
NCI-H1944,44491742,3.732177387700191
Jurkat,11485656,1.7204006951846988
Hs 578T,11485656,1.5061337844813831
SNU-5,9927531,5.646839183086857
SK-MEL-5,135875424,3.6602054011582137
HCC827,12003241,-4.000089472829944
K029AX,135398744,6.420759462552213
A-549,6610216,4.4512033607640475
MOLP-8,12003241,-1.4499361325619826
COLO 680N,9936388,1.5299770165572488
NCI-H28,54618164,4.110674659923601
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
C2BBe1,12003241,-0.6014753337621667
TE-8,10296883,3.8933893456121984
SNU-1196,9936388,1.7924578695982027
BT 330,11485656,2.0154555749445486
RCC10RGB,9903786,5.708919982977709
Hs 852.T,9936388,-8.265529958895947
KYSE-180,8515,4.449202894378201
BT 328,135875424,3.085389187382682
Lu-99,135875424,3.620221919582757
TE-15,148124,-8.056509685609365
A2780,36462,-2.0824592368546893
VMRC-RCW,10296883,3.756986073264271
Hs 888.Lu,3689413,-2.4401760719127092
NCI-H2172,168313200,3.683168062347926
HuP-T4,5460769,3.995973336692885
SNU-398,135875424,1.4197381428119091
U-251MG,439501,-1.7120275668154334
NCI-H1339,9927531,5.416434112117517
CAL-27,148198,-3.939292770233757
HuH-28,3689413,-1.8867540967033527
NCI-H524,9936388,-8.40858165815813
HCC1833,3689413,0.395553245761409
SK-LU-1,44491742,5.866940990531296
BHY,24180125,2.855472953055454
MM1.S,12003241,-0.8577985614667851
TE 441.T,6505803,-1.628255920679656
GB-1,9927531,4.312258679101311
OE21,46943432,2.2967121363038707
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
A-498,135875424,4.978423270774445
SW1088,11485656,3.080394465182635
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
NH-6,409805,3.714423410444853
J82,107985,-3.8389067423667615
T3M-10,148124,-4.172364991012526
SNU-1105,107985,-1.9707036045790447
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
KP-3,5460769,4.226589336768475
OCI-AML-3,5460769,2.571994692264208
CFPAC-1,12003241,-0.6323170147703681
BT 231,36462,1.8404297564151428
SNU-601,6610216,4.325542610449876
Kasumi-2,54618164,3.8625919459899833
BC-3C,12003241,-1.7584420473179934
L-428,24180125,3.211915408201291
OCI-Ly19,409805,2.778499480281169
OCI-AML-3,107985,-5.918636177044622
KYSE-410,9903786,4.00816844948711
HEC-151,135423438,1.588330635557561
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
Ci-1,168313200,3.521334574329343
L-540,36462,-0.279391918254195
SET-2,409805,5.152205992309063
RPMI-8226,107985,-4.099902309572239
EB1,439501,-3.6025033052563553
KNS-42,44491742,4.252498617041353
IGROV-1,3689413,-0.3633634632064185
NCI-H358,12003241,-1.009244775405437
AsPC-1,11485656,3.206693439346989
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
COR-L88,24180125,3.759046455796738
MDA-MB-468,6505803,0.9541010396346138
L-540,26596,-2.7361292622141806
DAN-G,26596,4.046660448506208
TE-15,439501,-2.48025284068881
KMS-27,26596,-2.324040117520084
Mel JuSo,6505803,-1.4537757141410834
Reh,54618164,3.699236852109201
OE19,148198,-4.200030852664729
8505C,9936388,-0.6863572564067597
SNU-182,107985,-4.121441833862979
HuT 78,9936388,-7.168553730777331
DMS 79,159324,2.5822231714188493
KMS-28BM,439501,-2.813687034658713
NCI-H1838,3689413,1.1347617687317235
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
PC-14,11485656,2.0369141609233656
GCT,135398744,7.690422491741855
697,selumetinib-GDC-0941 (4-1 mol-mol),0.5718014976116145
MeWo,168313200,2.0312188098871595
DB,5460769,1.8834181213891803
ACC-MESO-1,36462,2.9779299416618237
NCI-H1666,135423438,1.706411429493964
YD-38,26596,-1.5752818654632963
EM-2,5460769,2.512608661279844
M-07e,24180125,2.673847094626436
RT-112,159324,2.695611824284584
Karpas-299,46943432,1.2059894220984688
REC-1,6610216,3.8618283441811054
OCI-Ly3,5460769,0.7293331267323642
UACC-257,6610216,4.056795010377407
KMS-28BM,9903786,-0.1585542654155638
BT 187,54618164,3.97391253184756
SF126,439501,-2.7774123769651315
PSN1,148198,-4.413280426545966
TE-14,439501,-3.001573063863178
NCI-H196,409805,4.55561469724075
BT 333,6610216,4.264982488375611
COLO 668,26596,-1.2429093822877924
EC-GI-10,439501,-3.666361132208791
CAL-51,8515,3.5852991976047863
DV-90,11485656,1.6337920005269289
TTC-709,6505803,0.8575358462555939
DAN-G,439501,-2.2705852872142236
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
OUMS-23,107985,-3.0365791826627553
A-549,12003241,-1.903076073453771
COLO 829,9936388,-8.135727269739062
LP-1,9903786,3.180613462551036
SNU-407,46943432,1.5271600155892695
NCI-H929,409805,3.661820790042666
SK-ES-1,26596,-2.5080764618558775
NCI-H322,148124,-6.072159104918049
SW1417,24180125,3.5799680228726065
U2OS,11485656,2.250878225413065
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
DB,26596,-3.691509767021521
HEC-251,9903786,4.825179909690824
HCT 15,3689413,1.3698068653375808
NCI-H2452,159324,4.677055932941875
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
IPC-298,8515,4.582627951903999
CAL-85-1,11485656,1.9018323097644911
MOLT-13,3689413,-2.356450494712317
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
HEL,11485656,1.96241131365886
23132/87,54618164,3.944833088107541
B-CPAP,36462,2.9049699830233733
A-375,3689413,-0.7182003405560186
NUGC-4,JQ-1-carboplatin (1-1 mol-mol),-0.8477062663812829
SNU-182,148198,-3.912494487684412
MDA-MB-453,8515,4.14044832994183
YD-38,11485656,2.58437498447116
BT-549,10296883,4.161421407524775
697,148124,-6.674056959330551
NCI-H1184,148198,-3.201792375751558
CL-11,6610216,4.297262569438173
CMK,5460769,4.702047832953649
NUGC-4,9903786,1.3800210436357438
TE-5,168313200,1.9838946788634588
SK-UT-1,3689413,-2.3572164451465105
TCC-Pan2,135875424,4.2350171007948685
L-540,439501,-2.6441519340115236
SNU-626,46943432,4.418446938895329
NCI-H1339,148198,-2.9438729710882963
PLC/PRF/5,44491742,4.0953370325315355
NCI-H1355,9936388,0.5035386429798234
SW1271,12003241,-1.4062779923685875
SNU-601,6505803,1.2450249306670702
KE-37,159324,0.190528965424999
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
SW1417,135875424,4.272780059645497
SCC-9,6610216,4.4695629784882795
NCI-H1975,73707440,4.623007313356143
PC-3,5460769,3.04554817499368
TUHR14TKB,12003241,-2.6792741920200815
NCI-H2122,8515,3.1724007167677297
LS513,5460769,-0.3272270852290284
YD-38,159324,3.3433539214120516
Li-7,selumetinib-GDC-0941 (4-1 mol-mol),0.6490035918823776
KYSE-410,159324,2.9190840710884385
DK-MG,3689413,-2.444320741118214
THP-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.4555480818826622
KYO-1,JQ-1-carboplatin (1-1 mol-mol),0.7001099842135994
COLO 201,409805,4.408175293808457
M-07e,54618164,3.9701708331958585
IM95,135875424,4.902055922324696
J82,168313200,3.8217993883294903
RD-ES,439501,-2.2858768035402623
NCI-H2141,11485656,1.4987808894190335
TUHR4TKB,26596,-1.9685779873935287
KE-39,12003241,0.559414259019648
OE21,54618164,3.767482528775002
NCI-H2030,9936388,0.4850325164954482
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
HPAF-II,107985,-3.421837559840437
HD-MY-Z,10296883,3.8983586745084033
NOMO-1,9927531,5.049638663441057
VCaP,107985,-3.79754975163278
SNU-1,12003241,-2.3799966933109262
SH-4,148124,4.2777999739630586
253J,36462,1.5975956987115052
SNU-81,439501,-1.707157001292212
ZR-75-30,24180125,2.6868616439052353
BT-549,11485656,2.9441987555380855
OV-90,12003241,-0.4315626967505086
HT-55,44493528,4.268967793319167
SW1353,3689413,-1.8577928934605696
ACHN,439501,-3.3245140147129684
BICR 56,11485656,3.1292110693028237
KYO-1,439501,-2.3318531278707555
NB4,54618164,3.68838507272964
HCC1428,135875424,3.1301464909874546
TE-9,36462,2.2329796959977894
EPLC-272H,49836020,-3.920805882597204
SNU-449,135398744,6.632733291537939
GSU,selumetinib-GDC-0941 (4-1 mol-mol),-0.0301350261262937
RS4;11,6505803,0.6734811242477595
CAL-51,5460769,1.3780575552768597
GI-1,439501,-2.4273681178364837
Hs 611.T,JQ-1-carboplatin (1-1 mol-mol),1.233772265287216
LS411N,12003241,-0.0946051023392001
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
EPLC-272H,5460769,1.6244755024215547
BT 145,JQ-1-carboplatin (1-1 mol-mol),4.281045912366545
BT 228,44491742,3.950846154014159
COLO 678,36462,3.8196751045227786
SNU-C1,6610216,4.164433839119208
NCI-H2228,159324,3.317306961688271
SNU-81,9936388,-6.314751034125396
A2780,3689413,0.5219259729031659
HEC-151,26596,-1.920762353069635
PE/CA-PJ49,44491742,3.950119634705539
NCI-H929,439501,-2.3111413664478513
BT 139,9936388,1.6173516252245872
SCaBER,12003241,-1.3613478880946173
SNU-1,107985,-4.014141337071334
A-549,11485656,2.1977599259975764
MDST8,409805,3.941558883413243
MDA-MB-468,107985,-2.837120090613579
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
Reh,12003241,0.0982187894519585
NCI-H1155,26596,-2.1815551982286885
KALS-1,6610216,5.229804141244247
HCC2279,JQ-1-carboplatin (1-1 mol-mol),3.2942402482720707
VCaP,409805,3.668756202422648
SNU-C2A,11485656,2.2484892549692104
NCI-H1341,8515,3.70555816086862
NCI-H889,135875424,4.039374159627762
Mel Ho,12003241,-1.328246141696159
NB1,107985,-2.2681430923409405
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
LCLC-97TM1,107985,-4.222636663811031
8305C,6610216,4.272424943672388
TM-31,11485656,2.0452435879602087
OCI-M1,6505803,0.7665872263269772
BT 159,107985,-3.1496718736589324
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
UM-UC-3,26596,-0.252554246147762
UM-UC-1,107985,-2.6380239496901328
JMSU-1,107985,-3.68348103798744
COR-L279,8515,3.7910565659393254
OCI-AML-3,12003241,-2.086986892339566
MKN1,159324,3.5689159418986005
EC-GI-10,3689413,0.4203199772849357
KMS-34,6505803,0.7585459942154548
SCC-9,5460769,4.655053652221148
VMRC-RCW,6610216,3.7289316051742274
NCI-H520,439501,-2.5978412941351405
NCI-H1299,107985,-2.368506308925934
NCI-H2052,9903786,2.0027287626066297
HDQ-P1,6505803,-0.3319389932283364
BT-16,107985,-4.283991863773396
NCI-H1568,10296883,3.9462373745058863
253J,409805,5.259163480359584
BICR 6,168313200,2.895523161821981
BxPC-3,12003241,-1.7282705692868598
SNU-1077,8515,4.803726365696702
Hs 578Bst,3689413,-1.7241892879585388
TYK-nu,3689413,-0.8961723591289054
KG-1-C,6610216,3.995568855023672
MIA PaCa-2,148198,-3.7289909178632383
SW1353,107985,-2.47114721264714
U-937,26596,-4.272350751013951
NCI-H1155,46943432,1.3010281013857317
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
HMC-1-8,12003241,-0.3368702938294806
MOLM-6,26596,-3.738191164501696
CAL-148,11485656,2.5370782509727356
SNU-761,44491742,4.113182762091863
NCI-H1838,9903786,2.204739159527363
MM1.S,11485656,1.9684027845110144
EJM,46943432,3.619668904272789
TF-1,JQ-1-carboplatin (1-1 mol-mol),-0.0928028716388946
MOTN-1,26596,-3.629503770216574
BFTC-909,3689413,0.9841636034152118
HCC15,8515,2.8931769079597767
SNB-75,54618164,4.754323338158202
OE21,12003241,-2.4283256435660205
BT 164,12003241,-0.888203268787868
RERF-LC-A1,135398744,8.259619126952485
MJ,24180125,3.2687573062983484
OE19,6505803,-3.540605672493051
SNU-668,36462,2.9048047671619877
KMS-18,6505803,1.18095143270811
NCI-H1395,9927531,4.9557176619227015
TCCSUP,11485656,2.4858219651419966
NCI-H2171,26596,-1.7584148860978708
YKG-1,26596,0.9408189524000934
DU145,107985,-2.6553199343257483
SK-MM-2,JQ-1-carboplatin (1-1 mol-mol),-2.35535314984042
YD-10B,148198,-3.6118455313709186
KMBC-2,44491742,4.484748547607026
NCI-H2126,135423438,4.586735604556358
OCI-Ly10,6505803,-1.8295734917413131
SK-UT-1,148198,-4.4190978779578565
JHUEM-2,8515,1.9041010044405784
HT,148198,-3.46019179150445
HuG1-N,9927531,4.775383733857977
BT 416,439501,-5.114778373309692
NCI-H446,439501,-2.615106266936583
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
HeLa,107985,-3.0123177853339262
NB4,3689413,-2.3833174829698085
TE-11,439501,-2.6156568819541435
YAPC,6610216,4.2275333940091215
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
TE-15,11485656,1.960576997256463
HCC1195,107985,-2.277898834430922
RERF-LC-A1,439501,-2.669244370935075
OPM-2,148198,-4.827513159673032
IM95,107985,-4.271252977544848
BT 444,6610216,4.33218996136642
SNU-16,135423438,0.927911457885393
MDA-MB-157,9927531,5.35009923211275
G-361,135875424,3.221019513636021
G-401,12003241,-2.103305079214356
T84,439501,-3.2363484717371964
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
NCI-H1581,409805,5.312436768520535
NCI-H1581,3689413,-2.373014481120326
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
NCI-H929,54618164,3.87455268818749
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
Yamato-SS,6610216,4.637948726074207
FaDu,3689413,2.633100488394503
HEC-108,6610216,4.664785359409005
KYO-1,36462,0.4535313414522903
BICR 56,148124,-4.641918027930953
HCC1419,12003241,0.329008083865116
SH-10-TC,10296883,4.6565479517394355
MOTN-1,5460769,0.7518419346698605
NCI-H1581,9936388,-5.169397744708478
PK-45H,148198,-3.448845301231553
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
TCCSUP,135875424,4.238752084680578
EPLC-272H,148198,-1.1949908417722128
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
NCI-H2029,9936388,-1.4677878209950324
SK-ES-1,49836020,6.460464214010888
KALS-1,JQ-1-carboplatin (1-1 mol-mol),0.9205030835960966
HMCB,11485656,2.0030375268355116
TT,selumetinib-GDC-0941 (4-1 mol-mol),2.303935736572117
ONS-76,439501,-2.2755976390662163
OVCAR-5,9936388,1.186466547849794
CL-11,12003241,-0.9595086367475664
KYSE-30,6610216,4.130988054246519
Jurkat,135875424,3.3200547810241496
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
CAL-12T,6505803,0.5711509755258141
786-O,36462,2.9279083981584217
SNU-1,135423438,1.6465849203291467
NCI-H1341,JQ-1-carboplatin (1-1 mol-mol),1.5093857547528675
Namalwa,135423438,1.9520788575137753
BT 187,148198,-3.907036314471468
BT 245,148198,-4.884445563516914
OCI-M1,135875424,3.745039628073017
769-P,3689413,-0.2029622109765157
L-540,46943432,0.6608749912510412
TM-31,24180125,3.310728036937333
RERF-LC-A1,159324,3.1171864929596977
WM1799,107985,-2.5278242987340525
NCI-H23,3689413,-2.6057234529472098
DLD-1,135875424,4.314785833755313
OVISE,9936388,2.6758567859836826
Hs 888.Lu,135875424,4.614690828514689
NCI-H661,12003241,-1.8871798966926587
MKN7,11485656,2.688559348237845
SNU-840,selumetinib-GDC-0941 (4-1 mol-mol),1.257752895410429
SNU-1076,selumetinib-GDC-0941 (4-1 mol-mol),-0.5128697942190128
VCaP,12003241,1.0138144203532238
ST486,6505803,1.144321831733621
Jurkat,5460769,1.807388363251775
MDA-MB-435S,selumetinib-GDC-0941 (4-1 mol-mol),0.7675119040231712
SW1990,9927531,5.3345214594202695
JURL-MK1,8515,2.887291129545749
PC-3,168313200,3.1941153689733137
MHH-ES-1,12003241,-1.3957716684214538
NCI-H2405,36462,2.5920366371132295
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
COLO 678,6610216,4.078758372603592
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
CAL-33,9936388,-7.915687157978736
SU-DHL-1,9927531,2.969590320438058
SNU-119,439501,-2.3303537311085143
8305C,439501,-2.556096692618791
OCI-AML-5,107985,-4.549772728055964
SCC-25,10296883,3.5302402637637145
NCI-H1975,8515,2.4112113946369824
SCC-25,6505803,-1.2912802856416608
8-MG-BA,11485656,3.634324102236689
OV-90,49836020,4.456425733691278
DMS 79,3689413,-2.460389219665011
Hs 944.T,selumetinib-GDC-0941 (4-1 mol-mol),0.0800181936999451
BT 112,12003241,0.1954695576836523
Capan-1,3689413,0.3362458713829924
COLO 201,11485656,2.5416615004104237
786-O,107985,-3.3525447115072113
OVTOKO,12003241,-1.0973416897014734
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
FTC-133,44493528,6.31419839504633
WM266-4,148124,3.1567402822869006
KYSE-410,148198,-1.166924431681682
Caov-3,409805,4.119200456986889
KMRC-3,36462,3.377440322331922
Jurkat,44491742,-1.1697965410945943
HT-55,selumetinib-GDC-0941 (4-1 mol-mol),0.6831799344698409
Hs 294T,9936388,0.7679572566977205
G-292 clone A141B1,439501,-3.0998279845902723
TE-15,24180125,5.117300850152298
NCI-H520,11485656,2.0255953186148674
8-MG-BA,6505803,0.3942705554258823
A-253,6610216,4.2278797808455595
NCI-H1184,107985,-3.039102604454098
BT 147,9936388,1.2294480842266318
SNU-1105,6610216,4.763085557010596
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
BT 504,439501,-3.1394850364876907
Hs 729.T,135423438,2.291077671494273
T98G,54618164,4.528778720409905
BT 440,9936388,1.094365580931073
HuP-T3,5460769,4.291069487745317
BL-70,26596,-3.7588271568583953
GSS,12003241,-1.231369265985878
KYSE-150,107985,-3.63550255760894
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
NB1,selumetinib-GDC-0941 (4-1 mol-mol),2.4185204185307527
SHP-77,6610216,4.505956352880749
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
CCK-81,selumetinib-GDC-0941 (4-1 mol-mol),1.1249387686067662
HCC78,selumetinib-GDC-0941 (4-1 mol-mol),2.9308548857555303
NALM-6,135875424,2.687254524498793
DU4475,46943432,1.711697790565195
EFE-184,9936388,2.4089760191608462
BICR 6,148124,-7.961236400149058
NCI-H196,11485656,3.8330163114503337
BT 248,409805,5.374494739188799
Lu-99,439501,-2.3036425217634395
SNU-878,3689413,0.601904749344492
SK-LU-1,JQ-1-carboplatin (1-1 mol-mol),2.4628830674055933
Becker,11485656,3.616159279519061
TCCSUP,6505803,-2.3370703799020323
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
HSC-4,5460769,1.9290612526481368
TT,11485656,1.9272227240338475
MCAS,12003241,0.5308085719616568
SH-10-TC,439501,0.97642019578469
CCF-STTG1,3689413,0.3028996084806184
NCI-H520,135423438,3.6436020684370463
FTC-238,11485656,1.7631950190895933
Li-7,3689413,2.782987463580999
SU.86.86,11485656,2.809673440388426
Hep-G2,135875424,4.631021258019282
VMRC-RCW,107985,-3.1958686120278847
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
NCI-H1623,44493528,4.638812765070766
ESS-1,439501,-2.0978778954241215
MKN1,44491742,4.1588945650125355
CCK-81,3689413,0.410216547608945
UM-UC-1,9903786,1.5514700820318568
LOX-IMVI,439501,-2.207275092585139
TTC-709,JQ-1-carboplatin (1-1 mol-mol),1.695991072597723
FTC-238,6505803,0.5896695785026528
LOX-IMVI,44491742,5.895851784959737
639V,3689413,3.093093365439167
ESS-1,9927531,5.52249907084491
IGR-39,9936388,0.7486960389852466
Ci-1,5460769,3.784060470776022
HeLa,12003241,1.4760559160729645
HGC-27,8515,2.5882195628771565
SNU-1272,409805,6.302573635067764
G-402,6505803,-2.2482825610741095
Kasumi-2,135423438,1.5853456579896534
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
Hs 940.T,168313200,2.06590708272712
HPAF-II,9936388,2.7106140569939097
BT 498,409805,5.970409290821295
T98G,9936388,2.8447022467541956
U2OS,107985,-5.01906931244061
OC 314,12003241,-2.177807668538587
T-47D,11485656,3.194758516284648
NCI-H1355,5460769,3.1635335423218907
OVCAR-5,24180125,3.2133850290549453
MDA-MB-468,148198,-4.179391115817734
EB1,11485656,1.3368120139710602
COR-L51,JQ-1-carboplatin (1-1 mol-mol),0.8526356625711052
EB1,9927531,2.850216647233053
TOV-21G,3689413,-2.863324096900296
CA46,439501,-3.521132637790176
HT-1376,36462,3.4187537470401654
T98G,168313200,3.906117729639882
NCI-H1666,5460769,-0.3925578984877662
ST486,JQ-1-carboplatin (1-1 mol-mol),-0.3320701641895573
SR,439501,-3.204976665793822
NU-DUL-1,54618164,3.711799821766253
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
AM-38,9936388,-6.913644192260965
LK-2,439501,-2.6408972828107053
RL95-2,44493528,4.087337574657741
MOLM-13,36462,-3.0478349617512466
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
CAL-78,439501,-1.7848444921283717
BT 333,44491742,4.348369839159046
KMS-12-BM,148198,-2.3401169496211778
NH-6,8515,3.897866563890799
DEL,54618164,3.780724488131313
A-673,44491742,3.844993574977925
HCC1195,6505803,0.0153756164057107
HuT 78,12003241,-1.0527217193191982
YD-15,9936388,-5.281829985034155
NCI-H1694,9903786,3.3065111756665564
NCI-H810,3689413,-2.3374294855019566
DBTRG-05MG,6610216,4.298255841710492
SNU-668,6610216,4.4411016597411095
KU-19-19,148198,-3.572091199224797
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
JHH-4,168313200,3.853941558159315
SNU-182,9903786,3.6716358007160546
BV-173,11485656,1.9026592403549776
HPAC,5460769,1.6003677750846823
CAL-85-1,148198,-3.2727903710905744
NCI-H23,6610216,4.207957061685163
A-673,36462,-0.225010248526114
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
SNU-899,409805,3.7254900165561193
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
NCC-StC-K140,11485656,0.9204064726485376
Capan-2,44491742,5.038963412977017
MHH-NB-11,8515,2.6125195663266183
SK-N-DZ,26596,-3.5191168188453603
SNU-387,8515,4.093986926326484
MCF-7,JQ-1-carboplatin (1-1 mol-mol),-0.3789372065214004
NCI-H1693,6610216,3.7517214461557193
KP-N-SI9s,26596,-1.674008327181718
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
NCI-H1581,6505803,1.0030627815723745
Lu-65,10296883,3.98979643435714
COLO 320,135875424,2.711405074162338
NCI-H1838,selumetinib-GDC-0941 (4-1 mol-mol),2.2361071015638445
M-07e,JQ-1-carboplatin (1-1 mol-mol),-0.796008398970337
DMS 79,JQ-1-carboplatin (1-1 mol-mol),2.1232478586327215
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
A2780,5460769,-5.6757466443406575
OC 314,9927531,4.337134005776663
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
T3M-10,6610216,4.111876884549565
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
HuG1-N,44493528,4.884146273169327
KU-19-19,5460769,4.3332822587900255
ESS-1,9903786,1.7886366060040666
786-O,148124,-4.286157152066718
OUMS-23,409805,3.624784880015449
JURL-MK1,9936388,-6.026953880051591
AN3-CA,36462,2.7690899161359774
JHH-6,3689413,0.376454666699167
NCI-H292,6505803,0.1482155149138876
JHOC-5,9903786,4.996792602991681
JM-1,9927531,4.0230036766634125
EFM-192A,148198,-2.4678841503843363
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
SNU-C1,3689413,-0.1776191587992591
PF-382,439501,-2.5741395884768377
SET-2,6505803,0.5122894661821437
A-172,107985,-3.900201208452829
Ri-1,159324,0.7122942359336857
SCC-25,409805,3.725109800952581
HCC1806,9936388,-6.293878706667742
YH-13,11485656,3.672447929172867
SK-MM-2,24180125,2.1802693421852943
SW620,9936388,-0.3653098163020092
MDST8,9936388,-2.5080849755955485
HEL,439501,-2.350875236844296
HPB-ALL,44491742,4.0686707496415835
BT 422,148198,-4.041161285965411
FU-OV-1,6505803,0.8019489696335256
LAMA-84,26596,-2.1995969037049936
CW-2,12003241,0.1847256343211754
OCI-AML-5,JQ-1-carboplatin (1-1 mol-mol),0.5116033389333992
LS513,107985,-2.540628881225553
Rh30,168313200,3.8308139252747737
CML-T1,439501,-2.361432010025089
BT 232,10296883,4.252681745204764
NCI-H2023,54618164,3.138297226755115
SNU-886,6505803,-0.0303295506780238
A-375,11485656,2.720000014361131
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
NCI-H292,54618164,4.184972812062346
NCI-H23,11485656,1.2913107211319887
VCaP,JQ-1-carboplatin (1-1 mol-mol),-0.2826597777645429
Hs 683,9903786,4.056971165383086
HuNS1,JQ-1-carboplatin (1-1 mol-mol),1.1759253044065412
CAMA-1,135875424,4.608485379364883
BICR 16,5460769,4.333999441494942
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
HCC2108,54618164,5.127082823492277
NCI-H810,439501,-2.873270400537551
Calu-3,selumetinib-GDC-0941 (4-1 mol-mol),0.8119052170432226
HPB-ALL,3689413,0.032224825554501
K-562,439501,-2.3563528898814905
NCI-H226,159324,5.235188537951406
GaMG,159324,3.8399876349206634
OVCAR-5,135423438,1.1993513830056843
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
NCI-H1838,36462,1.5494898748578776
MM1.S,5460769,2.129502129742311
NCI-H358,24180125,2.9959066083616
NCI-H1385,9936388,1.359050451063743
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
KLE,6610216,4.690158924143472
HuG1-N,JQ-1-carboplatin (1-1 mol-mol),3.9513233413995983
HeLa,3689413,0.6540693787829278
253J-BV,409805,3.806048297229197
CAL-51,168313200,3.900876548563449
KNS-42,9927531,5.582016236081196
HuH-1,6610216,4.319132810982458
CAL-78,10296883,4.297149072748996
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
HuNS1,26596,-3.648585672469648
NCI-H2122,9936388,-2.3512808318812555
SU-DHL-10,168313200,3.8517286241032327
EKVX,11485656,2.7917254369423055
ESS-1,12003241,-1.211695248693708
NCI-H526,107985,-2.411297633681474
HCC1588,49836020,4.436779912961811
DND-41,46943432,1.2374312030796195
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
BV-173,selumetinib-GDC-0941 (4-1 mol-mol),0.1025224911363418
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
Karpas-299,135875424,2.3425369765707913
SUP-HD1,409805,3.5122766692776852
KMS-34,JQ-1-carboplatin (1-1 mol-mol),-0.8418856206446907
786-O,54618164,4.145734663592518
JM-1,6505803,0.12933264701109
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
253J-BV,439501,-2.3122827098315515
SHP-77,9903786,4.085318424686739
KP-2,135875424,4.758790844331061
MOLP-8,24180125,2.8280981087253605
Capan-2,135875424,4.579171720877857
OE21,6610216,4.168001578531245
MFE-319,9936388,3.279926844383342
RCH-ACV,409805,3.911784107181204
Calu-1,44491742,5.4818200754646
Mel JuSo,148198,-2.598455094519584
HEC-1-B,9903786,3.578370658582295
BICR 31,6610216,4.499990209090508
NUGC-4,9936388,-5.886331938622264
MOTN-1,JQ-1-carboplatin (1-1 mol-mol),-0.1739413245124559
HL-60,44493528,4.339853474381488
G-402,12003241,-1.3833657940583168
A3/Kawakami,148198,-4.4977809283586865
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
SF126,36462,1.4248363949575364
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
SF539,9927531,4.183842431586729
BICR 18,12003241,0.2549770836209779
G-402,36462,0.8225931821467894
RPMI-8402,148198,-4.480624262249758
EM-2,11485656,1.7010188292526576
Hs 936.T,JQ-1-carboplatin (1-1 mol-mol),2.819300005463285
TE-11,135875424,3.5127349276031996
BICR 56,selumetinib-GDC-0941 (4-1 mol-mol),-1.0561550719087085
TF-1,148198,-5.222866140328133
NCI-H1341,6610216,3.743623323763183
PE/CA-PJ41 (clone D2),9936388,2.7789010886628422
PK-1,10296883,4.277974392891681
F-36P,5460769,6.312488647887553
NCI-H716,148198,-5.232540582479685
253J,6505803,-1.7434391894499837
FTC-238,44493528,4.472163529420613
LNCaP clone FGC,168313200,2.110708126530363
DMS 114,135398744,6.443015881513616
Hs 294T,6610216,4.3443465389355715
OCI-M1,44491742,3.801673396413645
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
KMS-27,6505803,-0.687237988201334
NCI-H292,8515,4.694095877434875
RCH-ACV,9927531,3.1896486071629724
LXF 289,12003241,-2.348837864712453
SKM-1,107985,-4.676728901872281
KHM-1B,159324,1.2436512528819574
IGR-39,5460769,4.0932684480850074
A-549,36462,3.3558444938413707
SiMa,JQ-1-carboplatin (1-1 mol-mol),1.754117349948639
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344
KMS-18,439501,-2.5838956635173287
KYSE-410,44491742,3.6208474241241473
HSC-4,10296883,4.12801319058873
BT 504,24180125,2.722819243904145
KMH-2,9903786,1.3660293069385576
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
MSTO-211H,6505803,-0.0669493563910609
EM-2,135875424,3.8606951218736287
SNU-1214,11485656,2.376217579776436
HCC44,46943432,0.5777599911467732
HCC366,44491742,5.047439553601353
OVCAR-4,3689413,-2.062187861989016
COR-L105,6505803,1.059348129706536
HEC-1-B,JQ-1-carboplatin (1-1 mol-mol),0.0800794652195035
SNU-899,135875424,3.6622876573155336
Mel Ho,409805,3.6793455853418497
MKN74,409805,5.7612246650948356
OUMS-23,46943432,4.9765962498164855
SK-N-DZ,5460769,3.5679680619882617
A2058,26596,-1.435799382276171
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
A101D,24180125,2.7039616559486706
KMS-21-BM,JQ-1-carboplatin (1-1 mol-mol),-1.6939988291679535
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367
NCI-H841,44491742,3.87806302811964
A-375,107985,-3.1836628445194592
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
HCT 8,9936388,2.3288203761031885
PF-382,135423438,0.1628237790601052
Peer,3689413,-2.558911360370697
Lu-65,107985,-2.4100126884744015
SNU-503,168313200,2.972776504185133
NCI-H1573,24180125,3.4680270269053173
SNU-175,159324,0.7701191527474731
NCI-H1693,12003241,-2.0700110042259072
YKG-1,3689413,0.6324676509110861
NCI-H28,44493528,4.782322739725782
OCI-AML-3,9903786,2.1236549190588097
KLE,11485656,3.08308998793154
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
BT 504,409805,3.844578236593203
OVCAR-4,135398744,7.790531663529689
G-292 clone A141B1,selumetinib-GDC-0941 (4-1 mol-mol),0.4997156895846377
RD,409805,3.088380106022685
NCI-H358,439501,-0.5524451893811123
SK-LMS-1,135875424,4.759949001069946
TOV-112D,148198,-4.684933210891632
MSTO-211H,5460769,-2.0887143253822615
Panc 08.13,6610216,4.173498185647784
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
HLF,409805,3.842162011075353
JHOM-1,selumetinib-GDC-0941 (4-1 mol-mol),2.18755430310554
WM88,54618164,3.999670280417755
LS411N,46943432,5.879073426568822
NCI-H2286,9936388,-4.7248658959842
HCC1438,36462,1.679262377304474
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
MOLM-6,3689413,0.3128747542373787
SKM-1,3689413,-2.418262014134033
HCC2218,JQ-1-carboplatin (1-1 mol-mol),4.076746377800596
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
TCCSUP,36462,2.278863397956304
LOX-IMVI,3689413,-4.023880524547255
K-562,409805,3.7514940654800064
F-36P,44491742,3.961170859118446
NCI-H1869,44493528,4.333760189181675
RERF-LC-Ad2,439501,-3.088259445062755
Ku812,49836020,4.574644913995472
HT115,11485656,1.923791762912221
GaMG,409805,3.7457473501027394
MHH-CALL-3,8515,3.3812196301764104
SNU-449,54618164,4.194291334344069
L3.3,10296883,4.354494828099719
COLO 201,6610216,4.151677108273465
WM266-4,8515,5.000160733889161
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
MOLT-16,148198,-4.088839016877876
SNU-46,12003241,-0.9132341104689335
BC-3C,9927531,5.131139518306293
SEM,439501,-3.163159816591066
SF295,11485656,3.5430104374180806
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
SNU-620,439501,-2.3713510132267923
SK-UT-1,135875424,3.143376991018657
BT 504,168313200,1.7545727786068688
HT115,JQ-1-carboplatin (1-1 mol-mol),2.098973716553155
REC-1,11485656,4.187438515257482
NCI-H838,439501,-0.7442992299750818
NCI-H1581,6610216,3.4507986270156965
BT 359,6610216,4.170909037500597
KMS-20,54618164,3.4319678497850705
LCLC-103H,159324,3.784520620712173
RMG-I,135875424,4.352584072598887
EC-GI-10,107985,-2.914072916658783
HuG1-N,5460769,5.358196013663695
PaTu 8988s,9927531,5.1297297992623605
697,6505803,0.3097004019947232
SF295,439501,-2.4386536619135137
SK-N-SH,10296883,3.689781558622769
LAMA-84,8515,3.598543173895061
BT 248,6610216,3.912037893092857
SK-N-BE(2),10296883,3.8653649395268896
JVM-3,73707440,6.054081463346775
SNU-1076,107985,-2.9776717311334777
PE/CA-PJ49,9927531,5.215467759359
SNU-685,148198,-4.368451814809559
Kuramochi,159324,3.3473872153511164
NB1,9903786,2.052998466280315
T24,26596,0.1047033051772514
BICR 56,135875424,5.509002498442888
KMRC-3,6610216,3.658221932699825
OAW28,44491742,4.754653012158477
Caki-1,135875424,5.125575206992357
G-361,12003241,-2.5867066735550623
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
COLO 678,168313200,3.5853655224611907
COLO 201,44493528,5.016521655582729
PANC-1,26596,-1.3824156046290312
FU-OV-1,168313200,1.721890351327649
HuCC-T1,8515,3.548265730968943
BT 271,36462,1.9954282482695451
KMRC-20,12003241,-0.2043728031762648
NCI-H211,5460769,0.8923450706014173
OV7,9927531,3.7573149322821937
NCI-H2228,135423438,0.7954817184322217
SK-MEL-30,10296883,3.708722133804856
CAL-29,159324,3.720645478916591
MOLT-13,107985,-3.8104926329516857
A-549,159324,3.3469799601732366
Hs 852.T,36462,0.4490530549542245
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
23132/87,24180125,3.7531790021712994
DV-90,10296883,3.593064780015178
MG-63,409805,5.820012776028697
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
NCI-H2085,6610216,4.266678057471213
KMS-18,26596,-1.560934239345236
NCI-N87,159324,0.0331676951949142
KMRC-20,148198,-1.1031106323256945
NCI-H1623,11485656,1.644044907667622
BT 179,9903786,4.337350994333445
CAL-12T,107985,-2.701919142348095
SNU-1,6505803,-3.5096009035536593
Panc 02.03,135875424,4.996461687769912
2004,selumetinib-GDC-0941 (4-1 mol-mol),4.378845407517423
SNU-1105,439501,-2.4533098010215024
TUHR10TKB,409805,5.937613129628935
EPLC-272H,9903786,1.2271384419186997
MOLT-13,168313200,3.2034774165201236
NCI-H2110,9927531,4.774812830583443
UO-31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0895128254081629
MV4-11,6505803,-4.621529690475533
NALM-6,8515,2.281297065499861
NCI-H1703,26596,-2.7803694480879857
8-MG-BA,44491742,6.487107858540147
KYSE-140,159324,2.642529178463094
SCC-25,159324,1.9288959923249809
KMS-12-BM,439501,-2.5993845366115016
MSTO-211H,409805,4.793476239157615
NCI-H810,168313200,1.5895353190591883
BT-12,135875424,5.671526751726921
DV-90,46943432,2.0897997474065484
OVTOKO,6610216,4.538768148253175
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
COLO 699,12003241,-1.6460659518938752
SCC-9,107985,-2.37702169012632
ESS-1,135875424,3.182582939188363
IGR-1,selumetinib-GDC-0941 (4-1 mol-mol),0.2767905376035742
NALM-6,9936388,-6.74372502576803
MDST8,9903786,2.958137426904596
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
HCC202,409805,3.852512528644294
OE19,12003241,0.3915460727280876
MDA-MB-231,49836020,-4.061290256388782
TE-6,9903786,2.448917190367821
BT 340,439501,-2.6874072240019617
BxPC-3,135875424,4.118804534986376
U-BLC1,6505803,-1.6216028529729
A4/Fukuda,9903786,0.7546004224414102
SK-LMS-1,3689413,-2.0473825870324935
SU-DHL-1,11485656,1.6397040363022437
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
OS-RC-2,135875424,4.485922096178854
HD-MY-Z,44493528,4.44799186118661
TE-9,159324,3.4565682419203827
OCI-Ly10,12003241,1.0181729921478868
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
Hs 729.T,54618164,4.299572624294171
KP-N-SI9s,135398744,6.4391278360731246
SNU-449,439501,-4.772752939359215
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
KP-2,44493528,4.335007894737588
Ishikawa (Heraklio) 02 ER-,9936388,-5.11124273822625
EB1,6505803,0.7002035239944829
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
DV-90,409805,3.719667841684698
U-251MG,9927531,5.06166571476347
T3M-10,148198,-1.9174912256431331
BT 422,107985,-3.238764101436753
A-549,168313200,3.5389649746345815
DU4475,selumetinib-GDC-0941 (4-1 mol-mol),-4.053577940845995
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
KYSE-70,6505803,-1.025033993677824
EFM-192A,3689413,0.6464751811970497
BHY,135423438,4.398718869974742
LOU-NH91,24180125,2.532676427085935
NCI-H1092,6505803,2.777743929422052
SNU-308,409805,5.466137259646633
SR,12003241,1.5749280257994038
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
SNU-216,11485656,2.7250861397389463
KMRC-2,44491742,3.971638428490517
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
KP-N-YN,44491742,4.254136072994776
OAW28,54618164,4.207465894202405
MHH-CALL-4,26596,-1.7349356502662407
NB4,11485656,1.2735256596960405
BHY,9903786,2.1017831140065844
SK-UT-1,54618164,4.334674071191232
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
SF126,73707440,4.55142805783094
KMRC-20,11485656,3.1191450490376673
RVH-421,8515,4.612413055321368
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
NCI-H2291,46943432,2.103514044788886
BHY,49836020,5.6544174202433855
PSN1,26596,-0.5365301326145567
SK-MEL-28,9936388,2.4934378473061902
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
HH [Human lymphoma],44491742,2.6350452695028888
HCC2279,439501,-2.2925635815610006
Hs 578Bst,24180125,2.67706598994645
NCI-H1092,439501,-3.60207444945155
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
NCI-H526,11485656,2.2032947019554627
SNU-1272,9903786,4.921324329124853
RS4;11,439501,-2.445140752441031
CL-11,9903786,2.342392371257784
GP2d,439501,-1.2526235353612607
Capan-1,54618164,5.43601274442026
EBC-1,24180125,2.7534112587240194
ACC-MESO-1,159324,5.7222118158510344
COR-L51,439501,-3.194299942621501
NCI-H2444,11485656,3.180889910704459
Hs 611.T,49836020,3.6507368971801983
NCI-H1339,JQ-1-carboplatin (1-1 mol-mol),3.0025540987138326
BV-173,135875424,3.775066116863956
AML-193,439501,-3.193215284595587
HeLa,135875424,4.463353648372455
AN3-CA,6610216,4.1751650141546826
NALM-6,selumetinib-GDC-0941 (4-1 mol-mol),-0.5223211713783823
GDM-1,26596,-2.9755879350812964
DU145,135875424,4.588838795967896
BHY,11485656,2.162098397654175
QGP-1,11485656,2.192012938394494
AN3-CA,9936388,-6.467722299824651
OV7,5460769,0.8621725528933663
YD-10B,9903786,0.9692609848682356
AML-193,9927531,3.384669993922374
MOLP-2,6610216,5.084956215990001
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163
Hs 729.T,9936388,1.6599440767787133
TE-1,409805,5.040342242889771
HT-1080,6610216,3.897305485410011
KMS-34,6610216,3.222571288765256
KP-2,9927531,5.1844073401368735
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
P12-Ichikawa,5460769,2.2031078708702196
Karpas-422,11485656,3.579952167071255
DMS 114,5460769,0.4207237171136718
KYSE-410,107985,-2.92528025460227
MeWo,148124,3.0579930768236863
SH-10-TC,409805,5.166085352116196
BT 179,10296883,4.29112387952489
OVCAR-5,36462,3.071671268495135
NCI-H727,3689413,0.3749801507161196
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
PK-1,11485656,1.889467088034988
NCI-H322,12003241,-0.9727084564838948
SK-ES-1,148124,-6.718341740227861
OCI-AML-5,439501,-3.3473386459158583
NCI-H929,8515,3.198792100225454
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
COR-L47,9903786,1.6785820828918676
MCAS,8515,4.589748627719716
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
LOX-IMVI,135398744,6.429324407359154
NCI-H1155,135423438,2.3311426063926795
HEC-265,409805,6.072404202005754
VMRC-LCD,36462,3.4209043337731475
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
SW579,54618164,4.076406400124359
OV7,54618164,3.910711080289417
HDQ-P1,3689413,0.8200542052424229
OUMS-23,24180125,3.5739287540168276
NCI-H460,9903786,4.057661845653794
OC 314,6610216,4.261307355993507
SK-MEL-5,439501,-0.7759362068872153
SCC-25,168313200,2.150051154835275
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
MPP 89,9903786,4.435706117930943
PE/CA-PJ34 (clone C12),36462,2.153519991196826
NCI-H1915,3689413,1.3727527679359948
THP-1,44493528,4.188998476775423
NUGC-3,9936388,-6.309971467031446
BT 145,49836020,5.352704973250576
SNU-410,439501,-1.2001719961376376
SK-MEL-1,8515,3.632622061872653
LS180,159324,3.258862193159196
YD-8,107985,-2.331165064329628
SNU-869,3689413,-0.5659806105186423
NCI-H1666,24180125,3.343290006666379
COR-L88,9936388,-7.008316023847794
JVM-3,159324,-3.4640255837437333
CAS-1,159324,3.5765163905763577
SNU-1076,6505803,0.872724284931209
SEM,44491742,3.581981402307046
SCC-25,148198,-2.3874045507068895
KO52,107985,-4.972333164700203
Ishikawa (Heraklio) 02 ER-,135423438,4.463987581910629
NCI-H1105,135423438,2.0106385414009025
WM266-4,selumetinib-GDC-0941 (4-1 mol-mol),-1.002003549431085
Namalwa,3689413,-2.4943268400148715
LAMA-84,9936388,-4.994244165866005
PE/CA-PJ15,5460769,-0.4178373813349113
TOV-112D,54618164,4.105272858221818
SNU-478,36462,0.5519411952993932
EB1,24180125,1.0511946414672848
Sq-1,3689413,-2.2869880122730755
NCI-H1869,9927531,5.985290716685452
Hs 683,12003241,0.8693905406704602
MOTN-1,44493528,4.082381508431214
MCF-7,24180125,2.9305572287480466
HT-55,439501,3.0049152055175377
KYSE-140,9936388,1.9603983153875792
Caki-1,11485656,3.9506876057193456
SJSA-1,9927531,4.886165341408575
NCI-H647,9927531,5.004225610104877
KMS-21-BM,5460769,1.875881845654493
NCI-H524,159324,-0.4298723686665758
NCI-H2342,selumetinib-GDC-0941 (4-1 mol-mol),3.1490507666269307
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
YH-13,36462,2.0221735206643743
FaDu,11485656,1.8671846861559669
TTC-709,3689413,-2.3273701449747985
2004,5460769,0.3983589325904631
NCI-H1703,selumetinib-GDC-0941 (4-1 mol-mol),1.0120925414359212
EKVX,107985,-2.844082179808488
TCC-Pan2,JQ-1-carboplatin (1-1 mol-mol),1.852597236843256
Hs 895.T,148124,5.776719693412514
NCI-H2126,409805,4.003964998224064
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
NB4,10296883,3.07920263263956
MKN74,9936388,-0.1480822399843773
G-292 clone A141B1,5460769,2.9316291773021095
SCC-25,JQ-1-carboplatin (1-1 mol-mol),0.0141568039533375
SNU-201,409805,5.283587417567222
A4/Fukuda,12003241,-4.192136354440014
Panc 03.27,9927531,5.182143526242967
DMS 114,26596,-1.464727194464046
OVCAR-5,JQ-1-carboplatin (1-1 mol-mol),2.2287915879849116
ST486,409805,3.877677170131383
A3/Kawakami,8515,2.8179142633064416
OV7,409805,3.837815164614596
DB,36462,0.0092957670554277
SNU-119,54618164,3.949548457526877
SNU-886,9927531,4.416743823533711
HEL 92.1.7,409805,5.884627411024845
NCI-H2228,12003241,-0.7511130172017173
GP2d,24180125,3.074858377776044
NCI-H508,439501,-0.5256588079382335
NALM-6,54618164,3.178026109202162
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
C2BBe1,409805,3.7621977562133178
COLO 678,9936388,0.9023900644309476
P12-Ichikawa,9936388,-6.7424079460419435
OVSAHO,148198,-1.8727352509545991
Capan-1,409805,5.822948169887318
SW1573,54618164,4.339091959582753
NCI-H2030,44491742,2.996823060755576
Namalwa,44493528,4.097758002058851
MOLM-13,73707440,5.976327057082507
JHH-2,JQ-1-carboplatin (1-1 mol-mol),3.497557537915234
SNU-C5,409805,4.287269505497504
SNU-466,3689413,-2.151085855485809
TE-11,9903786,1.6089543664279713
Hs 688(A).T,11485656,3.741191414447006
SH-4,44491742,3.636684434382026
TE-5,44493528,4.238536644603732
MCAS,159324,3.426184358584357
COR-L105,107985,-4.244896937866387
IGROV-1,159324,2.8766947154825044
EJM,9927531,5.060130602494636
EFO-27,148124,2.931737870457193
NCI-H1573,107985,-3.560448544788339
G-402,JQ-1-carboplatin (1-1 mol-mol),0.5216010908440976
MOLM-13,46943432,-0.154947866345158
COV644,148124,-1.3281170130186468
NUGC-4,8515,3.8971798863642615
EFO-27,11485656,3.240498776862908
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
SNU-407,159324,1.4869936104521508
Hs 294T,JQ-1-carboplatin (1-1 mol-mol),4.214438557750139
WM793,11485656,2.688663515558037
MDA-MB-361,9927531,5.403888941869855
T24,5460769,2.1302621758873435
JHUEM-7,439501,-3.5721158792487646
KYSE-180,107985,-3.532250408088534
NCI-H929,36462,0.845260564861955
JVM-3,6505803,-1.4044558034159191
IST-Mes1,9936388,2.2275468363886763
T98G,24180125,5.608131007588369
BT 159,11485656,3.350505147528576
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
JMSU-1,54618164,3.9923887768961306
HMCB,439501,-1.1140754693945072
NCO2,8515,2.809674810948928
BT 340,24180125,3.546136736356622
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
BT 231,8515,4.035696345547394
IGROV-1,168313200,3.9938362637732983
TE-5,JQ-1-carboplatin (1-1 mol-mol),0.6958191987342512
Kuramochi,11485656,3.4177082965516328
NCI-H358,54618164,3.951567695583077
SUP-B15,107985,-3.9741449173851935
JHUEM-3,54618164,4.177522311849136
OUMS-23,54618164,4.001891095185354
CML-T1,12003241,-4.650247315633356
EFO-27,107985,-2.474640150808475
BT 112,409805,3.8696760433856774
SW1116,54618164,3.73631090457485
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
HT-144,6610216,3.8777683523486544
HT-29,148198,-0.9587327064995448
RL95-2,135875424,3.9099028993279905
EKVX,8515,3.3740935192492594
BT 320,6610216,4.229919303269505
BT 416,9936388,-4.783265609756594
HT-1080,3689413,-2.4389842103983583
HPAF-II,3689413,1.4854609616797476
MDA-MB-453,11485656,1.765591398344026
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
CCK-81,107985,-4.087159220561304
Hep-G2,54618164,4.2874336189086115
SU-DHL-1,9903786,2.5464454731205777
UM-UC-3,44493528,4.3547377371063405
MKN74,54618164,4.583505133133128
ONS-76,9936388,2.029236983033262
NALM-6,409805,3.549692379883557
EC-GI-10,26596,-3.5687172078755087
SNU-1214,3689413,-0.7711373431609502
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
A-549,36462,3.3558444938413707
SHP-77,36462,5.483645487837697
KMS-11,44491742,3.7132617808424704
EM-2,9936388,-5.706813199670236
A-375,9903786,2.3118659059614877
SK-ES-1,24180125,2.2207898097627856
NCI-H841,9927531,4.161760245261401
JL-1,54618164,6.423495302629067
EPLC-272H,selumetinib-GDC-0941 (4-1 mol-mol),-0.4942695564653549
HuH-6,6505803,-0.5786152978547117
SNU-387,9936388,2.7868328011584924
Yamato-SS,46943432,2.439746234122117
HuP-T4,49836020,4.250504685299003
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
BC-3C,5460769,2.335900284678582
SNU-119,36462,1.6001107706429532
MOLT-16,36462,-3.6278358680314136
WM88,148124,-3.466813167585588
TF-1,36462,0.8023388746533783
A-549,6610216,4.4512033607640475
OPM-2,439501,-4.648238189793765
HSC-2,9927531,4.076262005833891
HCC1569,46943432,3.698021495912772
SCaBER,26596,-1.7174475471543391
JL-1,10296883,4.327951566443025
697,3689413,-4.592685729606217
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
BHY,107985,-3.391565745275974
CAL-33,439501,-2.9579708224622423
KYSE-450,148124,3.78473118264584
MKN1,JQ-1-carboplatin (1-1 mol-mol),4.3566594896883934
BT 286,10296883,4.151589590813863
SYO-1,9936388,-7.327541769991975
M059K,9936388,1.0319872180787746
A2780,439501,-2.4090624878410316
HGC-27,3689413,-1.6532214726359813
OV-90,6610216,4.14944929140681
TE-9,439501,-2.406207557642534
T98G,JQ-1-carboplatin (1-1 mol-mol),2.716924678196497
B-CPAP,135875424,3.307629887397838
Granta-519,9903786,1.2937892753152922
SEM,54618164,3.8944596685913138
IGROV-1,439501,-2.1510551928674557
BT 145,8515,4.164809683477465
MOLP-8,439501,-2.9296652389863267
ALL-SIL,9903786,1.532435199339551
COR-L51,168313200,2.5521907876771848
HDQ-P1,selumetinib-GDC-0941 (4-1 mol-mol),1.336429644847675
BL-70,JQ-1-carboplatin (1-1 mol-mol),0.8530226058768635
JHOM-1,12003241,-1.2744243269669069
VMRC-LCD,54618164,3.9757148680155887
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156
SNU-175,6505803,-3.2820452967658778
A-172,49836020,6.443724072404216
CAL-120,409805,5.416377125024685
LN-229,6610216,5.1587041728274485
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
TTC-709,46943432,2.6440206287673513
FU-OV-1,46943432,0.7627718951481175
MCF-7,6610216,4.526807222364515
CAL-12T,selumetinib-GDC-0941 (4-1 mol-mol),2.008414160334409
HCC1395,409805,3.7256484492152087
BT 359,44491742,4.570849750938812
LMSU,10296883,4.275438301361486
KMRC-1,10296883,4.079927671527966
Kuramochi,6505803,3.382467599706822
SK-MEL-3,9903786,4.6944360721993545
CHP-212,9903786,1.1399886841606115
PaTu 8988t,6505803,-0.6279165545759258
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
Hep-G2,159324,2.69530902129888
NCI-H1568,49836020,3.1231470101883336
NCI-H841,selumetinib-GDC-0941 (4-1 mol-mol),1.7546401329299928
SR,159324,2.6135427463918885
BT 498,135423438,1.8216974125096568
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
Kuramochi,6610216,4.865432129789608
MG-63,9927531,4.972527766781062
BT 224,409805,5.8322302656386045
NCI-H2087,36462,0.787608907647275
KMS-27,3689413,0.1610585283674763
KYSE-150,135875424,2.978740895797715
Ki-JK,135875424,2.2623198423416255
HCC1395,5460769,2.101928934987084
BT 416,409805,6.33771322760139
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
OCI-M1,36462,0.2408416750567704
SNU-475,5460769,3.649857099977848
LMSU,54618164,5.037763382519864
CAL-51,148198,-3.728190383000159
SUP-HD1,6505803,-0.2605550921206995
OUMS-23,9936388,1.0481650973608996
MFE-296,439501,-3.0642012902552
HCC1937,54618164,4.424914641372808
BT 164,148198,-5.587345118223356
SK-MEL-31,439501,1.7901681191985463
HCC1937,44491742,5.446943100232909
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
NCI-H226,9927531,4.418189277296578
Hs 936.T,54618164,4.395374360312425
BT 444,selumetinib-GDC-0941 (4-1 mol-mol),1.0784151115799612
EN,9903786,3.730384858671513
SNU-398,11485656,1.495673016865192
HH [Human lymphoma],54618164,2.9270787065962733
RT-112,9936388,-6.676830833959952
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
TCCSUP,54618164,4.281824636120867
AN3-CA,JQ-1-carboplatin (1-1 mol-mol),4.617910971387189
T3M-10,JQ-1-carboplatin (1-1 mol-mol),3.984166000628971
NCI-H838,409805,3.793714806116016
NCI-H1869,12003241,-1.5114527115730307
HCC1195,9936388,-5.972335548961908
BT-12,3689413,-1.6226385767572318
MOTN-1,135875424,3.06502770536401
HCC1937,5460769,4.797106987757637
MV4-11,409805,3.572823269874292
VMRC-LCD,107985,-2.7871276455414273
BT-20,439501,-1.326762104121763
KNS-60,selumetinib-GDC-0941 (4-1 mol-mol),3.6071015552128873
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
SK-OV-3,12003241,-1.2313805329375749
Ri-1,3689413,-2.346816387466721
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
UACC-812,6610216,4.947422623598504
Kelly,5460769,2.22696841800341
GCT,11485656,1.7878903123598318
LAMA-84,9903786,1.7036046577565669
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
SNU-620,JQ-1-carboplatin (1-1 mol-mol),-0.5250735139206945
SK-UT-1,409805,5.339094874610304
LoVo,9936388,-7.372990206557469
NOMO-1,44493528,4.211717002525977
K-562,168313200,4.769830643466651
KMRC-1,409805,5.852991634240623
HCC1195,159324,3.4692745079061997
SW48,36462,-1.5563073788110886
LCLC-103H,11485656,2.3573418350596644
HEC-1-A,439501,-2.768971793153046
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
SNU-C2A,9936388,-5.314331610228823
KMS-11,selumetinib-GDC-0941 (4-1 mol-mol),1.0292581351367205
MOLM-16,26596,-3.9817084754511782
SK-N-MC,44491742,4.171908823838076
TCCSUP,107985,-3.010766846655704
DAN-G,409805,3.9735319479780618
FTC-133,11485656,4.087051585535102
P12-Ichikawa,148198,-4.791017453717943
42-MG-BA,6610216,4.456888675297936
TUHR10TKB,107985,-4.323692469229263
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
NCI-H929,24180125,2.4641763284453795
CML-T1,409805,3.5817002644537683
Rh30,159324,2.8052037123345572
OAW42,8515,4.937675036123391
AsPC-1,44491742,4.429887143828186
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
HT-1376,6610216,4.281490165857978
NCI-H69,409805,4.432674324966018
JHUEM-3,107985,-4.163953976414814
LOX-IMVI,10296883,4.016923639720429
BT 428,JQ-1-carboplatin (1-1 mol-mol),-0.3144310627215171
HT115,26596,-1.779298311907341
HuP-T3,439501,-2.469428626730465
BT 333,10296883,4.228869455795536
MOLM-6,148198,-4.479963053870103
DEL,135423438,0.2559505435004567
KE-97,135875424,3.346245315555186
OE33,54618164,4.547083841535975
SNU-685,selumetinib-GDC-0941 (4-1 mol-mol),4.064777169332982
HCT 116,135875424,4.043772794114506
SU-DHL-4,439501,-2.4807393804308777
SH-10-TC,168313200,3.5833535240153225
Fu97,12003241,-1.5366115434948442
Hs 294T,168313200,1.8901423010477436
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467
SNU-16,12003241,-4.948615651726049
BT 422,439501,-3.455801521940444
Daoy,135875424,3.817686781191165
NCI-H1563,8515,2.468674320283986
MDA-MB-231,10296883,3.96898040107769
T24,44493528,4.3959417909273215
JHUEM-3,36462,1.2759724443128675
A-549,44491742,4.437272986024
PL-21,107985,-4.0458026423659295
EoL-1,9927531,2.893857253769426
MPP 89,135875424,5.105268273979739
SU-DHL-8,9903786,1.70511202729143
Sq-1,5460769,2.958314651359677
VCaP,9903786,1.7887289169146705
NCO2,159324,-0.155118322085548
HCC1428,6610216,4.184563272791284
MOLM-13,5460769,1.2989705913507943
GSU,54618164,4.306708858865339
DEL,9903786,1.8347897300097875
DMS 53,5460769,5.120342551697822
LS513,148198,-2.3506631812777945
Hs 936.T,3689413,1.174689206695868
SK-N-DZ,46943432,5.457291961599217
LP-1,148198,-3.8284047012705846
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
CAL-78,11485656,3.0303268993035233
BT 131,439501,-2.852207869991737
NCI-H2087,409805,3.9409208481005864
PE/CA-PJ15,107985,-2.5858433218961108
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
NCI-H1792,107985,-2.015689810638849
BV-173,6505803,-0.0472737333369297
COLO 680N,6610216,4.637912806621915
SNU-5,26596,-1.206984929364511
EC-GI-10,6505803,0.7736206761478788
SK-HEP-1,168313200,3.8713243832650335
A2058,selumetinib-GDC-0941 (4-1 mol-mol),0.6721412852797596
NCI-H510A,26596,-3.9165599075217994
NCI-H522,12003241,-1.5672925136718587
SU-DHL-8,148198,-4.565516831047941
Li-7,11485656,1.4880931297803832
BT 228,JQ-1-carboplatin (1-1 mol-mol),4.047543030971835
NCI-H2196,36462,0.5304143478440299
NCI-H929,5460769,1.81013287796662
Caki-1,36462,4.125503864520119
SF268,JQ-1-carboplatin (1-1 mol-mol),2.4555584209908923
SNU-489,11485656,3.634321717493026
RMG-I,439501,-1.0670769936155349
Hs 746.T,135423438,3.2102823304550463
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
SW1353,6505803,0.3759495055091644
RPMI-8226,159324,-0.4184155328955503
HCC1806,12003241,-0.1866891199802881
DV-90,selumetinib-GDC-0941 (4-1 mol-mol),-0.7506307924929138
NCI-H1694,9927531,4.024250624925043
SaOS-2,24180125,2.5037581025896896
HuP-T3,12003241,-0.2833744856936582
BT 164,6505803,-0.6124673991006063
LK-2,409805,5.966172479711887
KYM-1,107985,-4.451776269961161
A3/Kawakami,107985,-4.442532010928943
KMS-21-BM,24180125,2.4218956668209732
PaTu 8988t,9903786,4.140175125497243
SCC-4,5460769,3.1702887923440466
TOV-112D,11485656,3.0452540655775473
VM-CUB-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2001367648558769
GOS-3,135875424,4.516628943420056
Calu-1,9936388,2.4202012833379016
ECC10,9903786,0.6869958735378703
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
HCC1395,12003241,-2.06138866466857
RERF-LC-Ad1,54618164,4.2675139031657325
KMRC-3,26596,-1.545617580729079
TE 617.T,24180125,2.0821537489988544
P12-Ichikawa,11485656,2.301138805430704
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
SW1990,148198,-3.981392088661051
NCI-H1339,44491742,4.759108525431012
BT 179,107985,-2.8341273333416823
TE-1,6505803,-1.9402426230347345
KM12,12003241,1.1245278791827416
SNU-1076,409805,5.848660522218034
ALL-SIL,9927531,4.600523700119875
HEL,159324,1.7687894675630291
KMS-11,148198,-3.359004885153461
A-375,9936388,-2.2482939434629223
Mono-Mac-6,135875424,2.7965119530378906
KMS-18,107985,-4.362262609163058
NCI-H510A,9927531,4.438228286684184
CL-34,JQ-1-carboplatin (1-1 mol-mol),-1.7099551390648522
NCI-H1568,8515,2.0721444777555327
NOMO-1,6610216,4.0700997553747325
NCI-H889,44491742,5.742464384520159
HuP-T3,9936388,0.6940852338085793
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
SNU-478,135875424,3.766557259457048
SK-LU-1,12003241,-2.6616586719339725
COLO 800,135875424,4.447518165388321
DK-MG,135398744,6.3715043377255665
BT 271,24180125,2.523261757319675
HDQ-P1,409805,4.8501849426838435
Mel JuSo,9936388,1.578964606957719
SNU-626,6610216,4.899097524700605
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
Hs 729.T,selumetinib-GDC-0941 (4-1 mol-mol),3.0623228913945684
SW1990,6610216,4.556945274841773
SF539,168313200,1.6661816240555782
BV-173,439501,-2.3365000657543415
Hs 766T,12003241,-1.434019858151168
NB4,168313200,3.5232840402565104
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
SNU-119,107985,-4.156641254925639
SK-MES-1,5460769,2.678686049759102
RS4;11,49836020,6.257665529441248
MOLT-3,409805,3.005730430773921
TT2609-C02,24180125,3.81784594908871
HCT 8,6610216,4.632290111635945
COLO 699,409805,5.831593665999148
MOLM-13,12003241,-3.578107028375036
MIA PaCa-2,148124,-8.04655725116999
CHP-212,148198,-4.905957419463446
SNU-C1,439501,-1.3608922935267702
CAL-54,3689413,-3.5113381718602756
KMS-21-BM,6505803,-3.224254978227179
KMS-26,11485656,1.8786999049789332
BT 482,168313200,1.7925441683039929
CCF-STTG1,148198,-4.129311374884182
LC-1F,11485656,1.8871769166571817
C2BBe1,11485656,1.765877240742798
KM12,9936388,-6.571860760975573
JHUEM-1,135423438,4.272448858092011
SUIT-2,409805,6.22384099753819
SH-10-TC,5460769,3.8511006484967223
HEC-59,5460769,4.548370162463851
CCK-81,54618164,3.3848592461901235
CAL-33,148124,-5.466499230660003
Karpas-422,49836020,3.572840137931533
NCI-H1341,6505803,-3.3380388018759772
Ku812,6505803,-1.520866948509506
SNG-M,135875424,3.588544936048006
MKN1,6610216,4.5143406810013005
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236
Hs 940.T,6505803,3.2300274365907486
SK-UT-1,10296883,3.957718672541511
NB1,12003241,1.4891548799263434
NCI-H1944,JQ-1-carboplatin (1-1 mol-mol),2.139349165329713
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
RL95-2,159324,-0.02735038906911
COV434,44491742,4.086933897953946
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
KYSE-70,135398744,6.338938630156892
WM983B,12003241,-2.729936813041864
Reh,46943432,1.093926651360919
NCI-H1755,135423438,4.382002312871588
SUP-HD1,54618164,3.232914065474842
EM-2,6505803,-0.543849671747512
Hs 852.T,107985,-4.821135599843027
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
FTC-238,6610216,4.327599165810429
SK-LU-1,9936388,2.205073285427917
BT-20,36462,2.88431470758021
NCI-H508,54618164,4.137087157011227
HCC1438,JQ-1-carboplatin (1-1 mol-mol),6.275002785263112
HEL 92.1.7,8515,3.031750348813886
SNU-1079,107985,-3.0381859059536387
LN-18,selumetinib-GDC-0941 (4-1 mol-mol),2.471662791203074
JHH-1,6505803,1.4428022461389338
BT 231,12003241,-1.271590527231957
PLC/PRF/5,9903786,4.947267974127204
ECC12,54618164,4.292399668156714
HT-144,9903786,5.3539912005761705
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
SNU-1196,148198,-2.167238950864192
HEL 92.1.7,11485656,1.7969731884547977
TE-4,135423438,2.180179409506435
Panc 02.03,54618164,4.482290203520866
Tm87-16,9936388,1.513062418046636
WM115,6505803,-4.475953396274594
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
CL-11,54618164,4.087111044121258
BT-16,135875424,3.384825931248148
CHP-212,54618164,3.610920674376875
BT 216,135875424,2.865998902674901
NCI-H1755,10296883,4.225143740358611
HCC1806,3689413,2.70275971282259
SK-N-AS,JQ-1-carboplatin (1-1 mol-mol),2.0637783416612767
LC-1/sq-SF,9903786,4.361015168836896
MPP 89,5460769,6.230455153292042
NCI-H441,148198,-1.1442516258972526
SIG-M5,11485656,1.8173379361731008
CAL-54,5460769,-0.0866419988438866
LK-2,10296883,4.228835920762888
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
T98G,36462,3.3490251622126985
EPLC-272H,409805,3.901233602819964
MOLM-16,9903786,-0.0890634921772537
COLO 741,107985,-2.8349814512900062
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
YH-13,10296883,4.196539709790054
VM-CUB-1,8515,3.53886241208846
OS-RC-2,9936388,2.9973803425590733
SNU-423,9936388,-4.810408284387772
KCL-22,107985,-4.081423087872043
DU4475,12003241,-2.262419788533744
MEC-1,107985,-5.111442171124094
UM-UC-3,439501,-1.7316159115926524
NCI-H2342,148124,3.3536352990429346
J82,selumetinib-GDC-0941 (4-1 mol-mol),2.8384419330971147
Hs 294T,135875424,4.177071063974562
TE-8,135423438,0.3747901099487811
MV4-11,selumetinib-GDC-0941 (4-1 mol-mol),-2.1623049126826372
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
HuH-1,24180125,3.1042255829435543
OCI-AML-2,10296883,2.8220982332294615
BT-474,44491742,4.780448859314668
RT-112,44493528,4.644994177683236
KYSE-450,9903786,5.350068255808832
NCI-H2141,148198,-5.2509826148997725
COLO 684,409805,3.735397320840961
Namalwa,135875424,3.1964963879327355
M059K,54618164,4.134728683938071
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
KMRC-1,54618164,3.981312375484732
NCI-H1666,107985,-3.5426960047273655
CCK-81,6505803,-1.799603519174377
A-673,54618164,3.9765209939943857
LXF 289,9936388,-5.793518221083613
ECC10,135423438,0.2657741812126756
NCI-H1623,26596,-1.1542368606327895
TT2609-C02,6610216,4.56614833018797
GaMG,6505803,-1.4041196242536171
TM-31,409805,5.9369651846195275
OCI-AML-2,168313200,3.6920405549769906
MOLP-8,36462,-1.3356090090333852
OE33,44491742,5.719021846419829
CGTH-W-1,6505803,-0.523636813552918
253J,46943432,4.809748990223763
Kasumi-2,135875424,2.5938758238859494
SF268,135875424,2.548556170220251
786-O,148198,-3.6446785838934352
NCI-H196,9927531,5.55374615852481
RVH-421,selumetinib-GDC-0941 (4-1 mol-mol),0.2332916793846582
Karpas-299,73707440,5.429383065350182
RL,439501,-3.24492764026673
KYSE-510,5460769,1.9314900427321815
NCI-H1395,107985,-3.679096931387758
TE-4,9927531,4.138970102101572
SiMa,9903786,1.5237540856212457
Karpas-299,44493528,4.12106151938678
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
KMRC-1,11485656,3.5314695534539045
Daoy,135423438,2.308652476959376
HEC-251,36462,2.48213942919338
RPMI-6666,9903786,1.3063050389166864
KYSE-180,148198,-3.2204698770091653
COLO 678,44493528,4.3871500555160035
Jurkat,9903786,1.902939896932713
SCC-4,6610216,4.252942757315656
SK-HEP-1,439501,-2.4482777943885856
NCI-H522,44493528,4.173254194812623
BFTC-909,26596,-1.7437210940555867
Hs 611.T,24180125,0.9846355561262036
SK-N-MC,JQ-1-carboplatin (1-1 mol-mol),0.7192818040209301
Karpas-422,9903786,1.5566107707645094
AsPC-1,3689413,-2.062701377390924
F-36P,3689413,-1.7757563129439584
ONCO-DG-1,439501,-2.5478488812484015
COLO 680N,5460769,3.8284698218745055
NCI-H1693,135875424,2.849397745802666
HuP-T4,409805,4.746505123210962
CAL-120,44491742,4.283004570772673
KE-97,107985,-4.681691793558965
Karpas-422,107985,-2.8458224127978733
T3M-10,24180125,3.807594514191483
LN-18,9936388,-1.1399684434607444
NCI-H2029,36462,0.6188245273183208
SCC-25,135875424,4.102070818018105
PSN1,12003241,-0.8593243794123258
LN-18,9927531,5.697950654725697
NCI-H1373,6610216,4.185689398284126
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
L-540,3689413,0.298858834558217
HCC4006,168313200,2.0042986308460247
CAL-51,54618164,4.021329289838694
KNS-42,148198,-2.941932964829523
Lu-65,9936388,-8.009646164485344
Panc 10.05,5460769,2.1730903163441444
Hs 822.T,9936388,2.249829055538111
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
K029AX,439501,-1.43360047701671
NCI-H929,9936388,-5.492803140929198
CFPAC-1,6610216,4.540388472392638
CAL-27,44493528,4.330239029111345
MJ,26596,-3.924273415415616
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
BT 504,6610216,4.285733774392814
KMS-28BM,46943432,0.6714739108250444
EFE-184,409805,6.4504565549042665
RT-112,148198,-2.2564798144286597
NCI-H716,26596,0.0248584598201427
IGR-1,135875424,5.003318891233818
OCI-AML-2,54618164,3.470070844486401
SNU-601,148198,-4.403803461658863
TM-31,6610216,4.436147332902249
SNU-1,5460769,1.879573497334996
HCC1143,12003241,-0.0421467164139253
JHUEM-3,9903786,2.091612721233031
NCI-H2029,12003241,2.5373322791001636
SK-MM-2,159324,1.4791508543366414
MDA-MB-453,6505803,-3.8322805026755806
JHH-5,JQ-1-carboplatin (1-1 mol-mol),1.839630269464315
MOLP-8,148198,-4.437033387624053
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
NCI-H322,135875424,4.689474609475431
M059K,12003241,-0.3753342750649466
OCI-M1,9936388,-5.157124392155609
BT 340,3689413,0.410444406671797
TE-15,6610216,4.337725089015336
Kelly,6610216,3.7963593955600863
JHOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.3752490539264866
MM1.S,49836020,3.8296017324588942
RKN,148198,-1.0178445286580065
MHH-CALL-3,selumetinib-GDC-0941 (4-1 mol-mol),3.01666713959806
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
MJ,168313200,3.5794941200353514
SNU-449,107985,-3.1392486992039235
EJM,12003241,0.5402616975347148
KE-37,36462,-2.890328899467379
SU.86.86,9936388,2.2696796585655
TCC-Pan2,12003241,-0.2350019856779653
T-47D,44491742,4.391034289015602
RS4;11,159324,0.3176154003787351
COR-L105,24180125,3.5925931777332676
NCI-H2172,3689413,0.3383001060602208
AsPC-1,6610216,4.465191830296224
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
NCI-H650,11485656,2.145946589400594
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
NCI-H1105,49836020,4.351413850540497
NCI-H211,36462,-0.9711027054177612
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
OCI-Ly10,135875424,5.106467369331284
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765
CAL-51,107985,-4.126908547019261
NCI-H1651,3689413,1.2718647351965997
Daudi,46943432,0.8866201698678313
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
KMS-20,10296883,2.054648014794474
Pfeiffer,168313200,1.5512920869619469
Panc 05.04,5460769,1.7514561399814712
COLO 829,44491742,4.1867442642539725
PLC/PRF/5,6505803,-1.356651808905463
SNU-423,24180125,3.626785562106237
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
H-STS,148198,-3.664450029895992
CAL-54,46943432,1.4547387585116591
SK-UT-1,6505803,-1.8087484782267416
SKM-1,9903786,0.91314187591027
U-118MG,10296883,4.307423912677154
M059K,9903786,3.785857349201863
HOP-62,3689413,-1.4977119259076146
SW1353,JQ-1-carboplatin (1-1 mol-mol),2.2379049663986437
BT 112,10296883,3.9999728699442607
JHOC-5,3689413,-2.3603805845843913
HCC15,54618164,4.329878027642837
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
KNS-42,135875424,5.020750527542343
A-172,8515,4.30738582530966
DMS 53,26596,-0.0361883728556599
SW1088,44491742,4.15883159123132
BHY,54618164,4.089792459606202
BT 428,6505803,-2.216718160472342
Hs 611.T,54618164,3.758252372543717
SK-MEL-24,9927531,5.248971858061216
RKN,5460769,5.79272629497122
A-204,148198,-5.205432048346018
Mono-Mac-1,6610216,3.235922016233304
JURL-MK1,6505803,-3.009657758249373
EKVX,135875424,2.863023045597006
JJN-3,168313200,5.49693974456191
DV-90,6505803,-3.886582260565957
BT 328,107985,-2.461939045328001
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
BICR 16,6610216,4.922312774683302
MOLM-6,107985,-3.6633646803559183
NCI-H520,135423438,3.6436020684370463
LS123,selumetinib-GDC-0941 (4-1 mol-mol),1.252033053606901
Granta-519,168313200,2.290121636997186
BT 239,6610216,3.2848009151202113
TE-5,44491742,3.7855362982761194
KMS-12-BM,9903786,0.6537757100604409
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
SK-MEL-30,6610216,4.414310809394379
786-O,6505803,0.1704415236348838
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
LCLC-103H,36462,3.06746452433931
U-BLC1,54618164,4.010954810772503
ECC10,26596,-3.5060948128404874
DV-90,439501,-2.858386639088026
HCC1569,159324,2.5758105004343093
HuP-T3,11485656,3.0565489144797224
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
CHP-212,439501,-3.066647647836344
SK-UT-1,107985,-4.193387591911345
HCC2935,9936388,1.1235911387260256
SNU-1079,54618164,3.1553824878915955
HL-60,9903786,1.6430909188137364
CHP-212,44491742,3.750067652008212
RVH-421,6610216,4.139285692264737
Caki-2,36462,3.5694693954856205
NCI-H1944,6610216,3.869359165778001
TE 617.T,12003241,-2.151805000440827
NCI-H28,9927531,4.6016482528028515
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
KNS-81,135423438,1.6796399573672585
Caov-3,11485656,1.8981464424658587
A-172,9936388,-2.441923795647272
OCI-AML-3,168313200,1.726224147374737
NCI-H841,439501,-5.095559559459305
KMS-28BM,36462,0.1305397549429897
Ishikawa (Heraklio) 02 ER-,6505803,-0.7712031048650526
Aska-SS,24180125,2.481672199133219
BT 232,148198,-4.3155726249188
EN,selumetinib-GDC-0941 (4-1 mol-mol),3.4742194134426168
JHOS-2,44493528,4.374607827213095
MM1.S,135875424,3.0538620465615587
Ci-1,44493528,4.267807025719403
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
SK-MM-2,135875424,1.809957653015655
KMS-11,6505803,-3.448917575969749
MHH-ES-1,26596,-2.3851189142163176
MOR/CPR,9936388,-5.6462813856837055
HSC-2,3689413,-2.0236874476208353
MEC-1,8515,2.108041369396499
SNU-899,8515,3.345073920637004
LUDLU-1,107985,-2.7518759622190463
SH-10-TC,12003241,1.4218324467353134
EJM,54618164,3.6862835131456455
BT-20,9936388,-7.739336729410493
SK-CO-1,36462,0.7476665664464673
GP2d,26596,-1.9076944219866043
SNU-5,159324,2.17123269045322
KMS-18,409805,4.843227783060013
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
HOP-62,107985,-3.8044998203346383
L-540,JQ-1-carboplatin (1-1 mol-mol),0.3906962491825653
Panc 04.03,107985,-4.416167995938274
MDA-MB-453,3689413,0.605092083526794
EPLC-272H,36462,1.6704265037574937
CAL-33,54618164,4.219830167888796
DV-90,135875424,3.100724148145735
SUP-HD1,12003241,0.3285815834035863
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
JMSU-1,9936388,-5.635407745986741
VMRC-RCW,44491742,5.061613878025198
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
HPB-ALL,107985,-2.867280224208332
NCI-H1793,11485656,2.9016215508551064
SK-MEL-5,JQ-1-carboplatin (1-1 mol-mol),5.709362170357264
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
RL95-2,JQ-1-carboplatin (1-1 mol-mol),1.5011912902975624
SK-MM-2,107985,-3.95683239720485
253J-BV,54618164,4.233946731936071
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
RKO,159324,3.5523933893017583
HEL 92.1.7,5460769,3.8355782077499248
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
SKM-1,11485656,1.846158462004935
NCI-H2106,9936388,1.6529338103280846
NCI-H69,8515,3.637799232844521
A-673,9927531,4.216692000672551
TE-4,6505803,-1.521875186657464
NCI-H1734,49836020,-1.214582633360451
BICR 18,8515,4.334551265456708
OVK18,5460769,2.4178106376045516
KYSE-410,9936388,-3.552366403662026
Panc 08.13,107985,-6.582499016918423
SNU-1041,135875424,4.844300116851518
NCI-H2110,8515,3.3908091407293433
C2BBe1,6610216,4.003349103028762
HCC2108,107985,-3.038738614535184
WT2-iPS,3689413,0.8966057482922113
SNU-C5,10296883,3.7798832653502727
MPP 89,36462,2.681597486796125
A101D,49836020,-1.073011415975237
COV644,168313200,3.3351573798183876
CAL-51,10296883,4.0377332681132305
KMS-28BM,54618164,3.643335143110872
KMS-12-BM,10296883,2.976049270226853
23132/87,11485656,1.6570697759405837
NCI-H838,JQ-1-carboplatin (1-1 mol-mol),6.320973453370018
BL-70,12003241,-2.1974938808167477
QGP-1,135875424,4.81787572087767
BT 428,36462,0.8626568513499365
NCI-H1755,6610216,3.888386039352291
Mono-Mac-1,46943432,0.6845329233652461
SHP-77,12003241,2.3628262056689384
LP-1,10296883,3.461993801411865
OCI-Ly19,44493528,4.78987758485686
COLO 800,54618164,4.241548358407708
697,44491742,3.706087965098128
COLO 320,135398744,6.463011253269961
TCCSUP,6610216,4.746461050840166
TYK-nu,5460769,2.633431315912765
WM983B,9927531,5.417064832255327
SW620,107985,-3.2092774586493245
SNU-C5,159324,2.115220402448434
OE21,6505803,-1.9429365414296416
SW1417,9927531,5.165268920139929
YD-15,6610216,4.291781319192343
LoVo,46943432,3.050109964187685
Rh41,9936388,-5.1529677708174235
M-07e,5460769,1.3910333770062682
SKM-1,5460769,2.732858525958475
SUP-B15,JQ-1-carboplatin (1-1 mol-mol),0.3674762383240116
SW1710,439501,-1.6962022164368444
Aska-SS,3689413,-0.2828072846638814
HPAC,135875424,4.409126746837932
NU-DUL-1,12003241,-3.7698079605480257
Hs 822.T,11485656,3.9087962472344744
NCO2,12003241,-5.3551857747003
RS4;11,148198,-5.281642952931228
HuH-1,44491742,4.9230469745960255
253J-BV,26596,-1.8629561826944263
SU.86.86,8515,5.04236611979258
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
NCI-H1581,439501,-2.58240650687765
DBTRG-05MG,9936388,2.4654274854338505
NCI-H1944,107985,-3.8930979106653183
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
A-204,54618164,4.119063693275809
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
YD-15,3689413,2.243668996765499
G-402,409805,3.601387191810419
NB1,8515,3.7226851195951287
RL,148198,-4.279305385936642
HEC-6,24180125,2.2718626747698383
SNU-8,5460769,4.64495536055113
BT 328,3689413,2.3836323832860673
MHH-ES-1,135875424,3.469224275097477
NCI-H1623,3689413,0.664737487618683
LXF 289,439501,-1.653941874457911
OVISE,148198,-3.4121309130102055
SNU-1079,8515,2.981643349971088
NCI-H1568,54618164,3.652866089784218
SNU-1076,159324,3.988028562574038
Kasumi-1,11485656,-2.0824070606449534
JHH-2,54618164,3.8508571156127056
EM-2,9927531,3.4413075859413556
SNU-1105,135875424,3.163533063025223
C2BBe1,9936388,0.7937210910014248
HCC2108,6610216,4.333266627123119
TE-14,168313200,3.700677169997579
G-361,9903786,2.8296470400432296
HEC-251,3689413,-0.622023028283223
WM983B,439501,-2.1469095584384608
NCI-H838,26596,-1.3070884520917134
JM-1,148124,-7.840698833354439
HuG1-N,8515,4.737419441534161
OCI-AML-2,26596,-2.6744696757916215
EKVX,9927531,4.418248493855361
MDA-MB-157,6610216,4.481014218943506
HCC1419,3689413,0.4398043880767979
NCI-H520,409805,3.8213964278284953
PLC/PRF/5,439501,-1.8160204684239925
KLE,49836020,-2.0520357560351714
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
CJM [Human melanoma],135875424,3.3018695486578573
Rh30,409805,5.11813479987097
HCC44,5460769,-1.4878647509683542
BL-41,3689413,2.890540357567194
COLO 699,11485656,2.4382594148828995
NCI-H1563,3689413,0.532874202175122
Hs 729.T,26596,0.627655143965394
NCI-H2087,49836020,4.38375865979883
Reh,44493528,4.04802880439871
F-36P,148198,-5.732875507822739
RS4;11,selumetinib-GDC-0941 (4-1 mol-mol),0.8544814441739125
KNS-42,10296883,4.193671249081411
SNU-1041,9936388,0.8457601319500153
NCI-H1755,12003241,-1.003418586049609
OCUM-1,11485656,1.6413054231904327
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
ALL-SIL,409805,3.511042482554543
SK-OV-3,49836020,-5.2191550029019025
SET-2,148198,-7.743060156944655
HCC1588,5460769,0.1168083541927539
A101D,135875424,4.8786521946508214
Kuramochi,409805,5.320822173869509
NCI-H1184,3689413,-2.309621936722181
A-204,3689413,-1.831192826185156
NCI-H1693,107985,-3.260996541727032
NCI-N87,8515,4.286102801865053
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
NCI-H358,159324,1.810337922367244
HCC1438,6610216,4.344154848601134
Hs 746.T,44493528,3.791108114559063
SNU-620,5460769,0.532888566426305
SW579,439501,-3.952222233094387
A-549,12003241,-1.903076073453771
KG-1-C,168313200,3.846719593184995
CFPAC-1,9903786,2.8562781406669653
DoHH2,36462,-4.28984156699345
HCC2935,107985,-0.5385208487376155
CMK,148198,-5.18058405335292
BT 444,9927531,5.530041138420047
NCI-H1623,5460769,3.63452416726077
JVM-3,107985,-5.208204796904964
NCI-H1915,54618164,3.9716628355262777
GSU,107985,-2.4596540151791135
SK-MEL-5,148198,-1.053859411744173
TE-9,9903786,2.6320007696302894
MDA-MB-361,9936388,2.003587918290059
SNU-182,409805,3.346621636723639
RERF-LC-Ad2,5460769,6.029186520623905
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
MOLT-16,6505803,0.4764435531440419
FTC-133,44491742,4.538470926749077
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
HPAF-II,439501,-2.2531231348817715
SK-BR-3,135875424,2.976147465835477
ALL-SIL,439501,-2.349752310116714
VMRC-LCD,409805,5.2545104964155485
SNU-475,168313200,5.3842891056630275
MM1.S,6505803,-0.1841114080814497
DLD-1,26596,0.8453725223634535
23132/87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1204952013387844
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
Jurkat,24180125,3.1420055994155787
ChaGo-K-1,148198,-4.908529159972166
BICR 56,6505803,-0.5151519512858532
JL-1,12003241,-1.4801638152381718
SNU-5,409805,3.988167342407501
GCT,49836020,-4.509787849566978
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
SNU-5,54618164,3.8244213161134497
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
SBC-5,3689413,-0.1482568941323282
42-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),0.6620658581773345
KYSE-450,439501,-3.185322034462323
HCC202,9936388,1.0165680238121546
KYO-1,8515,3.150065992884221
A-253,9927531,5.71272933596785
IST-Mes1,9903786,2.7623614356082458
TE-1,9936388,1.4235089598374957
GSS,JQ-1-carboplatin (1-1 mol-mol),0.1875541485462026
CA46,168313200,1.9493207867170304
KCL-22,148198,-2.536000653707389
MOLM-6,5460769,2.737785033090413
A2780,135875424,2.703796648613349
PE/CA-PJ49,439501,-2.9475727314168174
KHM-1B,439501,-2.4289183886287535
SCC-4,107985,-3.940753988745582
KMS-34,44491742,2.8856017326933965
MKN74,12003241,-0.9650452844715884
HEC-6,107985,-4.054974229274056
SW579,3689413,-0.123080329876746
NCI-H2171,439501,-3.0635131055453924
SK-MES-1,24180125,2.8011061593725244
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
BT 112,3689413,-2.4519950955667764
253J,9927531,4.121406347708415
NCI-H810,49836020,4.546134729481912
MJ,5460769,-0.0196671860810318
LCLC-97TM1,10296883,3.762301074740285
YAPC,148198,-3.117185181322903
KM12,168313200,1.821145068810447
PLC/PRF/5,44493528,4.794092403972537
COV434,9903786,2.975082903645508
HCC1195,409805,5.2534731416960465
SNU-119,135875424,4.208481763945608
8305C,6505803,0.0695536722094139
IGROV-1,6505803,-0.2382223795960626
TE-1,12003241,-0.9529252226933594
SNU-668,135875424,2.8972214679308084
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
NCI-H647,11485656,1.881364727029594
NCI-H647,44491742,3.8006488884614527
CAL-51,135875424,4.33643967165441
NCI-H446,9927531,3.935868593657491
NCI-H716,10296883,2.894605704782392
RPMI-8226,6505803,-1.0247105512133972
NCI-H460,107985,-2.632533954936978
P-STS,148198,-3.9239562601130022
OCI-Ly19,5460769,1.4066182919474557
HSC-4,9903786,4.262681016067309
JHH-1,26596,-0.7682069189838904
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926
OCI-AML-5,46943432,1.3940665878668066
Hs 895.T,439501,-3.8668511324468664
HCC1588,6610216,4.213759827124292
PaTu 8988s,9903786,1.8009975173036927
NCI-H1975,12003241,-2.295585009641022
GCT,6610216,3.8449912626290024
ESS-1,168313200,3.675041672586614
RL95-2,8515,2.830616732584445
EJM,24180125,2.4307327863044215
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
SNU-1214,409805,4.003952928265266
OV7,439501,-2.8665617033549515
8505C,selumetinib-GDC-0941 (4-1 mol-mol),0.125719667045265
HCC78,148198,-2.104540151198766
LN-18,148198,-2.0225880392940043
HEL 92.1.7,135875424,3.148841904096567
P-STS,135423438,4.306983999338839
Mino,135423438,1.6490290727182615
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175
LS180,9936388,-5.017955750811216
BT 333,36462,2.304869296279445
LS1034,49836020,4.406866434657065
BT 179,148124,-4.247300823001868
RERF-LC-A1,6610216,4.83230051596447
Hs 895.T,6610216,4.546912448476249
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
697,107985,-4.150889560119246
RPMI-8226,JQ-1-carboplatin (1-1 mol-mol),-0.0653783177632561
COR-L88,5460769,4.328731747643338
M059K,3689413,-2.3612434015729336
KNS-81,409805,3.4402496487682788
PE/CA-PJ15,54618164,4.606818581386584
BICR 31,6505803,0.2507928346620714
HEC-1-A,135423438,1.6269697099453948
TALL-1 [Human adult T-ALL],6610216,3.5711987866823933
SNU-1033,11485656,2.0602946184269917
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
HCC366,135875424,4.513036767183396
769-P,6610216,4.7962180972248385
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
NCO2,36462,-0.655679332462451
COV644,135875424,4.838301094582854
SET-2,44493528,4.2834335976641205
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
HCC366,46943432,3.5432880564657667
5637,JQ-1-carboplatin (1-1 mol-mol),0.0353131764923719
NU-DHL-1,12003241,-2.4677988287748915
BT 112,36462,-0.1329200912201302
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
NCI-H1838,409805,4.710230209082149
VMRC-LCD,148198,-4.056335514777046
TE-8,8515,3.692350191417914
Fu97,409805,3.71508023088682
CAMA-1,9936388,-3.1372789388983944
NCI-N87,6610216,4.734758596227503
HSC-4,439501,-1.7709622187792924
SW1573,9936388,3.0507391751654698
CCF-STTG1,135875424,4.233748796461769
DEL,12003241,1.2715450206031036
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
SNU-175,11485656,1.332587487801819
HEL,9903786,1.206049982415758
KYSE-70,3689413,0.9447440025313596
SNU-46,selumetinib-GDC-0941 (4-1 mol-mol),1.1203054933058916
PE/CA-PJ34 (clone C12),54618164,4.074052686035258
KMRC-3,11485656,2.7708610077746036
UACC-257,135423438,1.9285683204106765
Raji,3689413,-1.7827501217470076
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856
SNU-8,44491742,5.735879763811486
MKN74,5460769,3.534639533895065
Hs 746.T,49836020,5.866178883912361
NCI-H446,148198,-3.559974715415813
YAPC,3689413,3.09003195173071
HSC-4,135423438,1.814117839489682
LS513,12003241,-0.5342180043119649
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
SW1116,9936388,1.5004696743438164
BT 139,54618164,4.290643622410761
SUP-M2,10296883,3.1259811098442176
HT-1080,148198,-4.2926124844234765
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
HD-MY-Z,3689413,-2.31640912661536
NALM-6,107985,-3.482950091180729
HCC1438,10296883,4.228487573080105
BT 147,10296883,4.22717301234077
BL-70,135875424,1.380668609611053
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
ZR-75-30,12003241,0.0052055629667129
NCI-H520,44491742,3.7897459257936057
MDST8,10296883,3.644541291105843
GA-10,24180125,1.046455253129036
MV4-11,135423438,-3.04560179632734
WM793,6610216,4.179764818643997
JeKo-1,168313200,3.3744952164536537
EFM-192A,26596,-0.8945052736311969
Peer,46943432,1.3270987251698654
SK-N-FI,9936388,-7.982723182575795
VM-CUB-1,26596,-2.0768458829121745
SUP-M2,26596,-3.767571298105125
HuH-28,9903786,2.984330186348554
BT 271,12003241,-0.5875601678545488
KMH-2,107985,-4.440693549832868
ACC-MESO-1,135398744,5.83972457285084
SNU-C5,9936388,-5.010033217973313
DMS 114,10296883,4.0850638557883165
EC-GI-10,409805,6.0332797077156455
SU.86.86,54618164,4.265820025060501
OUMS-23,6610216,3.941285586562786
NCI-H1373,46943432,2.6710701637629684
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
WM266-4,9903786,4.44287748208762
NCI-H647,8515,3.931635124559011
MFE-319,168313200,2.8500220727002885
NCI-H211,409805,3.643232317573376
NCI-H1341,11485656,1.4261548687553274
SiMa,12003241,-0.7003588791224504
SNU-216,26596,-1.178501170162628
HCC827,9903786,1.5312362888468285
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
NCI-H2452,11485656,2.991875358712002
A-204,9927531,4.116017775807866
PANC-1,409805,5.697873707527969
COLO 201,5460769,4.015779319815586
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
LUDLU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.599632203402907
P-STS,9903786,4.008586814147432
EKVX,JQ-1-carboplatin (1-1 mol-mol),5.826710016487848
Rh41,24180125,2.1535312924430774
CMK,439501,-2.5697505618969547
23132/87,6610216,3.886794888295395
OAW42,135423438,3.883711298971531
ChaGo-K-1,409805,3.8445782197925022
NALM-6,24180125,1.7332354696580263
OAW28,11485656,3.2643123414600645
SW1417,54618164,4.206542858646136
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039
OCI-AML-2,135875424,3.3371422768909857
T84,135875424,3.2008335504024963
UACC-257,409805,5.778472558974471
HuP-T4,54618164,4.557554546423835
HuT 78,135423438,1.6811720044411254
T-47D,107985,-3.0431317154238564
LOX-IMVI,11485656,1.9351920109561
IMR-32,148198,-7.685974048863974
NCI-H2291,9936388,1.6916444639385806
KMS-20,12003241,-1.6984779188581272
IST-Mes1,49836020,4.276541253138442
SKM-1,44493528,3.979629908351757
NCI-H1373,135875424,5.093925660594389
Hs 888.T,12003241,-1.970204906844497
NCI-H1915,439501,-4.1452565317565995
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
Aska-SS,36462,2.182690934298482
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
Panc 10.05,54618164,4.233833301022668
KYO-1,9903786,1.1587901811719317
JJN-3,46943432,-0.2652979135727038
HT-1376,44493528,4.459541638540956
KMBC-2,54618164,4.620014952617177
Fu97,159324,2.7232800930597367
KU-19-19,73707440,5.592820593626321
NCI-H889,6610216,3.663657334895107
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
UACC-62,3689413,0.3229546491467058
DMS 273,9903786,1.811418424711566
Panc 05.04,107985,-3.471783339815776
NCI-H2087,107985,-3.934436633809772
SNU-489,6610216,4.923159792300278
HCC1954,24180125,2.3643947156873546
Panc 02.03,44493528,4.298055948100647
NCI-H716,9936388,-4.976580043871955
RKO,36462,3.4370564574699185
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
DV-90,3689413,0.3888446743511712
DV-90,26596,-3.568331067432308
HT-144,12003241,-2.1434131709855215
ChaGo-K-1,3689413,-1.075301905965469
OVTOKO,159324,4.080099664320937
TC-71,6505803,0.7879550085796516
CAL-148,439501,-2.3789265547219647
JHUEM-1,6610216,4.023660929600166
SH-4,409805,3.579343457445403
Panc 10.05,148124,-2.064207075816084
BT 416,148124,-5.33137477776155
NCI-H23,selumetinib-GDC-0941 (4-1 mol-mol),-0.1629435385383226
BHT-101,409805,5.910877889789324
Daudi,6610216,3.2134188501838494
NCI-H446,135875424,2.863790721987945
BFTC-909,148198,-2.03933057080943
GB-1,148198,-2.999255289786891
TE 617.T,168313200,1.7162313923101786
HT-1080,9927531,5.0886456677015595
HSC-4,12003241,-0.0373048915881231
LS123,54618164,4.135891189073094
NCI-H841,36462,0.9930050489592408
KPL-1,9927531,4.948797048783531
HCC1171,9927531,5.509897026708257
SK-N-MC,46943432,3.956950856766089
JK-1,54618164,3.4300382631920425
IM95,44493528,4.078779126887718
HCC2218,6505803,-2.0723621071637788
NCI-H1666,44493528,4.3408217178767545
SNU-1196,6610216,4.695877765522031
Panc 05.04,9936388,2.125359461331759
SNU-61,10296883,3.559313583941647
HSC-2,135423438,4.318138286967173
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
RERF-LC-A1,26596,-2.038549310603685
HCC366,9936388,-5.702122369307378
SNU-1041,107985,-1.9009359266781765
CAL-12T,409805,3.840728267752851
LAMA-84,107985,-3.5887213994965195
NCI-H146,6505803,-0.3489025917214021
NCI-H1650,44491742,4.220144565804619
A2780,409805,4.989244714218352
BT 422,11485656,2.164930986451698
WM983B,5460769,5.3340527249808005
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
NCI-H2106,8515,4.750503875422281
KE-97,9936388,-5.867495812584186
SU.86.86,6610216,4.433785390172563
COLO 684,148124,-6.705562486596054
BT 112,11485656,1.9046121738712176
BT 482,6610216,4.181360569534401
Detroit 562,409805,5.192900836800339
JJN-3,107985,-5.8157457701198005
Sq-1,46943432,3.156596182557323
SW1573,135875424,1.8143158468632437
DU145,439501,-2.7485794982467637
SNU-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1369641916187444
COR-L95,54618164,3.8157010413732406
HCC1395,9927531,6.948950349672662
KMRC-2,9927531,6.175340087469203
NCI-H1568,3689413,-2.0602171008804935
COV434,54618164,3.97479770969408
PE/CA-PJ49,168313200,2.725673225296459
SNU-475,6610216,4.19198835261524
SUIT-2,11485656,3.4408604141627763
U266B1,12003241,-0.5113173834247196
OCI-Ly3,3689413,-2.743608446400997
NCI-H1299,11485656,2.4848432250614843
ChaGo-K-1,10296883,3.916138257208464
JM-1,49836020,4.6064946369246025
KMH-2,24180125,2.3529996714086066
HLF,49836020,3.6461336560985087
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
BT 139,24180125,3.745397640720988
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
CAL-78,135875424,3.436960606583848
NCI-H1666,6610216,3.2218112987058207
BT 216,3689413,-0.8248802266685408
Kasumi-1,107985,-4.35650494929647
OV56,135875424,4.815096584327211
GaMG,107985,-3.038820725669045
Ki-JK,36462,-1.561717559675625
Reh,409805,3.28690682151102
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
SK-N-DZ,12003241,-0.5399118336559388
GA-10,26596,-3.772659675473913
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
SK-MEL-31,6610216,4.2630630920369805
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
MDA-MB-435S,9936388,-7.051147394229912
Hs 766T,72199289,4.423272467575485
WM793,36462,4.293096910683363
KMS-28BM,6505803,0.5045053527572001
BT-20,44491742,4.162819949257598
TE-9,11485656,2.3565091821731903
A-204,36462,0.1490097893290066
LoVo,12003241,-2.8621949377385465
K-562,135875424,2.7247406179323055
SW620,3689413,1.1437224923774536
Karpas-620,409805,3.9082623873755344
MOLM-6,439501,-2.481235369301624
TUHR10TKB,3689413,0.0025132381526345
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
MKN7,44491742,4.213117229463602
HuH-6,439501,-1.8507525220603604
HCC1937,36462,3.5030981675000974
L-428,JQ-1-carboplatin (1-1 mol-mol),-0.0487798287789179
ECC10,6610216,4.114118365396388
KM12,6505803,-1.021765760780758
BT 271,148198,-6.332121949886553
Mono-Mac-6,9936388,-1.750888467590725
F-36P,24180125,3.032691070219076
Daoy,159324,3.1880749066588696
Karpas-422,24180125,1.2333390816210612
HeLa,11485656,1.8522393336584817
HCC-56,36462,3.4551030637348146
TE-5,9903786,3.304893690679265
Hs 729.T,9903786,3.958862053564968
HCC1806,439501,-1.846359042641554
WSU-DLCL2,26596,-2.173424611684264
RS4;11,6610216,3.9207416036344855
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
KCL-22,36462,1.629414459296742
MOLP-2,36462,0.3007891095090442
SNU-620,9936388,-5.286800591769548
HT-1080,439501,-2.2877487074012026
OAW28,148124,5.441417229348929
Mono-Mac-6,11485656,1.0261248575156627
SNU-175,8515,2.468175220100517
JeKo-1,26596,-2.667287216238713
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
EFM-192A,135875424,3.7105346659107834
Calu-6,148198,-2.2255623368633746
697,168313200,1.615213458575926
HMCB,6610216,4.4861904027359145
HEC-108,3689413,1.021712931431184
647V,6505803,0.3251392573539524
AU565,107985,-3.572249289009051
HL-60,11485656,2.725132337131944
OVSAHO,44493528,4.8098678105580674
BT 145,6505803,-1.6156517406127768
SNU-245,9936388,-0.9809692402129652
NCI-H1703,8515,3.787684444790488
DU145,168313200,3.1229023319588363
DK-MG,selumetinib-GDC-0941 (4-1 mol-mol),2.430443160394254
NCI-H28,3689413,-1.886606090231827
NCI-H1435,159324,3.0916076560214125
HH [Human lymphoma],JQ-1-carboplatin (1-1 mol-mol),-1.6749963255545115
JHUEM-2,135875424,3.27601343648584
Ki-JK,9936388,-3.4426986748299955
NU-DHL-1,409805,5.5181498055430565
EFO-21,135875424,5.187448577491803
L-428,10296883,3.2610580713690944
KMS-27,9936388,-7.881651109846528
HOP-62,9936388,2.1829443174265997
MeWo,10296883,4.224617443246128
TYK-nu,selumetinib-GDC-0941 (4-1 mol-mol),1.6731134624767203
NCI-H526,24180125,2.1649005849600123
HEC-59,148198,-3.009683743491751
B-CPAP,12003241,-1.7111954205398938
HMCB,9936388,-4.997946026418023
GOS-3,54618164,5.027817061073729
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
NB1,10296883,3.4933227717672337
JHUEM-7,409805,3.8541488067969785
Li-7,9927531,4.31523724383209
Caov-3,439501,-0.6475406712801833
UM-UC-1,6610216,4.20419948705434
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
U-BLC1,439501,-3.0504776234222035
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182
SUP-B15,6610216,4.137405098787568
BT 422,12003241,1.9442582460098417
NOMO-1,148198,-5.33573798573566
KNS-62,6610216,4.3698518341430415
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
697,10296883,1.236413600919532
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
HEC-251,JQ-1-carboplatin (1-1 mol-mol),0.3625171381701316
NCI-H1339,135875424,4.767141568633495
KYSE-510,9936388,-2.6451183198904373
KYO-1,409805,5.008777152204713
SKM-1,148198,-3.315233928127138
CAL-148,107985,-4.556226518156489
HCC2108,9903786,2.237017286795856
NCI-H69,selumetinib-GDC-0941 (4-1 mol-mol),3.077666934797567
LXF 289,10296883,3.609856485747645
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
SNU-601,36462,1.1449893209829207
DOV13,5460769,1.9787074160604587
BT 187,107985,-2.5893459748283507
HOP-92,5460769,4.612763799526671
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
SNU-216,12003241,-2.3730818081536955
HL-60,26596,-1.7556952568708522
HOP-62,409805,5.513075555987367
Hs 729.T,10296883,3.893392968394133
SCC-9,54618164,4.4493976732458576
TC-71,10296883,3.4863812877107176
HEY A8,selumetinib-GDC-0941 (4-1 mol-mol),1.3817126396854498
NCI-H1299,3689413,-0.9598507897960026
HOS,9936388,3.3848022689257387
A-375,12003241,-1.2978704743837648
NCI-H1184,26596,-3.790175824084468
OCI-Ly10,148124,-3.653061072186916
BT 422,selumetinib-GDC-0941 (4-1 mol-mol),3.332699583710218
SNU-478,9936388,-5.768985040086462
PK-1,168313200,4.316243084639225
SU-DHL-8,44491742,4.1577476289633
DEL,44491742,3.848906849757271
NCI-H2110,439501,-2.2349143195011583
SW1710,135398744,7.400823424142947
A-172,6505803,0.7314329706083597
Toledo,9936388,3.05226126712226
NMC-G1,6610216,4.832544305447151
CAL-148,3689413,0.1534272524825109
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
JHH-4,107985,-2.4130923287232853
HEC-1-B,3689413,0.3558591242375798
L3.3,135875424,3.974579804692541
G-402,6610216,4.300869455279292
Mino,44493528,3.6548963085027
CGTH-W-1,159324,4.090671308826511
T24,10296883,4.197604631060403
SNU-466,selumetinib-GDC-0941 (4-1 mol-mol),2.355398867195719
Namalwa,409805,3.552483226107591
LoVo,6610216,4.332472846182503
KMS-20,26596,-2.568893435013116
253J-BV,5460769,4.4338655315193325
SK-HEP-1,5460769,6.10306620405049
COLO 800,439501,-0.358926557493619
RT-112,3689413,0.3015272221175239
MOLP-2,9936388,-6.6933037631173695
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
HCC1954,3689413,-1.9966165648344365
KMH-2,159324,1.5423120810193625
LC-1/sq-SF,54618164,4.300046156194216
SK-MEL-30,6505803,3.705919925101854
KE-97,9927531,3.606406667936729
NALM-6,12003241,-1.6085171342218008
HCC1937,409805,5.257165815525836
NU-DUL-1,9927531,4.217714200280878
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
SNU-869,9927531,5.42388661469149
SNU-119,135423438,2.0179604003543288
NCI-H1341,44491742,2.77003350871112
AGS,8515,4.67838267995859
L-540,44491742,3.302641301804856
SK-MEL-2,168313200,3.8202183973722144
SK-MM-2,3689413,-2.3519138228022367
JHOM-1,10296883,4.346647898166674
SNU-1,10296883,3.7174122839678336
Caov-3,46943432,3.5630834063683774
CFPAC-1,9936388,2.1130645315651444
NCI-H1581,9927531,4.312096995742435
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
SW1271,9927531,4.558020454092029
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
SNU-213,9936388,2.0534039631402994
BT 224,6610216,4.396023390217125
RL,135875424,2.9597814982763753
NCI-H524,6610216,3.735749352213653
NCI-H650,409805,3.6301362356627886
SK-LMS-1,168313200,3.682470833996821
HCC1937,11485656,3.1070041038533835
KYSE-30,409805,5.989157547538198
DBTRG-05MG,6505803,0.4569026356625297
AsPC-1,135875424,4.124114476494282
BT 147,9927531,5.037418148394567
SR,44491742,4.371664315658822
TC-71,36462,0.2309996783752871
TUHR14TKB,9936388,1.5897685475960623
NCI-H1339,12003241,0.6707609457385758
FaDu,49836020,4.381495172511739
HEC-265,36462,2.4271485175942207
SK-MEL-28,11485656,3.743045528473451
WSU-DLCL2,54618164,3.925367757043136
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
DND-41,12003241,-0.2098098510645495
NCI-H69,3689413,-1.5363030352959728
SNU-216,49836020,4.392080781330326
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
SK-OV-3,9936388,2.038842599711319
NCI-H520,135875424,4.041449952679746
NCI-H446,10296883,3.7190585184043337
KALS-1,36462,2.7301613620046803
BT-474,3689413,-0.6944310513118788
COLO 684,439501,-2.1381820034562944
MOLT-16,24180125,2.1628901306704833
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
KMRC-3,9903786,5.172590154682236
COLO 800,168313200,3.886241443900116
ES-2,9903786,4.393151500832027
BT 330,409805,3.8422840862788386
Hs 888.Lu,6610216,4.537869463630796
MDA-MB-157,36462,0.1516360669313773
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
Kelly,12003241,2.7454811269637145
PSN1,36462,1.208410017228589
M-07e,409805,3.874432405180439
KYSE-180,3689413,3.064535959483158
AN3-CA,44491742,4.617223070127138
SNU-5,12003241,2.4960585201420247
WM88,10296883,3.749160769987803
BT 444,10296883,4.263096612755244
SNU-5,6610216,4.615422889349808
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
KP-2,148198,-4.1307782439966365
SiMa,9936388,-4.904679848632844
Hs 895.T,168313200,2.9919479779776395
Sq-1,6610216,4.377642738532352
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
BT 231,11485656,1.3713674681165906
PL-21,10296883,3.1495852903666623
SK-MEL-24,54618164,4.106072127259134
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
SNU-245,24180125,3.6034150813328463
HCC1428,12003241,3.752026929973328
HOP-92,JQ-1-carboplatin (1-1 mol-mol),4.25217637860204
MKN45,9936388,3.1179555468131235
OC 314,selumetinib-GDC-0941 (4-1 mol-mol),0.5636308108859065
G-292 clone A141B1,54618164,5.2874340553249395
OE33,107985,-4.064645418730777
Detroit 562,6505803,-1.754599489690224
KMS-34,409805,4.804529897984003
SNU-182,9936388,-8.600901067529309
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
JVM-3,12003241,-2.550977818363364
RL,26596,-2.6100801443617336
EJM,107985,-4.84255557894517
HCC2108,135875424,3.411556630339189
HT-1197,135875424,3.754015840236683
Hs 888.T,9903786,1.8376079408341344
SR,9936388,-6.002984450827545
CAL-51,439501,-2.444412450902406
G-401,10296883,3.7583450228982342
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
TE-10,5460769,3.091987508758681
FaDu,36462,0.6827369212753006
MOLT-13,selumetinib-GDC-0941 (4-1 mol-mol),0.648080768379065
HeLa,5460769,5.484643109222549
SNU-620,159324,-4.60695282041012
SK-LU-1,11485656,3.4042769893477023
COLO 678,selumetinib-GDC-0941 (4-1 mol-mol),0.6470701140991139
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
NCI-H810,148198,-5.648047602621706
SNU-449,6610216,3.892858260461962
NH-6,12003241,-1.8219752869317325
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
RKO,135875424,3.829354185480349
SK-BR-3,26596,-2.188814054378237
A-204,11485656,-0.4332502433044572
NCI-H1792,439501,0.6605330204311965
CAL-78,5460769,3.8399978594136193
SNU-475,12003241,0.1195420556659512
KMS-26,409805,3.707967657643135
Kasumi-1,148124,-7.196205420916251
YD-8,73707440,4.452607469919264
Hs 746.T,439501,-2.632583453917954
SNU-878,JQ-1-carboplatin (1-1 mol-mol),0.3987725595760565
8-MG-BA,9936388,2.9775871054225256
HSC-4,3689413,2.5472025828962055
BT-12,439501,-3.217940129826054
PE/CA-PJ49,6505803,-1.5018082269654205
CGTH-W-1,6610216,4.780150555279878
COR-L105,12003241,-1.8759508779616432
NCI-H2444,44491742,4.369311972266699
KMS-34,9903786,0.5468687794140459
NCI-H1563,6610216,4.011992180782097
LAMA-84,159324,1.313982035436444
KLE,9927531,4.8057879583658405
SUIT-2,439501,0.993663636668041
LN-18,6610216,4.459676529320986
BT 139,9903786,4.553274987644657
HCT 15,148124,-3.0176054207650993
DoHH2,148198,-5.119936658223105
Jurkat,409805,3.8074447971093304
MIA PaCa-2,6505803,-3.969520749405985
A-549,439501,-2.483005959928592
NCI-H358,6610216,4.626865746041361
P12-Ichikawa,3689413,-1.803795844399087
MV4-11,135875424,2.3295422515214717
MDA-MB-435S,135875424,4.677381950528883
HCC1954,11485656,2.196220765169822
Ci-1,36462,-0.0663858372189062
MHH-CALL-4,44491742,5.077124852247723
NMC-G1,26596,5.43387943202461
HGC-27,168313200,1.6271310885098942
PC-14,107985,-3.662594404968572
TOV-21G,168313200,3.7401235687507226
BT 131,24180125,2.5620481352252806
ME-1 [Human leukemia],selumetinib-GDC-0941 (4-1 mol-mol),0.4788349760990721
Reh,26596,-2.983938152417055
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
BT 440,6610216,4.135662592287223
SH-4,439501,-2.6634763397724033
PK-45H,selumetinib-GDC-0941 (4-1 mol-mol),0.6996398674072702
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
NCI-H526,6610216,4.727896763820283
UM-UC-3,107985,-2.89914501463289
CW-2,159324,0.8988860789988596
PL-21,12003241,-0.83006256212438
BT 440,49836020,4.914023334980662
SNU-8,JQ-1-carboplatin (1-1 mol-mol),1.6259891864743636
Mel Ho,36462,3.5703976572231557
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
SNU-308,36462,4.516059663616316
GSU,159324,3.570193385076479
COLO 678,3689413,0.0140701655611088
BFTC-905,9936388,0.1811780464508788
JURL-MK1,107985,-4.050737585877582
SW1783,54618164,3.832878612817737
BT-474,439501,-3.058225040966164
T-47D,439501,-2.5781176863157524
NCI-H1793,107985,-3.799152046715067
NCI-H841,54618164,3.9276782291967343
Caki-1,9927531,5.587911994434885
NCI-H2052,409805,6.16020441783884
HCC38,107985,-4.581327421068375
T84,148124,-4.089534404816918
COV434,8515,3.3303185098504855
KYSE-450,148198,-3.4919685284150876
KMBC-2,6610216,4.214797525140246
SR,9903786,1.863499016732126
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
D283 Med,409805,5.788391613893814
EKVX,10296883,4.140951610899391
C2BBe1,148198,-4.96016580080056
PC-14,73707440,4.422438937843538
LMSU,3689413,-0.2257013593388283
LOX-IMVI,148124,3.752144785635508
NCI-H1355,409805,5.032584793280894
PSN1,9927531,4.910271279543014
KMBC-2,9927531,4.40438479738659
SK-N-BE(2),148124,-5.184083311017544
OVCAR-5,12003241,-2.4332289606556903
NCI-H526,5460769,4.454179309152686
GCT,9903786,3.1531512143319396
KYSE-70,6610216,4.087252338732691
JHH-1,3689413,-2.4023532817808304
RT-4,11485656,2.1371904728142
Caki-2,135875424,5.110553141792517
TOV-112D,12003241,-0.8504182456561812
JL-1,6610216,4.5150955732362545
LS180,9903786,2.2166672873522857
A-375,8515,4.080476351747669
KYSE-180,9903786,3.667884143051944
SK-MEL-28,6610216,4.386997968475678
KG-1-C,12003241,-2.4512871070373476
D283 Med,107985,-4.659724680199273
ChaGo-K-1,5460769,6.469611673758945
NCC-StC-K140,439501,-3.4454248624947437
HOS,24180125,3.251928139496708
LN-229,selumetinib-GDC-0941 (4-1 mol-mol),1.343707265826647
EPLC-272H,8515,2.6637644767045043
SiMa,26596,-2.340944971406374
CGTH-W-1,selumetinib-GDC-0941 (4-1 mol-mol),1.204610504332706
T24,6505803,1.3138000670292382
EC-GI-10,6610216,4.746695759285481
SK-N-MC,409805,3.444464894840386
PF-382,36462,-0.7112012842580974
HT-1080,409805,5.848431740020943
OPM-2,168313200,1.8002020874491595
22Rv1,3689413,0.3571323215452703
NCI-H1755,49836020,-0.0301714782676706
HCC1937,159324,3.7699321027619184
Detroit 562,159324,3.424275125039322
HCC1937,selumetinib-GDC-0941 (4-1 mol-mol),1.9717867215396572
WM88,26596,-3.3679469356752465
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
NCI-H1666,12003241,-2.860788946487449
HSC-4,148198,-2.795908666323494
MKN7,24180125,3.837837013146784
EFO-27,44491742,4.311239061696844
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023
Hs 746.T,9927531,5.239357337613853
NCI-H1693,49836020,4.720041053935088
SK-MM-2,9927531,3.423086236737343
BL-70,44493528,3.7970898660168584
RKN,3689413,-4.085525957083088
JHH-5,26596,-1.3669217407356802
G-401,6505803,-2.085126737120111
EM-2,439501,-2.360437246727397
Detroit 562,36462,3.393501213812867
BT 172,148198,-4.688822444710566
KNS-42,6610216,4.822184289035433
KMS-11,12003241,-2.8887213513956147
HCC2108,135423438,4.347791872690299
TUHR14TKB,46943432,3.23090491736855
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
NU-DHL-1,5460769,0.1990382783266381
JURL-MK1,46943432,1.476821322825177
SCC-4,JQ-1-carboplatin (1-1 mol-mol),1.0548546410991495
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
PaTu 8988t,24180125,3.300808715406375
Rh41,159324,0.6982198047031537
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
SNU-182,9927531,4.620682064232075
A2058,8515,3.856536936008478
NCI-H1944,54618164,4.026280621410548
JHH-5,9936388,-4.7805778905113705
GOS-3,24180125,3.35218152246705
U-BLC1,26596,-0.9383285983925695
COR-L88,selumetinib-GDC-0941 (4-1 mol-mol),4.210918027029114
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
TE-10,409805,3.752318426383352
SW1088,selumetinib-GDC-0941 (4-1 mol-mol),3.0866822201862374
CAMA-1,24180125,2.8471894665186785
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
KP-3,46943432,0.0179698171752152
Mino,107985,-5.05206384093963
NCI-H1299,12003241,-0.9760038754339474
NU-DHL-1,26596,-3.470221600864271
MFE-296,9936388,-7.084516673626579
VM-CUB-1,11485656,2.4689983316138076
IGR-1,8515,4.0894264165501895
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
ES-2,9936388,2.136137651865657
NCI-H1563,9903786,2.6215320097996684
PF-382,3689413,-3.8661032289286488
NCI-H1299,135875424,3.7950147310792257
BICR 6,107985,-4.058328125828726
JVM-2,12003241,-4.468160768320854
L3.3,409805,5.10307456372432
BxPC-3,3689413,-0.056748072256038
CW-2,135875424,-5.260207779048425
SNU-8,12003241,-0.8120802877527198
HCC4006,135875424,2.723174656617446
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
LN-229,148198,-2.165786846201969
BT 159,10296883,4.294831220705457
AGS,44493528,4.404376645123692
NCI-H1581,135875424,3.5038022021338415
MOLM-6,168313200,2.7727860502576487
GCT,135875424,3.965319619265028
EHEB,11485656,2.717011543878295
HCC1195,10296883,4.230054584219755
IGROV-1,5460769,1.6083174601829917
WSU-DLCL2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2724910625039847
NCI-H2405,148198,-1.980170877151075
HEY A8,107985,-3.8703126786131463
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
A3/Kawakami,409805,5.980791867932477
RPMI-7951,6505803,-3.4302306957343434
Kasumi-1,168313200,3.502716754645687
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
DV-90,12003241,-1.148500998331207
PaTu 8902,24180125,3.5735575491444505
WM983B,135398744,6.927047773444745
NB1,11485656,1.5825359819360478
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
CAL-62,439501,-2.324492116544492
HeLa,3689413,0.6540693787829278
NCI-H647,12003241,-2.504495302724225
Panc 03.27,11485656,1.610276290455132
NCI-H2087,6610216,3.791496413970123
BICR 18,selumetinib-GDC-0941 (4-1 mol-mol),2.10893562893339
RERF-LC-MS,44493528,4.358183394704722
OV7,49836020,5.356073606057271
EFO-21,10296883,4.412303624074482
HEC-1-B,46943432,0.7932990906575372
5637,26596,-2.698358850803536
Caov-3,148198,-1.1153010896864872
IM95,8515,4.597489728166281
FTC-133,9936388,3.0046059879710363
COV434,3689413,-2.336562516768729
MCAS,148198,-2.0312221156390717
NCI-H1339,6610216,4.6247766816350495
SNU-407,36462,3.691403252799668
TE-4,46943432,1.546828329811108
RKO,10296883,4.075814636405189
HuH-28,439501,-2.3734651091068693
SK-MES-1,135423438,2.7133393164015027
BV-173,135398744,4.1083578998819945
IST-Mes1,10296883,4.238957650390159
KMBC-2,5460769,1.880103554481412
NCI-H1568,11485656,1.8106242285910237
Calu-6,439501,-0.8430638577007564
TE-15,36462,0.8303129579402212
NCI-H1944,9903786,2.6495499411680785
BT 245,5460769,4.174087021944073
EFO-21,107985,-3.293348677001705
NCI-H2196,44491742,4.104688837740398
NCI-H2106,24180125,2.031975648499319
MDST8,6610216,4.3863838734153
253J-BV,24180125,3.4609613429738455
BT 228,148198,-4.966222395978798
COR-L47,148124,1.2838207358762983
Ci-1,24180125,1.336206508417529
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
ECC10,107985,-2.86450405382575
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
NB4,409805,3.793938928834636
SUIT-2,12003241,-0.3419407469483631
Karpas-620,5460769,3.7991710121936304
P3HR-1,24180125,2.923923284516129
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
NCI-H322,selumetinib-GDC-0941 (4-1 mol-mol),1.023926311645034
Karpas-299,159324,-1.063709784546932
L-540,selumetinib-GDC-0941 (4-1 mol-mol),4.246283194196457
MeWo,44491742,4.0764207569550255
NMC-G1,12003241,-0.7597442114064075
647V,JQ-1-carboplatin (1-1 mol-mol),0.8897727111065127
Malme-3M,49836020,-0.4276181558524726
NCI-H1915,409805,3.8141858706600904
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
HCC15,44493528,4.34604946513687
SW1353,6610216,4.8642492591567175
PC-3,135423438,4.806220333593262
UO-31,10296883,3.111389314005664
NALM-6,44493528,3.763100774394441
IMR-32,9903786,1.34691800492683
SUIT-2,159324,3.729714900714809
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
KYSE-410,54618164,4.094546226578619
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
Calu-3,409805,5.821032330735687
Ri-1,8515,1.7161399430410786
RPMI-6666,6505803,-0.9166803455399566
SNU-16,11485656,1.507998082337787
NCI-H1734,11485656,2.0530229474698194
MDA-MB-415,135875424,2.557894559104866
WSU-DLCL2,JQ-1-carboplatin (1-1 mol-mol),-0.9568070052125086
TUHR4TKB,439501,-2.4659071378458544
SNU-C1,26596,-0.0671330439663034
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
TT,159324,2.9854792013895324
KMS-27,JQ-1-carboplatin (1-1 mol-mol),2.20932469874721
SNU-840,409805,5.492227436828679
WM266-4,3689413,-0.1379446477721048
TT,9936388,-5.089054710470253
T24,148124,-4.481408537000778
KE-37,44491742,3.673383181125235
DMS 79,148198,-2.9658771448885197
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
Karpas-299,26596,-3.8097040773311246
CAL-51,9903786,2.1849161121493847
LS513,409805,5.865921710016113
TM-31,107985,-3.4988477305101857
CMK,9903786,0.6507335736439642
ONS-76,107985,-3.307412021608342
AsPC-1,409805,5.083096669481897
KMRC-20,9936388,1.9781775187030703
MOLT-16,selumetinib-GDC-0941 (4-1 mol-mol),2.290963052000247
KPL-1,44491742,4.061678740812618
SNU-601,135875424,2.726240370483818
TTC-709,148198,-6.610156845026196
639V,11485656,2.1157835371974287
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
CML-T1,24180125,2.207667320892802
T98G,8515,4.706991436731757
LS1034,selumetinib-GDC-0941 (4-1 mol-mol),-0.3273277386123449
LNCaP clone FGC,3689413,0.5325071990753445
MHH-CALL-4,12003241,-1.7117307202040182
NCI-H661,107985,-3.0533673433660393
NCI-H660,6505803,2.5478241570945026
BT 145,439501,-4.642543329116397
KMRC-1,8515,4.713762602344707
NCI-H1341,49836020,4.324192381476246
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
ONCO-DG-1,3689413,-1.9285483999998865
B-CPAP,9936388,2.314754665986152
Mino,46943432,-0.4971400671027619
HOS,11485656,1.9269410367905917
HL-60,135875424,4.0116269121044015
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951
P3HR-1,168313200,4.175609839213621
JVM-3,439501,-2.5078633176007803
JHUEM-1,10296883,3.9346694694253657
SK-MEL-2,24180125,4.1729350383120485
NCI-H2110,36462,0.5226581571760742
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
SYO-1,54618164,4.764499368515595
JJN-3,54618164,4.053175478908277
DBTRG-05MG,9903786,2.261180783210366
IGROV-1,12003241,-2.0122972114546904
MIA PaCa-2,9927531,4.662028210048159
SU-DHL-10,9903786,1.7653767834986365
HCC4006,selumetinib-GDC-0941 (4-1 mol-mol),1.2371025715535526
CL-11,159324,2.5736174893833046
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
Sq-1,9936388,1.5257442738884122
KNS-42,11485656,3.6641636837314873
MKN74,135875424,3.2262010711942484
SKM-1,12003241,-1.1629643414911237
SK-CO-1,3689413,1.2567954519757167
EJM,9936388,-8.624056137584708
JM-1,168313200,1.89690041567587
EN,439501,-3.211149849796052
BEN,159324,3.690228423182978
BT 216,11485656,3.383904918711706
Hs 944.T,9927531,3.41915171718772
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
QGP-1,3689413,0.2348303758640308
A-549,3689413,0.7236603744186211
OV7,148124,0.1757740490601124
KYSE-510,10296883,4.094303304653805
NCI-H661,159324,2.633762936698375
KP-4,54618164,4.199260962007676
MHH-CALL-4,49836020,-0.2445846673370129
L-428,12003241,-0.2572573546541544
B-CPAP,409805,5.0770120967965795
RKN,6505803,1.4092626649390017
PC-14,12003241,-2.6584563263219203
TC-71,54618164,3.730396690506125
SNU-5,11485656,2.318118129500767
HEC-108,9936388,-4.887528080420867
NCI-H322,5460769,4.726933223287107
SKM-1,135875424,3.1648969740603095
KYSE-30,168313200,1.925854495062808
JM-1,8515,3.19981027650634
Mino,168313200,2.290605070302401
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
2004,9903786,1.8272851025318924
PE/CA-PJ49,26596,-2.486533753867605
HuP-T4,135398744,7.1369518257480475
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Hs 766T,selumetinib-GDC-0941 (4-1 mol-mol),-2.707404573640349
RT-112,439501,-0.757801709231946
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
SNU-899,44493528,4.57982118171392
YH-13,9903786,3.849279075978848
WT2-iPS,11485656,-1.624206160773241
Reh,10296883,2.990424165005631
NCI-H211,3689413,-2.259187530744643
SF126,11485656,3.3837301563498894
KMS-12-BM,12003241,-2.27657533610394
UO-31,54618164,4.25959693646093
Calu-6,10296883,3.629960277454761
NCI-H2087,10296883,3.767340744960793
NCI-H2196,54618164,3.883343219938622
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
G-401,44493528,4.310857122389352
EoL-1,6505803,-1.4779318620644195
CAL-54,6610216,4.030390620028951
AN3-CA,168313200,3.821120909855463
NCI-H2444,selumetinib-GDC-0941 (4-1 mol-mol),3.5798793535857625
OCI-Ly19,12003241,-2.2360327877915545
SNU-1077,439501,-0.9206139201693064
CAL-29,439501,-2.337192610313779
U-BLC1,6610216,4.090780023293868
HCC2935,44491742,3.357572958697748
BT 224,148198,-3.2746720257013813
G-402,439501,-3.32986520483416
TYK-nu,159324,2.671430187813448
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992
BT 131,11485656,2.37569711489929
HT-1080,44491742,3.909011022661936
Peer,73707440,4.301856504216986
NCI-H1395,148124,3.756905797674181
BICR 22,439501,-2.4052901035443
SK-N-BE(2),3689413,-2.1106889399644273
SUIT-2,12003241,-0.3419407469483631
RCH-ACV,26596,-2.407585357799557
NCI-H1155,439501,-2.4258947741424572
TE-15,46943432,2.615867274491135
TE 441.T,135875424,2.9590043348173225
CFPAC-1,11485656,2.6116197546865663
RPMI-6666,54618164,3.989215345651126
BT 245,3689413,-2.318316316051159
A-375,12003241,-1.2978704743837648
HuCC-T1,6610216,4.873841301442745
SK-MEL-24,selumetinib-GDC-0941 (4-1 mol-mol),-1.728607730118346
COV362,44491742,3.68091331789624
SK-CO-1,135875424,3.678629656731489
OAW28,107985,-3.5497769626209217
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
NMC-G1,409805,5.417486676360457
NCI-H1568,107985,-3.6136890416333665
NB4,49836020,-4.1463475414292
OE33,439501,-1.244619642300935
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
BT 428,6610216,3.3816789870982547
DBTRG-05MG,409805,5.910721068124035
LP-1,24180125,3.144388402663548
SNU-601,44491742,3.984168627416036
L-428,46943432,1.673068883218937
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
ACHN,11485656,3.39588605431362
HCC1143,10296883,4.463772522749199
COR-L279,5460769,2.2116692629451338
TCC-Pan2,24180125,3.6360187099049424
Becker,409805,5.716119591245028
RPMI-8226,9903786,1.7655422214301637
DMS 454,135423438,1.477667151193616
PE/CA-PJ15,148198,-2.65559177778782
SK-MEL-30,409805,5.464609868118714
Kuramochi,9936388,1.4592676990765918
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
GMS-10,135875424,3.9988471135126633
TCC-Pan2,439501,-0.269334901836468
NCI-H292,9903786,2.498172259524573
RKO,5460769,5.660789679983863
Hs 888.Lu,107985,-2.999004046519961
WM88,9927531,4.19876481787408
Daudi,49836020,3.49644839546437
SNU-1077,3689413,-1.655364429789056
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
KYSE-520,3689413,3.1364277290203986
CL-11,6505803,0.4915645691833006
SNU-C1,36462,2.395230491502765
RERF-LC-Ad1,409805,6.089650612893954
OAW28,54618164,4.207465894202405
CAL-33,409805,3.659975816516364
KNS-60,26596,-3.4190498423081026
SNU-1196,3689413,-1.8376731206647552
CL-11,439501,-1.1528361936308975
HEC-6,12003241,-1.1839534104512932
BT 248,5460769,4.810999932000391
MOLP-8,6610216,4.187822370904977
COLO 320,36462,4.829983230652816
Granta-519,8515,3.731909716775835
LXF 289,3689413,0.4542816941401804
HEL 92.1.7,36462,0.1283658129204001
SNU-878,8515,3.5916120112772902
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
8505C,135875424,3.698353328169634
IGROV-1,409805,5.990596261907717
SK-MEL-28,107985,-2.7940500151600296
TCCSUP,439501,-2.3382973857263893
MOLM-6,24180125,2.3884082924328007
ME-1 [Human leukemia],439501,-0.373146825712067
L-540,168313200,3.887437294203427
VM-CUB-1,46943432,2.632481130332744
BT 131,107985,-3.205027267690814
KMRC-2,8515,5.486198436058084
BL-70,9903786,1.6201088809137068
EN,9936388,2.3210150451577394
MOLP-2,168313200,3.90782874190498
FTC-133,36462,0.6793689394766376
SK-MEL-5,159324,3.0838844609903355
MOLT-16,3689413,-0.0606324778239056
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
Calu-1,107985,-3.5408503665357385
KMRC-2,9903786,3.847767222952075
RCC10RGB,3689413,-2.0864832427963336
OE19,9936388,2.0659697731662083
NCI-H211,159324,-0.4282240371333439
MHH-ES-1,6505803,-0.7832039030153297
WM1799,6610216,4.147204970842896
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
LOX-IMVI,9936388,0.4128358081832157
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
TE 441.T,12003241,-1.1939319008466374
CAS-1,439501,-3.1948113083897223
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
ECC10,9936388,-3.931527167718931
CAL-33,6610216,4.068225921805276
Reh,6505803,1.7551372132350431
SNU-245,24180125,3.6034150813328463
HPB-ALL,8515,4.035374798889955
EC-GI-10,168313200,3.768770833109668
KP-3,3689413,-2.21572351958202
Hs 746.T,6505803,-0.4653374975150369
FaDu,9927531,4.819445610620238
HGC-27,409805,5.82933383605485
NU-DUL-1,11485656,1.905169788673151
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
RCC10RGB,9936388,2.3235560801623465
NCI-H292,36462,2.4286801987130486
BT 232,54618164,4.582446279989421
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
NCI-H1975,44491742,4.016351620338357
NCI-H1435,439501,-0.9104784538070396
MDA-MB-453,148124,-4.8335014079709975
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
OVSAHO,159324,3.32268951699503
GI-1,3689413,-2.447824191080865
DMS 454,6505803,3.432232665344106
DMS 454,26596,-0.4599730834169373
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366
HEC-265,159324,3.632221551836653
GaMG,selumetinib-GDC-0941 (4-1 mol-mol),2.5044066808337644
PE/CA-PJ41 (clone D2),6505803,-0.4507500369158054
COLO 201,3689413,0.7393302797479664
MKN45,11485656,2.493574157806649
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
CAL-33,12003241,-0.8317301463564554
NCI-H1869,439501,-1.575584272947446
IGR-1,24180125,3.269696921536744
KMS-26,JQ-1-carboplatin (1-1 mol-mol),-2.004743944030579
SNU-387,44491742,4.132370196510326
SNU-61,46943432,3.2717403410494397
BICR 16,9936388,-6.204978757825023
BT 112,54618164,3.5492837733522205
Karpas-620,168313200,4.02321934640799
BT 172,107985,-3.8940786147439166
ChaGo-K-1,107985,-4.444294596677252
G-361,6610216,4.217301714160164
KMS-34,159324,0.2662861612259365
GDM-1,54618164,2.5636313167651883
MDA-MB-415,6505803,-3.148015366392549
ME-1 [Human leukemia],6610216,3.827956045934504
G-292 clone A141B1,26596,-0.9634124714344006
NCI-H1435,409805,4.495961033647919
SNU-182,26596,-1.9870021319207585
Hs 294T,26596,-0.6328702993813093
BC-3C,135875424,4.794032428578798
GA-10,9927531,2.891443375149746
NCI-H2126,107985,-2.5508062145194264
YD-38,9936388,-5.278764060182601
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
NALM-6,3689413,-1.8173610448442752
JMSU-1,159324,2.2275853880777534
CAL-78,24180125,3.4673071847149157
KYSE-150,3689413,0.7938684230504212
RL,6610216,4.988986648643106
Rh30,12003241,-2.0054573943466876
Hs 940.T,6610216,3.790705993515773
NB1,3689413,-0.0909545830460423
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188
OAW28,168313200,4.298133692275281
COV644,54618164,3.7830759061699086
IGROV-1,8515,2.1861539315976053
Mono-Mac-6,10296883,5.539962555703235
Aska-SS,11485656,2.660522165344914
ME-1 [Human leukemia],54618164,3.464632833073843
BICR 6,44493528,4.427648512148668
KMRC-2,12003241,-1.7913952791170802
AN3-CA,54618164,3.8831604834020688
Panc 04.03,148198,-3.912302089259141
HCC2108,439501,-2.3356100476768145
ACHN,409805,6.312119487325195
BT 320,439501,-1.927418392306892
YD-38,36462,2.856164296020876
MCAS,46943432,2.7452690797646553
ME-1 [Human leukemia],135398744,6.466274911980868
MV4-11,9903786,0.7441932169203459
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
PaTu 8988t,135875424,4.8815767191826325
Mono-Mac-1,26596,-2.0508737654950036
SNU-C5,107985,-4.306903080015857
NCI-H1623,409805,3.8984511674912943
MOTN-1,44491742,2.9342913777963555
JM-1,148198,-6.864264453079388
COLO 680N,3689413,-1.68743506325492
Fu97,168313200,3.8201234302700495
BT 239,9903786,2.77679173166366
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
Hs 940.T,49836020,0.3433567165193816
JeKo-1,44491742,3.7422814982420056
KYM-1,409805,5.989098964780094
SNU-16,54618164,3.5842381712580367
NCI-H196,24180125,2.7124009343781665
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
MHH-NB-11,9927531,4.251740517213762
SNU-449,148124,1.515559327544478
KMS-12-BM,135875424,3.5247186168283453
HPAC,3689413,3.007667333136724
NCI-H2228,10296883,4.1270071752314275
HSC-2,54618164,4.204268013662146
BICR 31,107985,-2.559614665868775
PL-21,439501,-2.414753232425099
BT 328,439501,-3.1360046964577983
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302
Caki-2,54618164,4.240331615220768
U-937,159324,0.4160428463027863
SaOS-2,6505803,-1.001039194104569
SUP-T11,44491742,3.738526329456195
NCI-H889,159324,2.6623068972323085
BT 232,439501,-1.8419260323239657
IGR-37,9936388,-3.744387709560832
HEC-59,24180125,5.1543604770288525
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
HT-1197,8515,4.26553986516295
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
GSS,439501,-2.3619517329640782
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
BT 145,6610216,4.164156438874729
Raji,12003241,2.533123505917396
WSU-DLCL2,6505803,-0.444395871025773
MKN45,148198,-2.2480188061666913
KMS-20,46943432,0.2963080368709872
Karpas-422,12003241,0.4573968210074843
TE-5,5460769,-0.4523281217111792
NCI-H841,8515,3.715015096758455
SNU-119,3689413,-2.887862499697321
8505C,54618164,4.142090194837595
SH-4,135875424,4.59145070139426
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
SNU-1196,12003241,-1.2616769402260497
SK-LU-1,3689413,-0.1029638587908799
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
PK-59,159324,2.910821247421296
U-87MG ATCC,3689413,-0.5776108875278053
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
KYSE-180,44491742,6.4799420322622305
SW1783,3689413,0.540292166648154
HCC44,439501,-2.457856090784354
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
HOP-92,148198,-3.4956728974738756
A101D,148198,-1.280940502528239
CL-11,107985,-3.0176631781990313
B-CPAP,439501,-2.790842155958922
SW1990,6505803,-2.4928933936476048
AGS,107985,-2.9064741271933636
KATO III,36462,2.9602968750282743
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
Ki-JK,107985,-4.619834564372043
Becker,148198,-3.822753548425191
Li-7,159324,3.1204100188155777
UO-31,9936388,1.3141929110792994
SNU-478,5460769,1.0103147308873888
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
IST-Mes1,24180125,3.710624760267412
NCI-H1651,selumetinib-GDC-0941 (4-1 mol-mol),2.159962931758626
OVCAR-5,54618164,4.322369503213112
Mino,439501,-5.730054140979018
SF539,439501,-3.28606941940852
UM-UC-1,135875424,3.037930773608268
HT-144,44491742,3.9121735247647127
JHH-2,10296883,4.160944892429831
MOLP-2,12003241,0.9753237716846912
BV-173,168313200,2.966649127022457
COV434,12003241,-2.0451557846060537
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108
Namalwa,36462,-1.022429039126246
MEC-1,9927531,3.3122365402427816
TALL-1 [Human adult T-ALL],409805,3.458170600954479
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
697,36462,-2.3548422170765946
RT-4,24180125,3.633157370927589
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
TTC-709,9903786,2.3304378522453866
DEL,9936388,-6.471933624576076
RPMI-6666,44491742,4.997277859824789
MM1.S,26596,-1.4234323398175248
GP2d,409805,5.9524352500309545
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637
Kelly,6505803,1.0108033674457453
Hs 729.T,3689413,-2.0906347621795076
2004,3689413,-2.0950734579660417
P12-Ichikawa,36462,-2.2820035892706345
SNU-1105,5460769,2.875284182310896
Capan-1,11485656,1.8375535341364733
OAW42,54618164,4.146300677714183
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
SNU-81,148198,-1.0516438667772403
Namalwa,168313200,2.5159524673485074
Hs 688(A).T,3689413,-1.8044012386941577
HCC2218,6610216,3.6192910247057113
MOLT-16,26596,-3.5703441979693245
NCI-H2126,selumetinib-GDC-0941 (4-1 mol-mol),2.896687453534691
EC-GI-10,148198,-5.102000128684168
TE-10,107985,-3.1810326059958585
IGROV-1,439501,-2.1510551928674557
SK-N-BE(2),107985,-3.856206997250564
Hs 895.T,44491742,4.052136098794782
PL-21,11485656,1.7729113112041155
Kuramochi,135875424,3.969220594462324
647V,24180125,3.086887880848898
KYSE-70,12003241,-1.4257688129039825
SK-MEL-3,11485656,2.032350870448147
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
SF268,44491742,4.062737154124887
DLD-1,159324,3.5449234505854617
SF126,3689413,-2.3760985230108584
GCT,44491742,4.460609521265373
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
SW1990,409805,4.048741151107136
KYSE-30,44491742,4.262990240897069
NH-6,107985,-3.816681183106218
JHH-5,12003241,-2.221894796534897
KE-37,3689413,-1.780022958661614
HT115,409805,4.722359951707107
SNU-1076,44493528,4.4421057189980875
HOS,44493528,5.3157890671440855
COLO 201,54618164,4.070639238227262
MOLT-13,10296883,2.8313852072501966
NCI-H841,12003241,-1.6250883775981226
SK-MM-2,6610216,4.027814295753668
Yamato-SS,54618164,4.292621514596885
NCI-H727,9936388,1.6432072244848812
CML-T1,107985,-4.139753917879256
CHP-126,26596,-2.268724327317824
JM-1,44493528,3.997956862382446
HCC1438,12003241,-0.2782249625748692
TC-71,439501,-2.5028085406649336
GI-1,107985,-2.483024326686008
BC-3C,9903786,3.0556905946174537
JIMT-1,6610216,4.8659942522490365
SEM,5460769,-1.0690415880949575
Hs 294T,44493528,4.371769824264516
SK-MEL-31,3689413,0.7932345609098049
Hs 936.T,159324,3.4620555818904473
GDM-1,3689413,-2.3976693518494208
HCC1438,44491742,5.362050315054713
SNU-475,107985,-2.4628206364316005
U-937,11485656,1.9475205448486337
NCI-H524,439501,-1.5131923813940935
GSS,49836020,4.0402801556040036
SK-N-BE(2),11485656,1.869214340930476
LXF 289,6610216,3.700752852024682
YKG-1,9927531,5.706988241233545
SNU-423,148124,-5.293921885870976
KNS-81,9936388,2.4620371956354834
DAN-G,107985,-3.9359563763245458
UM-UC-1,JQ-1-carboplatin (1-1 mol-mol),1.521072888434132
KE-39,24180125,2.8951506389407053
U2OS,3689413,0.3310874452746708
BT-16,3689413,5.62862969112265
Rh41,54618164,3.138182443744225
SW48,12003241,-0.9746028071684796
SU.86.86,3689413,-0.2101757274961018
NCI-H1792,54618164,4.250571755822218
HuP-T4,11485656,1.6012031852576112
NCI-N87,11485656,1.873926788766734
MDA-MB-435S,26596,0.461113315638288
DLD-1,44491742,4.025001948780805
BT 444,135875424,3.072023667711102
HGC-27,9903786,1.5115157472800849
PaTu 8988s,135423438,2.605491208286135
NCI-H520,11485656,2.0255953186148674
Hs 940.T,selumetinib-GDC-0941 (4-1 mol-mol),2.512556445742238
MKN7,6610216,4.498643244512437
TE-4,409805,4.857897884045195
CMK,9936388,-7.015739641414748
OCI-Ly3,JQ-1-carboplatin (1-1 mol-mol),0.1227368323293568
BT 428,54618164,4.165032933518285
SW1990,36462,1.719748778334474
HCC1143,6505803,-0.5233928936461414
NCI-H2452,9927531,4.529523169776047
Calu-6,3689413,-1.4925549301996452
SEM,135398744,6.34358667151958
MDA-MB-415,9927531,4.701582574311918
EBC-1,49836020,4.041761576127936
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
THP-1,159324,-2.014853180774234
SNU-423,3689413,-2.448438848320713
JHH-1,409805,5.920363605270019
KYSE-70,26596,-1.4453873864890578
SNU-1033,135875424,3.081818614002125
HT-55,36462,2.885692973431166
EKVX,3689413,-1.7429314171810966
WM1799,159324,3.2661346124981008
HEC-1-B,135875424,4.054775379166637
NCI-H23,26596,-3.72229415651004
SNU-1076,54618164,4.328001812111135
HT-55,5460769,6.100853443002961
TYK-nu,8515,5.680791185105499
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
Hs 746.T,10296883,4.016339774932521
NCI-H2286,11485656,2.9598645626124576
BT 187,5460769,4.174601592946769
JJN-3,9903786,1.1978093816271655
BICR 22,44491742,3.912327775797625
KP-2,54618164,4.176470394746258
MOLT-16,10296883,2.3695958656227782
NCI-H358,11485656,2.220633179446384
NCI-H508,9903786,0.5730721211303239
SK-MEL-28,135875424,5.515491244041513
JMSU-1,12003241,-3.06340831413481
HCC1806,159324,3.5329859542664175
TT,439501,-2.411064207621025
GDM-1,6505803,0.9886277472188528
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
BT 286,6505803,-2.395900359039176
IA-LM,49836020,4.225846480888235
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
CAL-120,11485656,3.0524191278812975
Ishikawa (Heraklio) 02 ER-,159324,3.630524948383921
SK-CO-1,12003241,-0.9578793579943758
RPMI-8402,3689413,0.0751031286751058
A-172,168313200,3.7321565139608577
VMRC-RCW,9903786,3.331782716085826
COLO 205,439501,-0.8424951249003566
SNU-182,54618164,3.7450225513985753
A-498,409805,6.12415200666612
NU-DHL-1,36462,-1.7187718695601946
SK-MEL-24,9903786,3.6296294578661494
KYSE-30,135875424,2.992970338382266
NCI-H1573,9927531,4.21902889327973
T24,36462,3.7115537308708313
TUHR14TKB,9927531,5.242660147082698
BT 245,36462,1.2671899599855267
SNU-1105,12003241,-1.0789157776023728
SNU-620,9903786,1.530835439194961
A101D,3689413,0.2698790344581709
KMS-20,107985,-4.802194252756391
SJSA-1,107985,-2.8850477592405044
MV4-11,9927531,4.708512628737502
NUGC-4,107985,-2.8695226927077604
Hs 940.T,9936388,1.1653253774918717
769-P,9903786,3.979605140448373
KMRC-2,168313200,3.0339404412127324
GB-1,8515,2.0817327555549436
SK-HEP-1,148198,-3.434194259121147
NCI-H661,409805,4.01937565581764
BICR 22,168313200,4.032164885313491
SNU-213,12003241,-1.127561281071067
KE-37,24180125,2.169434675284816
HGC-27,135398744,6.47323705988127
PK-59,135875424,3.737021018611698
GaMG,148198,-2.2602125846072627
A2058,409805,3.820930046521051
KO52,44493528,4.373207696272561
T-47D,6610216,3.903210630252733
COV362,24180125,3.098482746662586
COLO 668,5460769,2.9607897533404244
NCI-H727,9903786,3.725485605999375
GOS-3,8515,4.692167574261379
MKN74,6610216,4.33380428824605
COLO 829,8515,4.719403655310812
GOS-3,409805,3.6304586799066967
NCI-H2228,JQ-1-carboplatin (1-1 mol-mol),3.687353697289914
DMS 273,44493528,4.2569430545307725
SF268,12003241,-2.0418893916572243
DMS 454,54618164,3.941051216840159
DU145,6505803,2.9308640693327126
KYSE-70,107985,-3.298359335305578
H-STS,44493528,4.270078015163244
NCI-H460,6610216,4.838717363885395
P31/FUJ,409805,3.653161003579303
SK-MEL-24,8515,5.656474730619789
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
SJSA-1,148198,-2.7316697840866673
HuCC-T1,44491742,4.260801380076742
BT 216,44491742,5.368329526940575
SK-MEL-31,54618164,4.23134710733717
RERF-LC-Ad2,12003241,0.07971757119013
PaTu 8988t,46943432,6.478561461465468
SF268,6610216,3.7969186447018455
DOV13,12003241,2.698298225737835
Mel Ho,9903786,4.6138306230888615
SF539,10296883,3.7658288303305976
JHUEM-7,24180125,3.52789412824338
SW1783,9936388,2.9056540363277796
SNU-5,135875424,3.5820845007608555
MOLM-13,54618164,3.841266236609366
Calu-6,54618164,3.923286506483291
HeLa,36462,3.354174189337733
CAL-78,159324,3.4477302000775776
697,6610216,3.629204031337067
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
MOLM-13,49836020,-0.1965532240483963
639V,148198,-2.584767342306116
RL,44493528,4.146088733572883
ONCO-DG-1,26596,-2.0057166886721625
RPMI-7951,JQ-1-carboplatin (1-1 mol-mol),3.054924141826928
A4/Fukuda,3689413,-1.7998697854540155
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
SNU-216,5460769,1.6923637113112366
NCI-H2087,46943432,0.8121400631384804
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
SJSA-1,8515,4.468492195997185
BICR 6,11485656,1.8767182695378195
DU145,148124,-5.577110103227381
SUP-HD1,10296883,3.4620113901204927
NCI-H1105,6610216,3.9896940586216663
Capan-1,439501,-1.7438578400457687
BDCM,8515,3.1088597237934423
OCI-Ly10,148198,-3.382160448081964
DEL,11485656,1.7732311398144052
DB,11485656,1.836409608032291
8505C,24180125,3.3007997702973797
SNU-886,11485656,2.594845566887895
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552
DB,107985,-5.7298347238370795
GSS,409805,3.734629262000393
NCI-H841,10296883,4.212542527018102
YD-38,44493528,4.189502567524798
D283 Med,46943432,1.9673056187100668
ST486,12003241,-0.1204499968223502
HLF,44493528,4.4251404257348295
C2BBe1,9927531,4.784416538426047
HCT 116,9936388,2.1629557808045146
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
BT 498,9936388,2.0435440687928614
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
BT 416,46943432,1.605055872741302
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
NCI-H647,148124,-3.9513276226558474
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
NCI-H2081,9903786,1.5566694513779922
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708
OVCAR-4,107985,-4.727068653630688
BHY,5460769,2.8101975648917468
SNU-423,JQ-1-carboplatin (1-1 mol-mol),4.402018355533478
WM115,8515,4.149615392892544
COLO 829,107985,-3.859000290830783
RMG-I,9936388,2.101682867932538
MSTO-211H,159324,-0.971759723426381
22Rv1,409805,3.669693952554832
NCI-H2023,11485656,2.100922570819449
HCC1419,107985,-4.0861920126491365
EBC-1,JQ-1-carboplatin (1-1 mol-mol),0.4045548074723116
LN-18,36462,1.6334561930516676
WM88,44491742,3.817934383194013
RT-112,10296883,4.279082989999429
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
BT 245,9936388,0.9041726045525886
LK-2,6610216,4.2207982837864275
OVTOKO,148198,-1.8970821230832648
Panc 03.27,439501,-1.8758236187541328
YD-10B,135875424,2.966969780143732
COLO 792,54618164,3.706316452740556
TOV-21G,8515,4.292104860970436
HDLM-2,36462,1.1917482107311113
KYM-1,148124,-5.892667990186819
KMS-27,159324,1.3693882554650931
KPL-1,9936388,1.598306973451347
U2OS,54618164,4.008388893072133
VCaP,6505803,0.850097300385562
OV7,44491742,4.062871601608624
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289
JHH-2,44491742,4.07921218281707
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
LOX-IMVI,44493528,4.127526604228942
SK-ES-1,6505803,0.0582919065380463
SET-2,5460769,3.4880653417656022
HT115,9877608,5.791889645309291
Mono-Mac-6,6610216,3.2864580018643452
NCI-H838,36462,2.0025187591380016
HEC-151,9903786,2.765131251863377
COLO 741,selumetinib-GDC-0941 (4-1 mol-mol),3.828549424884254
23132/87,135423438,4.4665628389477305
JJN-3,439501,-3.1655591002540864
SNU-C1,11485656,1.873181014714628
NCI-H1435,36462,2.835502283078309
Hs 688(A).T,409805,5.195577120542783
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
KMS-34,11485656,1.6591350008263417
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
NCI-H2196,9936388,1.3718542945695429
MOLM-6,36462,-1.03155130204684
JHUEM-7,9903786,1.8726211891462523
NCI-H526,selumetinib-GDC-0941 (4-1 mol-mol),3.379534287031186
MHH-CALL-3,26596,-0.8027776235461769
NCI-H1792,selumetinib-GDC-0941 (4-1 mol-mol),1.680387740806623
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
COR-L105,9903786,2.948812050867326
NCI-H1568,44491742,3.692908194165655
P3HR-1,36462,4.280628122452117
EC-GI-10,11485656,1.8249313771859752
JK-1,24180125,1.6438526742405235
SW579,148198,-4.901581686812131
NU-DUL-1,9903786,0.8090083924855098
GOS-3,439501,-3.404828566068769
PE/CA-PJ15,44491742,3.9025986426144934
COLO 684,selumetinib-GDC-0941 (4-1 mol-mol),1.3698128792946012
IGR-1,148198,-3.4768573180396496
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
KMS-12-BM,9927531,3.2870919606414963
LNCaP clone FGC,46943432,1.061880867154241
BT 440,439501,-2.9388364994679614
HCC95,148198,-1.75533613321643
KMS-18,9927531,3.9141727382936624
L-540,24180125,3.0668574427467994
HT,36462,1.6293065622755083
U-118MG,409805,3.6083081108044497
MM1.S,107985,-4.097612409872881
HCC1806,24180125,3.752298638781302
TE-9,26596,-1.3406326261923425
KMM-1,159324,3.5302445875104365
CA46,44491742,3.801952242992866
JHOS-2,9936388,2.4979733354975773
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
ECC12,26596,-1.2680544811101384
GSS,36462,-1.7824773633563245
BT-549,49836020,-1.94641857460656
LP-1,6505803,0.6581900547283019
KMS-20,3689413,-1.644811207648459
KYSE-140,107985,-2.0809038336660923
SK-N-FI,168313200,3.1298360952995674
SNU-1076,11485656,2.42943122254484
JHUEM-7,11485656,1.7197285505227566
COV362,12003241,-1.5516185540299623
MDA-MB-453,135875424,2.7753375231350104
BV-173,409805,3.938623385027597
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
RL95-2,439501,-2.2732011177914586
NCI-H2291,12003241,-0.3481975958318299
Capan-2,12003241,-1.76044802004158
BL-70,11485656,1.5979505669049718
FaDu,9936388,1.704724007289382
RT-4,159324,1.8094112077356237
P31/FUJ,11485656,1.9746673234827223
TE-4,12003241,-0.733911012282654
FU-OV-1,12003241,-1.039273875540509
MG-63,148124,3.329653323642378
LN-229,3689413,-2.3108318382356248
TCC-Pan2,159324,3.6009893052983406
CAL-54,selumetinib-GDC-0941 (4-1 mol-mol),0.8998815087239347
MOLT-3,10296883,3.393769807045215
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
BT 504,5460769,2.119344247070391
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
TE-14,3689413,2.902593123647125
Hep-G2,107985,-3.632879499618416
KMS-21-BM,439501,-2.3809491999533003
LS123,12003241,0.0406446748290718
NCI-H1975,selumetinib-GDC-0941 (4-1 mol-mol),-2.1756384403206326
SR,107985,-4.50871259775865
HCC38,JQ-1-carboplatin (1-1 mol-mol),1.2340294143226358
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
PE/CA-PJ15,135875424,3.5762101924458585
TC-71,44491742,3.7748114564226407
KMRC-2,148198,-2.5062257311600753
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
UM-UC-3,9903786,3.957731160225435
CAL-62,6610216,4.866037437234073
KO52,12003241,-1.0632598943321483
JMSU-1,9903786,1.2487858864951975
HEL,135875424,2.9448279330391927
Hep 3B2.1-7,36462,2.768405314394988
HEY A8,148198,-3.070106200413562
Karpas-299,9903786,1.3697827730065784
MES-SA,12003241,-0.7503338761579216
NCI-H1092,5460769,5.922318384562557
NCI-H2291,135875424,4.231484066090065
HCC-56,148198,-4.2665596925973395
HPB-ALL,44493528,4.688141259598365
UACC-812,6505803,-4.59801553223132
SNU-308,107985,-2.764112061523982
MKN74,439501,-1.7547166912858625
NCI-H1651,135875424,3.2371114243146453
GA-10,54618164,3.873784446701225
MG-63,135398744,6.808455799902383
JM-1,409805,3.649428990507172
SNU-16,9927531,3.2030544942563317
SK-N-AS,6505803,0.8631817321203803
DV-90,9927531,4.273842148602971
BT 164,3689413,-2.3779302902052444
LP-1,5460769,5.634254198515754
Hs 944.T,12003241,-1.584632945920027
Capan-2,6610216,4.161327281234416
MeWo,3689413,1.920191181250088
Hs 683,54618164,4.101275609218899
SK-CO-1,5460769,-0.7722931098274061
WT2-iPS,6610216,4.234940774221
AGS,11485656,1.9276189109477695
Caov-3,54618164,3.649978975153443
BT 216,9936388,1.282590182354356
WM983B,36462,1.7671342918989796
MOLP-8,5460769,1.8843864880791628
J82,148198,-3.1437568832553837
Karpas-422,439501,-2.968319248514649
CHP-126,8515,3.6293613784004815
MDA-MB-157,135875424,2.7117106005077276
LMSU,135398744,6.91211293627059
SNU-61,54618164,4.021673833793196
Hs 294T,54618164,3.87714618988063
NCI-H1694,54618164,4.0611966209465065
SW982,409805,3.909566266382756
NCI-H929,11485656,1.7872822459041733
BT-549,9903786,2.513972936103366
EBC-1,439501,-0.4192565995990754
P12-Ichikawa,107985,-2.752664509679756
HuH-1,JQ-1-carboplatin (1-1 mol-mol),3.110129386511311
ACHN,5460769,0.8804471145118281
SaOS-2,168313200,1.7182390433527042
NCI-H1155,44491742,3.896429855213272
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
TYK-nu,135423438,1.6233801732572664
NCI-H1573,439501,-2.416114223913521
VM-CUB-1,439501,-2.2859816602677077
TTC-709,107985,-3.8889296232752737
OV7,9936388,0.389883949605854
NCI-H1734,107985,-3.677393091141896
Panc 08.13,36462,3.423383845506473
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
NCI-H2172,148198,-0.2534137859754289
Ishikawa (Heraklio) 02 ER-,107985,-3.239655509933191
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
MIA PaCa-2,10296883,4.037005331930825
42-MG-BA,54618164,4.748966757965469
DMS 79,6505803,3.896341959956276
SNU-478,11485656,1.921129079492399
HMC-1-8,11485656,2.285231442211603
NCI-H2172,6610216,4.169971132764112
TTC-709,24180125,2.733519633655364
NCI-H2081,10296883,3.746053952557345
BT 147,8515,3.830553244560158
Kasumi-2,26596,-3.0246532529835273
SNU-8,36462,2.8022982828339957
YD-38,12003241,-0.5056624439731239
KLE,439501,-2.1797784747958477
SK-UT-1,44491742,5.121507877742128
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
BT 428,135398744,8.121810698450407
SUP-T11,3689413,-2.394245997939745
RCH-ACV,5460769,1.517415725106548
Daudi,439501,-2.973914496380735
UACC-62,selumetinib-GDC-0941 (4-1 mol-mol),-0.701178032611257
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
C2BBe1,selumetinib-GDC-0941 (4-1 mol-mol),0.2357334763777015
MM1.S,409805,4.03743481309792
5637,11485656,2.17002066337147
WM266-4,168313200,2.299042101542935
PE/CA-PJ34 (clone C12),168313200,2.559397227720179
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
NCI-H1693,5460769,1.1417796185034783
HuP-T4,9936388,-6.160630678520688
SNU-61,9936388,-6.308071034865157
AGS,409805,6.20500134764402
UM-UC-1,9927531,4.732850009488004
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
MDA-MB-231,6610216,5.495041065534818
NCI-H1155,11485656,2.0166410350389885
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
HCC1806,44493528,4.3111329846285456
MJ,6505803,-0.8623373124046138
EFO-27,3689413,-2.375877948841856
MOLP-2,44493528,4.982078328127478
BICR 31,49836020,4.313223650735915
NCI-H358,135875424,4.435153990168911
KNS-62,selumetinib-GDC-0941 (4-1 mol-mol),0.6177155702395645
Panc 10.05,JQ-1-carboplatin (1-1 mol-mol),5.298332174955392
Ri-1,11485656,1.6570467994982818
SNU-1,8515,3.60368190777916
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
SK-MES-1,107985,-3.478483308855868
KCL-22,439501,-2.3189522381647194
SW620,36462,2.219897715399993
KYM-1,9903786,3.7679848907863738
CAL-33,9927531,3.2885061744461273
AN3-CA,135875424,2.655467292479818
SK-N-MC,5460769,1.627780458373646
MOLT-13,409805,3.680221382907752
YD-38,9903786,2.8631306213752103
DND-41,11485656,1.1468177046699728
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
Panc 05.04,12003241,-1.2094626899686458
SNU-449,5460769,0.9117409452183444
Hs 688(A).T,135423438,1.627421563855232
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
NCI-H1650,6610216,4.520029622813093
CAL-51,12003241,-1.2189714227076325
OE33,168313200,4.319769864025677
Kuramochi,5460769,4.70110979591698
NCI-H1869,9936388,1.425696213804551
RPMI-7951,9927531,5.17840544344631
Hep 3B2.1-7,3689413,-0.8676280815745859
L-428,107985,-3.729853241887149
Hs 729.T,44491742,3.716267531008215
769-P,439501,-0.7998429700142536
BT-549,12003241,-0.9663956127583828
Detroit 562,135875424,3.611999355056841
TE-5,6610216,4.181469364811624
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
42-MG-BA,24180125,3.7179190306480527
A-375,148198,-2.551882325467432
SNU-668,107985,-3.9199396069518
MDA-MB-435S,10296883,4.225013123345449
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
HEC-1-B,11485656,2.1491894336103123
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
HEY A8,135875424,4.032445855238006
CAL-78,8515,4.135140304520332
DMS 79,5460769,3.0772238606557623
Panc 03.27,12003241,-0.3666669100111787
SK-N-FI,36462,3.092698670043595
JURL-MK1,9927531,3.9851065784934945
MOLP-2,26596,-4.180731486004902
BT-12,148124,-4.138669937120045
HSC-3,3689413,-2.2600837113951497
A-253,3689413,0.6147211160043753
OAW42,168313200,2.5927841071629407
PE/CA-PJ34 (clone C12),107985,-3.5683543961091138
SW48,409805,3.4729287041870127
HPAF-II,11485656,2.414916440294545
ESS-1,9936388,3.356877818481439
COR-L95,44491742,4.146782751375218
Raji,135875424,2.0989109294233264
NCI-H1435,JQ-1-carboplatin (1-1 mol-mol),2.9022740526211765
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
Panc 03.27,49836020,2.722888568283256
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
A-253,10296883,4.076083585934383
Hs 578Bst,11485656,3.9030782427040247
22Rv1,159324,1.7570868223743523
HEY A8,8515,3.710776284319144
SNU-201,9903786,3.5619464236544336
YH-13,12003241,-0.7443010060517422
SUIT-2,159324,3.729714900714809
NCI-H2170,3689413,3.058757672919766
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
CML-T1,9936388,-6.3994005254305995
CHP-126,10296883,3.566759468815065
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
HT115,159324,1.560184632739966
HuNS1,49836020,4.176817793282971
COR-L105,3689413,-2.1605707630353708
JHUEM-2,36462,-2.2677125501048176
KP-3,135875424,4.114191182933948
JIMT-1,44491742,4.195591062798884
NCI-H292,148198,-2.0841293800573446
NCI-H1975,JQ-1-carboplatin (1-1 mol-mol),1.6464051642952602
Kasumi-2,148124,-6.270957848916609
Kasumi-1,8515,2.586543049532785
IGR-37,5460769,4.3562687129012625
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
AsPC-1,36462,3.6552458214160506
HCC1569,9936388,1.7160045234798948
KO52,409805,5.182082476499644
HCC95,8515,4.1484820954799915
OE21,148198,-3.484738735179186
SNU-61,6610216,4.086517799339023
Hep 3B2.1-7,11485656,2.176020084132011
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
SUP-B15,168313200,2.8000345719543973
SNU-46,54618164,4.1308083358552246
HDLM-2,26596,-1.5696156753174118
KATO III,148124,2.7785183378157434
HD-MY-Z,107985,-4.509019468777268
TE 617.T,JQ-1-carboplatin (1-1 mol-mol),1.6979959142929375
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
TE-6,26596,0.4120128768036302
OCI-Ly3,439501,-3.305238194936377
639V,12003241,3.941533367074586
IST-Mes1,44491742,4.903550558956352
DV-90,54618164,3.589602707510897
EoL-1,8515,1.249672185146308
DAN-G,12003241,-0.4522104330137063
Rh30,11485656,2.766839981757524
BCP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.866380650613888
K-562,11485656,1.7795111963017332
NB1,148198,-3.561565130564965
SNU-213,409805,3.467553308221755
UO-31,135423438,1.1750437401104377
BL-70,148198,-4.761980486191778
CAL-62,36462,0.9586944674226984
Capan-1,JQ-1-carboplatin (1-1 mol-mol),2.2044130423038477
GA-10,9903786,1.0626395044563215
K-562,6610216,3.734328570580528
HGC-27,JQ-1-carboplatin (1-1 mol-mol),1.0978980363153934
ChaGo-K-1,12003241,1.029111103028103
BT 286,26596,0.1662425719802319
KE-97,439501,-2.4280531684579896
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
UM-UC-1,46943432,5.976790346070284
SNU-761,selumetinib-GDC-0941 (4-1 mol-mol),3.4718208794514167
DK-MG,12003241,0.4512209867473665
HeLa,6610216,4.731171636127949
BT 224,3689413,1.7352583151087375
NCI-H1155,135875424,3.2409208598380466
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
ONS-76,3689413,-0.2845128895134612
LOU-NH91,8515,5.2113767400480775
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
KNS-60,36462,2.6280581981988056
SK-MEL-1,11485656,2.5093092817296307
NCI-H1869,54618164,4.0885631456331035
NCI-H1666,3689413,1.2654271755000104
647V,11485656,1.780919145003727
RPMI-7951,409805,3.607253520959431
WM1799,10296883,3.650999018677617
RL95-2,9936388,-5.708399699553936
HOP-92,44491742,4.695490745837731
WM1799,selumetinib-GDC-0941 (4-1 mol-mol),0.0731579232599876
RERF-LC-A1,135423438,2.4770286699108857
CAL-29,49836020,4.434653881531219
DAN-G,168313200,3.898959212674069
LAMA-84,11485656,1.887389966808588
TE-6,107985,-2.7595126559033454
NCI-H1395,5460769,5.87662281780079
PaTu 8902,44491742,4.263402068757711
NCI-H196,6610216,4.943661751084643
NCI-H1650,36462,2.1466146201267833
A2058,36462,0.7228445250033858
PE/CA-PJ41 (clone D2),10296883,4.236451814997899
WM88,3689413,-2.428480680194512
CHP-212,5460769,-1.533156489217473
Hep-G2,6505803,-2.5933743398692894
BC-3C,36462,3.334767376058825
KE-37,5460769,2.542918791182312
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
SK-MEL-30,135875424,4.398067233460652
KNS-60,11485656,1.5594601831806838
NU-DUL-1,44493528,4.021728675000071
HCC78,44493528,4.5859040638932385
BT-549,6610216,4.341228931549091
TE-4,9936388,-6.469304697668828
TM-31,439501,-2.1329770748027426
Hs 683,148198,-3.2312790086257057
NCI-H358,selumetinib-GDC-0941 (4-1 mol-mol),-1.5970203411339507
BICR 6,24180125,3.6458211180566935
NCI-H2170,135875424,4.845645858275147
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
UO-31,9903786,3.174003298065322
COLO 320,148198,-6.470964602076055
SUP-B15,26596,-1.8657043517312688
SNU-C5,26596,3.4561899708021175
CJM [Human melanoma],8515,4.376116146258834
NCI-H838,107985,-2.6563013352867677
KP-4,148198,-2.7737316499717353
U-BLC1,3689413,-0.8991596677439855
RPMI-8402,439501,-3.664200727311063
NCI-H2291,selumetinib-GDC-0941 (4-1 mol-mol),-0.2991032125390215
A-673,5460769,1.3883868162718005
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
Hs 888.Lu,148124,2.240459751770133
SNU-1079,159324,1.9215483474213175
NUGC-4,26596,-1.113746804335536
FTC-133,148198,-1.6568063805549866
TE-15,3689413,0.9912236496957668
SK-MEL-3,107985,-3.869718224497346
Mino,6505803,-0.2823157410063563
Hs 294T,selumetinib-GDC-0941 (4-1 mol-mol),1.293217302318029
HEY A8,11485656,2.178163900753691
BT 440,107985,-3.431835776853905
MOLP-8,26596,-2.4791577040777812
HSC-3,107985,-3.2412158645238893
LXF 289,159324,2.685439807189008
SK-MES-1,439501,-3.0675595474826194
PK-45H,135875424,5.088820558877691
WM1799,135875424,3.6898811613748874
NCI-H1435,12003241,-2.5624704178121274
NCI-H28,135875424,3.040618130997964
KO52,10296883,3.770873498157397
NCI-H460,11485656,2.6212830818798065
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
HMC-1-8,selumetinib-GDC-0941 (4-1 mol-mol),-0.1007905970017958
HLF,26596,-1.3271956114296155
BL-70,5460769,4.3376670104082455
HuP-T4,6610216,3.8293883962639175
BICR 31,5460769,3.9433617709959696
JHH-1,5460769,4.810019702724217
MHH-CALL-3,6610216,4.42888193418578
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
HEC-6,9936388,1.177360441508745
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
YD-15,36462,1.1625892887713607
K-562,26596,-3.6076758496321832
EoL-1,54618164,2.9471076229602717
SR,8515,3.9218784416281975
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
Tm87-16,135875424,5.622886388921831
SCC-25,44491742,4.077227537084196
FTC-238,24180125,2.9412466456842408
RVH-421,JQ-1-carboplatin (1-1 mol-mol),4.487330987841125
NCO2,6505803,-0.6279815858005762
NCI-H647,9936388,1.0931922000405532
RVH-421,168313200,2.8621224678697903
OCI-Ly3,135875424,3.008011320829632
NB1,6610216,4.31899163465426
LOX-IMVI,46943432,0.8500052465051992
BFTC-909,9936388,1.702123766125507
SYO-1,10296883,4.0687623186484005
BT 224,11485656,3.221483556518939
NCI-H1975,49836020,-1.0893813245468835
HCC2218,5460769,-0.600250204778271
SK-CO-1,107985,-2.728069079888901
647V,6610216,4.420166343003129
BT 422,9927531,5.2521428794559
KU-19-19,409805,5.730069773001202
YKG-1,44491742,4.005192115909779
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
LP-1,107985,-4.335772464221896
LS513,24180125,2.1717772599454146
MCF-7,107985,-3.975928290403253
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
LNCaP clone FGC,5460769,1.4769173176739367
SK-N-AS,168313200,1.823483037418336
MEC-1,24180125,1.2281779471332437
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
KPL-1,6610216,4.881878965578164
HuH-28,409805,5.781601088371211
MHH-NB-11,36462,-0.963278155790924
ALL-SIL,107985,-3.6188373708521495
KMH-2,12003241,-0.520398442259763
BT-474,148124,-3.6450938662304457
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
SHP-77,JQ-1-carboplatin (1-1 mol-mol),1.995667602939756
OE21,36462,4.517672973298236
BT 131,9936388,0.7125118165046622
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
Pfeiffer,409805,1.9666886475443683
HCC1428,selumetinib-GDC-0941 (4-1 mol-mol),5.009115635429041
DMS 273,409805,3.6932334728164826
BT 131,409805,3.877386037090413
SW620,12003241,-2.6864351641930155
Karpas-299,10296883,3.126285958642229
CHP-212,6505803,-3.651985635286723
YH-13,24180125,3.319627413046534
Ri-1,24180125,1.2545611778962542
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
COLO 320,9903786,-0.1996043978745841
KMRC-20,9903786,3.936421872110463
SNU-175,9936388,-6.345283130310661
OUMS-23,6505803,0.855156690272806
MOLP-8,9927531,5.438833274000949
KYSE-450,107985,-2.5991622295290413
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
OVTOKO,439501,-1.8305159910800708
NCI-H2228,selumetinib-GDC-0941 (4-1 mol-mol),1.1807966887528696
WSU-DLCL2,135875424,2.114413324161352
HOS,selumetinib-GDC-0941 (4-1 mol-mol),2.6717134852728264
8305C,44493528,4.453346362405301
Karpas-422,8515,3.8543440231436135
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
Rh30,5460769,3.928559830912204
ONS-76,159324,2.5690437216419677
SKM-1,54618164,3.978394394327194
SF539,9903786,2.8297220739955993
K029AX,135875424,4.978137125833805
NCI-H2196,9927531,4.117400803944708
SNU-478,JQ-1-carboplatin (1-1 mol-mol),1.5753140485557118
AGS,73707440,4.5504628850403
BT 416,135398744,7.827037669937473
ZR-75-30,107985,-3.64211446272769
SUP-M2,JQ-1-carboplatin (1-1 mol-mol),-0.9276851107158648
HMCB,9903786,3.962700823971229
PE/CA-PJ15,36462,-0.1372192920508844
J82,135875424,4.806406086619794
SNU-878,9936388,-4.0204049031627935
HCC1428,439501,-1.870619220326862
TE-11,selumetinib-GDC-0941 (4-1 mol-mol),0.8389295990054343
HuP-T3,3689413,-1.422602865458103
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
KP-4,JQ-1-carboplatin (1-1 mol-mol),3.935772405145619
LS1034,11485656,1.821657133822141
MKN74,11485656,1.8439400608742984
OCI-Ly19,44491742,4.513227413160856
Panc 08.13,6505803,-2.482053644474571
Kasumi-2,24180125,1.6711646659047346
647V,439501,-2.3476085577035506
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
Caov-3,24180125,3.119929607419975
KMS-28BM,12003241,-1.6881209255451883
Kasumi-2,107985,-4.524149027848321
MSTO-211H,168313200,3.954855187852925
CA46,9903786,1.650432742323398
Panc 08.13,11485656,2.1540849890217815
BT 147,3689413,1.0613743234478148
KE-39,439501,-0.0752815835977172
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
SNU-C4,135875424,3.2044136454561896
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
M-07e,135875424,2.6099381217800897
F-36P,135875424,2.6086131482089363
NCI-H810,44491742,3.3983932232685756
SW982,12003241,-0.7831418604360746
HMCB,10296883,4.337758420607625
A-498,6505803,4.020571046679738
NCI-H889,168313200,2.633845785204046
DU145,9936388,-2.7050109048591287
NCI-H1105,439501,-2.509690538840725
NCI-H146,5460769,1.8747395178404
SIG-M5,24180125,3.729213633628688
Rh30,54618164,3.8447721242905337
HuP-T4,36462,1.609645546776352
HT-1197,9936388,2.7630776748899746
Hs 895.T,409805,5.888268513255627
GB-1,24180125,3.6098905921033015
NCI-H647,6610216,4.146662237643
PK-45H,6505803,-1.06717257205605
HCT 116,6610216,4.8185648619977295
OE21,44493528,4.16320367055504
HDLM-2,9903786,0.9941602221273084
MEC-1,54618164,3.764189598819816
A-172,409805,3.206630291974944
MeWo,36462,1.633566585190807
CJM [Human melanoma],9903786,6.367293868352352
Karpas-299,11485656,1.6568638130307944
KMS-20,36462,0.8301461091099265
COLO 741,26596,-0.5200940435510158
JHUEM-3,148198,-4.085540837584063
NCI-H1299,36462,2.6599488251356536
BT 145,168313200,2.3295884217970992
AML-193,135423438,1.545921076680538
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
NCI-H1755,6505803,-1.1693878768610966
BT 179,439501,-2.97680380093877
NCI-H1793,selumetinib-GDC-0941 (4-1 mol-mol),1.778228229757508
CAL-78,107985,-3.5540444379532747
TALL-1 [Human adult T-ALL],6505803,1.3130685662142687
HeLa,9936388,2.2030969514797256
NCI-H1703,JQ-1-carboplatin (1-1 mol-mol),1.5748995560231345
BT 179,135875424,3.093650685325698
NCI-H716,3689413,0.3516381459827891
KMH-2,135875424,3.335950960073661
MEC-1,12003241,-2.6195126554486223
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
NCI-H647,439501,-1.4518848962069395
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
BT 416,JQ-1-carboplatin (1-1 mol-mol),0.4698269492624847
5637,46943432,1.451495143544235
D283 Med,26596,-3.592310964496019
KP-4,5460769,4.107177099702386
MOLM-13,6505803,-3.0527041000310255
CMK,26596,-3.6157989534219497
KALS-1,9936388,2.309164316423604
TE-6,409805,4.941088473523551
NCI-N87,135875424,4.206412745126992
SCC-25,8515,2.6450161299147035
A-549,44491742,4.437272986024
PC-3,9936388,2.7801122668619738
SK-N-AS,107985,-4.041624187442296
EJM,44493528,4.28788220416213
Rh18,6610216,4.042060041352345
RERF-LC-Ad2,9927531,7.758899930646885
JHUEM-1,11485656,1.8254780068900092
SCaBER,selumetinib-GDC-0941 (4-1 mol-mol),-0.4937512054243923
IM95,49836020,4.204800354439791
NCI-H146,107985,-3.379993708562796
HPB-ALL,54618164,3.7864801195183704
JHH-1,selumetinib-GDC-0941 (4-1 mol-mol),2.043129184310282
SK-CO-1,409805,5.790109243945559
NUGC-4,6505803,-2.369150454841633
RPMI-8402,9903786,1.556072952295762
NCI-H2170,44491742,4.021640872612266
A-204,9903786,2.6800363782821517
HuH-6,9903786,2.683606252138214
GaMG,3689413,4.2258406300802145
COV434,JQ-1-carboplatin (1-1 mol-mol),2.068766497655691
TTC-709,54618164,4.259345795297247
NCI-H747,6610216,3.8291236169336007
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
HCC-56,3689413,0.2080037745541134
CAL-29,409805,3.6004869851493924
Hs 888.Lu,439501,-6.314665191885066
JVM-3,409805,3.3511108831994045
TE-5,11485656,1.9147399940941343
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
CL-11,11485656,2.5570502281521263
OC 314,9903786,3.545915763256713
NCI-H1563,439501,-2.9827403425963492
NCI-H747,135423438,1.6378864766896262
Hs 729.T,5460769,4.220142900655458
NCI-H2087,54618164,3.8851097061175786
EB1,10296883,2.8926613623150685
BT-16,148124,-5.849919168450062
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
MIA PaCa-2,24180125,2.6361206455792066
NCI-H727,11485656,2.2939690780404423
Sq-1,135423438,3.0560767843125793
Granta-519,36462,-1.2340392932323463
OAW42,36462,2.75457574041248
JHUEM-2,24180125,2.3682289915123107
TALL-1 [Human adult T-ALL],JQ-1-carboplatin (1-1 mol-mol),-0.5352778858852548
SNU-182,49836020,5.156218287298631
YKG-1,409805,3.8056431996277578
CJM [Human melanoma],54618164,4.212338227274922
253J,11485656,1.976874132149827
KMBC-2,12003241,-0.070536665370705
HCC2935,selumetinib-GDC-0941 (4-1 mol-mol),0.0464684942355828
KMS-27,9927531,4.171626738694902
KHM-1B,3689413,-2.4012228391908783
RPMI-8226,409805,3.8617443671491847
HEC-1-B,36462,3.274452342984035
COLO 829,6505803,-0.4572347239935848
KE-39,44491742,3.945663107977575
OCI-AML-5,3689413,0.2797126247075585
ESS-1,8515,4.728832630346152
NCI-H28,107985,-4.297660677476404
639V,409805,4.766769703110161
COLO 320,54618164,4.252894112657086
SW1417,8515,3.674156008172432
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
SBC-5,11485656,2.2866280503579812
EFO-27,9927531,5.387402639259967
COLO 699,JQ-1-carboplatin (1-1 mol-mol),5.401700421556877
SNU-601,9903786,4.302030389769322
HCC44,selumetinib-GDC-0941 (4-1 mol-mol),-1.5745455752339166
SK-UT-1,9936388,-5.820733292214098
TCCSUP,9903786,3.558837088709428
Hs 888.T,9927531,5.625894406785977
SCC-25,5460769,1.2990848940221191
HCC1500,148124,1.3380754252474834
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
NCI-H810,24180125,1.2081946563304828
RL95-2,54618164,3.997329839475735
JVM-3,135875424,3.424449119356365
Kasumi-1,44493528,3.994031742837349
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
ChaGo-K-1,11485656,1.7653957410813437
Mono-Mac-1,JQ-1-carboplatin (1-1 mol-mol),-0.3034213126939502
KMS-27,107985,-3.725151900067263
KHM-1B,11485656,1.807132568777105
SW1088,10296883,3.7456002290694954
SUP-T1,439501,-1.5599134432816564
RCH-ACV,10296883,2.7404232752674273
CA46,10296883,3.259152671675197
KYSE-510,JQ-1-carboplatin (1-1 mol-mol),4.538673492010493
NCI-H1355,439501,-2.6186321377113955
MOTN-1,107985,-4.057142604614257
RERF-LC-A1,9903786,4.61839139463389
TE-8,409805,3.3090914491624557
HEL,409805,5.92709656224454
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585
A-549,409805,5.689640893560965
DU145,12003241,-2.0135691280208876
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
MOLM-13,9936388,-7.059788369591511
NCI-H524,3689413,-3.856889937044058
CGTH-W-1,44493528,5.078721913165128
NCI-H1299,439501,-2.475221299124019
Hs 688(A).T,24180125,2.8493410351508133
LXF 289,36462,2.912637639845359
KMRC-20,159324,3.723725061334236
EFM-192A,10296883,4.154655152723566
U-BLC1,49836020,5.6845894274854585
NCI-H1792,9936388,2.616597511132069
SNU-182,3689413,-3.9177675224777406
GDM-1,135398744,6.258827934702185
SNU-478,3689413,0.4137881438833174
MG-63,3689413,-2.4336894587390323
GCT,9936388,-4.326749507903357
Capan-1,10296883,4.201537501236006
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
VM-CUB-1,54618164,4.270222083286748
EFM-192A,44491742,3.8805374650465905
HeLa,148198,-3.5416719655217976
CJM [Human melanoma],9927531,5.046484804612069
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
5637,135875424,2.9776269402245092
U-251MG,11485656,3.6122724638227184
SNU-1,439501,-3.7780257252431126
CAL-27,135875424,4.567542159153124
MDA-MB-231,3689413,-0.2652306492331258
NCI-H2087,8515,3.0210679259054003
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
SBC-5,439501,-2.4874901722547977
BEN,JQ-1-carboplatin (1-1 mol-mol),1.5811982122787027
EBC-1,6505803,-3.073804899709993
GA-10,148198,-7.740276698759935
Tm87-16,10296883,3.860781577822318
GDM-1,46943432,2.962315005619514
HDLM-2,5460769,4.226839303780804
LUDLU-1,44493528,4.4309476749658625
CAL-85-1,107985,-3.5267444048726215
SET-2,6610216,4.10264033472901
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
Ku812,36462,1.322759060978493
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
MDA-MB-468,6610216,4.200899612670793
SF126,135875424,4.31417208102172
SNU-449,6505803,1.2866498789511422
DU4475,107985,-4.755590050772039
MPP 89,54618164,4.107126861333459
LS411N,135875424,4.300305751936665
Malme-3M,107985,-3.617993222869164
HCC2218,9927531,0.7764965952119703
OPM-2,12003241,-2.9738714531294232
NCI-H508,9936388,-6.267876365775133
SK-MEL-30,168313200,4.435155789562201
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
HCC2279,135875424,4.219637022812179
COLO 684,10296883,4.095510288741906
BICR 22,54618164,4.171441086739322
Sq-1,36462,2.4167886575742505
M-07e,36462,-0.4519131345392329
M059K,24180125,3.2410022874201165
BC-3C,6505803,1.2910533343434352
SNU-1077,9936388,2.8901032001990954
LCLC-97TM1,49836020,1.9924259842665932
CCK-81,11485656,2.133914966176791
HCC15,107985,-2.9906891972859415
Pfeiffer,9903786,-0.8773679724419216
CAL-120,107985,-3.2720552365961364
KMBC-2,439501,-3.686477603107828
KMS-27,409805,3.6220211323899782
23132/87,6505803,-2.824747584715181
SNB-75,12003241,-1.444419761785008
NOMO-1,135398744,6.340708200805823
SNU-738,11485656,2.5933785348749243
Hs 683,107985,-3.457154115132212
HCC2935,135423438,1.9147959056392905
NCI-H2087,9927531,4.212541441573842
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
MSTO-211H,36462,1.134601353001676
RPMI-6666,135875424,3.217067635076314
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
SW1783,9903786,4.362374850125049
A2780,11485656,1.5628347007454235
Yamato-SS,409805,5.817097859197369
SBC-5,9927531,4.452264212548339
WM115,439501,-0.2667789802830004
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
HCC1143,49836020,2.702530837822698
KMS-18,selumetinib-GDC-0941 (4-1 mol-mol),2.1372948898179462
Li-7,135875424,4.067344810022126
KPL-1,3689413,3.184676645737856
OAW28,11485656,3.2643123414600645
Kasumi-2,5460769,1.467216518279754
RERF-LC-Ad2,3689413,-2.3718681179327143
HCC2279,9903786,3.291578502930839
Panc 08.13,3689413,2.756509749646428
ACHN,107985,-3.025937225373497
ZR-75-1,11485656,2.2776825234983087
JHOC-5,24180125,3.9180102124030407
U-937,107985,-4.172637526463277
NCI-H522,36462,3.1215227661343925
LNCaP clone FGC,24180125,4.5156786529947714
KP-N-YN,3689413,-0.8084843339395943
NCI-H2444,439501,-0.8074653551260249
BT 179,12003241,-1.00247586074096
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
Panc 04.03,5460769,2.0457621674825224
SK-LU-1,159324,3.7934671922435914
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
SCaBER,6505803,-1.4253513809076774
SU.86.86,135423438,1.7276185076707382
OS-RC-2,24180125,2.296082351399407
IST-Mes1,54618164,4.8538718291352945
NCI-H1693,148198,-4.945805473712113
Peer,24180125,1.7201532491127525
Rh18,10296883,3.770152183649725
TE-14,9936388,-5.01118425035393
NCI-N87,9903786,2.403456427338335
NCI-H322,439501,-2.585087913028924
VMRC-LCD,44491742,4.573213718781489
Hs 611.T,107985,-4.128065548423904
HEC-265,6505803,-2.0773679998805346
ECC10,36462,0.1453148822762285
JK-1,5460769,-2.680332547756694
DMS 53,46943432,0.4134239365557574
HCC2108,159324,4.9915636231764005
HuP-T4,135875424,5.011521901574996
LC-1/sq-SF,6610216,4.211537724220602
COV644,439501,-3.4357426903027273
HL-60,10296883,3.84878644864352
AML-193,409805,3.6159664447279583
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
KYM-1,49836020,-6.165786834710826
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
YAPC,5460769,2.316930709954587
A4/Fukuda,26596,-3.7061252239164553
MFE-296,10296883,4.050843841946721
KG-1-C,11485656,3.6519605363240495
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
SNU-119,5460769,2.8404840787101593
SNU-503,11485656,3.1307090285748953
RD,168313200,3.695848535571739
Ri-1,5460769,1.1375471412538625
NCI-H1395,12003241,1.698262392733821
SK-MES-1,12003241,-1.463616091527542
SU-DHL-8,107985,-4.356610955775537
DLD-1,3689413,0.9147561458684622
COV434,439501,-6.307025719899454
G-401,36462,-0.1566510321668276
SW579,36462,0.7742536602594905
SW579,9936388,-9.135357848638378
MKN7,409805,5.725297157679611
LOX-IMVI,135398744,6.429324407359154
SNU-1076,135423438,4.345092573001933
HOS,148198,-4.398135238674327
PK-1,6610216,4.445941439691273
VM-CUB-1,24180125,3.0164665959984505
HEC-6,11485656,2.017714855695412
ME-1 [Human leukemia],JQ-1-carboplatin (1-1 mol-mol),0.2037061432721303
UACC-62,409805,5.864664647014031
HCC1395,11485656,2.290865171040868
NCI-H2405,409805,5.061737779017571
BT 224,6505803,-2.453220276677442
HCT 116,8515,4.318498680671023
A-375,8515,4.080476351747669
HPAC,6505803,-1.845067175670312
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
NCI-H1734,JQ-1-carboplatin (1-1 mol-mol),1.68501877850312
SW620,6505803,-2.457729118039499
HCC15,3689413,0.3467742153458734
BT 164,135875424,2.686622551466718
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
TCCSUP,5460769,3.7572024912117103
BxPC-3,49836020,-2.380895293574403
HCC2279,11485656,2.9593776026466756
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
SH-4,24180125,3.014930921556756
U-BLC1,44491742,3.768443657215341
HCC1171,24180125,3.3495461519544723
DK-MG,44491742,5.623663094967997
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
L-363,12003241,0.3787290467646389
NCI-H2052,12003241,-1.5616837194527835
Sq-1,44491742,3.879734584111586
IGR-39,36462,0.7712371318565482
RT-4,12003241,-1.8542714118634884
COLO 684,6505803,-1.3840458684273105
NCI-H810,409805,3.8950776421244377
Kuramochi,3689413,-0.3905926620288846
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
OCI-Ly3,168313200,3.770083870930309
CAL-85-1,135423438,4.043372499873488
MV4-11,24180125,3.615373705139622
JHUEM-1,168313200,2.223638194513654
Hs 888.Lu,44491742,4.101401149351862
SNG-M,11485656,2.558394091061047
SK-N-BE(2),8515,2.7204268583320785
BV-173,10296883,3.0067160543994045
KYSE-410,12003241,-2.1155115062785805
Becker,8515,4.701222217711314
HSC-2,409805,5.8439599049225714
MSTO-211H,9936388,-4.464575449065994
HT-144,3689413,-0.1147563319413739
PL-21,36462,0.4732785028115152
NCI-H1092,9936388,1.337118908669493
TC-71,9927531,4.177938465440418
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827
OAW42,11485656,1.8505528524867976
NCI-H2029,54618164,3.735530661044435
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
Hs 944.T,439501,-0.9410683695438108
UACC-62,6505803,1.051812418083976
SW948,168313200,2.3052543991742933
SNU-719,159324,3.1054428054736793
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
CA46,6505803,0.7805822725654986
HSC-4,11485656,2.41592786996926
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
U-BLC1,5460769,1.2363713333826207
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647
SW1353,439501,-2.4341280198681248
KYSE-180,12003241,-0.805265861116592
BV-173,26596,-4.295505465502321
OAW42,9903786,3.91324183381597
SK-LU-1,135875424,4.823970968633346
NCI-H2110,5460769,2.6451142093153326
Hs 578T,439501,-3.2814601954597915
NCI-H1105,168313200,2.3078853426841732
CAL-85-1,54618164,4.01765600829776
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
NCI-H520,6505803,3.2437812579556864
WM115,54618164,3.776567993994872
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
M059K,36462,3.1426101410832623
HCC1833,439501,-1.5774129771640248
OV-90,5460769,5.624374105443753
A-549,9903786,1.8644448309659765
LOX-IMVI,46943432,0.8500052465051992
SNG-M,selumetinib-GDC-0941 (4-1 mol-mol),2.713078980516464
OVCAR-5,9927531,5.160514110518488
Pfeiffer,36462,0.9316278821467424
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
A-172,selumetinib-GDC-0941 (4-1 mol-mol),2.629230075004273
TYK-nu,409805,5.027177142631053
MOLP-2,439501,-3.1752212130018163
HGC-27,135875424,2.7794180683242575
5637,12003241,-2.3897344760826775
DND-41,49836020,1.1250375058635431
VM-CUB-1,12003241,-0.6809659848466374
BEN,439501,-2.2680431594189727
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
SNU-503,9936388,-4.768623005936061
HCC1806,6610216,4.4100641961164415
BT 224,36462,3.757538934765096
697,JQ-1-carboplatin (1-1 mol-mol),-0.9101343627046008
U-937,12003241,1.6522375422653783
LC-1/sq-SF,5460769,2.491763650512152
AU565,49836020,5.742264990221176
BT-474,12003241,-0.1629967020972257
UACC-257,44493528,4.38032126564653
KNS-62,9936388,2.361337776362267
KYSE-70,5460769,2.831605222646697
KYM-1,3689413,0.9025287359400416
SK-MEL-2,9927531,5.603550958927875
TE 617.T,9927531,4.756324122053051
NCI-H2172,409805,5.805224348451236
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609
OVISE,6610216,4.867128617935935
ST486,439501,-3.700540877794945
BT 216,5460769,4.97858517740557
BV-173,44493528,3.470262409540001
LNCaP clone FGC,9927531,4.548275216558741
AN3-CA,26596,-3.5868272426759584
U-937,selumetinib-GDC-0941 (4-1 mol-mol),2.5351871004530713
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
ECC12,439501,0.4068206161036775
DOV13,54618164,4.008619106307457
A-204,439501,-3.495173266920804
HT-1376,135875424,3.6702822969792193
Lu-65,6505803,-2.14133792645673
Hs 944.T,3689413,0.6165521340275051
KNS-42,24180125,3.2622163839270053
KMS-20,44491742,3.719914001289463
OCI-AML-3,36462,-1.1325661730855037
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
LMSU,5460769,3.9630418347665857
Caki-2,148124,-4.081609911291364
Calu-6,409805,5.233099124624357
SK-MM-2,6505803,0.930978545894494
NCI-H1184,54618164,3.853145757284716
HuNS1,9903786,1.9338093787028072
COV644,6505803,4.248640118534715
HT-55,6505803,-1.0332246956791955
OAW28,135875424,4.470041991889524
SCC-9,148198,-2.735497552895971
Ci-1,44491742,4.040597879597693
SNU-1,9936388,-8.466890078347713
JHH-2,168313200,2.204559089339404
SW1990,148124,-0.559061851738452
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
LS411N,49836020,4.501659667614969
KMBC-2,11485656,2.7390953396220588
BT 359,11485656,2.534841639455838
Panc 03.27,9936388,-5.075789023716421
SNU-387,107985,-2.31227385081207
SNU-869,9903786,4.230852859752073
GA-10,135875424,2.5269087035880844
Ri-1,439501,-2.801888786170529
U266B1,11485656,1.9579580018826064
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
NCI-H2141,54618164,3.5839160777119723
SNU-466,11485656,2.57362986775831
RKN,107985,-3.0900461086436404
MOLT-3,5460769,-0.5989426440895276
KYSE-30,10296883,3.7447664313518767
Jurkat,73707440,5.030996622710699
JeKo-1,54618164,3.7993181207921127
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
JL-1,168313200,4.033515228256602
CAL-51,9936388,-5.638746232401389
SW620,159324,2.851268234917908
8505C,9903786,3.4608112423981874
KYSE-520,168313200,5.3167549348023675
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
GSS,9936388,-5.73118994601309
SUP-T1,10296883,3.2156381873423725
NCI-H1944,168313200,2.1739063289963254
NCI-H2444,36462,2.8343186120313875
KE-37,409805,3.6967057157078953
JeKo-1,36462,0.9579475504198862
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
KMS-21-BM,44491742,3.2404662940088205
DAN-G,44493528,4.283490884814904
KCL-22,11485656,1.0950104532816525
EN,44493528,3.9032470450473657
DMS 454,107985,-4.311392502564405
BHY,12003241,-1.9102935005607824
SNU-16,26596,-3.716787103027543
NCI-H2087,6505803,-0.9340345564408612
EHEB,5460769,-1.3281679410072365
NCI-N87,6505803,-6.101345662019038
NCI-H1373,5460769,2.0630814106312543
IGR-1,3689413,2.7517007326117957
SNU-C1,JQ-1-carboplatin (1-1 mol-mol),1.0012449564207797
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
BT 172,11485656,1.8257973782589136
ECC10,159324,-0.9362506976016994
G-402,44493528,4.750595450232596
KP-N-SI9s,selumetinib-GDC-0941 (4-1 mol-mol),1.114910325038949
IMR-32,26596,-3.972445110403932
LoVo,6505803,-0.2027234925460443
KMS-12-BM,9936388,-7.442749057312851
B-CPAP,8515,3.305571052734727
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
SW620,9903786,1.7872370567942188
MOLM-6,10296883,2.5763077662070195
OVSAHO,11485656,2.294193584233593
LUDLU-1,26596,-1.0531529741547596
JMSU-1,8515,2.4008483201809776
YAPC,135875424,4.215334227700636
AsPC-1,44493528,4.313387127964929
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
TE-9,54618164,4.023601318956505
Panc 04.03,409805,5.536204895331733
IST-Mes1,409805,5.880779442140838
T84,9936388,-5.402148456291863
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
TUHR10TKB,10296883,3.708176518593342
SNU-1272,135875424,4.314381098584833
KP-4,44493528,4.395451461814576
EoL-1,107985,-5.04062397019842
NCI-H2106,6505803,-2.4996848836853176
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
LoVo,5460769,-2.1468642890382412
EJM,409805,3.072892420926549
SNU-466,409805,4.306373877119286
BICR 6,54618164,4.1919991620440245
HPB-ALL,10296883,3.0547886036343663
SH-4,107985,-4.329814093111425
KMS-20,5460769,-0.4034471516809727
Hs 944.T,168313200,2.970577482583042
SJSA-1,9936388,-5.643627471351419
NCI-H1339,9903786,4.835064182647526
KE-97,5460769,-1.2505802220316746
YD-15,135875424,3.8226191901992377
NCI-H2170,selumetinib-GDC-0941 (4-1 mol-mol),2.2424418004959654
SK-N-AS,10296883,4.111462357552098
NCI-H2405,107985,-4.119694758302467
OC 314,36462,0.0152019987062778
MOTN-1,8515,4.069271127937523
L-428,9936388,-7.639006974415921
SNU-761,11485656,2.6338171581508494
EJM,439501,-2.5591027297640565
KLE,159324,3.6720597167388
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
FaDu,6505803,-3.622954111449815
IST-Mes1,11485656,3.5408910362273835
Becker,10296883,4.31752254310815
OPM-2,6505803,-0.5489645461029444
DU4475,3689413,0.1265439413603304
BT 320,135875424,3.1120862947515255
SK-CO-1,9936388,-6.4137542305703015
U-118MG,54618164,4.155330932675476
SNU-1272,107985,-3.786570861641408
HCC1500,168313200,1.6452616775244175
CAL-33,6505803,1.0338529577109443
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
OVCAR-8,135875424,3.0307558865901285
HEC-265,26596,-1.38176914424549
LOX-IMVI,54618164,3.986772519561911
HCC1588,selumetinib-GDC-0941 (4-1 mol-mol),-0.6693543343840518
Karpas-422,6505803,-0.6034425689167541
SNU-182,8515,5.711375206756832
ST486,6610216,3.852624167573134
G-402,selumetinib-GDC-0941 (4-1 mol-mol),1.3603902664341745
BL-70,36462,0.1930899985409087
BT 164,selumetinib-GDC-0941 (4-1 mol-mol),1.5214027789841535
BT-20,6610216,4.194352657176605
PE/CA-PJ41 (clone D2),148124,5.794245590172473
DBTRG-05MG,135875424,3.4879962097655057
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
SNU-478,107985,-3.774597875845584
TC-71,168313200,3.674389674642696
NCI-H358,409805,4.640022804792819
HCC2935,3689413,-0.3223376962809587
NCI-H747,44491742,4.012258870504445
SF126,9927531,4.99089280929888
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
BT 245,107985,-3.2343864047016706
NCC-StC-K140,44491742,3.703030524506224
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
DU4475,439501,-1.9980477376201553
PC-3,54618164,4.238833791567503
IPC-298,439501,-1.1668969195749603
Namalwa,11485656,1.3808834074055636
P3HR-1,54618164,4.280315965962759
NCI-H1793,9936388,1.8612470505024563
TUHR10TKB,49836020,-1.137446729131538
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
HCC1588,54618164,4.057398763745221
HT115,46943432,1.3324028915874655
WSU-DLCL2,49836020,-5.951866834778445
JeKo-1,9903786,1.7626830163965443
THP-1,36462,-0.696245024899833
NCI-H2170,6505803,-0.4260199985432408
CAL-78,12003241,-1.8526248382085972
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
SYO-1,12003241,-0.4468506697584958
HD-MY-Z,JQ-1-carboplatin (1-1 mol-mol),1.7743689460569436
LUDLU-1,439501,-1.4236131557498473
AU565,54618164,4.092787142183454
JL-1,107985,-3.423075177455306
DK-MG,148124,-4.482230615331879
LCLC-97TM1,8515,3.105500626842055
SET-2,9927531,4.801393694643548
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
NCI-H1581,selumetinib-GDC-0941 (4-1 mol-mol),1.7228993365162983
NCI-H2196,JQ-1-carboplatin (1-1 mol-mol),4.258041583976656
NU-DUL-1,10296883,3.165126973502135
IGROV-1,9903786,1.7387584479757865
SW982,439501,-3.0027408627821934
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
MFE-296,JQ-1-carboplatin (1-1 mol-mol),2.681039150373503
NCI-H211,9903786,1.4038112191361545
HuG1-N,135398744,6.4115232793077235
HT115,439501,-2.40828737906019
697,148198,-7.764222661633608
K-562,6505803,-1.797722788015983
T3M-10,135875424,5.0182916898666
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
LXF 289,46943432,1.4312531154305732
NCI-H520,36462,2.88085787375963
NCI-H1105,12003241,2.305570238632079
NCI-H520,6505803,3.2437812579556864
EoL-1,409805,2.9629225339184595
HT-1197,135423438,4.472256481601468
SNU-475,9903786,5.095134957133182
Caov-3,9903786,2.8083030393929276
NCI-H1869,5460769,3.405523512527605
NCI-H2009,54618164,4.160237516111787
SUP-HD1,168313200,3.656885167019891
LOX-IMVI,409805,4.011885260759597
SW1417,JQ-1-carboplatin (1-1 mol-mol),0.7027994901214438
D283 Med,168313200,1.8321011656642825
HCC1588,3689413,0.6550602760333641
RPMI-8226,44491742,4.60819314657813
SCC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.2085595072680022
HCC1833,135875424,4.246764438360678
SJSA-1,135423438,1.6287779060663292
JURL-MK1,148198,-3.3107104288363027
RKN,135875424,3.6230459419726526
HeLa,168313200,4.248438421303553
A-549,439501,-2.483005959928592
CAL-33,107985,-3.788445171000951
MOLT-16,9936388,-8.915282355135908
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
MKN1,11485656,3.044092336546056
HOS,9903786,4.58127571794388
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
DU4475,148124,-4.703321943228874
SW982,8515,3.1924163308331073
SNU-466,5460769,0.9969525340042612
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
769-P,107985,-2.9874753130628418
SW620,11485656,1.8999997266011384
NCI-H1838,5460769,4.113464535509182
CAL-85-1,6505803,0.4315173316533146
M-07e,44491742,3.818170293843834
PC-14,3689413,2.901459905806189
G-361,54618164,3.8947838668805272
SF268,36462,1.3172986940401454
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
LC-1/sq-SF,439501,-1.6562365641481254
GB-1,9903786,2.9752485766111936
BC-3C,107985,-3.218950986835144
WM793,10296883,3.657255931485473
KMS-26,36462,-0.4512101792241657
SH-10-TC,44491742,3.905889235687173
WM88,439501,-1.2543537382039465
OCI-M1,148124,-5.179396495011338
SW48,439501,-2.266376314928653
MHH-CALL-4,5460769,0.3846301145612474
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
MDST8,8515,5.547245054967808
K029AX,3689413,2.968023656376896
SW1417,44491742,4.02538714893742
P31/FUJ,9936388,-7.166815071220185
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
U-118MG,3689413,-0.7349249104266066
Karpas-299,6610216,4.00419918923577
COV644,12003241,0.3541041054737522
NCI-H1793,135875424,3.2087606409419087
VM-CUB-1,6610216,4.439081031884477
ONCO-DG-1,JQ-1-carboplatin (1-1 mol-mol),2.9184611678719667
CHP-126,6505803,1.8994279506826215
YD-38,135875424,3.801699719504721
22Rv1,11485656,2.087552873694697
HCC366,selumetinib-GDC-0941 (4-1 mol-mol),2.581638032416284
TT,9927531,4.594242153757871
OUMS-23,159324,3.593990796600562
OVTOKO,JQ-1-carboplatin (1-1 mol-mol),3.861822916435348
KMS-11,9927531,3.9884073246481058
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
NCI-H1869,409805,5.751744182014799
DMS 114,24180125,2.571127008152471
A-172,26596,-0.1948539739463346
SK-N-SH,36462,0.1553406914879444
MDA-MB-468,26596,-0.798846302362186
G-402,5460769,1.138003238352945
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
MEC-1,409805,3.8127631340240247
NCI-H2023,409805,5.555285179015439
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
Hs 578Bst,6610216,4.2048816923862935
LS123,6505803,-0.3996553163472341
MIA PaCa-2,135875424,3.180139545836177
DEL,107985,-3.4805705994684293
EB1,8515,1.7583266480090207
253J,439501,-2.369438844197353
HEC-1-A,selumetinib-GDC-0941 (4-1 mol-mol),0.8454811422727944
OUMS-23,135875424,4.57705137123218
SUP-HD1,148198,-3.3843356772130826
SH-10-TC,6610216,4.446804869208645
DU145,54618164,4.17145351900014
NCI-H1105,11485656,1.7078200129444954
Lu-65,8515,3.512181420890395
NCI-H747,5460769,2.4677950435240814
EPLC-272H,JQ-1-carboplatin (1-1 mol-mol),0.1127668354525981
Hep-G2,24180125,3.881955939132959
EBC-1,46943432,1.1267327481647815
BT 159,148198,-4.153567410174437
NCI-H716,12003241,-5.132639925352329
SK-MEL-5,107985,-2.7442566338787473
SNU-308,8515,4.888482056700149
RPMI-6666,36462,-2.242944553811851
OCI-AML-3,10296883,3.1586909460466455
BT 239,3689413,-0.6991113979789645
COLO 201,159324,3.0318609324112087
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
NCI-H508,409805,5.189849293513136
NCI-H1703,135875424,3.0256597823887725
SNB-75,10296883,4.213369443684623
TE 441.T,11485656,0.4823826130235241
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
PF-382,26596,-2.06856872789975
SH-10-TC,135875424,4.945714860516567
OV56,135398744,6.336681474599488
SNU-8,9936388,-5.172305126613517
NCI-H28,46943432,2.0555870948876147
RERF-LC-A1,3689413,-2.1513750225162114
NCI-H841,44493528,4.365937622754757
Hep-G2,409805,4.627773602187177
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
SF268,168313200,1.683727721969487
HEC-1-B,107985,-3.3155337139042413
KE-97,24180125,2.577843918420162
HEC-251,135875424,3.4387509729179913
SNU-8,159324,3.7143577321129393
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
KNS-62,12003241,3.5800547148534165
HSC-4,6505803,0.688410933428746
HT-1080,135875424,3.167289548700629
BT-16,9936388,1.3930931201421013
Ku812,5460769,3.1615206717567608
SU-DHL-6,9903786,1.8029536633965553
Sq-1,107985,-3.109149408233463
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
LMSU,9927531,5.404187778104352
HCC2279,5460769,5.144403730026711
HCC1954,135875424,3.784549105915095
HOP-92,168313200,2.171997683243581
NCI-H2122,409805,6.0508402213506995
SNU-216,107985,-4.706172049082236
COLO 678,11485656,1.706527066043961
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
JHUEM-2,26596,-3.440401418336309
Malme-3M,11485656,2.111075680137388
SK-N-AS,8515,4.55115290186792
MFE-296,44491742,4.423113386396404
HCC1500,54618164,3.7944844711277264
KYO-1,46943432,0.7907971392982073
P31/FUJ,46943432,0.8368365469264624
KMRC-3,54618164,4.408138675224867
LCLC-103H,439501,-2.3624899744714956
DU145,44491742,3.929497920305024
KLE,9903786,3.130074514321622
GMS-10,148198,-3.621238851602685
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
HSC-3,148198,-2.120282407341815
KU-19-19,12003241,-0.0608702413973226
YD-15,409805,3.695516943836326
JHOC-5,409805,5.771239426741445
KNS-81,selumetinib-GDC-0941 (4-1 mol-mol),3.534657473122144
DMS 79,409805,3.6783125614989656
SCC-4,9927531,4.977228114447549
GDM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.4015630537734989
ALL-SIL,49836020,-3.56746653346715
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
OVSAHO,409805,5.076222131658727
LUDLU-1,409805,5.791089657297664
BFTC-909,36462,4.374665451212183
KYSE-180,11485656,1.9289585779871232
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
EFM-192A,409805,5.233985235852892
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
NCI-H2170,54618164,4.169811342731195
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
NCI-H1838,12003241,-1.140669133543194
Ku812,9927531,3.686533687467188
GB-1,JQ-1-carboplatin (1-1 mol-mol),3.1926244646475
NALM-6,9927531,3.382690661986343
H-STS,148124,4.085792664518574
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
Rh30,8515,3.718568437073075
5637,107985,-3.0961708485715667
NCI-H1155,8515,3.600042269708465
TALL-1 [Human adult T-ALL],36462,-1.67614091927168
BL-70,8515,3.824466165102045
BT-549,3689413,-0.9397914335397376
ONS-76,73707440,4.1934861569389845
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
RCH-ACV,24180125,3.0709250936055037
MHH-NB-11,3689413,1.2467762283849737
Caki-2,3689413,-0.1901377653832866
OCI-Ly10,selumetinib-GDC-0941 (4-1 mol-mol),1.0181444461611715
CAL-51,8515,3.5852991976047863
F-36P,11485656,2.0495534401946647
UACC-257,selumetinib-GDC-0941 (4-1 mol-mol),-0.8117172075049729
ES-2,54618164,4.408028245984097
CAL-51,159324,3.1794720270506307
EFO-27,9936388,3.039710224097925
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
RPMI-8226,24180125,3.774747192059227
NCI-H1915,6505803,-4.13754619223685
UACC-257,168313200,2.4079622754907
UO-31,5460769,0.456698735836774
BT-12,6610216,4.719873266038045
HPAC,409805,4.12816985614744
NCI-H322,6505803,-2.5278966657136577
NCI-H1694,135875424,2.6288634269875075
SW579,26596,-1.623870534815972
EB1,148198,-5.218004052941106
SW1783,11485656,3.310538702987134
RPMI-8402,6610216,3.283119634553979
HT115,selumetinib-GDC-0941 (4-1 mol-mol),-0.4177192932655061
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
SHP-77,6505803,-0.6748725536499449
8305C,135875424,4.357413208917153
SW1783,135875424,4.794068332474245
BT 248,135875424,2.546043839111523
KMRC-20,24180125,2.1292230700197874
PE/CA-PJ15,409805,3.811497133930035
BT 112,439501,-2.896282798681624
NCI-H810,135423438,2.2822714598344764
SK-N-FI,12003241,-1.9986022359494329
SW48,9903786,0.6824641791663469
HH [Human lymphoma],6505803,-0.1440406835782353
T-47D,3689413,-1.6434373642176223
HEC-6,9903786,3.848299658438586
NCO2,9903786,1.4505958737560818
OVK18,6610216,4.184858807398399
BT 179,409805,5.844677427581124
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
NCI-H441,3689413,0.4936421850915237
AsPC-1,36462,3.6552458214160506
MG-63,9936388,-4.191645899593892
BT 333,168313200,2.125969547052707
OAW28,135875424,4.470041991889524
MFE-319,11485656,1.6496792677763226
KYSE-70,148198,-2.193158047226166
KYO-1,11485656,2.321902105017357
HOP-62,439501,-3.0300699988747333
NCI-H2452,12003241,-1.7557808561862691
EB1,135423438,1.4973113179323292
DMS 454,selumetinib-GDC-0941 (4-1 mol-mol),0.8231378505894382
SK-MEL-3,439501,-0.9323794711246036
GSS,6505803,-2.9961696629002956
NCI-H28,11485656,1.9192630984441017
SNU-685,9936388,-1.1795394282273874
DND-41,36462,0.0569290379615615
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
KO52,11485656,1.6797102251271416
KMS-34,36462,-0.9076906015398876
BICR 22,9927531,5.395078942533075
Ri-1,409805,4.02318209858409
HCC1438,5460769,1.743757679133544
EB1,12003241,-4.025525342770554
SNU-466,9903786,3.45397809087946
VMRC-LCD,24180125,1.3284719175549995
SU-DHL-8,9936388,-6.541298738392362
LS411N,107985,-2.091782559178726
GSU,148198,-2.846893382841785
Detroit 562,26596,-2.098444949143179
KMS-21-BM,11485656,0.7331254638608181
NCI-H69,11485656,2.3871214683206152
COR-L51,409805,3.3081108683837477
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
A-172,6610216,4.231003065610573
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
CAL-62,135875424,4.048990845421642
A3/Kawakami,44491742,3.8621679307370953
COLO 684,6610216,4.066976905700023
HCC1954,44491742,3.88484853713588
Ci-1,409805,3.8967919389594554
NCI-H1581,159324,1.3429919034073754
CML-T1,44493528,3.9716542826771297
NCI-H838,168313200,3.790005263370213
NCI-H929,9903786,1.9183912305018265
ChaGo-K-1,9903786,4.114689259573735
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
HCC1954,9903786,3.647576872659031
JHUEM-7,6610216,4.204761293016812
BT 333,12003241,1.72597197998683
SNU-201,6610216,5.085362707909801
CAL-54,24180125,3.209095438677072
FTC-133,3689413,-0.3036251064519336
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
A2058,6610216,4.291634255564362
JeKo-1,12003241,-2.1711036059300963
253J-BV,JQ-1-carboplatin (1-1 mol-mol),2.2786098419782403
BT 131,44491742,4.605626488786133
OCI-AML-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.789265040727208
NCI-H1339,8515,4.704049354821168
EFM-192A,107985,-2.7346010401820595
BT 416,6505803,-2.5410330503454173
NCI-H650,36462,2.691387318972264
JMSU-1,44493528,4.427701991229088
Daoy,selumetinib-GDC-0941 (4-1 mol-mol),2.0496212726424914
G-401,44491742,3.951665256591854
NCI-H838,11485656,2.6537102203842613
PaTu 8988t,148198,-4.283282973565046
IST-Mes1,107985,-3.865584471784785
Lu-99,9936388,-2.3280603077053317
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
CADO-ES1,5460769,-0.4724140531139457
HT-1376,3689413,2.4091899536551264
Calu-3,36462,-0.1671565267971208
EFE-184,107985,-2.347351341568452
SaOS-2,54618164,4.337585482929099
SR,135875424,2.4827533420158376
JHUEM-2,9936388,-5.407825047744209
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
U-87MG ATCC,9936388,3.5467326028454087
HCC38,3689413,-2.099341250488443
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
C2BBe1,54618164,3.820082525950668
PaTu 8988s,24180125,3.4136901052211246
IA-LM,439501,-4.16745845294267
NCI-H2342,168313200,3.849648690300757
U266B1,107985,-3.8867784962638927
NCI-H2141,26596,-3.569863113976208
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
KE-97,409805,3.6508236514703176
P31/FUJ,6610216,4.336076332167018
ECC10,54618164,3.9379373119604657
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
SNU-1076,3689413,-0.3890418815015654
SNU-423,44491742,3.863177146863686
SNU-16,148198,-5.297053925095674
P12-Ichikawa,6505803,0.5806976705214316
647V,409805,3.493912848864435
SNU-475,11485656,2.631087250262813
NCI-H1792,6610216,4.406425138927489
L-363,JQ-1-carboplatin (1-1 mol-mol),0.6579201637920293
NCI-H841,24180125,3.3524098176171835
VM-CUB-1,107985,-2.186887836117853
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
NCI-H1105,5460769,2.617523266083722
U-118MG,9903786,4.127288494791117
697,9936388,-7.51713340803998
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
HCC1428,10296883,4.338608751562579
SCC-25,49836020,1.4878182873068626
SK-LMS-1,6610216,4.4083288999249
NUGC-4,11485656,2.4536140227741776
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
KMM-1,54618164,4.235991930740478
FTC-133,54618164,4.149608396421597
CJM [Human melanoma],409805,5.948377664787024
NCI-H1838,148198,-2.358170233860321
A-549,107985,-1.903643524605076
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
SNU-466,12003241,-1.792822949683991
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
JHH-5,36462,0.9315397136596794
NCI-H1693,JQ-1-carboplatin (1-1 mol-mol),-1.0867749942115603
ChaGo-K-1,6610216,4.215426179079186
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
Rh18,44491742,3.876019031257375
M-07e,11485656,1.7704573347594663
LOX-IMVI,12003241,-2.813518393614124
OC 314,10296883,4.120910871567529
KE-39,6610216,4.077734835238396
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
COR-L88,44491742,3.2658502599700188
DU4475,36462,-2.7502991283141247
OPM-2,54618164,3.637238343412542
FTC-238,selumetinib-GDC-0941 (4-1 mol-mol),2.3347122521245396
T84,135423438,1.8548659324700536
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
NCI-H1092,107985,-3.3152950865622564
HMC-1-8,9903786,2.873770542760651
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
BV-173,6610216,3.640744959880511
SW982,26596,-1.3061424276940652
BT 248,148198,-3.920391313180545
M059K,135875424,4.531925541014952
Ku812,46943432,4.280814189443877
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
A-204,148124,-4.816977213952127
LUDLU-1,8515,4.620878696519872
SUIT-2,3689413,0.4029780891432681
ONCO-DG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.679099331983427
SNU-886,9936388,-5.3251547250946825
SIG-M5,26596,-1.691579811002482
TE 441.T,49836020,3.964912597269393
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
IMR-32,3689413,-3.464498060379514
HuP-T4,26596,-2.6464216672474783
RPMI-8226,46943432,0.8335520159387311
Panc 04.03,135875424,4.739147054003967
HeLa,9936388,2.2030969514797256
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
NOMO-1,439501,-2.35226533453039
SK-N-FI,107985,-2.4954057138608423
TUHR10TKB,168313200,3.817818184854305
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
DND-41,selumetinib-GDC-0941 (4-1 mol-mol),0.5695513725916952
D283 Med,12003241,-3.4539176227720794
SaOS-2,36462,1.0480120523183942
Karpas-299,9927531,5.423795277339213
TUHR4TKB,409805,5.922934417095481
AML-193,107985,-4.640089928252453
NCI-H226,3689413,2.4864282663543302
MV4-11,6610216,3.0151553142886844
NCI-H23,409805,3.610834753190227
BT 224,168313200,3.82077392857396
KM12,159324,1.9877209753043628
MDA-MB-453,9936388,0.6028011486270662
MOTN-1,49836020,2.722382817781131
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
Daudi,5460769,0.2326576177581661
RKO,44491742,4.905526099010324
Li-7,9936388,-1.419334332710526
AsPC-1,439501,-1.6009280184427317
SH-4,49836020,4.187960947372796
Peer,11485656,-0.7259490318952384
NCI-H650,3689413,-2.023136862594463
SW1353,135875424,4.282925625560305
PK-1,6505803,-1.4956454507755823
MEC-1,168313200,1.7851966829253256
ZR-75-30,11485656,1.735891499698879
Jurkat,439501,-2.365566126578654
ECC10,24180125,2.9361406436920694
OPM-2,9903786,2.6412283094975657
RPMI-7951,12003241,-0.9511728924240472
SKM-1,439501,-2.678240610691138
IMR-32,135875424,2.969458523828033
JHOM-1,6505803,1.4741173976655575
SJSA-1,439501,-2.834147074322405
HEC-151,JQ-1-carboplatin (1-1 mol-mol),1.2344499659819954
NCI-H1734,3689413,-2.032752334102639
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453
BT 164,107985,-3.1834960037296884
AN3-CA,409805,5.126415304640116
HuH-1,3689413,3.5538877505923097
BL-70,6505803,0.7841621895069785
Hs 578Bst,9927531,5.122326242765859
HLF,168313200,3.4120776318454205
HuH-1,439501,-2.8772683526572496
LS180,6610216,4.524725364990245
BT 187,12003241,-0.5243066739913107
SNU-466,159324,2.142776155886243
U-87MG ATCC,selumetinib-GDC-0941 (4-1 mol-mol),3.2770460011243308
Lu-65,26596,-0.6076566338784338
SNU-1,168313200,3.5647189331529296
KG-1-C,6505803,-0.4264272439200833
MOR/CPR,11485656,1.924898920968698
RS4;11,44493528,4.150848985906847
UACC-62,135423438,3.882587391697005
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
Li-7,46943432,1.2726339003447924
Calu-1,36462,2.444973660840076
JL-1,439501,-1.5766228751230973
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
SCC-9,12003241,-1.125345709331217
K-562,3689413,1.0071697658281389
ES-2,409805,6.0186236492097365
OCI-AML-3,148198,-5.6942586662557035
NCI-H146,135423438,2.8528911509997137
SNG-M,26596,-1.5448516753437405
BICR 16,148124,-4.759947113058055
PSN1,6505803,-2.1554317854287097
NCI-H1734,26596,-1.406622025931408
Hs 766T,3689413,1.3725594081850794
NCI-H1395,439501,0.2163751108150007
B-CPAP,3689413,-2.370401360424748
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
BICR 31,12003241,-1.4237270953299652
BT-12,409805,3.8947657591707414
KP-N-SI9s,107985,-2.511989940136039
SW579,107985,-3.0336987926164376
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
HCC4006,9903786,3.3433056456258585
HEY A8,49836020,5.6501572313244885
TT,107985,-2.900739403078763
TTC-709,409805,3.604457775701489
KP-N-YN,409805,3.805476541257568
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
NCI-H1341,148198,-4.8101463840826595
SNU-761,9903786,5.568583080204817
LN-18,409805,5.6020657668162706
U266B1,9903786,3.1119057024478094
LoVo,439501,-1.7683171506776545
Panc 03.27,3689413,-0.1085312900774309
LMSU,9903786,3.928631993031556
NCI-H2009,11485656,2.228831542035607
ES-2,159324,3.623206092591176
OAW42,9936388,-0.5306764798725707
TE-14,148124,-4.465123316500658
LAMA-84,135875424,3.803439858623824
SNU-398,5460769,0.8679915096242241
SNU-5,46943432,1.3354145069427903
NH-6,selumetinib-GDC-0941 (4-1 mol-mol),1.9246197081776155
MDA-MB-468,JQ-1-carboplatin (1-1 mol-mol),3.305072238295291
OCI-Ly19,46943432,1.1319125471752869
DEL,409805,3.7809568559059783
ST486,72199289,4.347318676727556
HuNS1,168313200,3.7440498292509257
OE21,3689413,1.0863405783683666
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
Mel JuSo,135875424,3.5685872974877824
CL-11,9936388,-1.838606364908758
PK-59,9903786,2.9850600541065764
JHH-1,439501,-0.896844817014076
COR-L95,12003241,2.921570030601445
GSS,9903786,1.9234294660474929
SCaBER,9903786,2.6079380846248568
ECC10,10296883,3.344976615043335
L-428,6505803,0.937044713122246
MOLT-3,6505803,0.4924044650744431
Peer,107985,-3.546191160246613
Daoy,36462,0.3997771841968469
Rh18,selumetinib-GDC-0941 (4-1 mol-mol),2.126634875194983
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
Ci-1,54618164,4.014733685345709
OVTOKO,11485656,2.8396644957108923
LS411N,54618164,4.167426775220608
KNS-62,148198,-1.7828109531829757
Hs 746.T,54618164,4.0798704781496875
UM-UC-3,135875424,2.7438914646322106
SK-LMS-1,10296883,4.497007332627828
A4/Fukuda,36462,-0.7730347482869518
T84,JQ-1-carboplatin (1-1 mol-mol),2.264364679539306
NCI-H1355,26596,0.1615668606609613
A-673,6610216,4.190818336865809
TCC-Pan2,6505803,-2.1340382600385035
OCI-Ly10,11485656,4.400930200004774
Kasumi-2,439501,-3.441659601561783
SUP-M2,44491742,3.782473940408551
SNU-668,24180125,2.58387790396355
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
Caki-2,selumetinib-GDC-0941 (4-1 mol-mol),1.5536102429563667
SNU-601,26596,-1.2729418504176535
IM95,6505803,-4.184612620621751
KMS-26,439501,-2.394060102049288
KMH-2,409805,3.8048240258679256
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
LUDLU-1,135875424,4.724968330377738
SUP-T1,54618164,4.107914943294929
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
HPAF-II,5460769,4.759612134982938
SR,JQ-1-carboplatin (1-1 mol-mol),1.1771203251260662
NCI-H460,54618164,4.49670945938676
NCI-H810,selumetinib-GDC-0941 (4-1 mol-mol),2.904538887533327
PE/CA-PJ41 (clone D2),24180125,3.647059315463406
MG-63,148198,-4.931736282287541
L-1236,selumetinib-GDC-0941 (4-1 mol-mol),3.573145022328455
Hs 683,44491742,3.840304182439804
Raji,9903786,2.8365362494251394
KYSE-520,10296883,4.455912187683782
SK-N-SH,6610216,4.236086050326451
Calu-3,9927531,4.58448758255864
SK-ES-1,36462,-0.9833921744862832
MDST8,26596,-1.25574590011264
HuT 78,3689413,-1.8719775604380453
HT-1197,107985,-4.558974920992082
HCC1806,11485656,2.35396149601903
NCI-H1703,24180125,3.814977015486634
LC-1/sq-SF,168313200,4.088253469827713
OVCAR-8,439501,-0.7603560285089889
CHP-212,46943432,0.8435958840220231
SNU-16,10296883,1.9530696041557936
HMCB,26596,-1.2966092010554455
HMC-1-8,8515,4.643530157234318
SNU-398,9903786,4.103035354116066
OVTOKO,5460769,2.45887134191899
PLC/PRF/5,409805,5.993816683766392
NCI-H2023,159324,2.5896832660391795
KCL-22,5460769,3.17116063608923
HT-1376,107985,-2.5673845406867635
JHH-4,6610216,4.057898484611385
CAL-54,148124,-0.1574179702231155
Hs 688(A).T,135875424,5.335047490558406
SNU-1214,26596,-1.0463524319184982
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
647V,107985,-3.8456170953130977
SF126,9936388,2.3000981317136433
HPB-ALL,159324,-2.283586200702136
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
OVCAR-4,159324,3.448279522604695
KMS-21-BM,36462,-0.9677921947133352
BV-173,148198,-4.631322243168152
PF-382,9936388,-6.688930185968071
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
U-118MG,9936388,-3.83393648054696
ONCO-DG-1,12003241,-0.5849918543503058
OAW42,26596,0.2521816339620648
RERF-LC-Ad2,409805,3.938022823911279
SU-DHL-8,36462,-2.8837378073360163
LUDLU-1,11485656,1.892840713859796
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
HEC-151,11485656,2.368331048173754
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
SW1116,159324,1.6231393918689625
JHH-1,8515,4.044626627434146
Peer,135875424,2.778289251682957
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
MDA-MB-157,3689413,-1.567220624306923
MOLT-13,73707440,5.68984628441443
MOLT-3,148198,-7.168257541547073
SNU-8,439501,-2.494664293068585
HEC-265,11485656,2.4370263560731926
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
Hs 611.T,8515,3.543970428456994
BT 228,135875424,2.3307111472907263
RERF-LC-A1,JQ-1-carboplatin (1-1 mol-mol),5.6290359475230725
NCI-H2141,44493528,4.465268919484744
COV434,148198,-5.709180459817414
HEC-251,46943432,3.087973517815583
DAN-G,135875424,4.48447178949668
OAW42,6610216,4.144894228463558
K-562,8515,4.039482215632923
CA46,26596,-3.5845712744961324
HuNS1,54618164,3.902045461689573
NCI-H460,36462,3.103581216464206
KP-N-SI9s,135875424,2.000984128197718
BT 232,12003241,0.7689860927775146
KMBC-2,6505803,0.8249091565927539
Yamato-SS,3689413,-0.7026666605397593
MES-SA,135875424,4.270871924895991
DMS 53,54618164,3.727499516081143
NCI-H1869,54618164,4.0885631456331035
KE-39,3689413,-1.8420159541718293
HCC1588,9903786,2.112519242014298
CA46,46943432,1.2105530921386296
SBC-5,26596,-2.1907470722084414
SNU-1272,135423438,5.060183017948369
KYM-1,44491742,4.6632878215143405
WM793,409805,4.444302991596743
HCC44,54618164,3.6703477587961464
NCI-H889,54618164,3.8719653516337176
BT 330,3689413,-2.329423623315505
IGROV-1,107985,-2.8971910842184516
RCC10RGB,439501,-2.548266242367821
PLC/PRF/5,107985,-2.4767035195687304
JeKo-1,9927531,3.3417502019075473
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
NCI-H460,159324,4.0462841352482855
SNU-449,10296883,3.939630786750968
KP-3,439501,-2.4441073658124837
CML-T1,6505803,-0.3633146304142068
PK-45H,10296883,4.020299525080379
DMS 454,JQ-1-carboplatin (1-1 mol-mol),3.538784914005209
KMS-26,8515,1.9708227229968656
HCC202,24180125,1.1972188242288753
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
EFO-21,409805,6.083434426266822
KPL-1,11485656,3.597830436123724
KYM-1,JQ-1-carboplatin (1-1 mol-mol),-0.1526503740959246
SK-MEL-1,9936388,1.368356716964437
CAL-78,409805,5.304478989871624
Panc 04.03,6610216,4.328711123736605
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
OE33,3689413,1.522493576982794
LCLC-97TM1,439501,-2.367039612081251
NUGC-4,5460769,4.378159421113783
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842
SNU-869,439501,0.8866471334792935
SW1271,9903786,4.005340236032604
JHOM-1,6610216,4.371443634148573
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
NCI-H929,44491742,4.424394304638718
NUGC-4,36462,2.0627213084673204
A-375,24180125,3.577996774573621
SaOS-2,12003241,-0.699813042979073
BFTC-909,11485656,2.882750602975944
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
NCI-H1703,168313200,3.951606007519328
YD-15,9903786,1.471025688701345
8305C,148198,-1.8799510169056712
ESS-1,5460769,-0.3251379363550979
NCI-H446,44493528,4.231535039215924
SNU-668,159324,3.408616564816967
SIG-M5,6610216,4.287770419963318
OV-90,10296883,4.385218547099001
COR-L51,6610216,4.366800356397278
SNU-C1,54618164,3.867223192302055
NCI-H1869,36462,3.1749992742870923
BT-16,46943432,4.318717641296422
HEL 92.1.7,3689413,-2.453708704317935
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
PE/CA-PJ15,9927531,4.562949408871821
KNS-60,49836020,-2.408070727278554
COLO 668,168313200,1.8456785422114392
BT 416,11485656,1.5705982486329817
NCI-H2141,44491742,3.797452560506029
ESS-1,6610216,4.607428871946369
U266B1,6505803,-0.3564252706563441
IGROV-1,49836020,5.658436828096057
Calu-6,9903786,1.9563383465911224
SBC-5,409805,5.881004535625117
HT115,54618164,4.046748219175573
SNU-869,9936388,1.2557424623780096
YAPC,6505803,-0.1975849276423945
HCC1143,54618164,3.885707225557291
MHH-CALL-4,439501,-2.5308829551991168
LS411N,3689413,2.701640891749041
RKO,439501,-1.8401322759847645
SK-MEL-24,6505803,-0.5263584853555022
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
DU145,9936388,-2.7050109048591287
SNU-46,9903786,2.745048797484884
SCaBER,10296883,4.146798449581147
SNU-423,6610216,4.208625011644533
KMS-21-BM,26596,-2.3391795645360403
CCK-81,6610216,3.772274031548382
KYSE-520,54618164,5.079154008745419
GP2d,12003241,-2.636823152177336
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
697,24180125,1.1965287917191645
MHH-CALL-3,168313200,3.032301492705872
Panc 10.05,10296883,3.775390801263641
KMS-11,439501,-0.5953872178744132
RMG-I,5460769,4.854195851393806
RVH-421,5460769,4.814862206766451
SK-MEL-3,5460769,5.404359476176559
MOTN-1,46943432,2.0865567355520107
RCH-ACV,439501,-2.6930538101979575
SNU-478,54618164,3.7807583613099256
Li-7,JQ-1-carboplatin (1-1 mol-mol),-0.1092601408867035
SH-4,46943432,3.9453747221340207
Hs 888.Lu,11485656,2.9342163037973563
SW948,8515,3.759025323790885
YD-38,6610216,4.740393089069458
CA46,12003241,-2.799565618947511
PK-59,12003241,-0.8874443449539482
HL-60,409805,3.622853668310883
Ki-JK,selumetinib-GDC-0941 (4-1 mol-mol),1.348149232454661
CAL-78,9936388,2.7062290727666816
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
H-STS,11485656,0.1079902200809361
NCI-H1355,3689413,0.7312644846226123
697,11485656,1.0677587184410018
JHUEM-3,24180125,3.5826346710476256
NCI-H1341,26596,-1.5435661996164969
MOR/CPR,6505803,-2.446657793445472
AML-193,148124,-4.5095548877680045
DMS 114,8515,4.5444932371015065
KYO-1,9936388,-6.33783178095698
EPLC-272H,24180125,2.4592552986941763
OVCAR-8,12003241,-0.599857829959187
HT-144,439501,-0.7742465567172142
LN-18,12003241,2.3352832275998927
CAL-62,26596,-2.09128877077726
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
COR-L95,10296883,4.074268886544182
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
RPMI-6666,8515,3.7122061672302378
BT 112,6505803,0.1257905254161033
KMS-21-BM,159324,0.3673742600745772
CHP-126,3689413,-2.431147866907691
HOS,3689413,-0.1573622709293647
HH [Human lymphoma],selumetinib-GDC-0941 (4-1 mol-mol),-1.1427111457994747
TE-8,12003241,-1.9101664586501004
SW1417,6505803,-1.211390297431511
SNU-685,10296883,4.374649581801884
Karpas-299,409805,3.4608601578721996
Mel JuSo,168313200,3.445079379631
MOLP-2,6505803,0.8225151705149113
AML-193,JQ-1-carboplatin (1-1 mol-mol),0.2220532745153866
DMS 273,11485656,2.8704893197930272
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
NCI-H2087,5460769,-1.5102005910697154
SNU-869,11485656,2.9373298298731463
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
Reh,11485656,1.8045158177085707
SNU-387,JQ-1-carboplatin (1-1 mol-mol),2.560433008803645
JM-1,3689413,-3.612287026066889
WSU-DLCL2,9936388,-6.090870232080744
SEM,10296883,-0.6538100941325019
Daudi,12003241,-4.903510386182724
Hep 3B2.1-7,135875424,3.596529657657783
HOS,6505803,0.7785174414799726
Granta-519,3689413,-2.6080640580656977
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
SNU-1214,46943432,1.6748160233466023
TUHR14TKB,24180125,2.812325476546893
SUP-B15,409805,3.825124436171416
KMRC-3,439501,-3.150982817952844
TE-6,9936388,-6.304125795740003
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
Tm87-16,49836020,-0.9947449056575012
HCT 15,409805,5.978368929801831
U-937,6505803,-1.2409770185958264
CAL-51,107985,-4.126908547019261
IGR-37,26596,-1.7212662992488197
BT 131,54618164,3.7702820257389273
CMK,24180125,3.476288444144944
A101D,8515,4.373950298019086
JHOM-1,36462,3.754138858913095
NCI-H727,439501,-2.2848783314382133
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
CAS-1,11485656,3.26266946526555
EHEB,135875424,3.250653126047009
JM-1,439501,-5.872076466297635
HPAC,10296883,3.470080354686621
MHH-CALL-3,135875424,3.7440034297864258
SU-DHL-10,439501,-2.5547095883933975
NU-DUL-1,24180125,2.788711571629837
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
NCI-H460,107985,-2.632533954936978
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
MES-SA,6505803,-3.213195974579349
MOTN-1,11485656,1.953778379439836
KYSE-150,44491742,4.452704490333977
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
TUHR10TKB,159324,3.1816852978480927
NCI-H2023,36462,1.4668895939390116
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
BT 328,135398744,6.520469371663204
JJN-3,26596,-2.098638975777458
Ri-1,54618164,3.351620474259991
Panc 05.04,selumetinib-GDC-0941 (4-1 mol-mol),0.8434992349336349
8-MG-BA,36462,0.9814615543613344
HuG1-N,3689413,0.3289715107360669
RCH-ACV,36462,-2.5687954278265535
KMH-2,5460769,1.5529919827376786
RT-112,12003241,-0.7712914992257113
QGP-1,6610216,4.870188716890213
WM983B,168313200,2.0257774924558176
DU145,6610216,4.286029823589705
FaDu,44491742,4.0645501932383095
F-36P,9927531,3.277951098444252
COR-L105,6610216,4.21117605455994
MOTN-1,135423438,1.8734384638779549
SKM-1,159324,-1.3530804275700197
SU-DHL-8,46943432,0.6195871683667687
BT 172,409805,4.682235249525739
BC-3C,168313200,2.4495117116245786
MDA-MB-468,9903786,1.7748497481459855
P31/FUJ,12003241,-0.93015536828776
SUP-T1,36462,-0.1805467194258707
MOLT-16,409805,3.602378767851464
SCC-25,439501,-2.292727593069412
UM-UC-1,10296883,4.123728630230191
NCI-H1651,107985,-3.5960692919806085
SW1417,148198,-3.336621640572291
OV56,168313200,3.853424001484558
L-363,8515,3.684456048259526
RL,46943432,1.3308901805339093
SW1088,159324,3.165882485712232
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087
NCI-H526,409805,3.795742136868548
5637,439501,-2.4129442020826697
HeLa,439501,-2.848382287027866
MSTO-211H,3689413,-2.1873545800685865
JHUEM-3,135875424,4.829807561587815
HEC-151,46943432,3.433057061661308
TE 617.T,44491742,3.9684227449531697
NCI-H1694,8515,4.10750470261541
NCI-H841,409805,3.6369674230030298
HOP-62,148198,-4.07466395157971
JHH-4,135875424,4.647713249642841
HOP-62,135423438,1.5837123025968611
LOX-IMVI,409805,4.011885260759597
BT-16,409805,3.917898602968281
Hs 888.T,409805,4.018843136639201
LOX-IMVI,159324,2.6537923363600937
T98G,3689413,-0.3099040936553002
COLO 684,8515,4.467603665883123
HCC1419,11485656,3.3617833706326277
SUP-T1,6505803,-0.1872119927245122
MOLP-2,54618164,4.374715103779399
SNU-213,11485656,2.091894408723056
BT 504,135875424,2.85163619011477
VCaP,selumetinib-GDC-0941 (4-1 mol-mol),1.6951262679306962
PL-21,135398744,6.318867550173511
Capan-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.340534390124913
P31/FUJ,54618164,3.783909273991047
SNU-C1,135875424,3.0946795282474007
KYSE-450,12003241,-0.0119879221972118
TM-31,6505803,1.056244562382091
JJN-3,JQ-1-carboplatin (1-1 mol-mol),-0.9961051054382296
KMS-20,135875424,2.456374257858295
CMK,54618164,3.8956255903978607
HT-55,10296883,3.42762863324558
SJSA-1,26596,0.7775759099492098
RERF-LC-MS,107985,-3.0933260647006215
BEN,54618164,4.350338596649304
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
HCC78,107985,-2.6460024224545493
COLO 668,9903786,3.4728233461843745
WM266-4,5460769,5.368369623882124
NCI-H508,10296883,3.4644363543099312
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
NCI-H2444,6610216,4.694771975747221
A-253,24180125,3.693466028102568
KE-37,135875424,3.024504733607955
KMS-20,49836020,5.970121389426133
SNU-308,159324,3.7188145940777617
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
HSC-3,44493528,4.631982422980787
253J-BV,107985,-8.331736502582213
BT-20,72199289,4.513177041132638
LUDLU-1,3689413,3.1550499386231325
AsPC-1,11485656,3.206693439346989
SNU-216,10296883,4.064330575642344
LMSU,6610216,5.122726082721053
OCI-AML-2,409805,3.662205368916432
NCI-H889,148198,-2.8403688866942804
TTC-709,10296883,3.6532150982477503
HCC2108,9936388,-4.897775231329417
HCC44,107985,-3.4962930705571136
L3.3,107985,-3.199791523822717
UM-UC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.321826526721954
HMCB,148198,-4.3449695976370055
KCL-22,6505803,-0.612713471586346
OE21,9903786,3.8183922804943298
SK-UT-1,26596,0.4182972999713699
Namalwa,9927531,3.1365070733929663
TCCSUP,9936388,1.8313124822353004
MOR/CPR,159324,3.1882046410016187
SNU-C2A,26596,-0.6540146277819451
Rh18,148198,-3.372937628836821
BV-173,9936388,-7.205824957487243
SNU-1079,135875424,3.1645684861148977
NCI-H838,24180125,5.001007503284622
EFO-27,135875424,4.6207788215281465
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
GCT,148198,-3.923024510865304
SF539,54618164,4.674024000945265
BT 482,12003241,-1.3288470463834767
CAS-1,107985,-2.532317162545706
OV7,26596,0.3804702126499801
SK-MM-2,9936388,-2.43514787246578
UM-UC-1,439501,-2.7541191906970224
OCI-Ly3,44491742,3.926689861618192
MHH-ES-1,36462,-0.1756976495711807
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
NCI-H2029,9903786,4.7445314067007
JURL-MK1,44491742,4.045631279535998
BHY,159324,3.6191013988599297
NCI-H1339,11485656,3.447182893453246
JHH-4,10296883,4.085569000531024
BT 159,8515,5.527889976942142
HEC-6,439501,-1.45021451422316
SUP-HD1,135875424,2.9213239436654908
CFPAC-1,JQ-1-carboplatin (1-1 mol-mol),2.3512621109850897
NCI-H838,9903786,3.3354692149309124
SEM,6505803,-1.7011482867291614
FU-OV-1,6610216,4.742914927321441
KMS-20,9903786,1.7377090782754483
Panc 08.13,selumetinib-GDC-0941 (4-1 mol-mol),0.8396472898062124
HEC-1-B,selumetinib-GDC-0941 (4-1 mol-mol),1.120792302253412
LOX-IMVI,168313200,4.329297638154407
KMBC-2,8515,4.644578296093967
SKM-1,8515,1.7539525603020008
SET-2,439501,-3.519167585481613
P-STS,selumetinib-GDC-0941 (4-1 mol-mol),4.834100084681968
NCI-H2029,JQ-1-carboplatin (1-1 mol-mol),2.876722869032902
SNU-685,409805,5.994418908902015
JVM-3,8515,3.3975589624762472
GOS-3,49836020,5.837697611269413
SUP-B15,5460769,1.5557801555914603
SNU-387,11485656,1.781894419315086
MSTO-211H,148198,-2.180219295506665
SUP-T1,409805,3.665439994658061
BT 340,135875424,2.9922583399282163
MFE-319,439501,-2.2775311995949035
NCI-H211,46943432,0.2016973908222597
NCI-H23,168313200,3.938630562254836
Namalwa,5460769,2.4239066035753054
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
BT 131,12003241,0.8855020405936681
L-428,44491742,3.8287631756244944
MG-63,10296883,4.161966556004564
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
LS1034,3689413,2.145943189168165
HL-60,9927531,5.393037826630499
SNU-46,135875424,4.168499733284657
DK-MG,9936388,-7.3302132848609665
SNU-719,6610216,4.511373507313099
HPB-ALL,36462,0.3626764904924543
KYSE-510,148124,-5.076093364813466
REC-1,9903786,4.191167368609226
NCI-H2228,9936388,2.203953103351002
CJM [Human melanoma],26596,-1.4087486748108544
OV56,107985,-4.137987723895467
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
KYO-1,selumetinib-GDC-0941 (4-1 mol-mol),1.8614571416094257
T24,24180125,4.53885129509785
WM793,148198,-1.495249919530428
EFO-27,24180125,3.663788732934096
Hs 839.T,6610216,6.404969449700832
SU-DHL-1,5460769,-0.475427190707336
BT 340,6610216,4.188331565981621
OCI-Ly3,54618164,3.7608035112102
MFE-319,148124,-4.371578171845129
JHUEM-2,54618164,4.173544512136638
BT 482,107985,-4.125051999378386
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
TE-14,107985,-3.6830592516934697
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
NCI-H747,12003241,-1.9291719472544329
HSC-2,26596,0.6802273350911279
BT 179,54618164,3.7942917299361105
EHEB,54618164,4.264105290178519
REC-1,10296883,4.285765558435674
KHM-1B,107985,-4.92843539421015
A-549,44491742,4.437272986024
BT 359,6505803,3.620605516662926
NCI-H1563,JQ-1-carboplatin (1-1 mol-mol),4.5120553214981625
Caov-3,135398744,6.775001868991772
A-375,439501,-2.387181275139254
COLO 678,148124,5.974841779410185
LXF 289,9903786,1.8485652979864533
ECC12,6505803,-3.012781394546517
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
HCC1195,selumetinib-GDC-0941 (4-1 mol-mol),2.113355514825289
SK-MEL-31,135875424,3.140384739154431
PSN1,9903786,4.143013374018909
OVCAR-8,159324,3.4796802978441614
HCC827,11485656,1.9566672010968855
SF126,159324,5.495945849667338
Fu97,26596,-2.255904398728495
LS411N,148198,-2.2204558676981576
OPM-2,135875424,2.796643273298537
FU-OV-1,409805,4.026686349090877
K029AX,409805,4.032491022499592
SNU-216,JQ-1-carboplatin (1-1 mol-mol),3.8633664512106622
HCC1195,439501,-1.494120316453499
HCC95,9903786,2.343121552943665
NCI-H292,6610216,4.846288432835765
SNU-C4,selumetinib-GDC-0941 (4-1 mol-mol),1.401600163987786
KMS-12-BM,24180125,1.472923036280714
PK-45H,107985,-2.8676088272844047
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
Caov-3,selumetinib-GDC-0941 (4-1 mol-mol),3.787884726335324
PE/CA-PJ49,9903786,3.1609136015972847
UACC-62,148124,3.975689175155842
PK-1,148124,-4.413253648153995
NH-6,6610216,4.244539451905319
LP-1,168313200,2.9786417938497807
Pfeiffer,JQ-1-carboplatin (1-1 mol-mol),-0.9123603269683516
MOLT-16,44493528,3.7613597484696104
JHH-5,6610216,3.708865198652102
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
BT 271,JQ-1-carboplatin (1-1 mol-mol),4.042067647182753
SNU-1076,6610216,4.3589064064708145
NCI-H460,439501,-2.362377537788676
RKO,11485656,2.16906736756012
HT115,36462,3.0779780996301707
SNU-81,8515,4.116210915577815
BT-474,11485656,2.39208559559141
NCI-H841,107985,-3.953236182986376
COR-L105,36462,5.237060103367249
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
PaTu 8988t,107985,-3.7439330143768106
EJM,3689413,-2.394173462666658
Kuramochi,148198,-1.655835644166272
KE-97,73707440,4.317298801738101
SNU-620,6505803,-2.9616664465853115
HCC1588,JQ-1-carboplatin (1-1 mol-mol),4.871781854862913
TUHR4TKB,9903786,3.6038306258320425
Calu-6,8515,4.504386605976223
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
Namalwa,54618164,3.970816819204835
J82,54618164,3.775864459109127
AGS,12003241,-0.4936842382500208
KALS-1,54618164,4.429142679036427
Mino,JQ-1-carboplatin (1-1 mol-mol),-0.9180856967211396
MKN74,135875424,3.2262010711942484
MKN45,JQ-1-carboplatin (1-1 mol-mol),5.954362231550531
Panc 03.27,44491742,4.225898186806888
NCI-H1184,6610216,0.5829186651523776
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
HCC4006,107985,-2.654507490141286
NCI-H2110,168313200,2.986185729607549
IGR-39,selumetinib-GDC-0941 (4-1 mol-mol),2.3690668734503415
MHH-CALL-4,44493528,4.165612428769394
T3M-10,6505803,-2.029388568048509
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
TUHR4TKB,46943432,4.891108936063827
SNU-869,54618164,4.157538962924349
SNU-407,11485656,1.7989255802763466
SK-MES-1,6610216,3.4550348226980536
Daudi,24180125,1.1000611971852634
CAL-51,44491742,5.152478206660974
COLO 699,24180125,2.6222593496169058
TE-5,439501,-3.2949389532726867
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
KALS-1,168313200,3.0482766453888024
HT115,6610216,4.006110298161749
COV362,148198,-3.7747045203467313
NCI-H1573,12003241,0.8925202340822594
SNU-119,9927531,4.042335314323924
786-O,135875424,4.398795427398002
CAL-29,24180125,3.292703215341267
J82,6610216,4.454251017755925
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
DOV13,9903786,3.8407513521100975
MKN1,9927531,4.774967251580727
MDA-MB-231,409805,5.172988734165277
U-BLC1,148124,-4.12148794810048
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
BT 416,54618164,3.776512207378467
MIA PaCa-2,8515,4.279549136929449
SNU-C2A,12003241,-1.200287436461147
BxPC-3,6610216,4.298723179439111
LOU-NH91,12003241,-1.4006618643370652
FaDu,6610216,4.337478991098613
NCI-H2122,135875424,3.891671536757885
JM-1,9903786,1.587415218469425
GaMG,11485656,3.146169706850776
HT-144,107985,-3.4210569798385864
P-STS,3689413,0.8859178339084445
SNU-685,6610216,4.175803994793872
Raji,148198,-3.0979012911214077
KYSE-510,54618164,5.681734700355768
GMS-10,107985,-3.618834006022873
NALM-6,46943432,-0.5536160766490446
TE-6,8515,4.062611311857455
RT-4,9903786,1.1299984693284726
IGROV-1,46943432,4.105714883822214
Kelly,409805,4.86847544408602
MKN1,9936388,1.1004986908741188
Toledo,10296883,3.728204772396323
T98G,135875424,5.101346341382456
Kasumi-2,36462,-1.2000537391874553
RPMI-8402,8515,2.725548300733334
SW48,135875424,3.469184081134181
BICR 18,135423438,2.266029017324442
A2780,9903786,1.372407357095215
NCI-H196,6505803,-2.584709085122825
WM983B,44491742,4.283339353588083
KP-3,JQ-1-carboplatin (1-1 mol-mol),5.58247855672367
SET-2,26596,-1.642607786787168
L3.3,148198,-4.142602322676729
KMS-34,439501,-2.83193731194203
CAL-54,148198,-3.3099024859791286
MOLT-3,44493528,4.004612742567489
SNU-46,107985,-3.76796629724838
Tm87-16,24180125,2.9564618948290255
NCI-H1563,107985,-3.7003517008173
LOX-IMVI,5460769,1.2475955137176375
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
J82,44491742,4.20149606168553
OPM-2,11485656,1.3184852346481954
SW1271,6505803,0.8186340021888412
HCC1833,9927531,4.651328537031639
SK-MEL-24,135875424,4.490880969896708
LK-2,135875424,3.2650387901291844
Mono-Mac-1,9903786,0.9536797288397608
U-CH1,selumetinib-GDC-0941 (4-1 mol-mol),2.4998386609630834
AMO1,26596,-3.5101711689538155
HT-1376,10296883,4.451130716286632
ECC10,44491742,3.5514188140431644
KMS-34,selumetinib-GDC-0941 (4-1 mol-mol),0.0635053645557878
RPMI-7951,107985,-3.3094239868135467
U-BLC1,148198,-4.602164076011155
BICR 18,148124,-4.300616978044816
SUIT-2,54618164,5.030082257565933
EM-2,3689413,-2.767286284866434
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
KMS-34,135875424,2.166327494960368
EFO-27,148198,-4.612142049540045
SU-DHL-1,49836020,5.336381428124731
Kelly,9936388,-6.593577223955802
BV-173,12003241,-5.971697113356734
AsPC-1,9936388,-0.8199656713038528
WM266-4,6610216,3.751452940387017
K029AX,10296883,4.016071874543954
BxPC-3,159324,1.5239234886257875
AsPC-1,5460769,5.795061807453513
HEC-1-A,26596,-0.4494032602178983
NCI-H2085,54618164,4.2368593069560925
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
8305C,11485656,2.5131422370464436
A-673,409805,3.491559756034339
OCI-M1,12003241,0.3090538594406519
SUP-M2,9903786,1.0371489832457852
NCI-H526,148198,-3.313175192053609
HCC2279,9936388,-5.134625350026444
KMRC-20,6505803,2.060614018584274
CW-2,11485656,2.601974992122327
HCC1588,12003241,-0.4884151161938169
SU-DHL-10,12003241,2.591682900303347
SIG-M5,9903786,1.9849552317824917
NCI-H1869,148198,-2.251684124095355
NCI-H520,selumetinib-GDC-0941 (4-1 mol-mol),1.617810838341725
BHT-101,107985,-3.610598538035865
C2BBe1,10296883,3.913780393696494
KYSE-70,9936388,-4.915846401119174
ACHN,135875424,5.052014083171249
NCI-H2405,11485656,2.273940058944612
JJN-3,6505803,-0.5101554809068779
NALM-6,439501,-2.425379213431436
COLO 205,9936388,-5.293351176311716
WM115,107985,-2.5041726579949857
OCI-M1,409805,6.068123689034305
NCI-H1341,5460769,4.302850791572325
TE-1,54618164,4.286971927920475
TE-1,6610216,4.2679140249391505
HEC-108,439501,-2.3418750446111347
NCI-H841,9903786,1.3953234404083057
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
SF295,9936388,1.8656949469177304
IGROV-1,148198,-2.659972993252853
A4/Fukuda,439501,-3.252400391503616
JMSU-1,11485656,1.6924908794215956
WM88,11485656,3.1313220477108996
HMC-1-8,439501,-2.9619639493833247
SU-DHL-10,54618164,3.9853572378848927
Calu-3,9903786,3.8990782508172495
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
PSN1,148124,-2.7634040442066476
LK-2,54618164,3.851858662918836
KMS-12-BM,26596,-3.7364157309734822
YH-13,107985,-2.561016282380613
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
Ku812,439501,-2.3195298765386587
HCC2279,selumetinib-GDC-0941 (4-1 mol-mol),1.829926030012146
LS411N,409805,5.900990799691521
YAPC,409805,4.253424942012428
LS513,9903786,1.9994254947829608
KMS-12-BM,49836020,4.363885927749537
RPMI-8402,54618164,3.265888368810329
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
NCI-H650,439501,-2.431498086573591
NCI-H1573,44491742,3.554417916622067
EFO-21,9936388,3.018454857449296
SK-MEL-24,JQ-1-carboplatin (1-1 mol-mol),2.7809090892182744
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
IM95,44491742,3.8617516807929873
SIG-M5,3689413,0.233032105010129
SNU-423,10296883,4.1095294295281795
Panc 03.27,107985,-4.41897786111236
SNU-489,159324,3.7813842942666382
GA-10,46943432,0.1410018979279226
NCI-H1869,24180125,4.3941927227643145
SK-N-AS,135875424,4.067320794930689
KYSE-150,12003241,-0.8115897611031261
HCC2108,12003241,-1.7779849182593923
SK-MEL-31,107985,-2.2802285323914213
SCC-25,6610216,3.3967716099500604
NB4,439501,-2.5545682554076805
BT 145,26596,-1.6561784022945174
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
DOV13,107985,-3.1919533435482697
MOLT-16,135875424,2.8305217651964463
SiMa,159324,2.416941297651996
HPAC,9936388,0.8938610961333106
MDA-MB-157,49836020,-4.4611089332084335
SF539,135875424,2.4028504168317473
NALM-6,26596,-2.8659414702792128
BT 333,3689413,0.756626575903668
NCI-H1299,54618164,5.089847136026273
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
KMS-11,44493528,6.397457291534785
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
A-375,159324,3.1651524914786333
Pfeiffer,107985,-4.631435651721851
A-673,49836020,4.096681472773702
ZR-75-1,159324,2.7368279541402987
LCLC-97TM1,12003241,-0.8351557307101188
CML-T1,6610216,3.6071739537574863
PaTu 8988s,11485656,1.7881493862367523
NCI-H716,107985,-2.4124318655022674
A2780,9927531,3.2712332494904226
Hs 934.T,135423438,1.6511410830672884
SNU-489,409805,3.7956139980045225
TE 441.T,168313200,1.7491212896878472
NCI-H1651,6610216,4.721038769964527
NCI-H1755,3689413,1.3270015579538552
SUP-M2,6505803,-1.2925324333028148
Lu-65,54618164,4.000249960497271
CAMA-1,11485656,2.6355660526495672
SNB-75,36462,2.650946261934248
TT2609-C02,3689413,0.4383684388125656
TE-6,11485656,1.5497099103986265
DV-90,44493528,4.133930960270083
Panc 04.03,44493528,4.362737332857046
TOV-21G,6505803,-2.649430601885361
CAL-33,11485656,2.164016105074951
G-292 clone A141B1,107985,-4.329663865653352
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
MFE-319,409805,5.809457892580604
NCI-H520,107985,-4.652189442077367
KMS-11,11485656,1.7244109146012885
COLO 792,JQ-1-carboplatin (1-1 mol-mol),2.0014474236818183
Detroit 562,54618164,4.201054272091685
TUHR4TKB,9936388,-4.816282931741809
Mono-Mac-6,3689413,-1.766017033423464
DMS 53,9903786,1.7776029378286846
Granta-519,24180125,1.2477770260094014
KE-97,11485656,-0.8260984210127809
NCI-H1563,5460769,4.309223313184859
KYSE-410,6505803,-1.395116732641888
COV362,107985,-4.013210896315973
T3M-10,36462,3.304739967460866
SNU-1076,36462,1.8413818217522735
SW48,107985,-4.220376672084107
NCI-H2081,3689413,-0.989992552174664
SNU-761,3689413,-0.7506907427890448
CCF-STTG1,107985,-2.0025512814929525
HuH-1,10296883,4.280217513091765
OCI-Ly10,9936388,-5.832060635266597
H-STS,9927531,5.457961831541725
MOLM-6,selumetinib-GDC-0941 (4-1 mol-mol),0.1291930510848496
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
SF539,5460769,-0.1125532875886319
PE/CA-PJ15,6505803,-4.077813218319251
Mel Ho,JQ-1-carboplatin (1-1 mol-mol),1.3630461698598746
OAW28,168313200,4.298133692275281
Detroit 562,46943432,2.661178412320311
LXF 289,135398744,6.087135496005038
Hs 766T,9936388,1.7778445616458998
T98G,12003241,-0.2247982599387034
Karpas-422,54618164,3.784290437567208
NCI-H1694,46943432,0.9969320768499224
SK-MEL-1,6610216,4.20996876122129
NCI-H146,46943432,1.2283557348915184
MG-63,439501,-2.9607530024491515
YD-10B,6610216,3.129867810058842
NCI-H2342,54618164,3.990918802805385
SW1990,JQ-1-carboplatin (1-1 mol-mol),4.363911496200424
MDA-MB-361,6610216,4.523037178271305
MeWo,107985,-4.390492182026979
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278
TUHR4TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.368524394039708
NCI-H292,409805,3.708436738901026
T3M-10,439501,-3.538112606826756
EN,409805,3.3343826376053154
SK-OV-3,11485656,3.3782074628341894
FTC-238,9903786,3.4467406025771705
CML-T1,44491742,2.876043803936746
Caki-1,12003241,-1.8863162536101896
PK-1,135875424,4.5989103647070655
NCI-H650,9936388,2.384400355821072
KE-37,11485656,2.1580092270767195
SK-N-FI,8515,4.830476271851616
Rh41,26596,-2.117854193038536
ECC12,409805,5.778567326982414
M-07e,9927531,3.229988201288456
LN-229,11485656,2.3407589435877187
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
CAL-54,6505803,2.0649330507339183
HuG1-N,26596,-1.6967804623376053
TYK-nu,9927531,4.342224808335168
Hep-G2,10296883,3.682570839684776
SF539,24180125,3.915045335194428
UACC-257,44491742,4.3075324328228275
SK-HEP-1,8515,5.0523689066797495
OV56,54618164,4.260141278815489
Jurkat,36462,0.5890465632038882
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
MOLT-13,6610216,3.560997479568521
HSC-4,36462,0.7755986988683452
HuT 78,6505803,-1.3012174270497974
SUP-T11,11485656,1.9960376933984711
BT 216,49836020,1.982286397666987
BT 286,148198,-5.76188834046235
SK-N-SH,6505803,1.028408820078618
MOR/CPR,409805,5.7867477385029815
Hs 683,11485656,3.0003726107919437
Lu-65,148124,-0.361922200988903
UACC-257,11485656,3.6556840450615065
HuP-T4,439501,-0.5281906022533748
NCI-H2009,26596,-1.5885219134108934
VMRC-RCZ,9936388,2.3109640343405418
HEC-1-A,10296883,3.968185450063831
SK-MM-2,26596,0.072150738405161
JVM-3,24180125,1.9129401450909584
COLO 792,6610216,3.916017741536628
SK-MEL-1,439501,-2.4358325657169035
PC-14,439501,-2.395737625467809
OVCAR-5,46943432,6.399067985837115
BFTC-905,5460769,4.235583914088274
HDQ-P1,9936388,2.1962114210589134
HPAF-II,409805,6.320045769749623
RPMI-7951,11485656,2.1770384312644246
NCI-H1299,24180125,3.786842850309645
AU565,9936388,-7.122590364363415
GI-1,6610216,4.189054008604763
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
BT-12,11485656,2.106070398144325
BT 231,24180125,2.6727981322820664
WM1799,54618164,4.23745707986816
NCI-H1915,JQ-1-carboplatin (1-1 mol-mol),0.8785852564094064
Hs 936.T,439501,-0.3006494435216346
OS-RC-2,439501,-0.684202622279705
NCI-H1650,54618164,4.20289726679049
NCI-H1299,54618164,5.089847136026273
BT 216,54618164,4.238322726276742
PL-21,44493528,4.151130838756699
NCI-H1869,11485656,1.8296978789565703
THP-1,11485656,2.379664942460744
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
BT 416,168313200,1.511876706612717
CAL-148,9936388,-7.397165329324112
KM12,44491742,3.983947326566667
DBTRG-05MG,36462,4.173854619503818
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
KMRC-1,107985,-3.501321688193531
HCC1954,44493528,3.86549842878492
YKG-1,135875424,4.553579428376037
KMH-2,148198,-4.1260923744300015
EBC-1,6610216,4.132089283309266
NCI-H1092,54618164,3.7504442983527104
COV434,107985,-5.084835264945118
NCI-H1944,148124,-4.646184919447912
NUGC-3,148198,-1.9201503205114672
Hs 294T,11485656,2.7928532706785143
LN-18,439501,-2.51749540441962
BICR 18,3689413,0.5803768983412222
NCI-H2342,11485656,3.078820685414162
SUP-M2,135875424,2.961544383480745
Yamato-SS,148198,-5.276509118521361
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
SW948,12003241,-1.7903806895013192
COLO 205,135875424,4.594078459695996
ChaGo-K-1,24180125,3.6677801491975006
COLO 829,409805,5.20595699419965
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
IPC-298,135875424,4.836826203485717
Panc 02.03,11485656,5.602754460209725
HOP-92,49836020,5.403656238129832
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
Fu97,9936388,-0.0217982395537123
SK-HEP-1,9936388,2.725726666175631
SNU-8,107985,-2.480678817312735
SW1710,9936388,-6.272511442902443
MeWo,26596,2.4666205413872953
IM95,26596,-1.182221472210093
NMC-G1,9936388,2.483063894359811
HGC-27,36462,-0.1990646362671453
NCI-H2023,9903786,4.254062749563359
JMSU-1,6505803,-3.090216312025297
Jurkat,159324,-0.2625759022362762
JJN-3,44491742,4.04042701265084
BT-549,135875424,3.804392758634582
MOR/CPR,12003241,1.56456971518695
AMO1,11485656,2.1088209303297853
CL-11,36462,2.482069407181084
THP-1,73707440,3.8767846220301254
MOLT-16,JQ-1-carboplatin (1-1 mol-mol),0.2899951204011434
MOLT-13,5460769,4.221123357906427
BICR 16,11485656,3.0485171549819476
KYO-1,107985,-4.0986784850985565
MHH-ES-1,5460769,-1.13601039501847
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
BT 328,409805,5.840944403536212
TE-15,9903786,2.5325936452806723
BT 504,10296883,3.915758265808419
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
BICR 18,9903786,1.845690489746328
JHUEM-3,9936388,-3.506110274235372
BT 147,107985,-3.8275487999717543
MG-63,46943432,5.483589733735585
NCI-H2087,135423438,1.5480624083633234
HuT 78,148198,-3.964995663982544
Panc 10.05,135875424,4.82827544995575
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 245,24180125,3.7251003604929167
Peer,409805,3.5038183532951837
MIA PaCa-2,135423438,2.2894715060157553
LUDLU-1,6610216,4.136129854061651
SNU-16,44493528,3.7043478102813543
NCI-H520,9903786,3.332228860924169
BT 422,135875424,2.9816233876655387
OVCAR-8,54618164,4.2136896289865815
K-562,54618164,3.946994253297547
VM-CUB-1,135875424,5.069346685135383
U-251MG,10296883,4.141522340635607
BICR 31,9927531,5.661036072082279
TT,44493528,4.253407146513618
CW-2,26596,-0.0212695413567751
NCI-H522,148124,-6.241132033807486
PK-1,36462,2.8123461467673954
GaMG,9903786,4.966976399953102
YD-38,54618164,4.14569311536785
NCI-H1568,148198,-4.9953315451672005
786-O,44491742,5.035169002663678
DMS 53,409805,5.806403713845953
RCH-ACV,9903786,1.555646026251057
BT 112,5460769,1.283415330936559
NCI-H322,10296883,3.9806006473812
LK-2,9903786,3.191424869539257
COLO 678,44491742,3.8306560761300696
8-MG-BA,6610216,4.756696338182891
PE/CA-PJ41 (clone D2),6610216,4.420679698302765
SNU-407,44491742,3.765091282887518
BT-16,439501,-3.235694513476061
WM88,9903786,2.087799458877892
EFO-21,5460769,5.67589124107342
K-562,9927531,3.3022164605184763
RL,11485656,1.724412415409439
JHH-4,439501,-2.8819289141126596
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
COR-L105,46943432,2.471907312248233
AU565,439501,-2.8703859168743384
CAL-78,44491742,4.7670188278775605
LXF 289,24180125,2.8590757937383517
KP-3,107985,-4.13659757249414
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
Sq-1,49836020,-1.2584721229421645
SK-ES-1,107985,-4.064224654159369
KO52,36462,1.66960340133658
L3.3,439501,-0.248470622878828
SW1990,11485656,1.987828191145096
OV56,3689413,-0.2367136689985935
KNS-81,11485656,3.966409180746404
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
MHH-CALL-3,148198,-0.6982118974436664
CAL-54,12003241,-2.3491200847554103
MDA-MB-435S,409805,3.705135997804818
TALL-1 [Human adult T-ALL],selumetinib-GDC-0941 (4-1 mol-mol),0.2604149322081276
NU-DUL-1,439501,-2.935576515069395
HEC-108,26596,-0.981636576627464
NCI-H322,135423438,4.4893674583899505
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
NCI-H2087,12003241,-2.8362492565909543
A-549,3689413,0.7236603744186211
NCI-H2405,439501,-2.240122833517123
SK-UT-1,36462,1.790037225485122
TE-8,148198,-4.4276968910766525
UM-UC-1,6505803,-2.248189153857155
COLO 829,5460769,5.712006369948703
U-87MG ATCC,409805,6.211942294277447
HCC1438,selumetinib-GDC-0941 (4-1 mol-mol),1.8999757097381424
HCC1500,26596,-0.8174609850015592
LNCaP clone FGC,JQ-1-carboplatin (1-1 mol-mol),-0.8145893926012049
HD-MY-Z,439501,-3.7474534787438714
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
JHUEM-1,JQ-1-carboplatin (1-1 mol-mol),1.8045893002317055
BT 444,9936388,1.54368416560238
NU-DHL-1,148124,-5.1269699362990195
MKN74,24180125,3.4034235920876648
CML-T1,26596,-2.14043660837674
NCI-H1568,9936388,-8.53108348301746
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
GI-1,26596,-0.9174030047278064
WM88,107985,-3.5954290536778526
IST-Mes1,12003241,-1.7187710036837192
NCI-H520,26596,-1.7163548151943342
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
HEC-1-B,9936388,1.5004168586274125
Namalwa,10296883,3.754455655563699
SNU-1076,26596,-1.989905852137358
HCC15,159324,2.6315252421023536
JK-1,409805,3.271370781273113
MDST8,46943432,3.6174081091701886
DV-90,5460769,-1.416729974856236
ESS-1,11485656,1.966597488234831
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
8305C,409805,4.694735989662373
SNU-899,9936388,1.721308391499284
HGC-27,148198,-6.389013328136406
MHH-ES-1,44493528,5.035499242362303
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
Hs 934.T,12003241,-1.701018905102148
NCI-H2087,9936388,0.7446762448927194
SNU-840,44491742,6.442056780348467
NCI-H69,26596,-2.134877782649339
8305C,selumetinib-GDC-0941 (4-1 mol-mol),-0.5953379888353332
SNB-75,5460769,5.271808255832039
Reh,9936388,-7.618651347698478
VMRC-RCW,9936388,-1.838517301167892
Jurkat,54618164,1.967118142382213
Jurkat,148198,-2.758721203845009
HuP-T4,9903786,1.2000554865922293
Mel JuSo,6610216,4.789088987376648
Peer,148198,-3.8508497827716264
SH-4,6505803,0.0908209591031931
SNU-503,135875424,5.104819930335823
Capan-1,26596,-0.6895285509385911
YKG-1,6610216,4.705494965359816
ES-2,12003241,0.0508402342945085
Mono-Mac-1,439501,-2.692243954974466
TE-10,selumetinib-GDC-0941 (4-1 mol-mol),2.2597459184044593
BT 145,36462,-0.4946142525250538
RPMI-7951,159324,3.4055874402556725
NCI-H1755,44491742,6.2867569407900215
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
GA-10,3689413,-4.87834364200375
WSU-DLCL2,409805,3.8476512869273143
NCI-H2172,10296883,3.8919469305692256
Lu-99,6610216,4.764177880919915
SNU-201,9936388,2.3725441363874236
Lu-99,9903786,2.034349953938994
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
SK-N-AS,12003241,-1.4595382352216486
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
CAL-51,26596,-1.4638590943230956
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
OCI-Ly10,54618164,4.491918084820433
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
SW1573,159324,2.9705070550476274
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
U-937,135423438,1.73395278295497
WM88,6610216,4.233732506418395
DMS 273,3689413,-1.7704206659692223
23132/87,439501,-2.5239735825770797
OCI-M1,3689413,0.2396810105329112
D283 Med,54618164,3.747562396348618
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
RL,36462,0.1375591629555872
CAL-85-1,44491742,3.820376025852422
HEC-151,5460769,2.7656616945667
HEL 92.1.7,44491742,4.540639923778426
TE-14,6505803,-1.7378811047388565
OCI-AML-2,11485656,1.8915689976488803
MDA-MB-361,135875424,3.2859719831181176
HuCC-T1,11485656,1.9622878399892336
P12-Ichikawa,46943432,1.0816569815891666
CML-T1,159324,0.3275039904336689
Calu-1,9927531,5.244935764908175
SK-LMS-1,24180125,3.932034764154328
NCI-H226,8515,4.767920255127791
HSC-3,6610216,4.3028162807700365
LOU-NH91,9936388,-6.294191236399446
NCI-H838,5460769,0.2411735941540018
KP-N-YN,6610216,5.097327149655238
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
Detroit 562,148198,-1.4589401504544364
TE-4,159324,3.1903380659828726
HEL 92.1.7,54618164,3.7534010848013626
PE/CA-PJ41 (clone D2),54618164,4.303600867099711
NCI-H446,8515,3.948412073118329
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
SNU-1041,159324,4.667459378229219
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
PK-1,148198,-3.6704242534149296
LP-1,46943432,-0.1218139199537091
SU-DHL-8,409805,3.916081656156952
ECC10,135875424,2.912404124811061
HeLa,5460769,5.484643109222549
BT 286,3689413,-0.1900658377643967
A-375,439501,-2.387181275139254
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
HuH-28,11485656,3.308019517544549
Hs 294T,3689413,-2.200259258980444
SNU-398,12003241,3.2060207303790924
RL,49836020,3.855414326561088
SCaBER,107985,-2.9954009190049655
HOP-92,3689413,-2.4488363425715076
RERF-LC-A1,36462,1.7424004173726408
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
L-540,159324,1.0115426220210637
NB4,159324,-2.3898009821965545
YD-8,135423438,0.9954856602627224
Mono-Mac-1,135875424,3.0350686584049473
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
TE-5,9927531,4.466928464790859
OC 314,409805,5.931538015771662
OCI-Ly3,46943432,0.8013367057950229
CAL-51,148198,-3.728190383000159
NCI-H1105,107985,-2.481705593652425
SU-DHL-8,12003241,-0.8632235676270862
CAL-51,24180125,2.8082301472193203
BT 145,9903786,2.2676133006053965
JM-1,46943432,-0.1491870155181681
SNU-738,12003241,0.0747510600230264
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177
ECC12,44493528,5.669506647714131
GDM-1,11485656,-1.9414124993158248
EBC-1,409805,4.585447738175281
NCI-H1666,159324,1.3832647781032974
COLO 668,44491742,3.890577146633183
MSTO-211H,439501,-1.1644309958543906
MV4-11,36462,-3.152783197580454
GA-10,6610216,3.4837383876323975
HDQ-P1,12003241,-0.8789475866858393
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
BT-16,168313200,2.2094468908534144
COR-L51,6505803,-0.8323566824264805
SNU-1066,6610216,4.76095782121934
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
JURL-MK1,26596,-1.965499498470982
RPMI-8402,5460769,1.919918299685469
PC-3,3689413,-2.1836829404040157
Capan-1,9936388,2.896402107939059
SNU-466,36462,2.8940246438070063
CGTH-W-1,135875424,4.831147205394264
T3M-10,107985,-3.7399321689723872
Daoy,3689413,-2.377724406680773
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
NCI-H1703,439501,-1.5312988936027676
IGROV-1,135398744,6.402844237905131
NCI-H810,135875424,3.034466151027353
5637,selumetinib-GDC-0941 (4-1 mol-mol),0.4079577317339777
B-CPAP,5460769,4.36425483182296
ZR-75-30,selumetinib-GDC-0941 (4-1 mol-mol),2.2960611598253178
BT 172,3689413,0.915101391559166
SNU-182,11485656,2.307342205342044
NCI-H1651,11485656,2.5009504795873516
SUP-HD1,6610216,3.934832448864895
JURL-MK1,439501,-2.5160318205813432
CW-2,439501,-2.020246340202773
MOLP-8,6505803,0.6382990348001342
NCI-H2126,44493528,4.793880451858377
TTC-709,5460769,-2.125391207652167
SHP-77,409805,5.959913467190761
F-36P,26596,-3.451633292118186
Ishikawa (Heraklio) 02 ER-,148198,-2.3973242740422407
BT 179,24180125,5.244229269731757
SNU-668,6505803,-2.4015311663396535
HuCC-T1,409805,5.126439787387785
SK-N-SH,54618164,3.749880315376081
SNU-503,selumetinib-GDC-0941 (4-1 mol-mol),1.4877260570474324
SUP-T11,6610216,4.082537730275983
TF-1,selumetinib-GDC-0941 (4-1 mol-mol),1.467323615098958
U-251MG,168313200,1.707119335082743
OUMS-23,44491742,3.6829653315357818
HCT 8,148124,0.3582614048757344
TE 617.T,6610216,4.021742193250995
GSS,159324,1.2139166709223652
Jurkat,12003241,-1.1785607025510931
BT 216,439501,-3.37474066613204
NCI-H28,148198,-2.5352174155891234
SNU-119,9877608,5.864690809801913
TE 441.T,3689413,-1.0112421393817166
ST486,107985,-3.099452908911552
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
LN-18,159324,3.14866398912549
NCI-H2452,409805,5.262030999116563
FTC-238,44491742,5.664145193267726
NCI-H292,439501,-2.469830491210978
LMSU,36462,2.6264812061116127
RT-4,6610216,4.294846652425395
NCI-H2228,135875424,4.666656797632995
NCI-H727,409805,5.9670224431598875
NCI-H2452,135423438,1.816833708086427
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
NCI-H2122,107985,-2.1476502559508828
NUGC-4,54618164,3.9566801833139063
SW1353,9903786,3.629285684044714
PK-45H,9936388,1.8966458551256495
VMRC-RCZ,135423438,3.1126992087806427
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
RL95-2,36462,1.5615779458309782
KE-37,46943432,0.342927335586204
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
SF268,8515,3.901709895631083
Hs 822.T,409805,5.747938151507347
GaMG,9936388,1.1516041835416544
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
U2OS,439501,-2.693554795919347
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
NCI-H1666,36462,4.161489561000207
G-292 clone A141B1,3689413,-2.069808730051662
Capan-2,409805,6.718498972992748
UACC-62,6610216,4.142739754949153
KMRC-20,409805,5.905260063235434
SK-N-BE(2),439501,-3.274978008142144
SCC-9,9903786,2.6448761987997917
KCL-22,26596,-1.6030605550543997
KATO III,selumetinib-GDC-0941 (4-1 mol-mol),2.4282234364089863
647V,12003241,-0.2300893498058843
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
OCI-AML-2,12003241,-1.1091047572975106
KMS-27,36462,-0.3122628984401899
HT-55,9936388,-1.3601859214377197
CJM [Human melanoma],44491742,4.278888606986291
JHOM-1,409805,6.220624680941808
TE-1,3689413,2.462483014763608
NALM-6,36462,-2.029352271609264
NCI-H2452,8515,2.9816658051225344
BT 147,12003241,0.4037100837513208
NCI-H1792,135875424,3.896639880830057
SNU-C5,11485656,2.423735661577291
KE-37,9903786,1.3543500174719385
JMSU-1,409805,5.116602138696932
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
GMS-10,11485656,3.67523785200594
OV-90,135875424,4.80016944702245
JHUEM-1,12003241,-0.7244634318456832
SK-MEL-2,54618164,3.880613274058296
PC-14,135423438,1.1691167584744715
SEM,135423438,-3.9763751688577527
BT 330,5460769,2.587250000288721
PL-21,409805,3.3512475851853067
MDA-MB-231,12003241,-1.774974219486486
HCC95,12003241,-0.8735704800502477
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
BT 416,148198,-4.446669528218965
AU565,12003241,-0.6235660341918571
DMS 114,148124,-6.476256055928947
SBC-5,9936388,-5.234314033557506
SU-DHL-6,26596,-1.882707371112463
HuCC-T1,6505803,-2.738852814934829
JHOS-2,11485656,3.1858119636686104
MOLT-3,8515,2.858943668273086
OVSAHO,3689413,-0.988138970272714
NCI-H1975,159324,-3.209262840922576
COR-L95,11485656,1.8696119642586884
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
JL-1,9936388,-5.012158882257613
PE/CA-PJ49,36462,0.5276653245054587
EHEB,6610216,4.931191689693455
COLO 205,9903786,2.133695985637416
DBTRG-05MG,12003241,-1.7775035610862775
BT 340,11485656,3.382353579781301
GA-10,JQ-1-carboplatin (1-1 mol-mol),-0.7456185194400317
VCaP,54618164,3.6777604686118854
A-375,107985,-3.1836628445194592
TALL-1 [Human adult T-ALL],26596,-1.974209938729662
CGTH-W-1,107985,-2.4076610868668293
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
NCI-H647,148198,-1.832862483065856
LOU-NH91,36462,3.2256365983613677
CHP-212,135875424,3.192345870347938
COLO 829,439501,-1.3241633043003287
SNU-685,135875424,4.288569640305719
TE-11,26596,-1.418568182466745
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
SNU-308,135875424,4.501679724510711
Raji,107985,-3.425855595457866
MEC-1,5460769,1.3276972601062724
HSC-3,26596,-1.4868403003967878
JeKo-1,6505803,0.6415741653854196
A-498,6610216,4.284288503720797
OVK18,6505803,-0.991074322239109
BT-12,9903786,4.28961947380918
D283 Med,9903786,1.479416225891386
HT-1376,148198,-2.6714995080003767
HEL 92.1.7,107985,-4.351266385158589
WM266-4,135423438,3.754515663812223
8305C,26596,-2.120596559409719
CML-T1,9927531,3.1672020542525674
SNU-719,9936388,-4.601692458666014
SNU-1,49836020,4.400146563188995
YD-15,26596,-1.9516647022251905
Becker,6610216,4.575848391008017
GA-10,12003241,-5.009664542431325
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
253J-BV,11485656,2.0873911665192555
SW1271,6610216,4.395476769861187
IMR-32,6610216,4.098372993728488
CAL-33,26596,-1.0071366013877838
HT,409805,3.66117299534608
PF-382,107985,-3.9923551873687497
Hs 895.T,10296883,4.2502082152330685
BT-12,6505803,0.2176692391310213
RPMI-8226,135875424,2.066297647502018
COV362,168313200,1.936761185306669
PE/CA-PJ41 (clone D2),36462,2.2016180933991594
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
COLO 800,36462,0.9245101871398812
AGS,6505803,-2.0321610426726364
RPMI-6666,3689413,0.7706229516172245
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
SW1088,107985,-2.686062802475412
8505C,6610216,4.483516940856299
Mono-Mac-1,3689413,-2.253738856829829
KE-39,9927531,6.019185228760376
KMRC-1,148124,2.1112012667960656
CAMA-1,6610216,4.829015970075941
JHUEM-1,8515,2.058426071264184
A-549,159324,3.3469799601732366
OV-90,8515,4.3083559611212285
BT 216,36462,2.576537789076833
SNU-878,54618164,4.41938540885837
Hs 839.T,135875424,5.214579617970531
KMS-26,107985,-4.9565801235489095
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
HCC366,159324,3.430182711772013
G-361,148198,-1.9326173225508625
A4/Fukuda,409805,3.596796639089143
MES-SA,409805,5.855306292131352
NCI-H1563,9936388,1.5935308347912875
SK-N-AS,11485656,1.7301696835910343
SK-N-SH,135875424,2.927968967811746
PE/CA-PJ34 (clone C12),409805,3.8621146596524087
HCT 15,9936388,-4.893709722395259
CGTH-W-1,8515,3.401940014880097
SNU-1077,159324,3.2853516722485994
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
OVCAR-8,JQ-1-carboplatin (1-1 mol-mol),4.213615448912052
NCI-H446,3689413,-2.437056347343706
NMC-G1,8515,3.7052773234568224
TT,46943432,4.6815412381056625
SW1710,44491742,4.487431108260269
SK-MEL-5,409805,5.871261975473595
KE-39,12003241,0.559414259019648
TT2609-C02,148124,-4.668480712908027
WM266-4,44491742,3.776227470260235
COLO 792,12003241,-1.2493881793514412
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
NCI-H2444,44493528,4.4653307538151354
P3HR-1,6610216,4.758792166812945
HT115,44491742,4.056949016282338
TOV-21G,6610216,4.421232020851441
Mel Ho,439501,-2.4053312201946055
COR-L279,439501,-3.5163381606181243
NCI-H1341,selumetinib-GDC-0941 (4-1 mol-mol),0.3827497304694547
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
NU-DHL-1,46943432,0.1764476025909112
SUP-T1,46943432,0.6688423816159417
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
TC-71,6610216,4.613001823007589
CA46,409805,3.3808362620175187
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
JHH-5,168313200,1.7531156599727438
TYK-nu,148198,-1.9214322639595771
CAL-85-1,JQ-1-carboplatin (1-1 mol-mol),0.6697793962766999
Rh18,8515,4.352254127140013
YD-8,8515,3.9380466861306616
Hs 839.T,9927531,5.8565553238540655
HSC-3,11485656,2.2428743548360863
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
BT 422,8515,4.965432900049668
SUP-HD1,8515,3.978055127644485
ESS-1,3689413,-0.979855371465586
HCC95,6505803,-0.8812410115134491
NCI-H2030,9903786,2.824655549380346
OCI-AML-2,46943432,0.5250106522086783
LS123,9903786,4.141854621966089
SU-DHL-10,148198,-3.583469156036767
IST-Mes1,6610216,4.781215155625892
Mono-Mac-6,54618164,3.3682959793737783
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
MDA-MB-157,9903786,1.458865596348786
OV-90,148124,3.1650494027578953
SW1990,44493528,4.327134813333531
RL,5460769,2.816259716284544
NCI-H2052,selumetinib-GDC-0941 (4-1 mol-mol),-0.0438612547991499
HuG1-N,168313200,3.1832418774206332
JJN-3,12003241,-0.0138977078234466
NB4,6610216,4.109528798583204
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
M059K,439501,-3.0131166353991703
HEC-59,36462,2.2040301999677965
C2BBe1,44491742,3.6465315929226967
U266B1,24180125,1.6976262238565638
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
TUHR4TKB,148198,-1.0832218520186652
Panc 02.03,5460769,1.6540560754425335
HCT 15,168313200,4.218417458600112
AML-193,9903786,0.8964959082150169
JHUEM-7,10296883,3.9492602271456065
Hs 746.T,107985,-3.710644419417041
BT-20,3689413,-3.3374276278199972
LAMA-84,36462,1.556247382234922
NCI-H1838,44493528,4.677704143001884
HEL 92.1.7,12003241,-0.5838184983387604
OCI-AML-2,6505803,-2.2709004607894583
HT-55,107985,-2.548300966518349
UACC-62,135875424,4.412505043477628
MEC-1,26596,-1.4944057602934653
MCF-7,439501,-2.51567390987342
SW1271,3689413,-1.2412691685690602
Caov-3,6505803,-1.4448132497594957
BT 245,54618164,4.011070558028337
22Rv1,135875424,4.290538379246911
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
HMC-1-8,9936388,-5.4088494773522395
OCI-Ly10,9903786,3.2654189555082493
Hs 839.T,selumetinib-GDC-0941 (4-1 mol-mol),3.521332428924413
RL95-2,5460769,2.3147567331395753
HuH-6,36462,4.673839664670026
OVCAR-8,107985,-2.4814474476882205
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815
CHP-212,10296883,3.383005137854127
GA-10,439501,-3.812594537001909
YAPC,36462,2.246335150310725
WM266-4,54618164,3.8908549160673744
SNU-1196,409805,5.507491068612232
Kasumi-1,36462,-0.6385365283830048
NU-DUL-1,36462,-1.877117130563615
HT-1080,8515,3.909948065157196
NH-6,36462,-0.7358252400441799
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
YH-13,6610216,4.911134346587397
BT 159,44491742,4.231002554874911
ZR-75-1,135875424,4.30667404331582
RERF-LC-MS,12003241,-0.3897829713203344
KMRC-20,36462,3.67134556506655
REC-1,9927531,3.800278065681949
IGR-1,6610216,4.151123445028036
Panc 08.13,9936388,-1.7608820575386173
JHH-1,12003241,2.181152294070196
KP-3,11485656,2.673409024797461
ECC12,159324,3.6946340273911233
Ishikawa (Heraklio) 02 ER-,36462,2.657616435798718
MOLT-3,9903786,0.9925932748260368
HCC1438,107985,-4.155444801050546
BxPC-3,148198,-2.171424706341701
HCC-56,10296883,4.321936359264917
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
KE-39,439501,-0.0752815835977172
DU145,148198,-3.066698935751989
HuP-T3,9927531,4.952379772704904
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
TOV-112D,409805,5.782770805049322
KO52,5460769,4.4327211318187745
TE 617.T,135875424,2.9015039808938483
Hs 944.T,9936388,-9.161226763585232
DOV13,159324,3.690202624549136
NCI-H1184,10296883,3.900599246219188
BT 245,6505803,1.0921416598826974
OC 314,3689413,-2.4202845950234466
OUMS-23,3689413,0.7829309194563772
MDA-MB-231,159324,3.5380667679319115
COV434,5460769,0.4340369587181126
NCI-H211,135875424,3.0832009645931073
23132/87,9903786,3.7145887754512414
NCI-H2009,8515,4.894015987740437
THP-1,135875424,2.9650391263515057
Caki-1,10296883,4.233557259626662
Mel JuSo,409805,4.551755026005568
MDST8,12003241,0.3559193403256231
Ri-1,36462,-0.3836251292851517
CAL-78,selumetinib-GDC-0941 (4-1 mol-mol),2.58322288214442
JMSU-1,3689413,-0.0210585182318067
EB1,JQ-1-carboplatin (1-1 mol-mol),1.505411442976691
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
Calu-6,11485656,1.862079385018863
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
HCC-56,6505803,2.324726755657099
HuNS1,36462,-2.348831996229756
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
BT 131,3689413,-1.953613680223501
IPC-298,148198,-2.1157958847718237
CAL-33,selumetinib-GDC-0941 (4-1 mol-mol),-0.2245005212599697
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
TUHR4TKB,12003241,-0.5778416487283387
A-375,36462,2.2806967665334894
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416
NCI-H1573,3689413,-0.5514389876644209
SK-ES-1,JQ-1-carboplatin (1-1 mol-mol),1.3011647537174793
NCI-H1915,44491742,3.914803792289667
GDM-1,5460769,2.283984174479844
HCC827,409805,5.870124087870235
NCI-H211,12003241,-0.3344728899219033
COLO 800,9936388,0.9254157883591568
NCI-H1299,12003241,-0.9760038754339474
GB-1,73707440,4.5407422473928785
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
MKN1,36462,1.8541033449175903
SNU-1077,54618164,4.137569965283994
MHH-CALL-3,11485656,2.28461838550351
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567
AML-193,24180125,3.91654561081322
SNU-449,3689413,-2.168376107627999
OCI-AML-3,8515,2.0861016142229705
KYSE-510,9927531,4.748041591600806
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
NCI-H2171,168313200,1.615164123973231
BV-173,135423438,-1.0531729027332817
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
KMS-21-BM,54618164,2.5308412572805836
DND-41,409805,3.476288751598273
SK-MM-2,10296883,1.2028909628230222
HCC-56,168313200,3.0468065774377338
NCI-H660,148198,-5.84244418437934
NCI-H2030,439501,-1.2331748188079374
HEL 92.1.7,selumetinib-GDC-0941 (4-1 mol-mol),3.657513004741347
HCT 8,6505803,0.5074441333519764
SK-N-SH,439501,-1.8318448964157588
LN-229,36462,3.5635069108611024
HCC2935,409805,5.908480125054504
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
SK-N-AS,3689413,-1.598597846908754
Namalwa,439501,-2.8468436546580524
BT 139,6505803,-5.215267056081471
Hs 852.T,selumetinib-GDC-0941 (4-1 mol-mol),1.139310291685008
HCC1419,24180125,3.0714283426147913
NCI-H28,49836020,4.481045778865963
EPLC-272H,12003241,-2.3102763219954867
NCI-H2291,409805,4.599417888514884
KYSE-150,409805,6.128139333480887
JJN-3,409805,3.7646023994786457
Caki-1,24180125,3.8854994918963377
J82,3689413,2.7361853242444045
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
DND-41,135875424,2.6793866497378698
PE/CA-PJ15,168313200,2.967546559162406
NU-DHL-1,107985,-5.852649208769622
NCI-H1623,9936388,-4.968103162812744
EPLC-272H,439501,-1.68247015094151
NCI-H1092,148198,-7.112179510843006
VMRC-RCW,439501,-1.1623161811429144
Kasumi-2,11485656,1.64011250363507
HCC1428,44491742,4.031952184974023
HLF,54618164,3.959273462123582
HCC1419,148124,3.4097288339682863
KO52,168313200,1.5421636413024
Pfeiffer,24180125,1.142289052885765
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
U266B1,135423438,1.4944799516316452
Panc 08.13,135875424,4.727963468605648
DEL,5460769,1.5827510666329687
SNU-46,3689413,0.3621274861005061
COLO 792,6505803,-2.4277417436087294
MFE-319,54618164,4.567083420097771
OAW28,44491742,4.754653012158477
PaTu 8902,36462,3.471634301287976
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
PaTu 8988t,3689413,2.4784022576221836
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
HGC-27,135423438,0.8474032670168677
RVH-421,135423438,4.562658125390885
A-204,135398744,7.3650683487349236
A-375,54618164,4.173421291280232
CW-2,JQ-1-carboplatin (1-1 mol-mol),0.838354754464334
SNU-449,36462,4.301758862194218
CL-11,46943432,2.565067482985585
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
NCI-H2009,3689413,0.5343246791806224
RT-4,439501,-1.136247834932354
MOLM-6,9903786,1.0024208305438098
TE 441.T,36462,0.1000718625113496
KMS-11,409805,4.522377485375502
HCC1428,8515,5.291455907802894
COLO 792,409805,3.780647350221477
Hs 683,6505803,-1.9207933299910505
CAL-29,6610216,4.4281336083452745
MOLM-16,11485656,1.7000856268128752
Karpas-422,6610216,4.297042652021984
EM-2,24180125,3.3243546283066836
KYSE-30,3689413,-2.4041486305877497
YD-8,409805,3.827275743082073
SK-MEL-30,11485656,2.585249816423364
CAL-85-1,10296883,4.0142951898227155
CAL-78,168313200,2.244410124236573
A-673,3689413,-2.493408888485536
HDLM-2,24180125,2.355202505563582
NCI-H1385,439501,-0.294435314613152
P-STS,6505803,1.2409378245961384
NU-DHL-1,439501,-3.591448694271343
KMS-27,44491742,4.7290458888071765
SH-10-TC,JQ-1-carboplatin (1-1 mol-mol),1.9237782728423225
JM-1,44491742,3.590859136704876
ONS-76,8515,4.109060881613791
BT 416,5460769,1.3706696040691966
JJN-3,36462,1.4427355466822882
TE-11,3689413,2.9978037995561126
BHY,36462,2.366380052455501
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
HuP-T3,409805,5.703463345532586
DK-MG,6505803,1.1282501869631134
HCC-56,12003241,-1.1028800957118954
MDA-MB-435S,24180125,3.6420485522200505
Daoy,9936388,-5.3939036036909656
NCI-H2023,9936388,2.0021755277076045
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
NCI-H1693,9927531,4.77981113730065
HEC-108,159324,3.617209831238773
RL,54618164,3.8601476099735894
Sq-1,12003241,-0.6972908416742193
MCAS,10296883,3.979435703813419
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912
A-253,9936388,1.4333351862699826
NCI-H322,168313200,2.9385162240660483
COLO 680N,11485656,2.5082408058849945
NCI-H2009,24180125,3.399696031265864
JIMT-1,9936388,-4.798396731889527
MOLT-13,44493528,3.6363745725597663
MDA-MB-468,12003241,1.1497525105309832
TE-5,24180125,3.064941852164732
H-STS,168313200,3.688822033835753
OCUM-1,9903786,1.5374110288154037
AsPC-1,409805,5.083096669481897
GaMG,439501,-0.9687040114702524
CJM [Human melanoma],3689413,-1.0332065150817793
HPAC,6610216,3.983150861287026
VCaP,148124,3.889989547535533
SW579,135423438,-1.0918455211139204
Lu-99,11485656,1.95403594931143
COLO 678,24180125,3.7441922268279297
HT115,9927531,5.770411786358663
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
EJM,11485656,1.52616093441074
Hs 766T,54618164,4.329849128814947
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
L-540,10296883,2.97370959547478
KMRC-1,439501,-2.7889227637684773
SNU-478,46943432,1.8221345859000824
TT,6610216,4.542755453833215
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
HCC1588,8515,3.3452170463409585
M059K,148198,-3.174973470049168
SNU-475,10296883,4.244707148014393
253J,26596,-1.986846221842857
RD,49836020,4.595069513532316
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
P-STS,107985,-4.020719010327622
DU145,168313200,3.1229023319588363
SW579,168313200,1.6746607195468155
ACHN,selumetinib-GDC-0941 (4-1 mol-mol),3.1627804075909727
CAL-51,439501,-2.444412450902406
NCI-H1341,9903786,1.643545486774536
SUP-T11,24180125,1.2702519400611516
DB,6505803,0.2792419606143702
SK-MES-1,409805,3.68215710914594
SK-N-AS,5460769,4.709590087634428
SK-LU-1,409805,5.4476736017437135
RERF-LC-MS,135875424,2.839581382146162
SK-N-AS,24180125,1.1974349379888387
NCI-H1581,24180125,2.253474610987822
KALS-1,3689413,-0.2176182562401838
KYO-1,12003241,-5.7976599099380595
BHY,135875424,4.814173497924925
JHUEM-3,10296883,4.22416361613302
KU-19-19,6505803,0.0199416611110358
Namalwa,26596,-3.71974803891978
DB,24180125,1.2652524681153203
DLD-1,12003241,-0.215038024432674
OV-90,107985,-2.78767562727801
CHP-212,409805,6.004594677417721
MOLM-6,6610216,3.643225548274676
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
Hs 578T,12003241,-1.9219753364875385
U-251MG,9936388,1.7501129357253542
SW579,12003241,-1.7693862144500747
LK-2,3689413,0.6891361192494543
SF539,6610216,3.974614801985701
SF268,26596,0.6172202345506846
WM983B,135875424,3.018238153031043
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
SF268,135423438,1.590927583342323
SNU-398,168313200,2.6056728837341265
GI-1,6505803,0.8519906132881799
NCI-H1184,11485656,2.662632991644762
HCC44,36462,1.2916349335156851
HuT 78,409805,4.736359437343851
A-375,148198,-2.551882325467432
COV362,9936388,0.426614716920504
KE-39,9936388,1.1689372039333712
SNU-C5,12003241,-1.9279387541899935
BICR 6,selumetinib-GDC-0941 (4-1 mol-mol),1.9156863537341864
SK-MEL-24,6610216,3.528879249084507
IGROV-1,9936388,2.10108466287406
NCI-H1666,54618164,4.069380954979025
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
SW1783,5460769,4.078393209152703
8305C,8515,2.895902676854517
SUP-M2,11485656,1.133597782869627
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
NCC-StC-K140,3689413,-1.9001520150301452
HT-1080,5460769,3.028756475221219
NCI-H1703,409805,3.824185286554961
ZR-75-1,148198,-2.6538383263533674
HLF,10296883,4.080114065573622
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
253J-BV,9927531,5.275278966830564
BT-549,439501,-3.1266914034371567
RPMI-8226,3689413,-0.772061371238599
MFE-319,36462,2.8535196136146626
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
KMS-20,8515,3.454893590517526
SNU-119,9936388,-1.2994148300283177
KO52,6505803,1.22031024799857
K029AX,5460769,3.760325914422788
SK-MEL-28,3689413,3.3385356968233744
RPMI-6666,JQ-1-carboplatin (1-1 mol-mol),0.5557739670518063
THP-1,26596,-4.239434805167959
Lu-99,159324,2.0061046344011944
PSN1,135875424,4.38320892941454
SKM-1,6610216,3.825535401377457
HCT 8,54618164,4.218038509865035
SW982,148124,3.628082211575536
SNU-C1,9927531,4.924275506690927
Mino,36462,-1.1921094192987896
G-292 clone A141B1,6610216,4.8384725678373055
DB,135398744,6.337933152850909
COLO 800,107985,-2.5958331032462785
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
SK-CO-1,159324,2.1120355222347738
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
Capan-1,148124,-0.5288233157580327
NCI-H2122,6505803,-2.4477843500675207
NCI-H28,5460769,-1.4379241893426098
NCI-H1693,439501,-5.586339578501797
EFO-21,148124,4.836772792254713
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
CAL-120,148198,-2.0212341580767283
IGR-1,9903786,4.216869468062427
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
NCI-N87,9936388,-5.070095106907016
DU145,3689413,-1.3535401671184424
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
HCC4006,6610216,4.265469654914691
L3.3,36462,1.8942720792997911
YD-38,5460769,0.587016845611175
EC-GI-10,10296883,4.124587788483945
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
OPM-2,107985,-4.911691484457119
CL-11,44493528,4.354621073890832
MIA PaCa-2,JQ-1-carboplatin (1-1 mol-mol),-0.0764118739989751
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
OCI-AML-3,49836020,4.587745933093821
SCaBER,36462,1.9141331234054
AMO1,9903786,2.4699152046705253
LS1034,9927531,5.052618610074112
NUGC-4,46943432,0.134646197138115
BT 422,6505803,-0.9027311495147816
ONCO-DG-1,6610216,4.49894571194037
SH-4,10296883,3.644987847906302
NCI-H1650,11485656,2.650722608935496
8305C,54618164,3.798882631789012
MeWo,6610216,3.8113300714365126
SK-HEP-1,11485656,3.3898088020096324
SU-DHL-1,6610216,4.061950863639378
639V,9936388,1.6138439311041346
NCI-H69,159324,2.8496599319969236
BT-12,JQ-1-carboplatin (1-1 mol-mol),4.599252590032938
NCI-H2228,6505803,-0.5994588294177822
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
HH [Human lymphoma],3689413,-2.48685445642347
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
OUMS-23,JQ-1-carboplatin (1-1 mol-mol),4.676027552287151
WM983B,JQ-1-carboplatin (1-1 mol-mol),2.7485302033318084
ZR-75-1,5460769,4.241529452507845
NCI-H2085,11485656,3.209743954630266
SNU-407,439501,-0.9775272958011642
GI-1,5460769,1.3544320917610908
MOLT-13,9903786,1.350785557130732
DoHH2,9936388,-6.050878325143338
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
Kasumi-1,9936388,-5.775038458721337
NCI-H841,26596,-2.5240216748283393
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
P3HR-1,135875424,3.923960378133027
BFTC-905,159324,3.4792203482378117
CAL-29,44493528,4.2702919799030035
KMRC-3,135875424,5.901870515016819
Caki-1,439501,-1.3714154371315346
THP-1,6505803,-1.3271534570910488
SW1463,439501,-0.3046644173954531
AN3-CA,148124,-1.73779448723161
DV-90,JQ-1-carboplatin (1-1 mol-mol),-0.681487288410465
SK-MES-1,3689413,0.2897315368024132
SK-MEL-1,49836020,3.8417397632517143
NCI-H647,135398744,6.542739498462596
BICR 22,24180125,3.296229177015365
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
8-MG-BA,439501,-0.5992510337528919
TT,9903786,2.2571281683889253
TT2609-C02,selumetinib-GDC-0941 (4-1 mol-mol),0.2335990554024833
Hs 611.T,168313200,3.4582352812742516
SUIT-2,54618164,5.030082257565933
HCC1438,3689413,-0.4859764672187859
L-428,439501,-3.0695670825388848
NH-6,44491742,4.075747370877145
KYSE-410,8515,3.4355456987988666
MDA-MB-453,12003241,-0.9610578830621354
Hs 940.T,36462,4.160294821791898
WM115,3689413,-0.1044392328624619
SK-MES-1,36462,0.91416353270613
T-47D,24180125,2.7686038082444258
KYSE-70,439501,-1.7979650249976522
HCC95,11485656,2.1465787672402104
NCI-H209,439501,-3.220511958386942
HMCB,3689413,1.1423939419443525
MDA-MB-157,6505803,-0.678815881739905
SUP-B15,6505803,0.8159138339473696
MCAS,409805,5.6817502143710685
22Rv1,439501,-2.2106497946316175
EFO-27,5460769,4.47484627366887
KG-1-C,148198,-3.394740607582078
TE-4,54618164,4.0804928749027525
SNB-75,JQ-1-carboplatin (1-1 mol-mol),6.178448608970183
SNU-398,24180125,2.40534960031443
KMBC-2,409805,6.016015175624214
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
TE-14,26596,-1.531582993203474
MHH-NB-11,54618164,4.186809252576314
639V,6610216,4.900491657762806
PLC/PRF/5,5460769,4.572267252029585
NCI-H650,159324,3.050208255297658
MSTO-211H,12003241,-2.79016034960529
NCI-H526,8515,4.139215532971162
Kelly,148198,-5.169099507303906
KE-37,44493528,4.221773830878064
COLO 201,135875424,3.4896254753557354
SNU-1214,JQ-1-carboplatin (1-1 mol-mol),3.0225618728899675
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
Mino,135875424,2.8874232883749578
SF295,3689413,-1.7224429364651286
ACHN,148198,-2.704969639683015
COLO 205,36462,2.948773828131636
GDM-1,10296883,3.3265560717041436
JVM-3,36462,-3.3738719116101743
HCC1419,439501,-1.0086934548500974
HEL 92.1.7,9927531,3.309303309112431
LAMA-84,409805,3.9758377692098823
KYM-1,148198,-4.868238794811474
RPMI-8226,148198,-2.569854341665414
BT 231,135875424,2.2081545391597728
OVCAR-5,168313200,1.7680254665185893
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
Karpas-299,54618164,3.901671399515938
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
HuH-1,12003241,0.2926250163716364
SR,168313200,3.9565761385686895
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
HCT 8,3689413,3.2270836788045054
COR-L51,107985,-4.427716506009149
QGP-1,9936388,-1.1142521734336477
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
VCaP,135423438,2.0671137172311305
DU145,12003241,-2.0135691280208876
RMG-I,selumetinib-GDC-0941 (4-1 mol-mol),3.743143666757181
NCI-H322,9903786,4.921113869322727
NCI-H522,439501,-5.784929410118117
CAL-148,6610216,4.859622527364858
KYSE-410,409805,4.5262440773568
JVM-2,9936388,-5.513780712750178
SNU-387,selumetinib-GDC-0941 (4-1 mol-mol),1.4136760504697403
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
NCI-H2196,6505803,0.6828723886008686
Mino,3689413,-3.624730843514525
NCI-H23,49836020,3.049554437236292
U-CH1,439501,-1.675454590298179
KP-3,12003241,-0.3092638329597765
DK-MG,148198,-2.831494942566311
LK-2,44493528,4.239006121981403
NB1,409805,5.083487988100444
KYM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.885650004060589
NCI-H1299,148198,-1.8449433288311332
Hs 895.T,9936388,3.096853408439268
OE21,24180125,3.3854112835406625
KO52,46943432,4.605559929302298
Hs 852.T,135875424,3.670536454912576
SaOS-2,6610216,4.351676798413151
SK-MEL-3,3689413,0.509275079548213
NUGC-3,3689413,0.9569280148265664
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
SHP-77,159324,2.7703794768385746
HCC1438,148124,-5.1651120367888375
YD-10B,107985,-2.948727836915783
SUP-B15,135423438,2.052738806118931
HCC44,159324,1.9748678599967435
OCI-Ly10,6610216,4.298741404567049
Karpas-422,44491742,3.8079113446891424
CCF-STTG1,148124,-4.009391944909006
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984
G-401,11485656,1.708547873036538
UACC-257,9936388,2.2230563753853754
K029AX,6610216,4.396133565066132
NCO2,24180125,1.8902157789920653
SNU-182,JQ-1-carboplatin (1-1 mol-mol),2.6048292871272865
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
SUP-T11,JQ-1-carboplatin (1-1 mol-mol),1.338159132216547
TE 441.T,JQ-1-carboplatin (1-1 mol-mol),3.6275074638677465
Hs 888.T,3689413,-2.4304159299205215
QGP-1,148198,-2.838050109034932
NCI-H2286,9903786,1.3981147995547691
NCI-H2170,409805,5.700788165859039
A-253,36462,1.0164756428097503
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
NCI-H460,9936388,2.3098343611543415
GB-1,54618164,4.489453248455872
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
SNU-1077,135875424,3.798963502018643
SNU-C4,107985,-3.918027903558023
HLF,11485656,2.0345771970927924
NCI-H2081,12003241,2.480414390654569
TCC-Pan2,9903786,4.661219913833123
DMS 53,3689413,-1.7302649812310384
MDA-MB-453,9903786,4.505035222499518
VM-CUB-1,JQ-1-carboplatin (1-1 mol-mol),1.087386470094272
COLO 205,12003241,-1.1256209046349093
SF539,9936388,-8.641778658087059
CL-11,409805,5.877907477859192
HCC1438,54618164,4.347012651025305
SUIT-2,6610216,4.902807448612422
BT 271,135875424,3.267528631727611
SK-MEL-5,3689413,3.463644790263917
HuG1-N,11485656,1.8957868376228804
SEM,135875424,2.4848737039506426
EFO-27,54618164,4.628305371415217
L-540,135875424,3.4045526292316017
HH [Human lymphoma],148198,-7.602984000747502
RPMI-8402,44491742,5.171904167752256
HCC95,5460769,4.4862905703550355
KYSE-510,107985,-3.785009433750071
BT 333,9936388,1.082637149291879
HCC1588,9927531,4.588881343798492
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
LoVo,107985,-3.583734032756361
TE 441.T,9903786,2.9236317230426465
KYSE-30,439501,-2.11333824600192
SNU-308,5460769,2.0996672061045976
SNU-738,148198,-3.393002799947117
NCI-H1395,409805,5.969168563416671
TE-6,159324,2.2752469114709695
LoVo,11485656,1.8604760547282393
NCI-H1755,9903786,1.073033240421295
NCI-H2444,107985,-2.8004583921356465
COLO 678,409805,5.274751310644635
HEC-151,409805,5.612668913895041
SNU-C5,JQ-1-carboplatin (1-1 mol-mol),5.5029017516630345
HSC-4,107985,-2.2656284906222144
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
HCT 15,24180125,3.5081385414094397
SF126,54618164,4.040751371978287
YKG-1,168313200,2.942374611054984
BT 340,8515,6.087313039636692
Calu-6,107985,-3.229797304625017
L-428,9927531,4.649182566177492
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
SaOS-2,5460769,2.263492155098724
SNU-387,6610216,3.9381426749214743
SNU-398,3689413,0.8860664930016563
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
GI-1,409805,3.4701849775585902
VMRC-RCZ,9927531,5.06353509308392
SNU-1041,439501,-2.4187407213181085
SCC-4,148124,-5.0837387423667515
HCC78,6610216,4.730533991770319
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
NCI-H2291,JQ-1-carboplatin (1-1 mol-mol),4.431893565977406
U-118MG,44491742,3.985342348777434
HuG1-N,135875424,4.4582955762312055
CCF-STTG1,168313200,3.710540265594596
MOLM-6,12003241,-5.9234672860619995
KE-97,3689413,-2.1029735471074225
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
NCI-H1105,148124,-3.080281083040765
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
HOP-92,9936388,1.480575569609934
WM793,44493528,4.356787444460569
WM266-4,24180125,3.8729057396991062
JHH-5,135423438,3.9719572001946344
RCH-ACV,46943432,0.6634078457695299
KYSE-510,409805,5.991865357716927
YD-8,10296883,4.26925641885348
PaTu 8988t,10296883,3.999790485906541
BxPC-3,26596,-1.629746525957504
EBC-1,36462,1.5329334165812265
L-540,8515,3.762633351070898
NCI-H1339,5460769,-0.265386406275254
HCC1954,6505803,-2.3098961788546655
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
EFO-27,9903786,4.039986452778869
SCC-9,11485656,3.6663619913543446
KMS-27,148198,-3.735247787675698
LS123,JQ-1-carboplatin (1-1 mol-mol),4.3726195228270175
SCC-4,12003241,-1.1287847624263156
BT 239,148124,5.770262355155013
YH-13,135875424,4.585935280505426
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
YD-8,3689413,-2.153430400522153
A-375,135398744,6.486116496095493
697,8515,1.5898758887599602
SNU-C2A,107985,-3.3916676058064916
KMS-12-BM,44493528,3.477782404349953
HCC1419,10296883,3.973664807604541
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
DMS 114,439501,-3.85283118857385
PE/CA-PJ49,5460769,0.8323029326456293
Mono-Mac-1,44491742,3.632264372511232
SK-LMS-1,6505803,0.606445374310417
SNU-449,9936388,0.4589950900054629
Rh41,11485656,2.1642426716140877
ST486,5460769,4.068144147085423
Hs 888.T,439501,-5.801037223256167
NCI-H2106,135423438,0.968781117866004
RPMI-8402,24180125,2.381809209442335
WT2-iPS,409805,6.008881915911806
TUHR10TKB,9936388,2.290376539920044
KP-N-SI9s,10296883,3.538113469874099
NCI-H2085,9936388,2.2479758965135828
LP-1,54618164,3.411691931198772
LS1034,409805,5.876916886757288
NUGC-3,159324,2.9089691628310845
SNB-75,148198,-3.914832369251688
OCI-AML-3,11485656,1.6382059446521733
Granta-519,11485656,1.6660529916447626
LS1034,54618164,3.795976603744235
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
NCI-H1435,6505803,-2.6053022646715207
Calu-3,5460769,-0.6817561012415637
SNU-840,159324,3.351473356944552
WM266-4,107985,-2.683759376298984
SCC-4,3689413,-0.212283545233458
HCC1195,6610216,4.922829824877741
PSN1,3689413,-0.2980036400640658
NCI-H1694,6610216,3.5634403823031975
CAL-27,409805,3.558351659435831
MV4-11,73707440,5.432484386170161
SW1271,36462,1.4389686814792042
SNU-C4,44491742,4.387584080211158
PK-59,10296883,3.535365595306604
HuH-28,49836020,4.5831032591173635
NCI-H1975,6505803,-1.9841603923716855
MeWo,135423438,3.135774621295312
2004,JQ-1-carboplatin (1-1 mol-mol),0.7466571410916254
T24,9936388,-4.864379366787304
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
KMS-26,135875424,3.4699512465530713
GMS-10,9903786,4.533895537186943
SNU-620,54618164,3.868609371723324
GCT,24180125,3.1414885039024
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
HCC44,12003241,-2.184153343310603
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
SW579,24180125,2.7515487502079954
LUDLU-1,10296883,3.7997906540073623
MOLT-16,54618164,3.317019420322426
LUDLU-1,5460769,4.034100561481378
IA-LM,148198,-11.384967135346804
OV7,selumetinib-GDC-0941 (4-1 mol-mol),2.168494345054348
HCC827,3689413,-1.9670372316713456
JHUEM-3,JQ-1-carboplatin (1-1 mol-mol),0.1044516957131188
PE/CA-PJ15,24180125,3.914289437715523
CMK,11485656,1.9879747340083027
A-673,6505803,0.2745970276233078
WM88,24180125,3.83387165557686
PC-14,135875424,3.4913396696572523
ONCO-DG-1,49836020,4.455184005808947
SK-MEL-24,409805,5.296906798765406
BFTC-905,6505803,1.2859108596962958
VMRC-LCD,11485656,1.8176321806721345
DLD-1,439501,-1.8196175209339427
NCI-H2444,159324,3.226784094447535
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
Pfeiffer,6610216,3.245133119862502
DMS 53,6505803,0.1213526787251841
NCI-H358,44491742,4.317463726649291
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
TC-71,8515,3.820519321601544
BT 440,135423438,-0.018963982293905
COLO 678,10296883,4.183536343390627
MDA-MB-453,148198,-6.384072425395857
SK-N-BE(2),54618164,4.328131029932168
SNU-407,409805,5.485481651178567
CA46,9927531,3.0223750820915978
HT-1197,11485656,1.6876827017729057
SU-DHL-1,3689413,-2.511818154735677
Karpas-299,49836020,-1.2149928929897504
KM12,10296883,3.701493082192586
A-549,3689413,0.7236603744186211
KMRC-1,12003241,-1.418239320082467
HEC-1-A,24180125,2.8351912410354925
SNU-626,3689413,-0.5930983813401607
UACC-257,148198,-2.410232304331187
MV4-11,49836020,2.655795655295622
KMS-34,148198,-3.0196318169893224
BT 330,148198,-5.294661964865024
HOP-92,8515,3.613790274585256
Karpas-620,159324,3.63089099947116
PaTu 8988s,54618164,4.048235772282788
U-BLC1,9903786,1.0981923916711085
MOLT-3,54618164,3.5300048072544596
PaTu 8902,3689413,3.662647678116459
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
CA46,3689413,-3.563387503989764
IMR-32,9927531,3.188320479836116
MHH-ES-1,JQ-1-carboplatin (1-1 mol-mol),0.9828156633335828
SNU-1079,3689413,-2.2789240635037182
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
SW982,49836020,1.3794416609441722
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
TE-15,135875424,3.16520710682736
JeKo-1,409805,3.852708089186558
KE-37,JQ-1-carboplatin (1-1 mol-mol),-0.7652010802718352
BT-12,9936388,1.0683866861493725
Karpas-299,12003241,-0.4647539333721411
Caov-3,44491742,6.286074544034756
K-562,148198,-4.073315546446919
Caov-3,26596,-1.3429927330101894
CGTH-W-1,54618164,4.475524470506254
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
KCL-22,46943432,1.9547601965976713
DND-41,8515,3.5602022897853596
SNU-308,12003241,0.0879961923245038
GaMG,36462,3.666925262154629
WT2-iPS,6505803,-3.1225934149726156
DEL,46943432,4.922842544494177
NCI-H522,8515,4.67214972936148
SNU-869,168313200,3.0083612902281778
SNU-201,44491742,4.436109231936613
NCI-H1563,135423438,1.6420520323004266
NCI-H508,6610216,4.542164721447458
Pfeiffer,10296883,1.0462803777158507
HT-29,409805,6.035174315554334
TE-4,8515,3.815282832964878
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
ME-1 [Human leukemia],11485656,2.505616015022391
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
HL-60,9936388,-5.148540194165726
HT,6505803,-0.8511885729054358
A-172,54618164,3.734087150642515
HOS,439501,-2.316181578495001
SaOS-2,148124,-5.379251304292956
KE-37,9936388,-6.941921188286439
HSC-3,24180125,3.0095192248544897
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
NCI-H322,409805,3.9848119699309303
SUP-T11,8515,4.480563126453878
PK-1,44493528,4.319827010327948
RCC10RGB,24180125,2.398663234613943
D283 Med,11485656,1.7629558217294734
CAMA-1,9903786,5.004529624345284
HuH-28,44491742,4.601953674704061
Hs 729.T,168313200,2.1406023043716917
TM-31,26596,-0.9336571735173056
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
BT 498,3689413,1.8744771197995864
SNU-61,44493528,4.287806417412906
OV56,36462,2.307029600595231
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
HT,159324,0.5774269994513854
NCI-H1184,5460769,-0.2786372914944621
NOMO-1,168313200,3.152434526133537
KYSE-140,135875424,3.5989722346209927
DV-90,107985,-7.11158707744724
C2BBe1,439501,-3.497031397635042
ALL-SIL,26596,-3.0181503922951674
BT 340,selumetinib-GDC-0941 (4-1 mol-mol),2.751381864792414
Ri-1,26596,-3.083821338619051
COR-L95,6505803,0.0712785503404296
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
KMM-1,9936388,3.2700380564057543
JHUEM-3,168313200,3.1500775290057543
LK-2,24180125,3.0932795926537047
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
SK-N-MC,12003241,-1.5670005679110546
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
NCI-H508,44491742,4.239299300064597
SK-LMS-1,439501,-2.6023396475730967
RS4;11,9927531,3.90062082158746
RL95-2,6610216,4.274118828365147
A-375,135875424,3.696378355879961
SK-CO-1,44491742,5.1736211152382285
VM-CUB-1,5460769,-0.9631116017936964
SK-N-AS,36462,1.8684432223869436
DB,3689413,-2.3561309099852448
FTC-238,36462,0.2646772322690526
SW1710,12003241,-1.2750404815852618
HCC202,168313200,4.148349775691495
SNU-216,6505803,0.9385001329114314
NALM-6,11485656,1.650692330200231
TE-6,135423438,1.6945535495060131
KU-19-19,9903786,4.470072542277405
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
42-MG-BA,439501,-2.6369598322141967
TE 441.T,54618164,3.69134760573576
SK-MEL-30,159324,3.913782047256045
L-363,selumetinib-GDC-0941 (4-1 mol-mol),2.240470367275986
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
COLO 668,148124,-4.465196721579442
YD-10B,12003241,-3.1216797421568847
CAL-62,11485656,2.1726256294721167
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
CAS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.9599714674157864
BT 428,9903786,3.72207082245763
CJM [Human melanoma],9936388,-7.628341639171254
OCI-M1,9903786,1.4970236133945398
HCC1438,409805,6.120376102853313
SK-N-AS,54618164,3.832348053095005
NCI-H1869,148124,3.56569848819375
HeLa,409805,3.8139652884767377
OAW28,12003241,-0.542287488877267
Hs 839.T,9936388,3.1884497736912567
SNU-423,409805,5.272007162134597
Mono-Mac-6,5460769,2.7333685745073457
HuT 78,54618164,4.24138057284203
MV4-11,54618164,2.9131493918068205
HT-1080,148124,-7.262422789124051
COV434,135875424,2.939089760708004
NCI-H1694,24180125,1.3513315872671017
MDA-MB-231,9927531,7.115369189993137
NCI-H716,6505803,-2.390779236038046
AsPC-1,10296883,4.32215490848641
786-O,3689413,-2.4095930887688546
BT 112,26596,-1.3919420546275056
Mono-Mac-1,54618164,2.5791045372216703
DMS 273,168313200,2.725135044490621
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
SNU-761,44493528,3.842181398457216
HCC95,JQ-1-carboplatin (1-1 mol-mol),-0.3599763977581854
DEL,24180125,2.6043593138043537
Panc 10.05,148198,-3.9084182720611618
EB1,168313200,1.71707382114801
WSU-DLCL2,439501,-2.4187850283326933
BT 416,44491742,4.3969888889672415
Calu-6,6610216,4.633820357162049
Fu97,24180125,3.629213171199319
JIMT-1,6505803,0.7397672871240382
NCI-H1650,148198,-2.4983400542684895
SNU-C5,36462,2.1753757989582923
SW48,24180125,2.6937498240420457
COLO 668,3689413,-2.474838617448709
SBC-5,36462,0.3494520767872783
TT,5460769,2.0834356012703155
BT 172,10296883,4.205503162843324
SNU-398,JQ-1-carboplatin (1-1 mol-mol),3.701774883690344
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
SNU-719,JQ-1-carboplatin (1-1 mol-mol),0.748518031379031
DMS 79,439501,-2.1979819291914224
UM-UC-3,135423438,2.517852030384128
JK-1,36462,-1.2857255048045515
KYSE-30,9927531,4.7729245028370055
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
JK-1,107985,-3.996309073067597
NCI-H292,135875424,4.14052752249008
NCO2,44493528,3.738913102707939
BT-16,6505803,-2.626677217469799
KYSE-30,107985,-4.08037761036898
HH [Human lymphoma],168313200,1.5669719889178435
OAW28,107985,-3.5497769626209217
JHH-2,26596,-0.057413924712861
NCI-H460,409805,5.4278006548731295
L-428,6610216,3.9920108953728
NCI-H508,selumetinib-GDC-0941 (4-1 mol-mol),1.363383946626654
MOLM-13,135875424,3.721528356214304
SNU-620,12003241,1.204190065135074
NCI-H446,159324,1.5850808860876966
8505C,6505803,0.879841655503536
MDA-MB-231,107985,-2.831885179026934
BT 440,135875424,2.9900391536065354
BT 216,10296883,4.1939688234140435
JIMT-1,409805,5.21285843677131
OCI-AML-5,148124,-5.059033950577293
SUP-T1,148198,-4.331447588752824
LS513,439501,-0.8485123993452164
HuG1-N,6610216,5.087045080663945
RPMI-6666,10296883,3.884924501065409
22Rv1,selumetinib-GDC-0941 (4-1 mol-mol),-0.8202887961023889
A101D,12003241,-1.0986495828587448
PaTu 8988t,439501,-3.4446792284706347
BFTC-909,44491742,4.0640318167931255
HGC-27,9927531,3.8749849093672744
SK-N-AS,44491742,3.868464169325176
JHOS-2,409805,4.008405308224089
KYSE-70,9903786,2.353212274658888
MCAS,135875424,3.596680652923431
K029AX,11485656,3.468308407397126
BDCM,135423438,1.7676973941849825
JMSU-1,439501,-3.223216777280016
SUP-B15,10296883,2.342173612428345
SW1088,54618164,4.072630032274273
RERF-LC-Ad1,3689413,-1.7788688033713365
KHM-1B,5460769,1.8331932839616616
COV434,6505803,-0.6125824697560679
SK-MES-1,11485656,2.7243488930071607
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
C2BBe1,135423438,2.0550808175205755
BT 172,selumetinib-GDC-0941 (4-1 mol-mol),1.268434466812915
ECC12,8515,4.870326922262876
CL-11,24180125,2.5016118150307305
SNU-668,409805,3.673506618604681
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
Mel Ho,24180125,2.179184648721862
BT 228,6505803,-0.8466206341020581
DK-MG,10296883,4.218475231126156
RD,9903786,3.633793884549444
YH-13,148198,-2.7695139562786526
PaTu 8902,148198,-2.774580136562139
MES-SA,selumetinib-GDC-0941 (4-1 mol-mol),2.335158862320408
SNU-16,24180125,1.3205612093228705
PE/CA-PJ49,409805,3.747059655038111
BV-173,46943432,0.5850233145807464
RT-4,5460769,0.3645225539442671
CCF-STTG1,12003241,0.9586959919868534
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
HGC-27,24180125,3.8514022431268113
CAMA-1,44493528,5.154958060978957
SK-MEL-3,9936388,1.3818026560314072
NCI-H226,439501,-0.8440362022647064
OE33,10296883,3.414380068882816
NCI-H2405,12003241,-1.91851712943585
HCC202,148198,-2.7548108602388783
AGS,selumetinib-GDC-0941 (4-1 mol-mol),0.9665370398813388
JHH-6,135875424,5.397184820434736
JHUEM-2,6505803,-3.169169021996555
COLO 792,11485656,2.715792347654397
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
Hs 729.T,12003241,-0.5985537077535523
NCI-H1703,49836020,-2.068142260286603
CJM [Human melanoma],44493528,4.221846100020477
KALS-1,11485656,3.631175776194637
NCI-H929,12003241,-1.2414676879861424
COLO 205,6610216,5.036861870134594
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
JK-1,6505803,-1.233807201849435
HuH-28,36462,5.296756264251177
SCaBER,409805,5.759469281447201
TE-9,selumetinib-GDC-0941 (4-1 mol-mol),2.552175387754049
YH-13,26596,-1.6020780091570677
NCI-H1755,11485656,2.6347035901065654
MCF-7,9903786,3.2865331154211743
DU4475,9936388,-6.520654557034823
RPMI-7951,8515,4.057754260895621
Panc 10.05,6610216,4.284201088218815
TUHR14TKB,3689413,-1.483434528636918
BT 498,24180125,4.887627247892678
2004,36462,1.0954964379532657
KYSE-510,26596,-0.7866712659714874
T3M-10,9936388,1.68149243193284
TALL-1 [Human adult T-ALL],9903786,1.5190576712457438
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
MHH-CALL-4,148198,-4.435182205055272
MOTN-1,36462,-1.0452584205395847
DV-90,6610216,3.9781363588857888
NCI-H520,10296883,3.906496007421639
SNU-1,54618164,3.71429087796208
SK-N-MC,selumetinib-GDC-0941 (4-1 mol-mol),1.42335889342789
OVCAR-8,11485656,1.8119689787001292
EBC-1,135398744,6.3334705093468235
C2BBe1,135875424,3.7823394766863863
CHP-126,409805,3.885062870941733
LAMA-84,JQ-1-carboplatin (1-1 mol-mol),0.9812608136784076
SK-LMS-1,148124,-4.355018265532959
PE/CA-PJ41 (clone D2),11485656,2.035669448740327
A-375,135875424,3.696378355879961
SNU-869,107985,-4.294928990441944
NCI-H810,9927531,3.2474997445381693
JIMT-1,135875424,5.902712544312733
A-253,409805,5.897270499181996
A-204,26596,-0.948226132815995
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
WT2-iPS,selumetinib-GDC-0941 (4-1 mol-mol),0.0160943327982104
JHH-1,11485656,1.826654230939741
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
SNU-466,6610216,4.064309540178012
COV644,5460769,6.215803603541286
OVK18,439501,-1.6105511378028463
LP-1,3689413,0.1149626145640583
REC-1,12003241,3.6312404592907614
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
SW48,44493528,3.8128145383765992
YD-15,107985,-3.0618096206093934
NOMO-1,409805,3.6617718212828874
RPMI-6666,26596,-1.6823570129437355
PSN1,439501,-2.156746892791343
SNU-738,9903786,3.5811355233288773
SK-MEL-1,135423438,4.488053456325811
COV644,9903786,3.8438435409952456
KP-N-SI9s,6505803,-1.8312599777173428
LOX-IMVI,24180125,3.3051299487129415
SNU-C5,135875424,2.310166721767538
SW620,54618164,4.563373873734706
SNU-C1,168313200,1.7390139209303623
L3.3,44491742,6.349276489474054
G-361,10296883,3.484714996081857
HEL 92.1.7,439501,-2.540174469055436
BT 286,JQ-1-carboplatin (1-1 mol-mol),3.0626602949719226
LCLC-103H,9936388,2.1573494470182593
SNU-685,9903786,5.039547940758868
PaTu 8988s,148124,-0.8669711950509935
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
NCI-H1563,12003241,-2.3981612742304614
BICR 6,439501,-3.4433349442086234
JVM-3,26596,-2.348515642559758
Aska-SS,46943432,0.9231523980754076
NCI-H2106,selumetinib-GDC-0941 (4-1 mol-mol),2.731448809919849
OCI-Ly10,5460769,4.307631470824749
NCI-H1339,148124,-5.674249092402399
HCC366,36462,1.9549292972241572
BT 228,439501,-2.264868941994625
OCI-Ly3,6505803,0.3462361722784563
KNS-60,148198,-2.9392498414813075
WM1799,11485656,2.91398377958601
A-375,3689413,-0.7182003405560186
A-549,9936388,1.4749208650316612
G-361,26596,-1.652088739985509
BT 131,6505803,-1.6388820093496137
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
GSS,107985,-3.999302317591999
MKN74,44493528,4.689150119305487
NCI-H211,49836020,0.8643825091547783
HEC-108,11485656,3.338600175698492
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
A2058,10296883,3.853282697194753
SNU-C1,8515,3.4568553627029552
NCI-H1581,12003241,-3.141909657100737
Daudi,11485656,1.7254760898020216
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
GCT,135423438,1.822480313844277
Calu-3,159324,1.8349438271720837
HMC-1-8,54618164,4.128727023921018
HCC1143,11485656,1.8564802256291268
HT-29,159324,3.659418703810202
BC-3C,26596,-0.2711171382512473
COLO 800,24180125,2.8848784664507416
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
PaTu 8988s,6610216,4.229616892314871
NCI-H520,409805,3.8213964278284953
IGR-37,168313200,1.7746354442745738
HT115,5460769,1.7158101929675542
KPL-1,135423438,2.328481946215466
KP-N-YN,168313200,3.2829506752497415
SNU-C4,439501,-3.0543903815418547
Kasumi-2,9927531,4.453654232617923
KMS-27,46943432,1.1908434425451844
Ki-JK,159324,-1.5316296354530343
NCI-H460,6505803,-0.4074860596498978
SNG-M,36462,3.976185127999424
SNU-719,107985,-3.2235683767483607
SNU-899,12003241,-1.150293591999144
AGS,JQ-1-carboplatin (1-1 mol-mol),3.380502968435776
BT 248,44491742,4.160095989296475
LNCaP clone FGC,439501,-2.4937134944398176
A-375,6610216,4.632433700861142
SNU-407,3689413,0.4751617374249986
JK-1,11485656,2.0269272789358332
MKN7,10296883,4.147888797827488
CAL-54,9903786,1.6300874124823186
HCC-56,54618164,4.385422668938835
HT,9936388,-5.879912313959706
COR-L51,12003241,-0.3418570343381517
NCI-H28,44491742,4.1731257553412116
MCAS,6610216,4.229351733917807
SNU-1196,107985,-3.2649450239606166
NCI-H524,JQ-1-carboplatin (1-1 mol-mol),1.4939916755553018
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
AU565,168313200,1.787588028354966
SCC-4,6505803,-0.4511168499672106
SF268,3689413,-1.0049822928368335
SK-ES-1,135875424,2.8714720771033297
A-204,24180125,5.792095309981467
SNU-119,148198,-2.509458516530883
HCC4006,JQ-1-carboplatin (1-1 mol-mol),4.481735519200737
NCI-H1581,36462,2.0643710775083894
Lu-65,9927531,5.027796470849251
JeKo-1,44493528,3.836571201329888
T98G,11485656,2.7510926894657977
SK-N-MC,36462,-0.6057353178382218
HCC38,6610216,4.397537915498448
NCI-H209,9936388,1.6716697805480627
NCI-H1184,159324,2.6311703367057735
SNU-478,409805,4.514239248818933
BT 482,9903786,3.918124147791562
RPMI-8226,6610216,3.804422876207064
NCI-H2196,409805,3.7550378026386104
P-STS,36462,-0.5821459330594502
MDA-MB-361,11485656,3.163991716829106
NCI-H322,6610216,4.294116113185311
IGROV-1,11485656,1.900409616013456
RERF-LC-MS,148198,-3.5927713028936834
NCI-H2081,439501,-4.570953887500971
Hs 294T,439501,-2.312914558527944
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
MM1.S,148198,-3.54523038003387
WM983B,10296883,3.9280678477622857
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
KYSE-150,6610216,4.783964747125549
SF295,148198,-2.5868327776728517
P-STS,10296883,3.777775874485648
SiMa,439501,-2.281270120889317
PF-382,8515,3.0389731440801224
AU565,6505803,-0.7592801042803803
HEC-59,6505803,0.8725276425647639
RCC10RGB,72199289,4.762339751475906
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
OAW28,44493528,4.631141764792384
NCI-H2052,11485656,3.009511423148426
TE-11,8515,2.1932181679605476
RMG-I,54618164,3.80773173127852
Hs 888.Lu,9936388,3.0019673480858455
NCI-H1155,6505803,-2.994970974649892
HCC38,148198,-4.709757817936847
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
BV-173,54618164,2.9660436540247903
ACC-MESO-1,44491742,5.613898283692527
BICR 22,6505803,-0.8504421983690468
LAMA-84,6505803,-0.5453051583932805
CAL-54,168313200,2.733747480595619
TE-5,135875424,4.0614047836246
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
VM-CUB-1,36462,1.410082358150048
OS-RC-2,3689413,-2.40669101710066
L3.3,54618164,4.298111449535211
JHUEM-7,5460769,0.024222502884872
Raji,44493528,4.013963979075194
PLC/PRF/5,24180125,4.178076837557003
SK-MEL-28,148198,-1.1695105826491254
Hs 578Bst,439501,-1.046807547420411
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
Detroit 562,3689413,-1.858060179976838
SNU-601,selumetinib-GDC-0941 (4-1 mol-mol),-0.2622654032095929
NCI-H647,36462,3.0130697946404874
RT-4,107985,-3.170589180041932
Lu-65,439501,-2.896459054469027
NCI-H1339,54618164,4.412872879489402
GI-1,54618164,3.901626722229882
EC-GI-10,54618164,4.293079526845323
SK-UT-1,6610216,4.443950873518219
SK-MEL-1,9903786,3.576716533884559
TE-10,11485656,2.3373155876615463
MIA PaCa-2,44491742,3.8709962970987464
JHUEM-1,148124,-4.41926729244999
SW948,3689413,-2.2648112033429824
ACHN,3689413,-2.388175172833965
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
NCI-H747,135875424,3.2442393754776178
HuH-6,159324,3.549059872612121
Toledo,3689413,1.25181961816846
SUIT-2,439501,0.993663636668041
Li-7,148198,-2.409975630589331
SW1088,6505803,-0.5883716848555307
SW1353,409805,3.732446628282932
TM-31,148198,-3.484551999538721
SNU-C1,9936388,1.0138657245137583
OPM-2,9927531,3.0625153090482757
A2780,12003241,-2.743381978251489
AGS,148198,-2.2056365427591307
Fu97,6505803,-2.9243122575537552
KYM-1,168313200,1.7447791340634575
SET-2,54618164,3.897456065397519
EFO-21,148198,-3.998028917288756
Rh41,135875424,2.4863940955705517
SUP-T1,9903786,2.605502996973438
KP-4,107985,-3.0581190073780524
NCI-H1869,168313200,3.875520299128645
SUP-B15,439501,-4.354200278672526
HCC2935,168313200,1.8160572268695407
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
CCF-STTG1,54618164,4.4288958648043915
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
NCI-H2405,135875424,3.4546844746128476
HCC1937,9936388,1.6949856124341256
HT-1197,168313200,2.2416260588252546
REC-1,8515,2.9172768808189096
HH [Human lymphoma],6610216,2.9617433337623256
NCI-H660,3689413,-1.4753207784543096
KALS-1,159324,3.9170291523443126
GOS-3,107985,-2.049266528770901
CHP-126,9903786,1.6217083088403044
PSN1,168313200,2.63140160708384
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
Rh30,439501,-1.3281255322499272
SU-DHL-1,8515,3.677486404661737
TE-6,3689413,3.2359405444130473
SK-ES-1,54618164,4.268925362543446
HT-144,36462,4.669629516323279
KYSE-30,11485656,2.6374732663532794
NH-6,26596,-2.8225281366091375
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
ME-1 [Human leukemia],107985,-4.174267195785912
GI-1,10296883,3.999407360262004
Mel Ho,54618164,4.508267995414237
SIG-M5,12003241,-2.3044245068014826
EN,8515,5.1955673070106565
SNU-61,9903786,2.1391845181717373
HEL 92.1.7,6610216,4.098541714440695
HCC1954,54618164,3.861561263773434
Hs 940.T,8515,3.5056691644991087
DU145,409805,7.850532015731276
SW1088,148198,-1.1652739532057856
MKN74,12003241,-0.9650452844715884
BT 440,12003241,-2.6320772698218793
SW1353,11485656,2.8326664945571585
PaTu 8988t,409805,3.676693079768219
BT 440,9903786,3.1498376271679533
Daudi,26596,-3.612902475241139
DK-MG,26596,-1.5409696775062258
SNU-626,11485656,3.731914296666243
HuH-1,26596,4.2639260913768755
KE-97,8515,2.5331907619060603
Becker,107985,-2.6804749742466347
TE-4,26596,-1.4080950714953673
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
DK-MG,JQ-1-carboplatin (1-1 mol-mol),1.3379136622287715
SUP-T1,3689413,-3.2638224504497195
Raji,11485656,1.8853842234896017
KMS-27,54618164,3.8128826777039047
MHH-CALL-4,3689413,-0.1881082259185382
BT 440,409805,5.991281028290434
L-540,12003241,-2.1812715398766844
VCaP,49836020,3.7297112197262337
Rh30,3689413,-2.408934939466004
HCC827,159324,3.279991136949679
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
BT 224,12003241,-0.3430722292852487
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
UACC-257,12003241,-1.8114895383547025
BV-173,107985,-3.6311226655481086
A-549,9936388,1.4749208650316612
DB,135875424,2.935208390580705
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
NCO2,409805,3.4174299709806704
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
BT 112,148198,-3.0030353997640074
SNU-449,9927531,4.924705078398161
SK-OV-3,9903786,2.611217845094376
COLO 684,9927531,4.094715698749933
MDST8,107985,-3.301997074358414
SNU-620,46943432,0.3384301465912348
A-172,439501,-2.9680565651311723
SIG-M5,10296883,3.681364440246351
NCI-H2141,148124,-3.613831420136023
NCI-H2170,9903786,3.56987053348202
SNB-75,107985,-3.636454982238337
NU-DHL-1,148198,-4.718908672184396
HPB-ALL,46943432,0.8713024480628602
HCC1806,5460769,-0.192100809913994
PK-45H,24180125,4.426735459673925
JHH-2,12003241,-2.42929005443543
UO-31,148198,-4.317632208433169
SNU-1272,6610216,4.610007140028073
NCI-H1694,148124,-5.208031501758842
JeKo-1,6610216,5.101386243640172
RL95-2,3689413,-1.8797416437850616
Lu-99,12003241,-1.7463019078510122
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
NCI-H1341,12003241,-1.9101542939935303
AN3-CA,6505803,-3.3327049528719312
JHUEM-7,54618164,3.823825423336211
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
COLO 668,24180125,3.093687435572166
FTC-238,439501,-2.852234724495685
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
EM-2,6610216,3.792859820218109
HCC1569,12003241,1.6977916939082411
SNU-201,159324,4.275700676511976
SNU-449,148198,-4.785889264279132
Hs 888.Lu,6505803,0.1464853570019931
BT 504,11485656,1.8828721795315295
NCI-H1435,54618164,2.9434068497251147
LoVo,135398744,6.330186357549225
NCI-H1568,135875424,3.0063280878885967
RPMI-6666,11485656,1.824028622976644
HT-1376,159324,4.157820954342544
IGROV-1,6610216,4.310938387105607
RPMI-6666,409805,3.46469330142704
PK-59,148198,-2.6043559024802763
HMCB,54618164,4.179643558652394
CAL-78,44493528,4.952058712183874
MIA PaCa-2,26596,-1.1158295610303952
SNU-423,11485656,3.131370831257297
KMRC-1,9903786,4.024109374851969
OCI-Ly3,selumetinib-GDC-0941 (4-1 mol-mol),1.725768146081181
MES-SA,8515,3.777635178770389
YD-8,9903786,2.667696713101927
HCC2935,9927531,5.26637836845999
HPAC,148198,-2.210118845880014
OE21,49836020,4.665936469802933
KE-37,selumetinib-GDC-0941 (4-1 mol-mol),2.002060120469268
RPMI-8226,8515,3.584522978705492
JL-1,3689413,-0.3699196862305292
TF-1,9936388,-7.588879673689913
NCI-H2141,9927531,4.975438094968349
CAL-51,3689413,0.5709426612715743
NCI-H322,107985,-3.3534970616476945
KMS-27,6610216,4.611195004957726
JHH-2,6505803,0.8669908144871188
SET-2,11485656,1.7886595096067897
MFE-296,5460769,1.1407160363759563
SH-4,9903786,3.356674972156618
HEC-151,12003241,-1.83751972949174
SNU-685,168313200,3.8994642144724105
HuP-T4,8515,2.1627340479037183
NOMO-1,10296883,3.647443685498321
MOTN-1,10296883,2.890144008228283
Pfeiffer,54618164,3.4474799956716344
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
SCaBER,135875424,4.404727092025364
KP-4,9927531,4.133132471869078
SW1783,168313200,3.606419156743755
CAL-148,26596,-0.995899107261143
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
GCT,10296883,3.718708218585829
SHP-77,135875424,3.698611964350599
GMS-10,selumetinib-GDC-0941 (4-1 mol-mol),1.7760805254050829
SK-N-BE(2),9903786,2.0499315562907627
NCI-H2081,168313200,2.364564714683474
Fu97,9903786,2.3049271395078827
NCI-H2029,409805,3.806732327162768
YH-13,6505803,-0.6394660445903715
TM-31,selumetinib-GDC-0941 (4-1 mol-mol),1.793600027043238
KMBC-2,10296883,4.242347433736866
NCI-H2023,selumetinib-GDC-0941 (4-1 mol-mol),2.6884050561180253
NCI-H1869,148198,-2.251684124095355
Karpas-620,135398744,5.497457460597933
NOMO-1,54618164,3.731990472759892
WM1799,9936388,-1.7027793320208122
CAL-51,11485656,2.6541256228973773
EFE-184,3689413,0.8995807831619225
BT 179,6505803,-3.5400824860100224
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
Daoy,9927531,4.407816470136583
K-562,9903786,3.6050720376028105
HEC-151,54618164,3.8374774746461706
GMS-10,439501,-2.5226384823579404
HCT 116,12003241,-0.2623292503702257
UM-UC-3,6610216,4.133120450303845
Mono-Mac-1,409805,3.1107516004642406
CAL-27,JQ-1-carboplatin (1-1 mol-mol),1.5591369487847715
HEC-6,6610216,4.405730732858135
SNU-C2A,9903786,2.8672741986738193
COR-L95,148124,-0.3758104123213183
NCI-N87,54618164,3.997308077582706
TTC-709,168313200,2.5540587155219385
BxPC-3,54618164,4.016743819691475
NOMO-1,26596,-2.074766602044621
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
NU-DUL-1,168313200,3.0422997950716346
QGP-1,24180125,2.573216603875163
Panc 05.04,159324,3.075264483571336
NCI-H2085,36462,4.466396535558883
CAL-85-1,9936388,-7.895376476927265
GA-10,36462,-2.446264155422686
BT-20,44493528,4.336473935891848
BCP-1,439501,-3.5020472552151904
HCC366,409805,5.5100661130237105
PaTu 8988s,439501,-3.8776790772528864
HEL,148198,-3.399100076616297
HCC15,36462,0.276886424919507
JHH-2,107985,-3.242858350400616
NB4,9936388,-6.659724835082886
HOP-62,54618164,5.192278696523286
KYSE-180,36462,3.219917830306027
SNU-869,selumetinib-GDC-0941 (4-1 mol-mol),1.3245686314727811
KMRC-20,6610216,4.741983793565595
JHUEM-1,9927531,4.870867049217503
OVCAR-4,409805,4.907357976433214
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
NCI-H2029,6610216,3.944731784894563
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
NCI-H292,159324,3.210621191245253
HEC-151,8515,4.452182396163437
MEC-1,9903786,1.8402940604427764
HuG1-N,148198,-4.107954267026698
OC 314,11485656,2.060949002481836
NCI-H358,26596,-1.6094838950604715
KMS-21-BM,44493528,3.35720206113814
NCI-H1341,54618164,2.6162570827682483
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
Ri-1,168313200,2.421861912259082
SW1088,409805,4.031370410742822
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
NCI-H1915,148198,-3.0728174941376603
TT2609-C02,168313200,3.68339689842754
SCC-25,9903786,1.6185741180598072
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
OS-RC-2,12003241,-1.2099466565873536
COLO 792,3689413,1.4913457514232935
KYSE-180,5460769,3.044274290576871
OAW42,44491742,3.912370337658794
CW-2,10296883,4.166950774210748
SK-MEL-31,selumetinib-GDC-0941 (4-1 mol-mol),3.550007018724769
8305C,12003241,-1.8647493707838596
NCI-H1395,11485656,1.9214345391656065
A-549,54618164,4.216271974260082
Pfeiffer,148198,-5.248523074657563
SNU-61,159324,1.5880493113453718
OE33,9927531,5.791665708309609
LP-1,49836020,4.554043159133258
ECC12,24180125,3.733466398448284
U-937,10296883,3.442205161599926
HCC1143,148198,-3.881060339055355
T98G,439501,-1.9696613143180952
MFE-319,26596,-1.024111788947852
D283 Med,36462,-0.7003958685437419
SNU-C2A,36462,2.7016140630002714
UM-UC-1,36462,0.7932866865942573
BT 147,9903786,1.444914560684451
BxPC-3,409805,3.7922849099240734
HuP-T3,44491742,4.372770131484514
CCF-STTG1,24180125,3.0142725993324064
RCC10RGB,11485656,3.364959979667133
EKVX,6610216,3.33628219638057
Calu-3,135423438,2.2441987111134254
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
NH-6,44493528,5.783725141488281
VCaP,8515,3.1878682585900258
U-CH1,135875424,4.885628111434567
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
OCI-M1,107985,-4.64577499507645
KMH-2,46943432,1.9293526492233928
EJM,135875424,3.8151689174566665
TUHR4TKB,9927531,4.964100941716243
Ishikawa (Heraklio) 02 ER-,135875424,3.942443711237878
CAL-78,9903786,2.899593269782219
CA46,135875424,2.985562686352135
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
NU-DUL-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.5711505169578749
HSC-3,409805,5.892445537848464
SNU-478,439501,-2.527106469117114
COLO 741,3689413,2.799435260821197
Hs 578T,6505803,0.7930921136576904
NCI-H2030,3689413,1.2400324738328432
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
ME-1 [Human leukemia],409805,5.503532465022727
BT-16,5460769,2.094030868827637
U-CH1,44491742,4.471385772399255
ACC-MESO-1,5460769,5.633127442709169
M059K,107985,-2.8475109777363703
Caov-3,5460769,3.7832431235533903
NCI-H1869,3689413,-0.7267032921286074
BT-474,135875424,5.915453425364125
HOP-92,36462,2.3533766692120737
Capan-1,12003241,-1.403867722449874
BT 231,107985,-2.768732072411436
NCI-H650,5460769,3.805855578074832
COLO 320,439501,-3.5765221681419805
Daoy,107985,-2.3537821634376836
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
MJ,135875424,3.3337154689139914
TYK-nu,9936388,2.2854724724454254
PF-382,54618164,3.241191825495517
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
VCaP,439501,-3.1099303166106087
Capan-2,5460769,2.6167760530795654
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
CCK-81,26596,-1.410251638303959
MKN74,44493528,4.689150119305487
BT 228,12003241,-1.6653206714884845
NCI-H522,5460769,0.5614535105182378
KMS-18,54618164,3.80046237886975
RPMI-7951,44491742,3.876790810560562
MDA-MB-435S,148198,-3.0522052699566613
L-363,49836020,4.471751893617592
BICR 22,26596,-1.8883514509946957
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
HT-1080,JQ-1-carboplatin (1-1 mol-mol),3.260374124157549
HCC2218,8515,1.7075905965554727
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
RT-112,9903786,2.0638797497197237
CAL-33,5460769,2.348968888608987
NCI-H1105,26596,-1.464012997205303
PSN1,54618164,4.143205151056231
CJM [Human melanoma],36462,0.3474499275701578
Capan-1,9927531,5.621022347820903
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
NCI-H1573,6610216,3.8835594235884674
BT-12,148198,-4.094223347380762
SK-MEL-30,3689413,3.4376299216272685
Calu-3,54618164,4.033225679465255
SW1088,8515,4.5200926698213255
KG-1-C,148124,-2.4914776723153995
P31/FUJ,26596,-2.2448149587984836
ZR-75-1,409805,4.246614706181892
GP2d,135875424,3.142612243202518
SUP-T11,409805,3.2172414171416177
NCI-H2029,26596,-1.020700117051714
SW1417,9936388,1.1366395190949656
MHH-ES-1,439501,-2.339727963154972
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
NCI-H889,10296883,3.661891434193148
BT 239,54618164,3.809265619154791
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
WSU-DLCL2,159324,1.4979420988042116
U-251MG,JQ-1-carboplatin (1-1 mol-mol),3.361706194293166
HEC-59,107985,-3.77739031414332
WM115,135875424,2.968517855352779
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
HCC15,12003241,-1.0460858766179792
SW1417,107985,-2.8502235433428695
SNU-1076,439501,-2.344859624762999
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
AsPC-1,54618164,4.187549957668634
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
SNU-387,9903786,4.748130611639421
SNU-1033,44491742,3.84113608449774
NCI-H1755,8515,2.8473258016948777
Hs 578T,10296883,3.7096057485466223
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
Kelly,107985,-2.874856101829992
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
HCC1569,135875424,2.981320238705361
NCO2,3689413,-3.837216983883232
BT-549,409805,3.826135579342285
ALL-SIL,6505803,0.7073572306495796
SNU-387,12003241,-1.416188991629313
MOLT-16,46943432,0.6588573243704352
WM983B,3689413,0.8501817874784955
BT 504,12003241,-1.3815102310326015
RS4;11,135423438,1.0348635952337828
KATO III,439501,-0.4584208934437059
Hs 895.T,5460769,5.961347926985583
LN-18,9903786,3.1734737643120696
HCT 15,135875424,3.2134473566688726
HCC4006,3689413,-2.273135078427732
Hs 766T,11485656,2.6459826736539376
SNU-175,12003241,-1.252002444372071
COLO 741,9936388,-5.068982881561057
SK-UT-1,11485656,2.414217391257394
CAL-27,26596,-1.6130291256541474
KATO III,24180125,3.0892826783746674
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
MeWo,24180125,3.515144215556771
NCI-H716,135875424,3.9271515423817047
OUMS-23,44493528,4.557464457918189
ESS-1,44491742,4.277473074701454
MIA PaCa-2,9903786,3.251255785633491
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
AU565,148124,-5.63717967948206
SNU-61,409805,4.743067556302579
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
OCI-Ly19,168313200,3.801805147160126
OAW28,439501,-0.9322268226633188
THP-1,148198,-1.1701008098943837
OAW28,10296883,4.314409366833216
TE-9,148198,-2.1853005512510273
Hs 611.T,3689413,-2.7004104072546133
HL-60,JQ-1-carboplatin (1-1 mol-mol),0.4804402451119697
2004,148124,-5.699591779896403
KMM-1,409805,6.5114621307755
PE/CA-PJ41 (clone D2),168313200,3.0210086537721574
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
Namalwa,6505803,0.5277329545448584
PaTu 8988s,JQ-1-carboplatin (1-1 mol-mol),3.780889611052604
HCC1569,36462,1.738183418675638
Panc 03.27,148198,-3.6739287682620967
GMS-10,3689413,-2.2812112324373057
SNU-719,12003241,0.0299382028109862
U-BLC1,10296883,3.798592374745875
Karpas-422,JQ-1-carboplatin (1-1 mol-mol),-0.5867346052444206
Aska-SS,49836020,4.404663805549638
BHT-101,12003241,-0.6402723165837827
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
CAL-51,409805,3.8515087112009656
MG-63,168313200,3.691285308934156
SNU-245,JQ-1-carboplatin (1-1 mol-mol),1.4160097038546082
OCI-AML-5,36462,-0.4701169998838825
OVSAHO,selumetinib-GDC-0941 (4-1 mol-mol),2.882517977180431
CAL-54,44491742,4.012557158379019
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
COLO 678,107985,-2.812245296747932
A2058,JQ-1-carboplatin (1-1 mol-mol),3.692426829341752
Ci-1,6505803,1.2287490885597057
HT115,135875424,4.178256004737694
TE-14,135875424,2.9954156144381203
SW48,46943432,0.8743166493146273
NCI-H2110,26596,-0.8689069076907829
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
LP-1,44493528,4.0079037689618815
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
SNU-620,11485656,1.82591162033248
NUGC-3,12003241,-0.6366922027749422
LS1034,6505803,0.7621506671828905
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
NCI-H838,6610216,4.350007220120111
BT 416,9903786,2.244954394725016
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
DU4475,6610216,3.725870143122914
FTC-133,168313200,3.883948141330694
COLO 680N,148198,-2.677671359011621
TYK-nu,26596,1.1864585547757855
TC-71,26596,-3.193308290167961
SNU-1,36462,-1.3160240759966046
EHEB,46943432,1.4009693182531664
NCI-H2122,26596,-0.3703174924227287
8505C,159324,3.0622451450386485
Rh18,409805,3.5116052994739304
RPMI-6666,148198,-3.3774260453354015
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
SNU-213,6610216,4.06770286109328
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
NCI-H1299,159324,2.855064979130342
HEC-151,159324,2.248651561242496
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
Aska-SS,9936388,1.048322458845263
SK-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4310498502666769
SNU-878,26596,-1.9589890224119235
NOMO-1,3689413,-2.5325178418163174
NCI-H1666,10296883,3.734666163240881
SET-2,8515,2.781692301096623
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
BT 504,26596,-1.373211017914528
Karpas-422,26596,-1.4945297758647662
Ri-1,148198,-2.551976890306858
IPC-298,24180125,3.708538473010715
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
WM266-4,9927531,4.893127770626654
SK-MEL-5,44491742,4.058095878540579
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
EoL-1,3689413,-2.5778346492897266
HCC2108,36462,2.7422106684318077
SIG-M5,9927531,4.880658167161108
AU565,148198,-3.941648532890003
KATO III,JQ-1-carboplatin (1-1 mol-mol),1.5255725604391266
BT 139,44491742,4.209444035840443
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
A101D,9936388,0.7934880504993692
ONCO-DG-1,107985,-2.464298331408582
HT,JQ-1-carboplatin (1-1 mol-mol),-0.8971683298362426
SK-LMS-1,44491742,4.239159149665423
OCI-AML-5,12003241,0.3941324977706439
Hs 578T,148198,-5.652583246713905
YD-10B,54618164,3.9161764608824
SK-LMS-1,107985,-2.0791216357249054
P31/FUJ,3689413,-2.495432751898851
IGR-37,9927531,5.0345741970674975
WM983B,11485656,1.9141384633865923
KE-97,36462,-1.9325928146088365
SK-MEL-31,159324,5.415671108450597
NCI-H1793,36462,1.7217915676129778
SNU-C1,409805,3.9064210448467054
MeWo,selumetinib-GDC-0941 (4-1 mol-mol),-0.6155502943571556
Mono-Mac-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3199178680358683
MKN74,159324,3.1954005731407604
LAMA-84,5460769,3.9784862352409105
RPMI-8226,168313200,3.781951804453522
LS123,159324,3.095427292134196
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
SYO-1,135875424,3.5152559775635
BT 245,6610216,4.100969243175901
HT115,107985,-3.2937342736448074
LS1034,6610216,4.176781620186853
SW1463,6505803,0.5252870082270547
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
M059K,26596,-1.203189408299565
NCI-H292,11485656,2.2579953762585725
CADO-ES1,159324,-1.4511857186718804
22Rv1,9903786,3.2246012387786536
Hs 766T,36462,5.389792201057677
IM95,3689413,0.7350625809131119
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
HCT 8,24180125,3.86603834239024
DMS 114,9927531,5.183306198807951
BICR 16,selumetinib-GDC-0941 (4-1 mol-mol),2.023123629912069
Becker,3689413,0.4493271202500121
BT 228,5460769,3.1734234469755775
NCI-H2087,9903786,2.3520196427400717
SNU-1077,409805,6.04127283545163
DMS 53,12003241,-1.7395700319118894
Panc 08.13,5460769,-0.1924357520120825
KMS-28BM,3689413,-2.3321976244932134
COLO 205,26596,-2.0120712396922475
CCF-STTG1,10296883,4.282837475963798
MDA-MB-361,439501,-3.0458993456169168
MEC-1,10296883,3.7478105751485646
HOS,409805,5.854955980569708
SNU-899,11485656,2.609975330684587
SNU-685,11485656,2.7967045381666877
MPP 89,439501,-3.0783668430470574
RKN,36462,2.460575122343829
HEL,9936388,-3.337900467930123
CMK,3689413,0.9967323135888336
OV7,168313200,2.2683947493105627
SNU-1,9903786,3.1259833622650315
TE-5,9936388,-0.0111298591303443
WM1799,3689413,0.6160914431487012
HCC2935,148198,-1.8652602121018471
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
BT 232,6505803,-2.078004846595285
ACC-MESO-1,135875424,3.861508499056134
CAL-29,26596,-1.7040802846973448
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
MDA-MB-468,10296883,4.0590713051476115
HCC366,148198,-3.0667828762214344
LS123,11485656,2.4615924556875575
NUGC-3,26596,-0.5443807488000636
SU-DHL-8,168313200,3.8526529776928498
SNU-899,159324,3.687445596334971
BL-70,9927531,3.241092589782463
SNG-M,8515,4.053426121946113
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
8-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),3.0365797378883843
SCC-9,148124,-0.9222891029936632
Raji,46943432,0.8190341583035305
SNU-423,36462,3.755778828040023
SK-N-MC,54618164,3.6876271141926926
RS4;11,107985,-3.735535817739186
HEY A8,439501,-1.1544595971592837
NU-DHL-1,11485656,2.738678590842112
COLO 800,selumetinib-GDC-0941 (4-1 mol-mol),-0.6648524830772472
KMS-21-BM,3689413,-1.8694843012427496
EKVX,9936388,2.132401654750859
JHUEM-1,135875424,3.0885966905905433
HEC-265,135875424,3.9538578477076136
RPMI-6666,5460769,0.788563204465766
RVH-421,9927531,5.089842816937553
FTC-133,135875424,4.265925786122884
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
SNU-5,36462,1.2095773487529122
SU.86.86,44491742,4.316349403220542
MEC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4728620848599026
ECC12,9903786,2.9866335342643953
BFTC-909,54618164,4.281231487810877
KM12,8515,1.6366887963761436
EBC-1,3689413,0.3969440473796213
HEC-1-B,6610216,4.285731274243315
BT 248,12003241,-0.5635987052840526
SNU-761,10296883,3.572250767719841
RL,168313200,3.374202089321372
BC-3C,148124,-4.411439012775604
SNU-46,159324,2.6204586444716784
BT 147,6610216,4.32528553211185
NCI-H69,9903786,3.032908802365876
U-BLC1,12003241,-2.3919609664555543
RL,6505803,0.5926513253188753
AU565,6610216,3.647426232490327
Lu-65,12003241,0.1595843887204832
TE 617.T,5460769,-1.488012889612994
BICR 16,439501,-3.169207556484136
HuG1-N,44491742,3.596787790528333
HD-MY-Z,11485656,2.631776760715326
TE-15,6505803,-1.869936847714552
BICR 18,9936388,2.6183672071363175
HT-1080,26596,-1.5262132269513464
RD,10296883,3.864434451204585
MFE-319,135875424,4.6574477212915015
HCC2279,8515,5.4381882059058775
NCI-H2106,3689413,-2.547861084772001
Li-7,44491742,3.4427957124518325
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
HCC44,8515,2.31120341608701
NCI-H1299,148198,-1.8449433288311332
Hs 746.T,409805,3.593124858795494
SK-OV-3,54618164,4.236989567252486
Pfeiffer,46943432,0.0278801234257352
PLC/PRF/5,12003241,0.8244509806325866
Hs 888.T,9936388,1.4712772927415676
Mel Ho,9936388,1.523642966825596
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
BT-474,107985,-3.5381874365688293
NOMO-1,5460769,4.769752092364765
PL-21,46943432,1.1872479034734134
T84,44491742,3.592181787537852
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
LS180,409805,6.164182483443964
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
COLO 680N,54618164,4.295037295066884
RL,12003241,-0.503691110401914
NCI-H1573,135423438,5.2743221635386215
WM266-4,44493528,4.3133023998571565
NCI-H1385,135423438,1.627035115180022
SNU-8,6505803,0.4041272460627742
GI-1,9903786,1.7362048371434178
NCI-H1651,5460769,-1.7567427214342684
SUP-M2,168313200,1.600763528501759
Ci-1,JQ-1-carboplatin (1-1 mol-mol),1.531401836561634
NCI-H1666,135875424,3.51211447124405
A-204,8515,2.864869889805365
COLO 320,409805,5.814717482714791
COLO 699,54618164,3.9618004812637326
YAPC,439501,-1.3344819600707327
BT 232,3689413,-0.4723000491663335
RVH-421,11485656,3.351347691760053
KYSE-520,135398744,6.453499706252085
RPMI-6666,44493528,4.272159691282271
JHUEM-2,3689413,-0.0908621852790934
HEC-151,135875424,3.433906350348657
HLF,148198,-4.949405415415342
AsPC-1,10296883,4.32215490848641
NOMO-1,12003241,-0.5951695723430065
JHOC-5,5460769,2.0469189795608447
TE 617.T,54618164,3.769426855939867
AsPC-1,8515,4.986545700595871
LNCaP clone FGC,148124,-8.012505540487231
LOX-IMVI,3689413,-4.023880524547255
SU-DHL-8,439501,-2.4804073416438626
THP-1,6610216,3.770684705131464
Calu-1,3689413,-2.465191800637427
Granta-519,107985,-5.079154139769343
KP-4,409805,5.81471054655713
SK-MEL-1,3689413,2.3373069635982495
MOR/CPR,54618164,4.108199329752357
KMH-2,JQ-1-carboplatin (1-1 mol-mol),1.5982474569998335
HEC-1-A,6505803,-1.1464384293678307
HCT 15,12003241,-0.9489590343068364
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
MJ,135423438,2.050663035644961
PANC-1,11485656,2.097269968494983
WM983B,24180125,2.8843311676242345
HCC1428,168313200,3.288386425250625
NCI-H2122,54618164,4.161455181946263
MOLM-6,409805,3.963738362596128
GDM-1,12003241,-2.0828988572069487
CAL-148,5460769,1.0209449875435856
HCC1143,135875424,3.1375636080090925
BL-70,54618164,2.8033577999904633
OE21,10296883,3.8232218432120058
SNU-886,135875424,2.126718157354228
TYK-nu,44491742,3.839739340970965
FaDu,148198,-4.955627855681465
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
L-363,6610216,4.393739110734271
BT 286,5460769,1.8515527065353563
SW48,8515,2.6507036204950256
SH-10-TC,9903786,4.254901914328344
U-118MG,6610216,4.6753902919745
GA-10,11485656,1.0334565111558187
SNU-119,159324,3.0008353242690045
D283 Med,44491742,3.738153910971064
HT-144,135875424,4.403596226349448
COV362,5460769,5.303432014507575
ECC12,44491742,5.882219614933299
HSC-2,36462,1.805398470141545
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
IM95,12003241,-0.6158272527459553
A-549,8515,3.6622074868184464
BT 232,24180125,3.864278163608165
Panc 08.13,44491742,4.265130925236368
EFE-184,135423438,1.8647999692760415
SNU-119,26596,2.579410873890194
AsPC-1,3689413,-2.062701377390924
Hs 766T,135875424,5.942184015876385
OVCAR-8,3689413,0.7986129838675038
SNU-423,9927531,5.196680575825113
KP-4,159324,2.838161812781853
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
SJSA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9428552640575236
Rh18,9936388,1.9794921916079815
PLC/PRF/5,11485656,2.5978340800355544
WM88,6505803,-1.994136504003607
LNCaP clone FGC,49836020,4.788899602776088
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
NCI-H2291,5460769,2.25244251110153
HD-MY-Z,36462,0.9002235780520323
BT 159,9936388,-6.930864213478757
P31/FUJ,135398744,5.7727848933678
LXF 289,135875424,3.2815298243266553
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
JHOM-1,439501,-1.2372155535522604
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
PaTu 8902,44493528,4.360494725244959
IGR-1,9936388,-6.544031744867033
JJN-3,6610216,4.182778929763247
JHUEM-1,9903786,2.799765938694702
CAL-62,9927531,5.042893811802322
SW1271,159324,2.241950485620868
HuCC-T1,9936388,2.1654759502470755
BFTC-909,159324,4.114702101808939
L3.3,11485656,2.040790548836277
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
COLO 792,10296883,3.769618463238052
SNU-213,3689413,0.5464532854962126
IGROV-1,135398744,6.402844237905131
5637,6610216,4.322793648631034
G-361,24180125,4.598924085949766
TT,36462,5.01376764525677
BICR 22,72199289,4.441607504718354
Fu97,46943432,1.3928994026129526
NCI-H1385,12003241,1.7057998630948272
SK-ES-1,135423438,0.9314581283921904
SK-N-DZ,6610216,4.064938654399556
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
U-CH1,54618164,4.479902968958697
COR-L88,54618164,2.493623736891049
CA46,107985,-3.181693098398671
Hep 3B2.1-7,159324,3.436377788042606
U266B1,selumetinib-GDC-0941 (4-1 mol-mol),1.5301935614482745
KU-19-19,439501,-2.2192304341921205
HuG1-N,selumetinib-GDC-0941 (4-1 mol-mol),-3.3555719378633375
HPB-ALL,9903786,2.3044154759834847
OCI-Ly3,9927531,4.54855652960748
NCI-H1355,selumetinib-GDC-0941 (4-1 mol-mol),2.7709082983519564
639V,6505803,-0.4780888890381856
CML-T1,8515,3.304453494146528
NCI-H747,9936388,1.1116037034519244
NCI-H2087,24180125,3.4986995074600356
YD-10B,JQ-1-carboplatin (1-1 mol-mol),1.656184810616646
COR-L95,9927531,5.207677506691081
253J,44491742,4.062821625609178
BT 482,54618164,4.35481469450108
BT 444,3689413,2.494766939004703
BT-16,selumetinib-GDC-0941 (4-1 mol-mol),1.0815618001864344
Hs 934.T,3689413,-2.375941767618157
KMRC-2,24180125,1.140997225837335
TE-8,selumetinib-GDC-0941 (4-1 mol-mol),2.5154311677987575
HCC1428,11485656,3.1033366258565938
HCC4006,135423438,4.2746750258396835
COLO 829,168313200,2.1419064065737277
MDA-MB-361,JQ-1-carboplatin (1-1 mol-mol),1.1182697854337842
LCLC-97TM1,11485656,2.4293249862604913
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
SNU-216,6610216,4.217598364125196
HuT 78,439501,-3.2848313932186315
JHOC-5,6505803,0.9816960895026916
JVM-2,3689413,-3.874282045367449
Hs 934.T,9936388,1.629687666609809
P12-Ichikawa,9927531,3.8027198390435792
JHH-5,11485656,1.7028166663809423
BT 172,6505803,-5.169287072935626
SK-MEL-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.2410221738936931
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
HSC-3,54618164,4.361792769190993
GP2d,148124,-6.606459612747149
HEC-251,159324,3.582550547343554
COR-L95,409805,3.71634228772174
WT2-iPS,10296883,3.9536732530855647
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
RERF-LC-Ad2,107985,-4.355232294484495
OCI-Ly19,6610216,4.329464958402344
FaDu,107985,-4.115257007798789
SNU-407,9936388,-6.677168792999783
CCF-STTG1,409805,5.227575027972168
U-251MG,54618164,4.511776015798793
NCI-H2171,46943432,3.4065574915710735
RPMI-8226,12003241,-0.708602453849348
SK-N-MC,107985,-4.0250065656934115
Kelly,168313200,1.7675491424494791
COV362,135423438,3.2580935345525672
IM95,168313200,3.500252264510834
JL-1,409805,3.9394900151572143
MHH-CALL-4,9936388,-7.2015851477673785
KE-37,12003241,-1.2024354482149269
MOLP-2,3689413,-0.0389139812968664
NCI-H2405,5460769,3.951574866457585
IGR-39,10296883,4.067420766140578
COV434,6610216,3.508453604079868
SK-N-DZ,9936388,-6.025086835164752
U-118MG,24180125,3.6933555825373983
SNU-81,49836020,-3.195484765979539
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
Kelly,26596,-1.7791948075234636
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
MIA PaCa-2,36462,1.2671989611626788
SUP-B15,44493528,3.997635669118944
KNS-60,159324,3.3920518874305023
BT 245,135875424,2.904149434910518
SUP-T1,24180125,1.3532366602003478
OVCAR-8,8515,5.505062921849074
OCI-Ly3,11485656,2.9823721346913654
ALL-SIL,6610216,3.679901693613009
NCI-H929,159324,1.2295170877350825
BT 504,148124,0.8340830795428085
A-204,107985,-4.730756256173954
COLO 201,9903786,2.3732534001710426
8505C,9927531,4.3206227244137745
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
MDA-MB-468,409805,3.012784504091546
L-540,5460769,1.6720211707369994
IGR-39,54618164,4.233555537459641
TUHR14TKB,135423438,1.0375302517653642
BT-20,9927531,4.105614320548644
VCaP,44491742,3.83752183909955
Jurkat,6505803,0.70436685648012
HCC1806,107985,-4.0802412440696525
NCI-H2342,6610216,3.8793869903029408
Granta-519,44491742,4.018752292224149
Kasumi-1,54618164,3.752212844120618
BV-173,49836020,4.1850611213091105
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
Panc 08.13,148124,-5.426526415917046
DU145,6610216,4.286029823589705
BT 359,54618164,4.243296371952982
639V,5460769,5.247401600018928
NCI-H661,44493528,5.823125515558819
SK-N-SH,12003241,-0.1782836435040178
HuH-6,135875424,3.823839910626804
NCI-H1694,26596,-2.376634499212247
769-P,11485656,3.1520053079529955
SK-MEL-3,24180125,3.765958030378214
WM266-4,11485656,1.8350601891994096
HCC1395,6610216,4.327049728345092
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
KMS-27,439501,-2.6111087383065597
NOMO-1,135875424,3.068632733482165
GP2d,168313200,3.749157716830288
JHUEM-3,44491742,3.947686960056495
C2BBe1,26596,5.1914595275269795
NCI-H211,6505803,-2.3118945325693216
ZR-75-1,6610216,4.248551703366494
HD-MY-Z,9927531,4.2813620085195625
HCC827,6505803,-1.7879054202576514
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
SNB-75,6610216,4.527522920111379
MEC-1,439501,-3.41979967464108
A3/Kawakami,6610216,4.023576597985235
Hs 822.T,168313200,2.754326247854747
PaTu 8988s,3689413,2.020164099747706
253J,107985,-3.879863196899193
SK-CO-1,54618164,4.180915062416914
SNU-C4,6610216,4.670910491319602
AU565,3689413,0.8257687517728082
U266B1,26596,-3.1243600455967906
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
NCI-H196,9936388,-3.664647197542574
EHEB,148198,-2.104475544842142
SK-MES-1,9936388,1.0310687201713455
SK-MES-1,8515,3.603504398534682
KNS-62,10296883,4.284329668268845
NCI-H322,8515,5.55433033335456
COR-L105,9927531,5.197941564874311
COR-L51,9903786,2.9541793607693267
BT 245,JQ-1-carboplatin (1-1 mol-mol),4.46215850472978
JM-1,54618164,3.458143614246244
MeWo,11485656,1.6470015852450477
NCI-H1915,11485656,1.946470366394693
NCI-H446,6610216,4.1198160320329
MOLT-16,159324,-1.742888303650328
BT 228,24180125,1.4765108272863283
SNU-C1,10296883,2.645859922334997
COR-L105,44491742,4.003695029376484
HDLM-2,46943432,3.238903302333344
CAL-27,3689413,-0.5192231908073464
SNU-308,9903786,2.008516122429012
RVH-421,24180125,3.4561148986253736
MHH-ES-1,148198,-5.108564856367707
SK-LMS-1,148198,-3.2983357402975484
SNB-75,11485656,3.1834770923218065
HuG1-N,10296883,3.840828409406213
A-204,selumetinib-GDC-0941 (4-1 mol-mol),0.2553877558733737
SK-N-SH,8515,3.203327445964139
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
SK-N-SH,3689413,0.7530548018951405
AML-193,54618164,3.973133793220512
NCI-H1703,11485656,-1.2144145653920837
786-O,6610216,4.251525959368826
A2058,439501,-1.4813488072157313
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
IGR-39,6610216,4.665927755877599
TUHR10TKB,135875424,4.420218264862005
JHUEM-7,26596,-1.8551798961299688
ChaGo-K-1,44491742,3.5931231049771126
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
HCC1438,9903786,3.876774477069639
NCI-H522,135423438,2.202740699610144
BICR 22,107985,-3.867593954539223
MHH-NB-11,selumetinib-GDC-0941 (4-1 mol-mol),0.4891965075201672
Detroit 562,JQ-1-carboplatin (1-1 mol-mol),0.26349976511481
Hs 729.T,107985,-3.631652767547101
NCI-H2023,439501,-1.9243866702684376
RCH-ACV,3689413,-1.349996625899334
CL-11,148198,-1.969557000481989
NCI-H2141,6610216,4.157777487639752
BHT-101,5460769,1.8781791917401816
Hs 936.T,36462,2.938435716058904
NCI-H2106,12003241,4.508121614525734
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
HT,135875424,2.176006504416359
NCI-H1341,36462,0.7775762591226743
HCC1937,439501,0.0308528134887005
ZR-75-30,135875424,4.922735562927052
2004,148198,-5.483041404726115
DLD-1,9903786,2.1877560593252343
TUHR4TKB,8515,5.826936165080946
LP-1,12003241,-0.1215623944522291
SK-MES-1,44491742,3.681896184622424
SNU-308,9877608,6.965514964870985
MHH-CALL-3,409805,3.975278749178219
SNU-1076,148198,-1.9796071848582624
PC-14,36462,2.3416403863743125
NCI-H520,10296883,3.906496007421639
VMRC-RCZ,11485656,3.731080366455795
ES-2,6610216,4.8266103176713155
MOLT-16,5460769,0.1124317409166702
DMS 53,6610216,3.0530173121612
OV7,6505803,-2.17823489191902
SNU-46,6610216,4.54643046921205
SNU-5,9936388,-5.37483340979982
NOMO-1,6505803,0.1224616163714439
KATO III,9903786,1.8271137188030744
JHUEM-3,148124,-5.835498657888768
YKG-1,6505803,-0.4747915631752394
HT-144,409805,5.790862994048412
SF126,148198,-2.289398797231852
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
YKG-1,36462,2.1375754999523915
Hs 611.T,6505803,0.4096396664447451
HuNS1,5460769,0.1719707153677664
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
SNU-182,6505803,1.4884406130314256
LXF 289,5460769,3.06478422280727
SUP-M2,3689413,-3.139623723794694
Namalwa,JQ-1-carboplatin (1-1 mol-mol),-0.7629380597950661
CAL-54,107985,-3.8206342608889856
AsPC-1,8515,4.986545700595871
SNU-407,10296883,3.619724008843853
KE-97,159324,0.6978324022921536
RMG-I,12003241,-2.7782598646997414
HCC95,107985,-2.9954438316062784
HCC1500,6505803,-1.3038553273576796
OVSAHO,9903786,3.817356196338304
CAL-62,9936388,-6.3411138463637
OCI-M1,439501,-2.6275325883029135
MDA-MB-435S,12003241,-1.2560113103811834
Toledo,11485656,1.9100858445006503
HCC1428,3689413,0.0072798037629334
KNS-62,135875424,2.885043849551813
NCI-H2141,3689413,-3.646913366295815
SK-MES-1,9927531,5.425786603716899
NCI-H1793,54618164,4.479745006931856
KMS-20,11485656,2.050412836201762
UO-31,12003241,-2.005680138773524
LOX-IMVI,8515,4.202942492571131
BT 228,3689413,-1.5659127438457598
NCI-H1734,9903786,1.4575898804478404
JVM-3,44493528,3.702239764390707
BHY,439501,-2.5036111867595823
CAL-33,36462,1.471703857493851
SNG-M,49836020,6.278284295689695
MDA-MB-468,54618164,3.7873537253294582
NCI-H2141,107985,-3.815362487743321
BT 139,6610216,4.145166206340405
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
Lu-99,135423438,2.1448370442307865
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
NCI-H1155,54618164,3.6742411601668103
P-STS,JQ-1-carboplatin (1-1 mol-mol),0.9856003461730172
AsPC-1,44491742,4.429887143828186
BICR 22,10296883,3.888864516393213
SNG-M,107985,-2.904988920711604
DMS 273,148198,-4.27913692458833
U266B1,135398744,6.53135676756175
CW-2,409805,5.860844498475822
A-204,44491742,4.019063545989705
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
NCI-H2342,10296883,4.213291341725321
NCI-H1694,107985,-3.656333029767555
BCP-1,26596,-2.6141791098451934
DMS 114,135423438,1.5631091750684547
SNU-C2A,3689413,1.145907285408548
A-204,168313200,1.780434655173201
SNU-1,46943432,1.799656324239712
SET-2,46943432,0.0852924787187384
GI-1,148198,-4.209323868036209
BICR 18,9927531,5.5562254884624895
HT-1197,5460769,3.9110228695560223
VMRC-LCD,135398744,6.4569642970049
HDLM-2,8515,3.3185322051747836
COLO 201,168313200,4.336574610328967
COV644,10296883,4.09466699132534
Hs 766T,439501,-3.031090708237588
NCI-H211,26596,-3.016523907085459
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
KNS-81,36462,4.397643214325172
RERF-LC-Ad2,135398744,6.529632870190649
BT 504,54618164,4.1210357013114365
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
HOP-62,11485656,2.83083000651899
SNU-1105,24180125,2.926642387261466
JHH-2,409805,6.415305067677875
RVH-421,3689413,0.478404210346996
NB1,135875424,2.0724069361168
SNU-407,6505803,0.2782297431267146
HCC15,409805,6.461768980239098
KP-N-SI9s,439501,-2.735040326022903
BT 232,409805,5.8765116213530195
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
A2780,44491742,3.4077888459991774
MG-63,36462,2.529493271020798
U-937,54618164,3.75737767809936
GP2d,6505803,-3.22314968715238
KMRC-20,439501,-2.469138258710991
CAL-12T,9936388,-2.4849922514623417
EBC-1,10296883,3.5123553698394336
SK-MEL-3,9927531,5.047514354060135
Mel Ho,44493528,4.666691199289373
A-673,11485656,1.6006257465541904
Hs 888.T,selumetinib-GDC-0941 (4-1 mol-mol),2.8983060042425484
P-STS,9936388,0.552871605050304
NCI-H441,12003241,-0.5712831750055372
COLO 320,selumetinib-GDC-0941 (4-1 mol-mol),1.1921670353492264
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
VMRC-RCZ,135875424,4.757952332015436
IMR-32,8515,1.8895636486981031
TCC-Pan2,6610216,4.233730029946295
BT 248,9936388,1.117792201973615
639V,36462,1.8340665533004876
NCI-H520,9936388,-7.179601192363118
BICR 31,36462,3.088359748996336
Fu97,10296883,3.8261692245769776
SK-N-AS,9903786,2.5201816871089653
CAL-85-1,49836020,1.7789600466695898
HCC1500,44493528,4.240662848371031
NCI-H1944,148198,-1.2530067367581603
NCI-H522,148198,-5.538025476960186
BT 187,44491742,4.194091483119568
MIA PaCa-2,409805,3.7490389776997466
Reh,159324,-2.447992261106491
SK-MM-2,54618164,2.8377773675531923
KMS-26,9903786,0.9658613723306017
ChaGo-K-1,135875424,3.8110724271208656
SIG-M5,5460769,1.4726407580947376
JHH-1,168313200,3.802482776709686
CAL-78,148198,-3.3120211354405953
Hs 611.T,11485656,1.370862895697381
SJSA-1,159324,3.80895338828845
Rh41,3689413,-2.4330549607978984
CAL-12T,54618164,4.192765891794065
SNU-216,9927531,4.928854217015946
Capan-2,6505803,-2.2561135668737533
NCI-H226,6610216,4.973981761059399
COLO 680N,12003241,-0.3137141462022448
Hs 611.T,135875424,2.7263445003410536
BICR 16,148198,-1.045482158065907
HCC1806,26596,-2.125787428122878
OVK18,36462,1.291640660059096
T-47D,135875424,2.636297002166631
BT 145,44491742,4.062519071433911
BT 328,148198,-4.14614868661324
KP-2,9903786,4.272294010971456
RERF-LC-MS,3689413,0.4263782886644774
KATO III,44491742,4.678429550063523
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
CCF-STTG1,6505803,-1.8344087076537687
JHH-5,54618164,3.840567565900515
SK-ES-1,409805,4.963965303720412
EFO-21,3689413,0.1102098212077115
NCO2,439501,-2.4046294895536446
KMS-12-BM,159324,-2.1850115101348
HeLa,6505803,-0.0506022751267441
DMS 454,9936388,1.3137576899177168
LAMA-84,73707440,4.880808269322907
HT-1080,10296883,4.176429034595713
JHUEM-1,439501,-3.414887087046791
SK-MEL-3,44493528,4.418694031341945
LUDLU-1,9927531,4.97566245035899
SNU-475,54618164,4.914308151118064
P-STS,54618164,4.361832979605855
TE-4,selumetinib-GDC-0941 (4-1 mol-mol),0.9436267923396215
HCT 8,439501,1.4071558312094663
GI-1,168313200,3.205196000452743
KMS-28BM,26596,-2.75100842761318
NCI-H2029,5460769,4.253529576580681
COLO 668,44493528,4.28656407628961
DB,JQ-1-carboplatin (1-1 mol-mol),-0.32501810171376
SNU-308,24180125,4.244524360791015
SNU-1033,54618164,4.351406762339218
LS513,6505803,-2.1765779470092332
OC 314,135423438,1.699134190233343
NCI-H810,11485656,1.6227483490056236
SNU-840,135423438,2.360395222844115
CAL-51,24180125,2.8082301472193203
HCC1588,439501,-0.8839537477169336
EKVX,44491742,4.084576713807475
COLO 668,36462,0.6333115343562025
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
NCI-H2052,135875424,4.438161541518592
Rh41,9903786,2.3999141751709763
BL-70,6610216,3.096911873339395
COV434,148124,-5.833905283054875
MOLP-2,9903786,4.729359936369518
BT 416,3689413,-0.9545304181237728
KMS-12-BM,46943432,-0.1840385129667849
NCI-H2009,409805,3.859994247591149
EJM,6505803,0.0546883993617254
OVCAR-5,107985,-3.75072662127644
SK-N-DZ,107985,-4.521449423175934
SK-N-DZ,168313200,1.8110359561996645
BT 286,135875424,2.624951262486574
PK-45H,3689413,-1.0199295796729335
HCC2279,9927531,4.656852539502924
JHH-6,10296883,4.397827548560224
A-172,3689413,-0.4114318334262174
TCCSUP,9927531,4.77726983491798
639V,44493528,5.149647090541137
SEM,6610216,3.5318840364079302
Daoy,9903786,4.877795508066272
SNU-81,24180125,-1.7131691030529954
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
OV-90,409805,5.341612919811814
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
SK-MEL-2,409805,5.943118564665864
FTC-238,3689413,-2.1600357182012493
HDQ-P1,46943432,4.5128763102829
SR,44493528,4.089009709270584
MHH-CALL-4,36462,-1.0581366443015845
DoHH2,6505803,-1.0222007356583789
HEC-59,11485656,2.515586983262965
MPP 89,9927531,5.277486378374347
SNU-308,3689413,0.3406956707675037
OVTOKO,409805,7.558218507012755
HCC2279,409805,5.199241011512385
JHOS-2,44491742,4.089494767364973
NCI-H1734,409805,3.958491853493927
SK-N-DZ,JQ-1-carboplatin (1-1 mol-mol),0.6864490875129473
BT 271,selumetinib-GDC-0941 (4-1 mol-mol),1.6032684287566925
PE/CA-PJ34 (clone C12),6610216,4.323795888758034
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
Toledo,148124,2.3723667360022085
NCI-H661,6610216,4.875851858170822
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
NCO2,54618164,3.044626652273742
SNU-626,12003241,0.7059762795421864
SNU-719,24180125,2.565384193053944
SNU-201,439501,0.2163207704150155
NU-DUL-1,46943432,0.4481984329414775
EJM,44491742,4.208016925641279
COLO 800,409805,3.923609141822486
SCC-9,9927531,5.254709651648818
KMH-2,26596,-2.508510760962814
HeLa,107985,-3.0123177853339262
TE 617.T,11485656,1.686521614831033
SW579,10296883,3.762097839369787
NCI-H358,3689413,0.3269344418253172
MKN7,selumetinib-GDC-0941 (4-1 mol-mol),2.574249068911848
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
NCI-H226,9903786,4.103639248775795
SW1710,9903786,3.726951851848614
TF-1,11485656,1.7797633161963615
SU-DHL-1,26596,-2.3613305357908625
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
FU-OV-1,3689413,-2.180005064661593
COLO 320,JQ-1-carboplatin (1-1 mol-mol),2.160423517862895
Tm87-16,selumetinib-GDC-0941 (4-1 mol-mol),0.1421801276665628
U-118MG,9927531,5.792159501722103
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
SU-DHL-10,46943432,0.4674442611482768
JURL-MK1,selumetinib-GDC-0941 (4-1 mol-mol),-1.4981298966453434
BV-173,24180125,2.570278092429548
NCI-H1355,54618164,4.22021081173676
Ki-JK,54618164,3.0258651969868984
LOX-IMVI,6505803,-1.7860593354464098
HCC366,5460769,-0.0088365115150554
EFO-27,10296883,4.235346466258499
U-118MG,6505803,-0.4944359132104617
NCI-H1092,44491742,3.604656167614849
TT,JQ-1-carboplatin (1-1 mol-mol),3.4641930949375572
NB1,26596,-1.7417489155233454
SIG-M5,36462,-1.757249636998404
SNU-1,3689413,0.5302948396087109
OCI-Ly10,8515,4.645209912252783
EB1,135875424,2.5798652139486262
SNU-1033,49836020,1.7840304926095434
MOTN-1,135398744,7.842138367791958
KLE,107985,-4.625155684647364
LCLC-103H,54618164,4.386311073286264
Ki-JK,46943432,0.1274829489062179
TC-71,11485656,1.8010543407786783
L-1236,9903786,-0.7492109399697982
SNG-M,9903786,2.9432381601198427
EM-2,409805,3.6085049629545543
HCC1419,5460769,4.36793897247466
KMM-1,JQ-1-carboplatin (1-1 mol-mol),5.732885286738059
SK-N-FI,439501,-4.082548455414269
A101D,11485656,3.576115374437905
HEC-1-A,12003241,-1.9132267433224897
KYSE-410,135423438,1.615361831673466
NCI-H28,36462,-0.200152211841913
BICR 6,3689413,-0.1381327952499849
WSU-DLCL2,3689413,-4.959446620100962
LNCaP clone FGC,6610216,3.917804193778173
THP-1,46943432,-0.1371263588377964
NCI-H2106,6610216,4.1015975696039035
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
HCC2935,10296883,4.009305839829136
SK-LMS-1,12003241,-1.0710207153229787
COLO 792,148198,-2.6366713074255475
Ci-1,439501,-2.567904110965142
TYK-nu,54618164,3.99587115064654
JVM-3,148198,-2.4779915493019646
Karpas-422,5460769,4.127517160029383
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
AML-193,6505803,-1.7450029346129687
SF295,54618164,4.313739773462804
THP-1,JQ-1-carboplatin (1-1 mol-mol),-1.7291574226431643
CAL-27,11485656,1.6862238781390195
BT 422,6610216,4.133334878582925
PaTu 8902,135423438,1.708930423466824
SW982,3689413,-0.7945580289517821
SK-ES-1,5460769,0.8929417744322142
OCI-Ly19,3689413,0.0585798733039559
DLD-1,36462,3.118491670951203
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
Hs 294T,148124,-3.306910428366027
GCT,5460769,3.4482432173572644
A2058,107985,-2.639980801689558
MHH-CALL-4,54618164,3.885057071185027
SK-N-BE(2),36462,0.1963310505924975
EJM,26596,-3.57565028157041
SNG-M,12003241,-1.3269427590967688
SNU-1272,54618164,4.215546778710406
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
NCI-H889,selumetinib-GDC-0941 (4-1 mol-mol),5.471466100727687
HCC202,11485656,2.3105434374490734
G-401,5460769,-1.872739736028161
OE33,5460769,3.7320924588923465
SK-N-MC,6505803,0.6222225816137853
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
BT-474,54618164,4.811471489444681
NCI-H28,JQ-1-carboplatin (1-1 mol-mol),0.6583342429642598
COLO 201,12003241,-1.3508897145637075
SNU-1066,148198,-2.6456216345814636
RMG-I,36462,2.9909817181283556
SU-DHL-10,159324,0.0335286607858622
CAL-12T,3689413,0.6503456712736767
ZR-75-30,6610216,4.132835515037586
BT 187,6610216,3.657952430063432
COLO 680N,36462,3.5817544778318213
IMR-32,44491742,3.818890533402266
KO52,3689413,-4.063517257373306
HCC1195,12003241,-0.4871999069137717
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
SCC-4,36462,3.425512380164829
NCI-H1395,8515,4.661084548760473
HuP-T3,135875424,4.261865095251217
NOMO-1,159324,1.6027654254866297
SNU-1079,11485656,2.444580254592115
A2058,54618164,4.0086140430818755
HCC1438,26596,-1.656092804302775
RPMI-8226,9936388,-6.980714667404577
Hs 944.T,135875424,1.9575051690352112
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
IGROV-1,135423438,0.764137689665023
NCI-H1341,439501,-2.6104164072221168
SK-BR-3,107985,-3.8808400341324543
BT 228,54618164,3.930760792437564
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
OCI-AML-5,11485656,1.9457799090606884
HCC1588,11485656,2.115335412589631
SW948,6505803,-1.4287073835677784
8-MG-BA,12003241,-0.0474192028844215
RCH-ACV,44493528,4.3115996529369705
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776
TALL-1 [Human adult T-ALL],10296883,3.2857162294996933
Rh30,24180125,3.823310947482733
Detroit 562,6610216,4.0643326669057505
NCI-H2405,54618164,4.576696764939436
KO52,44491742,3.2759729423779103
NCI-H526,JQ-1-carboplatin (1-1 mol-mol),2.899547040421834
Kasumi-2,148198,-6.27183434225638
KYSE-450,168313200,3.958386537902572
23132/87,36462,0.0399526858663723
CHP-212,135423438,1.6303147778889178
22Rv1,54639024,4.398565706055689
Kasumi-1,12003241,-2.8903721425855284
WT2-iPS,24180125,3.3778109257931086
TUHR4TKB,44491742,4.24148356171105
DBTRG-05MG,8515,3.42193819135595
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975
T-47D,9936388,1.741664063669155
NCO2,5460769,1.276478801243687
SNU-878,159324,3.1522028257412864
NCI-H1869,135875424,4.489996634847175
CMK,168313200,3.916925914759029
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
Hs 746.T,44491742,3.728027076014932
KMS-12-BM,11485656,1.287590694324435
NCI-H1339,168313200,4.075069570376525
NCI-H2170,11485656,1.87102057919161
BICR 31,9936388,2.7244047649519074
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
SYO-1,46943432,-0.013424201476548
BHY,selumetinib-GDC-0941 (4-1 mol-mol),0.2537821037586068
COLO 668,12003241,0.007541298710802
MHH-CALL-3,3689413,-1.9959162007922513
GSS,148198,-4.278267230656994
LOX-IMVI,9903786,2.476339692878584
NCI-H23,JQ-1-carboplatin (1-1 mol-mol),0.4166506199838714
IM95,6610216,4.228352536403903
MKN74,24180125,3.4034235920876648
NCI-H1703,44491742,4.242219664453596
MKN7,107985,-2.3572369506787036
M-07e,49836020,-3.7990494796960337
COR-L51,148198,-5.724973954604913
MJ,36462,-0.8152461099885887
NCI-H1155,3689413,-1.8427844176402348
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
TYK-nu,49836020,4.345378886251337
Sq-1,selumetinib-GDC-0941 (4-1 mol-mol),2.237150148829387
KYM-1,26596,-1.5759790260808906
COLO 320,10296883,4.10892826768056
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
LoVo,159324,-0.9516179858777442
HuNS1,12003241,-0.810335190638815
SNU-410,409805,5.168065352202116
NCI-H520,135875424,4.041449952679746
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
DB,10296883,3.486914708564097
TT2609-C02,54618164,4.21791188620747
HeLa,439501,-2.848382287027866
IGROV-1,409805,5.990596261907717
GI-1,44493528,4.237962570742694
HT-1376,439501,-0.8291876191032579
RPMI-8226,44493528,3.728684145979083
BFTC-905,439501,-2.3282671970513524
ECC10,3689413,0.143670384150019
Lu-99,9927531,4.1215148534256105
LOX-IMVI,44491742,5.895851784959737
Caki-2,9936388,-5.25151724619499
HSC-4,9936388,2.361545024779824
NCI-H1623,10296883,4.489600285768525
Yamato-SS,36462,3.621475553611929
EM-2,46943432,-0.289227345087642
T84,107985,-5.262211423380302
HCC44,49836020,-1.9143926504163185
RL,10296883,3.466522300927401
KYO-1,6610216,4.320602748188163
TE-10,9936388,-5.117656284676294
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525
Ri-1,12003241,-5.9425936829646435
HPB-ALL,11485656,3.05569165174981
NCI-H1693,409805,4.770245399026225
Jurkat,44493528,4.481797817086125
JIMT-1,11485656,3.0502841230880327
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
RCH-ACV,9936388,-7.0347905205950765
Ri-1,JQ-1-carboplatin (1-1 mol-mol),-0.4957222903174305
Mino,5460769,1.2525165030578538
ALL-SIL,12003241,-5.746631994241774
REC-1,3689413,1.860618150322578
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
D283 Med,3689413,-5.066385831563446
HCC38,44493528,4.3442022500374815
HCC2218,135875424,1.4940742692763715
BT-16,12003241,-1.8198494997272787
A-549,6505803,-0.295425809550202
DEL,6610216,4.0677868970779025
MDST8,135875424,6.383148165610491
RMG-I,6610216,3.921958740256552
RERF-LC-Ad1,12003241,-0.821513059069255
SNU-1079,9936388,-2.1340211532610636
JVM-3,3689413,-1.6537581501619123
HCC38,10296883,4.206787389129117
NCI-H1573,selumetinib-GDC-0941 (4-1 mol-mol),-0.038011367109904
OVCAR-5,148124,-4.373802935738603
HGC-27,10296883,3.371644583045061
KP-N-SI9s,3689413,-0.3839516560951015
NCI-H2286,107985,-4.428916091949213
SW1710,26596,-1.5930178898936072
SCC-25,11485656,1.624439793066487
NH-6,54618164,4.061108771946247
JMSU-1,6610216,3.9610283464836047
HEL 92.1.7,10296883,3.579285339073021
GDM-1,9936388,-9.102246983309657
SNU-C5,54618164,3.725409858172283
GSU,3689413,3.217966232949248
HuP-T3,107985,-4.90392348596967
EFO-21,6610216,4.722092549752213
Panc 03.27,44493528,4.213944098974542
RPMI-7951,135875424,3.929226739625062
BT 440,3689413,1.7448809021086664
NCI-H2087,11485656,1.6190221901711597
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
COLO 699,159324,2.737921515065639
MDA-MB-415,107985,-3.405012569202664
KMS-21-BM,12003241,-1.038159466289584
647V,46943432,2.2252821644532816
NCI-H1734,135875424,3.3840426001662727
SF268,selumetinib-GDC-0941 (4-1 mol-mol),2.7601032387039433
A-204,409805,5.78694452018541
MKN74,11485656,1.8439400608742984
NCI-H1299,6505803,-0.2534280947368875
Hs 888.T,11485656,1.7034904053704143
Yamato-SS,11485656,2.8272369805427435
HCC1143,36462,4.303888689757339
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
BICR 16,3689413,1.5183083645706292
HCC1569,5460769,3.8365065781624255
HCC4006,11485656,1.7497368979267094
HT-144,5460769,5.183826263672234
NCI-H2228,11485656,2.3007848748427184
HCC1143,3689413,0.0716522323698814
Ri-1,107985,-4.133158976783472
LOU-NH91,135875424,2.9424536382603215
SW579,135875424,4.01544080394069
OVISE,439501,-2.343202219776273
NCI-H2087,3689413,-1.4883160931257695
Calu-3,12003241,-0.8682368391192625
ME-1 [Human leukemia],46943432,3.4269165120424776
HuH-6,107985,-3.2482974624876175
IGROV-1,148198,-2.659972993252853
NCI-H1395,44491742,3.9607165302769514
CAL-33,8515,3.894510124825054
OV-90,36462,2.4384690112919793
HuT 78,11485656,1.3035734242835073
NCI-H196,3689413,0.3068410473600975
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
NCI-H2029,107985,-4.717829684480381
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
HPB-ALL,6610216,3.95852106841488
FTC-133,135398744,6.510037604259866
NCI-H747,409805,5.162158430196502
NU-DHL-1,54618164,4.2613527063162895
PLC/PRF/5,9927531,3.33785239114395
SNU-1196,36462,2.608286274647309
Detroit 562,5460769,3.1492937743842724
JHH-5,148124,-1.4571127407180036
A-204,46943432,2.665226658704685
Hs 852.T,JQ-1-carboplatin (1-1 mol-mol),1.014033031882682
NCI-N87,148198,-3.7864178683693774
Ri-1,44493528,4.227657049972306
CGTH-W-1,409805,4.778168346758229
HGC-27,439501,-3.477587502070629
KO52,54618164,3.705714044840163
DV-90,36462,-0.1530229688681401
Panc 04.03,9936388,2.385451093408398
GaMG,54618164,4.23185750242406
SK-MEL-24,9936388,-2.668445536248577
NU-DUL-1,107985,-4.8298197755406935
EBC-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.174699743525061
RKO,3689413,3.093382349703003
Karpas-422,44493528,4.27188958418413
COLO 829,selumetinib-GDC-0941 (4-1 mol-mol),-1.0343545456738177
NCI-H1355,9927531,4.199887735428921
OS-RC-2,409805,6.365104149544731
SUP-T1,107985,-3.4385434341277565
KMRC-2,409805,5.9581282148190855
NCI-H526,135875424,3.753853230919886
SUP-M2,107985,-5.103168602095624
Rh41,36462,0.7491505234443768
5637,409805,4.649585035607563
K-562,107985,-3.1543528536618175
A-549,54618164,4.216271974260082
MES-SA,148198,-4.473330928142554
U-118MG,135875424,4.484841768193188
Sq-1,6505803,1.095913417774702
FTC-133,148124,-3.926787463073679
ZR-75-30,3689413,-2.2209436804776805
DBTRG-05MG,439501,-1.6362214385175518
LCLC-103H,9903786,3.9967722976793696
SNU-761,439501,-2.8080514994136
BT 239,8515,3.59714906944717
HCC1500,3689413,-1.6712109221216571
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
KMS-34,107985,-4.800473220860728
TE 441.T,44491742,3.759624787095016
TE-4,6610216,4.0741132889098655
EoL-1,24180125,2.1114997357358485
SU-DHL-1,135875424,2.8587183873170847
AML-193,44491742,3.5122021187729184
SYO-1,11485656,2.328444383399514
NCI-H1650,selumetinib-GDC-0941 (4-1 mol-mol),2.5973614834330965
T-47D,selumetinib-GDC-0941 (4-1 mol-mol),3.2531063352612697
HCC1395,135875424,6.03600729555728
RPMI-8402,46943432,1.849232999724565
MHH-CALL-3,10296883,3.858328954118167
HD-MY-Z,12003241,-2.342795911905131
BT 286,12003241,-0.6969940125697452
Detroit 562,24180125,2.391091053779096
A-204,135875424,2.7744609418453887
HEC-251,selumetinib-GDC-0941 (4-1 mol-mol),3.2910402284708757
NCI-H1568,24180125,3.319632294157453
DU145,409805,7.850532015731276
A2780,6610216,3.3472253004646593
BT 145,54618164,3.7075953123228538
SW579,9903786,2.7100621017301516
NCI-H23,24180125,3.1166872284315894
TCCSUP,12003241,-0.9458347981681208
SNU-1077,12003241,-1.4220834787906382
CAL-51,159324,3.1794720270506307
Mel Ho,6610216,4.549497934194354
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
BT 245,168313200,2.0916764208189895
Mel Ho,selumetinib-GDC-0941 (4-1 mol-mol),-1.3923525506877812
A-549,8515,3.6622074868184464
IMR-32,12003241,0.5902035807991148
SK-MEL-1,107985,-3.868431540150408
RCC10RGB,135875424,5.859031260595621
NB4,135875424,3.6399380221617936
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
NCI-H1573,135875424,3.6449998804885064
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
PaTu 8988s,9936388,0.6570193749634515
JK-1,44493528,3.0964737259791812
BT 145,selumetinib-GDC-0941 (4-1 mol-mol),0.1649490649734122
SNU-C1,6505803,-1.67895267377521
Panc 04.03,54618164,4.2869772681873695
JHH-6,409805,5.874382301544695
BFTC-909,439501,-2.4866456286351095
HSC-3,36462,2.0858436100123847
KP-N-SI9s,6610216,4.1110809925176
SJSA-1,6610216,5.447146070074806
RPMI-6666,439501,-2.7068928395348935
KU-19-19,44493528,4.383684457454455
TE-6,10296883,3.6280455791463098
TE-10,3689413,-0.6087813624831553
SNU-489,9936388,2.9211262102294246
CHP-212,36462,-1.1784349371893996
NCI-H1693,148124,-1.129654365554156
QGP-1,44493528,4.309319516194894
IGROV-1,135423438,0.764137689665023
MFE-296,54618164,4.2521808435378805
RD-ES,12003241,-1.2305184687153958
SET-2,JQ-1-carboplatin (1-1 mol-mol),-0.9059473366978348
GSU,12003241,-0.2864311193180854
DMS 114,JQ-1-carboplatin (1-1 mol-mol),1.3957333814923674
Hs 729.T,409805,3.7605172739266655
EoL-1,36462,-3.6767399444136464
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
BT-16,54618164,4.087299705518295
OV56,10296883,4.933118307038668
OCI-Ly19,9903786,1.1452071440663905
JHH-1,107985,-3.0623416548282516
K-562,10296883,3.719487542859837
HDLM-2,9936388,-6.699544688001925
Hs 888.Lu,10296883,4.303649203246193
L-540,9936388,-1.294007802651234
NH-6,9927531,5.219237358239311
HCC2935,6610216,4.132006404666087
LS180,12003241,-0.6460664270988897
GOS-3,148198,-2.930015056129616
DMS 273,135875424,3.231864587804135
HuG1-N,9903786,2.6577848330965
COR-L88,3689413,0.2810588861379679
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
LOU-NH91,9903786,3.184012464559237
BT 482,5460769,4.579365975157546
HOP-62,6505803,-0.0366684489798773
SK-MEL-1,JQ-1-carboplatin (1-1 mol-mol),3.273117082595556
GB-1,409805,6.386301326274494
HCC1500,9927531,5.051014893697188
P-STS,168313200,3.851827102868452
TT2609-C02,12003241,-1.0431647024866548
JHH-1,JQ-1-carboplatin (1-1 mol-mol),3.3935500836468764
BICR 6,5460769,0.6237785323656337
647V,3689413,-0.9737590954891844
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
LMSU,168313200,4.186982561512388
NCI-H23,8515,4.438139635205895
Lu-99,3689413,0.965763177110082
KMS-11,9903786,1.9090096011276083
NCI-H2196,49836020,4.894055204627393
SUP-HD1,439501,-1.483428569132062
KMS-12-BM,3689413,-2.359728446736426
BL-70,168313200,1.5744509256656225
NB1,168313200,2.740392825488863
NU-DUL-1,8515,2.6851290714182543
VMRC-LCD,135875424,4.154555639991533
LS1034,8515,4.162892919499596
TE 617.T,409805,3.5642990209893024
MOLP-2,135875424,4.772032025808402
GSU,9903786,4.148563338701872
EPLC-272H,3689413,0.721701872436853
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
BT 428,148198,-5.072102147760655
PK-59,107985,-3.7968575257166495
OC 314,135875424,2.7859307759569467
SHP-77,3689413,-2.4730953136867297
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
HDLM-2,107985,-3.6724604658720623
IPC-298,3689413,3.077795295387571
KNS-42,409805,5.857508375467912
B-CPAP,148198,-2.876725444252461
Granta-519,409805,2.9966967612339417
HCC38,6505803,-2.5112247246736787
VM-CUB-1,6505803,-3.0574642511129833
RD,6505803,-1.3634143694838363
TE-1,49836020,4.425156685624386
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
CAL-85-1,135875424,4.15034145684821
BT 271,439501,-3.3712164407205916
HCC1500,6610216,3.984830656845064
SNU-719,409805,4.713440373446098
NCI-H929,26596,-1.2167182000669836
Kasumi-1,6610216,3.889187786361685
DMS 114,12003241,-1.1763340491850245
NU-DHL-1,44491742,4.098367852004394
Calu-3,JQ-1-carboplatin (1-1 mol-mol),2.436391578693632
RERF-LC-A1,5460769,2.531170153978
KP-N-YN,9936388,1.912535006220544
MOLM-13,8515,0.8268618162227004
SNU-1077,24180125,4.514438880816518
CCF-STTG1,24180125,3.0142725993324064
NCI-H2405,selumetinib-GDC-0941 (4-1 mol-mol),-1.6328323472989523
LS513,JQ-1-carboplatin (1-1 mol-mol),4.102727759059396
A2780,135423438,1.4521240670524396
HCC44,3689413,2.49151375476088
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
SNU-478,9903786,1.906264308135136
NU-DUL-1,JQ-1-carboplatin (1-1 mol-mol),-0.6986861691391648
HCC1428,9927531,5.49162668491902
OCI-Ly3,36462,-1.349949194465581
BICR 18,6505803,0.1715229764566586
MSTO-211H,46943432,4.749068259324704
KMS-18,9903786,2.604638475406196
GCT,439501,-2.020397475807145
Hs 729.T,24180125,3.283852866352467
MOLT-16,439501,-2.6339721487362775
NCI-H1568,168313200,3.516432771095034
P3HR-1,44493528,4.479492051657015
BT 216,selumetinib-GDC-0941 (4-1 mol-mol),3.6929291774805177
Detroit 562,11485656,1.622258504820096
Caki-2,107985,-3.705552980163056
NCI-H841,148198,-4.970110895605647
647V,selumetinib-GDC-0941 (4-1 mol-mol),1.2881187017164255
NCI-H1869,409805,5.751744182014799
GP2d,11485656,0.5695398212792343
FU-OV-1,10296883,4.259179003182187
TE-5,3689413,-3.902523210420284
L-1236,159324,2.5881501762218972
Hs 766T,44491742,4.434347985078199
UM-UC-3,11485656,2.116231508741626
U-251MG,6610216,4.237415282438965
A-673,135423438,2.29660224903782
SK-N-BE(2),135398744,6.372852995200929
HCC15,439501,0.3030845703669018
HOS,12003241,-0.4852200240623472
MHH-CALL-4,409805,3.699144877236461
NCI-H650,6610216,4.436979197607946
BT 248,3689413,-0.3734654016267222
Capan-1,107985,-4.358554315773558
MCF-7,11485656,1.7556597591503045
ESS-1,148124,-6.743563487136813
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
HCC1833,11485656,2.071891952669738
TOV-112D,10296883,4.52965667337078
U-87MG ATCC,24180125,3.962930986053808
SK-N-SH,107985,-2.488646937508133
F-36P,54618164,3.98982096718309
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
ST486,24180125,1.1737019727020874
TE-8,107985,-3.1643692279540026
HCC202,107985,-1.8930247098179032
NCI-H1703,12003241,-1.7949432370006393
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
KM12,439501,-0.9697085854354284
HMCB,24180125,3.3063760805557054
SK-OV-3,8515,5.143916520422132
P3HR-1,JQ-1-carboplatin (1-1 mol-mol),0.4067249254374854
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
PLC/PRF/5,168313200,3.731927316813972
LNCaP clone FGC,148198,-3.4579469990265124
SNU-308,6610216,4.383994283569161
BT 187,11485656,2.779756722479281
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
RERF-LC-A1,6505803,-1.6574767095757488
MCAS,168313200,3.057905648422764
U266B1,439501,-2.1640561417805686
SET-2,107985,-4.483879722090849
NCI-H69,54618164,2.7748520187560413
JHH-4,9936388,-5.466111968240916
COLO 201,107985,-2.8036862489291066
NCI-H1703,5460769,1.9042192719561193
HLF,6610216,4.251232152723098
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
DMS 454,9927531,4.138491843589823
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
BT-16,9903786,2.8143760707131347
Karpas-422,3689413,0.6826110279753447
Karpas-299,9936388,-6.586031756730676
769-P,159324,3.698580047376789
TT2609-C02,439501,-1.3899506791900362
HL-60,6610216,4.340783872079224
Hs 683,26596,-1.91567083647516
M059K,6610216,4.531022301416725
SaOS-2,3689413,0.0712794264513353
NCI-H1975,9936388,-7.660165830996957
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
CAL-27,439501,-1.3320445705497543
SNU-840,107985,-3.1383267361145335
HCC1833,9936388,0.4384818253571875
DMS 273,107985,-4.548014092027974
RKN,6610216,4.220445612403551
L3.3,3689413,1.7908878640591075
22Rv1,5460769,4.1007004291064675
COR-L88,12003241,-0.20090693258686
MPP 89,168313200,2.3014494159332815
NCI-H522,26596,-2.5500947066960276
OVK18,12003241,-0.5661348884613613
SU-DHL-10,107985,-4.179844199483331
ECC10,409805,3.5176729125359123
SNU-685,148124,-0.1872847523301088
SNU-216,3689413,1.0802163076061988
Karpas-620,24180125,3.3567090385415477
EM-2,54618164,3.877558145692375
IGR-1,JQ-1-carboplatin (1-1 mol-mol),-0.2178346273954091
NCI-H1703,3689413,-2.562471575946014
SNU-761,6610216,3.8236120023734497
NU-DUL-1,6610216,3.840354315421099
HuT 78,26596,-1.9929249611117947
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
CAMA-1,107985,-3.014648742580285
EHEB,24180125,1.8891722665908557
HuH-6,3689413,1.6433341745909646
SW620,439501,-1.8970460757593473
NCI-H1694,409805,3.645232485938763
T24,168313200,2.990559857289937
TOV-112D,439501,-4.317689883213593
DAN-G,6610216,4.336631036034785
A101D,6610216,4.171778403451026
SK-MEL-1,46943432,2.617200117528874
JHUEM-2,5460769,-3.615295030871829
HGC-27,6610216,3.4161175560596244
HCC1395,24180125,2.442140570538284
AML-193,12003241,-1.5379973109398848
CA46,135423438,1.6657304721140649
SNU-478,26596,-1.226862251098003
P3HR-1,409805,3.946032344990011
OC 314,168313200,2.155060879424653
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
ME-1 [Human leukemia],3689413,-2.217252079013703
HSC-4,135875424,3.4627713632233537
MEC-1,9936388,-8.61875613599576
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
Ki-JK,11485656,1.8508993883264373
KYSE-30,8515,5.061057481415257
BT-16,6610216,4.321968186952469
LAMA-84,24180125,2.7759007450862065
HD-MY-Z,135423438,3.7471437497344713
BICR 18,46943432,4.49639593671617
TUHR10TKB,JQ-1-carboplatin (1-1 mol-mol),4.175841940785285
L-428,selumetinib-GDC-0941 (4-1 mol-mol),3.762194755166614
LS513,9936388,-5.267981088058912
23132/87,5460769,0.87100881863978
ACHN,36462,1.8555718413800224
HEC-265,49836020,-5.012817345393805
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
Lu-65,409805,4.990129571781812
TE-5,12003241,-1.2234174090075007
NCI-H1184,44493528,4.250778003560126
HCC1569,107985,-2.9750377581153353
DAN-G,6505803,-1.4113382946218047
JK-1,9903786,1.7060026782988165
LC-1/sq-SF,44491742,4.404829993178961
GI-1,JQ-1-carboplatin (1-1 mol-mol),0.4755278036860928
HMC-1-8,26596,-1.609914747159897
GCT,8515,3.4172979303744175
UO-31,9927531,3.0316635123485693
SK-MEL-31,10296883,4.185495056611244
SW982,168313200,3.252090363192236
NCI-H1373,148198,-1.3691101479869838
BT 416,10296883,4.010101282848487
PC-14,159324,4.972641562462416
Raji,168313200,3.851087858415495
NCI-H727,5460769,4.510942150258337
L-428,148124,-3.3272903068622965
TUHR4TKB,107985,-3.5922280994521407
BT 444,6505803,-3.5785929274286694
LNCaP clone FGC,12003241,-1.977151768552247
OCI-Ly3,10296883,3.058188630852339
NCI-H522,135875424,3.5456342124976445
KHM-1B,12003241,-0.9345261470540068
COLO 668,135398744,8.327897360354253
NCI-H2228,36462,2.406587898355439
NCI-H211,selumetinib-GDC-0941 (4-1 mol-mol),1.1345350253302544
KLE,12003241,-1.9975693903430911
NCI-H2106,44491742,3.3894720811903976
LK-2,selumetinib-GDC-0941 (4-1 mol-mol),2.476952398707666
KATO III,168313200,2.8684670433977293
SNU-216,9936388,0.9315958331188322
SNU-478,148198,-2.0757049952791835
DK-MG,107985,-2.9987178051865593
G-361,JQ-1-carboplatin (1-1 mol-mol),0.286360842929743
VMRC-LCD,12003241,3.8307047822357343
BT 333,selumetinib-GDC-0941 (4-1 mol-mol),3.256611594261358
OV7,44493528,4.3650629685356055
SNU-1079,46943432,-0.9154654720433444
AU565,135875424,4.732736146663846
SK-MES-1,JQ-1-carboplatin (1-1 mol-mol),2.3477622395388495
CAL-12T,24180125,3.1463232755179225
OPM-2,409805,3.1459770002319023
T98G,148124,3.910493124351062
NCI-H2029,439501,-1.7622660866331608
NCI-H322,44491742,4.376212292863665
EoL-1,135423438,-6.8618615828632565
UM-UC-1,9936388,-3.585062742404864
DU4475,148198,-7.890760961486606
BT 231,44491742,3.9496827176131384
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
BT 320,168313200,3.0477072720221936
BT 179,5460769,5.470437683574026
HCC78,159324,3.9487688063657505
KALS-1,44491742,4.207872917974877
HMCB,135423438,4.419625220654583
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
RERF-LC-A1,135875424,3.889170235593284
CAL-51,9936388,-5.638746232401389
MDA-MB-453,54618164,4.967166731196573
Ri-1,9936388,-7.695738985409057
SW1353,159324,5.365297966496093
RT-112,6610216,4.21284209237931
HCC1500,11485656,2.6610961572019103
Karpas-299,439501,-2.5701669510398717
HOS,6610216,4.706108734526838
DMS 454,3689413,-0.1217907891040976
MG-63,135875424,4.139194892831929
RD,54618164,3.8582073092246394
DMS 79,44493528,4.912262221382906
BT 416,6610216,3.4319544702554405
NCI-H747,selumetinib-GDC-0941 (4-1 mol-mol),-3.828774406071909
BT 139,107985,-2.6737543341342316
HeLa,26596,-2.0330393314508868
A-673,8515,3.2253171108003023
DEL,26596,-2.2766928538396916
MCAS,9936388,-6.436874065356807
NCI-H1666,JQ-1-carboplatin (1-1 mol-mol),-1.0019835803629806
HDQ-P1,135875424,4.477728258448439
SK-N-DZ,36462,1.81042272439934
OCI-AML-3,439501,-3.711408671836436
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
SNU-1033,9936388,0.9211545103072076
BICR 56,9927531,5.497555124114839
NCI-H2052,36462,1.2640077105319876
DLD-1,11485656,2.3568944712776565
NCI-H1563,168313200,1.7986120411813236
AN3-CA,107985,-2.3733374503146414
NCI-H522,44491742,4.766943404170333
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
KP-N-YN,9903786,5.5444671223667825
MOLM-13,135423438,-5.2048777869707035
MOLM-6,8515,1.9113684591576323
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
MOLP-8,44491742,4.067907034019371
TOV-112D,9927531,5.049724327124321
U-937,9903786,1.2748798795403693
U-937,44491742,3.930782705930826
CHP-126,107985,-3.8801620613703087
253J-BV,159324,4.026452181971724
KMS-11,10296883,3.3073702256130693
JHH-1,9903786,3.3314474186941987
NCI-H841,3689413,-2.418219785730911
NCI-H661,6505803,-0.5859050253944337
HCC1143,9903786,3.3387804215378885
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
BT 340,5460769,6.248142012309782
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
TE-9,6505803,-0.9474092806204982
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
MeWo,9927531,4.558706173548934
SK-BR-3,9936388,-7.247395712922041
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
IGROV-1,6610216,4.310938387105607
KP-3,6505803,-1.05905255098836
OCI-Ly19,49836020,4.441664761754026
BT 228,9936388,0.9371184139441866
NCI-H226,409805,8.210178607703003
Hs 611.T,439501,-3.691204716302381
KYSE-520,44493528,4.570249805498521
BT 482,selumetinib-GDC-0941 (4-1 mol-mol),-0.4370874918517858
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
HT115,9936388,-5.559170111556583
DOV13,439501,-2.3645646799051754
HCC95,46943432,1.698230106706683
HuH-1,54618164,4.0584707784703635
SNU-620,409805,3.844199200919608
BT 504,148198,-4.360319644130701
SNU-8,54618164,4.22532753412944
SW948,5460769,-0.6640669541383749
ESS-1,10296883,4.371449070908232
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
UM-UC-1,135423438,1.3266275240072287
NCI-H647,6505803,-1.8408777306089303
COV644,11485656,2.222554358198117
UACC-62,107985,-2.9026849237328056
BICR 6,6610216,4.773782205197453
SNU-182,135875424,3.9739141814992056
HCC202,44493528,4.2464995661804235
NCI-H1435,9936388,0.980131608638386
DOV13,9936388,-0.6150425956780249
TE-8,6505803,-0.116387849534283
A4/Fukuda,5460769,3.0365194168079572
CL-11,44491742,4.051585264115174
Hs 688(A).T,9936388,2.197824687815799
A-172,10296883,3.776077319077153
COLO 680N,24180125,3.9685709218959744
HDLM-2,6610216,4.231283339415114
L3.3,8515,4.3523389716154455
HCC38,439501,-2.3943608626526536
COR-L105,148124,3.589067174421039
KP-4,135423438,2.950077613704309
U266B1,5460769,3.751565438771286
BT 172,439501,-3.021522386524776
MDST8,3689413,-1.6812703512916511
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
KMBC-2,135875424,3.177506278142116
LS513,159324,2.72198596150407
ME-1 [Human leukemia],159324,1.0154515833105568
BT 216,148198,-4.022421369072414
SIG-M5,46943432,-0.2982882437064111
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459
SK-CO-1,11485656,2.076616779710352
Hs 746.T,6610216,4.135271582579114
COR-L105,168313200,3.683873258385797
UM-UC-1,24180125,4.853668448035656
HT-29,6610216,4.713436573815237
TM-31,135875424,4.624744892996729
COV362,409805,3.5645157683747493
NCI-H2171,9903786,1.7901794952315444
NCI-H1755,409805,5.780114258541939
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
CAL-85-1,168313200,1.8264576279866271
CJM [Human melanoma],6610216,5.096973872510674
P3HR-1,44493528,4.479492051657015
ECC10,9927531,3.415986585333862
Lu-99,selumetinib-GDC-0941 (4-1 mol-mol),1.1181366334842004
CML-T1,9903786,2.526700219209825
HPAF-II,12003241,0.935672122739968
Reh,3689413,-0.3766335135286286
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
NCI-H1105,3689413,0.7120747688732703
KP-2,409805,5.00023719878481
BT 444,12003241,-0.4351069615199688
UO-31,3689413,-5.037713706278837
NCI-H2081,148124,-3.831662126446776
BT 239,12003241,-1.4894008844853184
CFPAC-1,439501,-1.9750103172149232
MKN74,168313200,3.6921900787072737
HCC1171,9936388,2.426947381666507
RT-4,54618164,3.1267558882512803
PC-3,409805,6.300814856028665
SUP-B15,135398744,6.752582090660733
SW1710,11485656,3.0628562061109976
TUHR14TKB,36462,3.356624970040771
Calu-3,6610216,4.332815727966212
BT-20,5460769,5.85454688440853
MOLT-16,6610216,3.5275636853369097
HEL 92.1.7,168313200,5.297199343733881
HuH-6,26596,0.8914215652548961
ONS-76,11485656,2.5953354109263262
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
BC-3C,54618164,4.2924903991284395
Kasumi-1,409805,3.430616862172681
NCI-H2342,409805,3.827518181723478
KYO-1,10296883,3.465187781350624
Rh41,46943432,0.9288175147210126
Raji,26596,-2.574302974428465
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
BT 159,6505803,-0.0386292738928562
JJN-3,9936388,-8.876764475546423
G-361,36462,1.8201725237050903
RKO,54618164,4.0326978900214705
DoHH2,12003241,-3.729445034849217
OCI-Ly10,168313200,3.867652157943873
NCI-H1155,24180125,4.048296338692506
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
JHH-5,24180125,3.480923085252071
A-673,44493528,4.641329710074662
NCI-H1373,168313200,3.9826413133900544
CCF-STTG1,12003241,0.9586959919868534
NCI-H1373,9903786,3.0736149101448893
NCI-H2052,159324,3.5848490402306
JHOS-2,148124,3.8692644642066023
NCI-H2286,168313200,3.816538366273192
KMS-18,36462,2.0376871774276557
DMS 273,54618164,3.989243888703328
MKN74,44491742,4.321441779997771
NUGC-4,3689413,0.1501840734639977
EHEB,6505803,-0.4928001321157277
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
Karpas-620,JQ-1-carboplatin (1-1 mol-mol),4.330604154257919
SW1783,44491742,3.6997355499837217
NCI-H460,54618164,4.49670945938676
JHH-4,148124,-4.377939547333403
SNG-M,159324,3.472464596542285
NCI-H2029,135875424,4.350194062307378
HCC-56,8515,4.24827596622419
MOLT-16,12003241,-1.273061825596023
CCF-STTG1,54618164,4.4288958648043915
SK-ES-1,8515,2.7531864061025013
SW1271,9936388,2.2656701786136315
BT 330,439501,-3.680620250809701
SK-N-BE(2),46943432,2.3862382436812215
SNU-1214,148198,-3.317197477709626
SYO-1,26596,-1.7250044942499454
PE/CA-PJ15,26596,-1.1054075726167758
RERF-LC-MS,9903786,2.6182355767545213
SEM,148198,-7.106649826649242
YD-8,6610216,4.600166157453743
5637,9927531,3.46604374571058
Namalwa,9903786,1.5886639412240358
COLO 792,107985,-3.7038898096904753
HuCC-T1,135875424,4.122331591088892
HLF,44491742,4.796533392480472
OVCAR-5,44491742,4.010152953024954
Kasumi-1,135875424,2.9305214666609904
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
DK-MG,11485656,3.787510091339842
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
COLO 201,439501,-0.4470167142560104
RERF-LC-MS,8515,3.770178660744851
OCI-AML-2,73707440,3.915095713182096
CA46,54618164,3.845436645537388
SF268,409805,5.731991783938672
SK-N-MC,148198,-7.75937089514698
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
NCI-H1155,159324,2.1677160102648263
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
GMS-10,6505803,0.344915295589296
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
JHOC-5,JQ-1-carboplatin (1-1 mol-mol),1.4333459148204122
SUP-B15,46943432,1.3299933032827167
8-MG-BA,9903786,3.978061546376923
HDLM-2,JQ-1-carboplatin (1-1 mol-mol),4.397812362748352
BxPC-3,36462,3.4182720226712457
JHH-5,135875424,3.15748575614029
Ki-JK,26596,-2.118639995094933
RPMI-8226,26596,-3.5550255900749623
NCI-H520,9927531,5.647411307076465
DMS 454,168313200,1.494818405259989
SNU-1076,5460769,2.5468440002865895
Calu-6,135398744,6.4194279820254465
SUP-HD1,5460769,1.3370486215581097
Caov-3,159324,2.774791318971609
FaDu,12003241,-1.459997114195287
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
HEC-108,409805,5.771065107307232
IPC-298,36462,1.8042428421244965
DU4475,135875424,3.0079145369477827
IGR-37,135875424,3.259806736853938
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
C2BBe1,168313200,1.8322203589058017
Kelly,159324,0.6122930076289157
HEC-1-B,409805,5.9664773850261055
Peer,159324,-2.537523306303502
MSTO-211H,8515,1.6806311840995682
SR,135398744,6.424256669199728
BICR 31,135875424,5.0736941678127945
SNU-C1,148124,-2.098825987189931
SW579,9927531,5.20286248500357
MCF-7,selumetinib-GDC-0941 (4-1 mol-mol),1.646510277694018
LP-1,JQ-1-carboplatin (1-1 mol-mol),-0.8126599405302602
Calu-3,439501,-2.024926202935107
NCI-H1573,9936388,0.6973837947866425
TF-1,5460769,4.30978412133691
BT 224,9936388,2.154938052183267
NCI-H2342,107985,-1.5657357451574807
SW1271,46943432,0.8939870827443378
MHH-CALL-3,24180125,2.697623286647445
SNU-1033,409805,7.650675265058521
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
SF295,36462,2.0611349093400926
NCI-H23,12003241,-0.7384604538146603
SHP-77,8515,4.097215117874386
NCI-H1623,12003241,-0.4868602659209724
SNU-1,148124,3.4248639616282777
VMRC-RCZ,10296883,4.271473325203521
RVH-421,148198,-2.605625112425235
SUP-B15,44491742,3.782518793178516
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
OVCAR-4,11485656,2.719318989709532
QGP-1,439501,-1.697500396570699
TE 617.T,439501,-4.266247423790402
NCI-H2081,54618164,3.631207373775394
OCUM-1,9927531,5.3600518663523244
CAL-85-1,9927531,5.462917800107974
HCC1954,12003241,-0.7991546925756471
HOP-62,10296883,4.184861943544038
DMS 53,24180125,3.220936237072825
Panc 10.05,36462,2.974503019627731
MOLP-8,9936388,3.4211096692910052
HCT 15,44491742,3.7262724808810295
SNU-761,9927531,4.19360542314586
BT 159,135875424,2.5273091114985777
SNU-1079,24180125,2.198682285744919
NCI-H1299,3689413,-0.9598507897960026
SK-MEL-1,36462,2.966778719187199
COV644,JQ-1-carboplatin (1-1 mol-mol),1.9465163410913973
Rh18,11485656,2.5820801285945927
EoL-1,6610216,2.588029624216937
CAL-120,selumetinib-GDC-0941 (4-1 mol-mol),2.9364136017139932
P31/FUJ,439501,-2.3575947617146475
GA-10,135423438,1.5263864558122735
KE-97,9903786,1.2492215046339803
NCI-H2342,JQ-1-carboplatin (1-1 mol-mol),1.5439939655053172
HCC2218,44491742,3.8267338846087497
HCC202,6610216,4.36654658645049
SNU-685,5460769,1.3668159641558515
HMC-1-8,JQ-1-carboplatin (1-1 mol-mol),2.246629703835433
U-251MG,135423438,1.776157398246975
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
SK-N-DZ,10296883,0.393447388652097
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
EC-GI-10,selumetinib-GDC-0941 (4-1 mol-mol),2.251648827392905
ONCO-DG-1,54618164,4.156815904485165
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
U-937,44493528,4.3838606909350055
ACC-MESO-1,9903786,5.156493229165983
RPMI-6666,selumetinib-GDC-0941 (4-1 mol-mol),0.4507229369642581
BT 147,135423438,1.671229902583041
JK-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404611397538406
SNU-8,9903786,3.356408381726989
Reh,6610216,3.95214078902228
NCI-H1385,44491742,3.386868498663753
A3/Kawakami,135423438,3.073341155380334
AU565,9927531,4.912755977802547
JHUEM-2,409805,3.9028131887521225
Hs 888.T,10296883,3.7100072063785534
TE-11,44491742,4.693263805058857
TF-1,409805,5.960314574590496
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
A-549,9903786,1.8644448309659765
JHUEM-3,439501,-2.1632963006772075
Hep-G2,439501,-0.8010222698535624
WM983B,54618164,3.908984274872335
HuP-T3,54618164,3.3933985234085755
HCC202,3689413,-1.588009861739516
HEC-151,3689413,0.5850952885102259
TF-1,107985,-4.016849467396239
SW948,36462,2.9711779559511604
WSU-DLCL2,107985,-2.886863580578064
QGP-1,36462,2.828572455595782
OCUM-1,10296883,3.433101608728151
Becker,6505803,-1.1443258225494983
KATO III,148198,-3.9142793385091186
8505C,439501,-2.435831139874658
HT-1197,54618164,4.009562616962898
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
8505C,36462,1.0764276752423854
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
YAPC,12003241,-0.7644111057992425
SW1573,168313200,1.7327341920391253
MKN45,6610216,5.033385649834963
NU-DUL-1,135875424,2.988818183719918
ECC10,44493528,3.789717888225728
U-118MG,8515,5.012125879248694
LCLC-97TM1,36462,0.8347023875377979
SCC-4,168313200,1.7103812894013133
SF295,6505803,0.007344164780963
CCK-81,159324,-1.287250290469648
23132/87,JQ-1-carboplatin (1-1 mol-mol),1.651339324624301
IPC-298,12003241,-0.6695697613758284
Reh,9903786,1.595846435725099
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
WM793,107985,-3.039809125194022
HCC78,11485656,2.324868520427576
SNU-449,8515,3.796953450261519
YD-8,135875424,4.059859189077627
KYSE-30,6505803,0.8895731520069545
NCI-H358,9936388,-5.546440676880145
OCI-M1,26596,-2.6046335322938927
TE 617.T,6505803,-2.094273905964543
Hs 729.T,11485656,2.9602548110779145
AU565,26596,-1.0644098452654434
NCI-H146,168313200,1.5894074456272884
IMR-32,5460769,-1.03513215878617
GB-1,36462,2.476017326318834
NCI-H1563,9927531,5.123884061924823
MCF-7,135875424,4.503633090652972
ALL-SIL,24180125,1.6553840753953686
SNU-626,5460769,3.7499472406611334
SNU-1105,159324,3.821652429773296
NCI-H1838,9936388,2.03456358859775
JURL-MK1,11485656,1.8097714180338824
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
HeLa,6505803,-0.0506022751267441
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
DB,8515,3.587281153546521
OCI-AML-2,9936388,-7.199814294099559
BT 271,9936388,0.913255428649528
HCC2279,107985,-3.355357540394359
SK-N-FI,JQ-1-carboplatin (1-1 mol-mol),2.3302491289766825
OAW28,3689413,-1.4375749125930504
ES-2,148198,-2.2318104062196102
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
KHM-1B,36462,-0.5615447034427615
LN-229,159324,3.086562742175474
JIMT-1,439501,-2.416769885537428
RT-112,selumetinib-GDC-0941 (4-1 mol-mol),2.1504291571764287
SW48,11485656,-1.6768123952056315
NCI-H2452,9936388,2.1806204942966803
CML-T1,54618164,3.634689828068523
Kelly,9903786,1.651293069080272
Hep-G2,3689413,1.297693127771037
GA-10,409805,3.0075509696192397
MCAS,36462,1.655496509759999
SNU-C4,11485656,2.7013405303612408
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
SU-DHL-4,26596,-1.8970615023372663
SF268,9927531,3.0957828421568396
TOV-21G,148198,-4.474336423229386
BHY,6610216,4.5023703498514855
SNU-1066,159324,3.912087986150624
BICR 31,46943432,4.176233154169203
KMBC-2,9936388,2.279378439007598
FTC-238,409805,3.813014825552704
MKN74,107985,-2.988368566005849
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
TE-15,5460769,-0.6910051691918724
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
M059K,selumetinib-GDC-0941 (4-1 mol-mol),1.9371226079768809
Jurkat,8515,2.2772162456887384
ES-2,11485656,2.323063224970118
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
CAL-120,9877608,5.792965508852075
HOP-92,9903786,4.828960304549442
Karpas-422,46943432,0.9846326291416436
DMS 114,11485656,2.3249247552624936
OUMS-23,selumetinib-GDC-0941 (4-1 mol-mol),1.2093335289094016
NB1,36462,0.5434852604618556
KYSE-520,12003241,-1.836986739794001
Raji,409805,3.871069859266368
RPMI-8226,439501,-1.9239295318483216
BT 271,5460769,1.6664418058692942
NCI-H1373,54618164,5.2479619812935425
BT 231,6610216,3.7441566513120863
ESS-1,6505803,-2.0071033756271106
NCI-H146,54618164,3.6762408834701423
A-253,135423438,3.929129844415613
SH-4,6610216,3.723529041441613
ChaGo-K-1,168313200,1.878692270372672
P-STS,44493528,4.057634229186882
NCI-H292,9936388,-1.1579069678838152
MM1.S,9903786,2.841249590923514
LCLC-97TM1,9903786,1.8016114643921617
RERF-LC-MS,9936388,-8.273067767637817
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666
SYO-1,24180125,2.3390732294097587
Raji,54618164,3.808171022146071
MOTN-1,12003241,-0.0935669928398487
RCH-ACV,11485656,1.6994895445887253
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
KMS-26,148198,-4.824995568216466
KP-N-SI9s,159324,2.5914550399213376
MHH-CALL-3,36462,-2.387414053634969
EFO-21,11485656,3.611716212098542
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
SEM,148124,-5.566475057371884
NCI-H2342,3689413,-0.4986291797575011
TE-8,9936388,-6.617390334695402
SNU-182,24180125,1.310847414241977
Panc 05.04,10296883,5.097523984239884
ST486,9936388,-7.5497220296798275
EPLC-272H,11485656,2.043332000791837
SK-N-BE(2),9927531,3.511797224243287
NCI-H1838,54618164,4.4678889451925725
G-401,26596,-1.5666727843222663
Lu-99,54618164,4.227320195350235
NCI-H2029,168313200,1.6583948504808603
NCI-H1651,148124,-6.206730462770721
U-CH1,JQ-1-carboplatin (1-1 mol-mol),2.2916861581051062
OVTOKO,selumetinib-GDC-0941 (4-1 mol-mol),2.323282098150216
A-549,409805,5.689640893560965
NCI-H2405,3689413,-0.5066399807315675
MDA-MB-157,44491742,3.772080854170876
23132/87,409805,3.587189240784534
NCI-H889,12003241,4.506379405890452
CAL-148,selumetinib-GDC-0941 (4-1 mol-mol),1.314198336751646
UM-UC-1,12003241,-2.5301689860244534
BT 147,148198,-4.643582632338319
Hs 683,135423438,3.058302675128977
LXF 289,44493528,4.295099384269069
RERF-LC-A1,54618164,3.9982996694871424
NCI-H661,3689413,0.5447440822016135
OS-RC-2,9903786,3.8385821896684433
SW1783,9927531,4.46381053918724
SNU-61,6505803,-0.8091898598550518
RPMI-6666,46943432,1.9212112931253864
MEC-1,6610216,4.139223176042876
BT 147,168313200,1.828641236275665
NCI-H2170,10296883,3.9799076581526855
KP-4,6610216,4.774737819722466
YD-8,11485656,2.558902022570011
Hs 611.T,44493528,4.184302816514897
JHH-4,148198,-4.065659017093723
ONCO-DG-1,159324,3.5589671354196017
Karpas-422,36462,0.1497993293193704
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
SK-N-SH,24180125,3.172499964081901
SK-ES-1,6610216,3.8025876712947944
NCI-H1944,3689413,3.2556823925737395
AsPC-1,9936388,-0.8199656713038528
KYSE-520,135875424,4.420553116763078
NCI-H1339,9936388,3.3861732240332314
Panc 02.03,36462,3.4500230117265933
YD-38,6505803,-1.6031716801172209
KMRC-20,54618164,4.251401203478906
RT-112,107985,-3.0957792723362134
LK-2,9927531,4.895223263990893
RPMI-7951,148198,-2.190615440736015
F-36P,135398744,6.4039586130062505
253J-BV,12003241,-1.283652626050959
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
COR-L95,36462,-0.8944975018350346
Hs 888.Lu,9927531,5.408720252144841
THP-1,12003241,-0.95805458474302
NCI-H1355,6610216,4.163423166007809
TT2609-C02,148198,-4.067682377200374
KM12,9927531,4.5473811141762965
SNU-407,24180125,3.709113643106665
L3.3,9903786,3.5860218860878263
SIG-M5,148198,-4.503742564102913
KMRC-1,135875424,5.075329697898493
YD-38,148198,-2.2054243046269044
UM-UC-3,12003241,-0.2552051516294621
BL-70,439501,-3.7904230490472623
NCI-H2286,159324,5.184730957482079
NU-DHL-1,135398744,6.409233084142903
BT-549,148124,3.591112191677911
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
COLO 699,26596,-1.9597259723317009
Karpas-620,9927531,5.121600131108068
SNU-668,5460769,3.895439916502409
SNU-213,148198,-1.214073512813324
BT 416,24180125,3.4995177261532917
RERF-LC-A1,148198,-3.1102576281385654
NCI-H2228,9927531,4.856676083567804
Calu-6,49836020,4.336137767537177
8-MG-BA,8515,4.986041270201842
A-253,12003241,0.3953648973902781
WM266-4,439501,-0.5871270471596414
NCI-H1435,6610216,3.78595053779861
LOU-NH91,11485656,3.2972382499502935
MFE-296,26596,-0.907337078157821
PaTu 8988s,44491742,3.6400918872033343
VMRC-RCZ,148198,-1.950525301286011
JHOS-2,24180125,3.2910798464952045
MOLM-13,3689413,-2.8005667715254017
NCI-H1105,9927531,4.896971855718655
NH-6,168313200,1.6877159521030758
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
SNU-C1,9903786,1.6227295920089169
TE-11,54618164,3.863333055844095
HuP-T4,12003241,-2.8459442311528154
BICR 16,107985,-3.614400369733834
SNU-407,8515,3.707708532160579
MOLP-8,3689413,-2.303477592076259
SaOS-2,9903786,2.3206358959344264
U2OS,26596,-1.797685053172872
SK-N-FI,11485656,1.359995170672745
NCI-H2052,439501,-0.5583326091598753
SUP-M2,5460769,0.4100409038325726
DU145,54618164,4.17145351900014
Ku812,11485656,2.1573639541519474
NCI-H1755,135398744,6.361982871837632
MCF-7,159324,4.695511418264858
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
PC-14,8515,3.8030363012759327
SK-MEL-24,44493528,4.28603676822274
IM95,9903786,2.260707421178731
KMS-11,9936388,-7.371852791095938
2004,24180125,-0.1305197339649844
YD-8,44491742,4.162245932134171
Ki-JK,3689413,-3.396353931218892
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
KYM-1,46943432,1.6560210739851535
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
BT 320,11485656,3.3413754154715796
HCC202,135398744,6.455993552330763
WM983B,409805,3.828493612521517
8505C,135398744,7.128245503588914
HH [Human lymphoma],107985,-4.868177894927375
JHH-6,11485656,3.907926018805903
A-549,6505803,-0.295425809550202
L-363,36462,-0.2320142299558898
DMS 53,135875424,3.815847763190564
HCC2218,12003241,-0.1021817446699859
MIA PaCa-2,5460769,2.8270884799697833
YD-38,107985,-3.704885076305192
HOP-62,9927531,4.3195662996069855
U-118MG,107985,-3.8386417530991777
KNS-81,439501,-1.422452321432204
BT 228,11485656,1.932859050078464
HT115,148198,-3.4561057287776653
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
Panc 02.03,6610216,4.56797737488032
OCI-M1,9927531,4.777784518044042
Ku812,107985,-3.8161281001358778
BT 145,107985,-3.863476066500092
BT 231,3689413,-1.816097223149399
SNU-719,11485656,-1.1383067501667237
JHOS-2,135875424,4.409473105758524
TOV-21G,148124,2.58358749612027
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
253J,9903786,1.7805297403151377
NALM-6,9903786,0.8985317533889718
WM266-4,12003241,-2.6604387870862745
Ku812,73707440,4.534867519967767
G-292 clone A141B1,11485656,2.845386478997394
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
SW620,8515,3.5759588402103137
NCI-H810,12003241,1.7210077749227564
CHP-212,11485656,1.772260285582149
NMC-G1,6505803,2.4700924205747827
B-CPAP,26596,-2.034534215785694
22Rv1,54618164,3.751112762504955
VM-CUB-1,159324,3.221139682544442
NCI-H747,6505803,-2.758197562665133
DU145,439501,-2.7485794982467637
MFE-319,9927531,5.194887870380863
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
BT 328,6505803,-1.1568571975604598
EHEB,409805,3.764078268707581
G-402,9936388,3.284430890401921
HEL,46943432,0.8947528664895825
JHOM-1,9936388,-2.304365188363062
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
IGROV-1,6505803,-0.2382223795960626
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
NCI-H226,9936388,2.9750619483400467
BCP-1,148124,-4.388861907430301
IGR-37,409805,5.961933065604735
SW1088,3689413,0.8885196557801914
RT-4,36462,2.6630323769700013
KM12,409805,5.283979490760359
CAL-54,135875424,4.317349634986473
SNU-620,26596,-1.49043613544065
WSU-DLCL2,11485656,1.973652823958906
LUDLU-1,148124,-7.004374520301572
NCI-H2106,148198,-2.940594124176384
TCCSUP,3689413,0.6301346851622357
NCI-H810,107985,-3.977106637098994
BT 145,12003241,-0.8369227670207208
MDA-MB-453,44491742,4.088527945953042
BT 139,3689413,1.1435542954681734
RCC10RGB,10296883,4.350673741830848
Hs 611.T,409805,3.119650007352079
NCI-H2141,9936388,-7.734442160433386
L-363,439501,-2.2383513664350394
SK-MEL-5,11485656,3.020253832456298
PF-382,409805,3.4085068464251997
BT 271,168313200,1.412028571962601
LCLC-97TM1,9927531,5.703886109604247
MOLT-3,11485656,1.5036964754289828
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
CMK,selumetinib-GDC-0941 (4-1 mol-mol),2.84334284857712
HD-MY-Z,5460769,0.4985347726770217
LOU-NH91,26596,-0.8372049149458933
TT,12003241,-1.2151389854631975
SKM-1,26596,-4.237929506963809
BT 232,9936388,1.379095675434134
NCI-H1373,107985,-3.7954259612019534
NCI-H1184,439501,-1.2905593318516702
EKVX,12003241,-0.995524269330736
NCI-H1755,46943432,1.8074214413650171
NCI-H520,159324,2.1886041190772834
UO-31,439501,-2.964555924947922
Peer,26596,-2.3725099322734193
OV-90,148198,-2.8305147037841425
Hs 940.T,24180125,1.6425567786070054
PE/CA-PJ49,44493528,4.271726954290608
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
KP-N-SI9s,409805,3.6251119237162177
LC-1/sq-SF,135875424,4.887954422220303
NU-DHL-1,10296883,3.6667794076879594
SNU-1077,44493528,3.708438186415119
NCI-H1869,3689413,-0.7267032921286074
NCI-H2110,148198,-2.105563861688736
OVK18,8515,4.179386139682472
KYO-1,26596,-1.5121743902030458
HT-1197,10296883,4.022509724629416
ST486,10296883,2.054791984575977
HD-MY-Z,9936388,-7.089387661668647
KMH-2,439501,-2.384989575251817
PK-59,54618164,4.180437133735424
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
LoVo,54618164,3.038824107117225
SNG-M,439501,-1.900276797941319
SU.86.86,159324,3.460908276663124
Hs 822.T,selumetinib-GDC-0941 (4-1 mol-mol),4.199779090816491
NCI-H460,36462,3.103581216464206
A-549,11485656,2.1977599259975764
TM-31,54618164,4.481591418748458
DBTRG-05MG,5460769,5.967153987898797
MPP 89,10296883,4.223562446240864
CL-11,8515,4.039522113658697
VMRC-RCZ,6610216,4.14448682308937
JHUEM-1,44491742,3.7957056019779345
JVM-3,11485656,2.278775985482816
OV56,148198,-3.008820928663164
NCI-H838,148198,-3.726135487587838
SNU-466,439501,-2.48566817429276
KHM-1B,46943432,-0.0724756226448156
Hs 729.T,49836020,4.229774154263897
SK-MM-2,409805,3.1176890725154403
JK-1,148198,-4.68047289678299
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
SNU-407,54618164,3.677398235586724
Hs 888.T,5460769,6.095978340264565
JHOC-5,11485656,3.0312189412234622
KHM-1B,9936388,-7.3262126051433425
TE-14,12003241,-0.291419040743519
DMS 114,6505803,0.1700974971727873
MEC-1,44493528,4.02747139301686
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
NCI-H841,168313200,1.7438487882833134
Hs 944.T,44491742,4.471544496147254
SiMa,3689413,-0.4508724532834644
MKN74,9936388,-0.1480822399843773
OE21,439501,-2.897438407377833
T84,9903786,2.2055003104833553
A3/Kawakami,46943432,-0.8824204154734967
NCI-H520,54618164,4.0316677264685135
NCI-H2196,11485656,1.855781545293995
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
SKM-1,10296883,3.074274434558128
NCI-H2171,9927531,3.1501077196413783
LS123,36462,3.241084731511916
FU-OV-1,148198,-3.302287500778492
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062
CAL-51,409805,3.8515087112009656
LMSU,409805,5.989527903576905
KYSE-150,11485656,2.368580585817062
BT 159,24180125,3.863363917993721
SNU-1105,9903786,3.6171667561714056
CAL-51,135875424,4.33643967165441
LXF 289,6505803,-2.367756082461904
COLO 678,54618164,4.04427262226164
SYO-1,JQ-1-carboplatin (1-1 mol-mol),-0.7857384720647894
HCC1806,6505803,-1.844009581745865
VMRC-RCW,11485656,3.110603770288861
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
A-549,11485656,2.1977599259975764
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
BT 422,9936388,1.1526185364967738
NCI-N87,26596,-0.8687464208841552
TE-14,9903786,3.4903828938175354
MOR/CPR,3689413,3.3711926349807797
Capan-2,9903786,4.9592857340128385
VMRC-LCD,9903786,1.8330708335593808
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
KO52,8515,2.033649946407287
HSC-2,107985,-4.058574397989757
SW1353,26596,-1.2000741302841849
MOLM-13,439501,-2.531564352317227
Peer,JQ-1-carboplatin (1-1 mol-mol),-0.0564533853445443
P31/FUJ,135875424,3.622681212031297
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
CAL-33,135875424,4.580844092260986
SCLC-21H,439501,-2.4331226834497612
NCI-H1385,JQ-1-carboplatin (1-1 mol-mol),2.259608589109217
KP-2,44491742,3.9373322425213138
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
WM266-4,10296883,3.7855589365633584
COR-L95,9903786,3.7357721387912513
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
SBC-5,107985,-2.339881885950972
JeKo-1,107985,-3.6689778441734777
RL,44491742,3.724190928980732
WSU-DLCL2,12003241,-3.4791532779073373
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
HCT 15,54618164,4.134275975821386
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
MOLT-16,49836020,4.026167262908274
TE-9,107985,-3.4628702596877856
Hs 936.T,10296883,3.997542153042743
KMS-11,8515,2.0394013986639066
SIG-M5,135875424,3.9161233057534584
KP-2,168313200,3.8973165337888807
KE-37,54618164,3.8582430054460337
SU-DHL-10,JQ-1-carboplatin (1-1 mol-mol),-0.069963148884663
SK-N-AS,148198,-4.149694989731526
SW579,11485656,-1.098369360988347
LOX-IMVI,9936388,0.4128358081832157
KP-2,135398744,6.663666573534304
JHOS-2,9903786,4.753698085205414
8305C,JQ-1-carboplatin (1-1 mol-mol),-0.8214093043098781
HPAF-II,6610216,4.592168242014849
MDA-MB-361,12003241,-1.091645986643679
BEN,409805,5.771182466366909
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
JHH-5,9927531,4.499670785521202
OS-RC-2,54618164,5.32762570536847
Daudi,168313200,1.4988300519601074
OVCAR-4,24180125,2.4780177997263304
Kasumi-1,3689413,-0.2693105089834908
QGP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3136510607151746
SNU-1079,5460769,0.9743779178913314
NALM-6,6505803,0.3598749037472731
NCI-H650,44493528,4.3603009222588645
SK-BR-3,3689413,-0.6055139082378386
RERF-LC-A1,107985,-2.1483108523550287
PaTu 8988s,5460769,4.375147735669684
SCC-9,439501,-2.6581193485563737
PC-14,9927531,4.079128694018213
NCI-H146,148124,-0.9007997951548676
TE-1,10296883,4.161455110097264
Daudi,6505803,0.7229387165377155
LAMA-84,46943432,2.187677081253157
SNU-81,3689413,1.1974270464491454
CAL-85-1,44493528,4.246011079202567
NCI-H838,9936388,2.922779996332477
SNU-201,11485656,3.6136965071696903
HCC1937,6610216,4.815854784432885
VMRC-RCZ,3689413,-1.2845787687356065
A-375,44493528,5.0092859091998205
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
RL95-2,selumetinib-GDC-0941 (4-1 mol-mol),-1.0392511344110156
BT 416,135875424,2.581275175967605
SU-DHL-1,36462,-1.6063137198477124
LN-18,54618164,3.805633117253899
KYM-1,54618164,4.171782985216563
RCH-ACV,168313200,2.215457911819633
OAW28,6610216,3.9661844518771185
OVK18,107985,-2.9046638122413904
HuP-T4,6505803,-1.7764683089441893
SNU-423,8515,4.7137159265579225
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
SNU-1214,12003241,-2.886982661469118
HCC95,409805,5.412444434020308
MHH-NB-11,24180125,1.5852022307139904
KP-N-SI9s,168313200,4.331383268876979
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
OVK18,3689413,-2.4624871166851965
KMS-34,12003241,-3.0064029669480528
KNS-60,9903786,2.981782520240843
AGS,159324,3.522997967735827
HuH-1,11485656,1.6610003065842192
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
SW1710,168313200,3.54622842973123
42-MG-BA,5460769,1.54562912999154
NCI-H196,439501,-2.4399998682634023
BxPC-3,107985,-2.51349631829315
GSS,44493528,3.3523152661805526
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
Hs 294T,5460769,3.362841605128932
ZR-75-1,6505803,-2.5048653445309297
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
BT 248,9927531,4.7076279917818225
G-402,24180125,4.207130674742538
HCC38,168313200,3.666246615050688
EHEB,3689413,-1.930959129148268
SNU-308,54618164,4.492572736691696
8505C,44493528,4.8824892045042585
CAL-51,9903786,2.1849161121493847
CCF-STTG1,9936388,2.748356806633847
NCI-H1694,439501,-3.146903361549278
BT 245,11485656,1.931183051045247
MM1.S,24180125,2.972534828152793
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
SNU-475,148198,-3.401436847771516
SNU-886,107985,-2.815059265270472
L-540,107985,-4.794689037122787
SK-MEL-24,24180125,2.040624055714523
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
Caki-2,6610216,4.487698471126339
DK-MG,135875424,4.206439943890902
M-07e,148124,-5.941925680697441
NCI-H510A,409805,3.660940228209235
HEC-251,11485656,3.0067875712953
COLO 668,6610216,4.122924669530787
DAN-G,148124,-7.819033791803524
OPM-2,36462,1.377546018006998
SNU-1214,135875424,3.75117609732274
P-STS,46943432,3.5979035534915833
FaDu,409805,5.757120599805432
Kasumi-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1995459699844852
MKN74,148198,-2.653452729835883
Hs 944.T,159324,2.0407130641641933
GB-1,9936388,0.1084454809521914
PSN1,10296883,4.046781040996588
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
FU-OV-1,54618164,4.603510021761196
MPP 89,409805,3.849347352715293
ONCO-DG-1,11485656,2.8081349041133663
TCCSUP,135423438,2.289740320598626
Fu97,439501,-2.2730678806091924
SNU-620,6610216,3.664265163527259
SUP-T1,JQ-1-carboplatin (1-1 mol-mol),-0.4695857122816443
CAL-27,8515,2.199074153497869
JM-1,36462,-2.702351282209385
DU145,5460769,5.167808415466422
DAN-G,36462,1.1415877491353317
CAL-33,148198,-4.199943057412928
SU-DHL-4,9903786,1.90197998733756
SW1417,5460769,5.65335320943634
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
OVSAHO,107985,-2.879970343748397
NCI-H441,409805,5.87304569757607
GB-1,135423438,1.7622813158496486
SW1417,439501,0.2964546756721697
Lu-99,36462,0.6677201445831182
NCI-H1105,10296883,2.7167194577249947
ACHN,54618164,4.499385578059577
23132/87,26596,-1.073494997011525
SU.86.86,409805,3.5437466689981676
HEC-151,44491742,3.809390131450424
GI-1,12003241,0.5382171766517799
DBTRG-05MG,135398744,6.409074750923468
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
JHUEM-1,3689413,0.044302486666068
TF-1,439501,-2.265040568492349
COLO 741,439501,-2.122340896395585
SNU-308,9936388,-0.5886369856263455
HuH-6,44493528,4.083061527046497
RL95-2,409805,3.800799243361298
SIG-M5,44491742,3.8291239619503905
ONS-76,6610216,4.821554065133985
SK-MEL-2,148198,-4.089267246303032
NCI-H2126,6610216,4.369254418230129
MDA-MB-435S,6610216,4.909822803895324
LMSU,12003241,-1.0531077396215482
NCI-H211,44493528,3.775895389954296
ESS-1,148198,-4.109415572856481
P31/FUJ,5460769,2.718083541162644
LCLC-103H,3689413,1.9966381223526644
CAL-27,6610216,4.47029742988655
K-562,44491742,3.373435641850853
TOV-21G,11485656,3.507052738885456
DAN-G,8515,4.673227824425852
Kelly,9927531,6.376471657693257
JM-1,10296883,2.092198976716966
IGR-1,168313200,2.5081796884105083
JIMT-1,26596,-0.816309459972074
SNU-738,135875424,5.435883526808027
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
VMRC-RCZ,36462,4.480481617354075
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
ACHN,10296883,4.360085471718373
MPP 89,6610216,4.468141875368187
NCI-H747,148124,-2.0882502485249788
ZR-75-30,44491742,3.706511746773907
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
KNS-42,107985,-0.308667703766746
KG-1-C,9936388,2.2222312234871957
TC-71,9903786,2.1601140442915736
SNU-1,409805,3.692783946246232
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
G-401,135875424,3.147536590476696
HL-60,168313200,3.790843536474408
Detroit 562,9936388,0.4800991198944179
KYSE-150,36462,2.2869489310806497
COLO 320,11485656,1.5000331440446593
HCC15,9936388,-3.3305479025951783
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
SU-DHL-1,159324,0.2044468524757833
HEL 92.1.7,46943432,1.358208914963814
IST-Mes1,6505803,0.837907313306775
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
HCT 116,11485656,2.5700211491492593
HCC1588,107985,-2.184487222231667
AU565,36462,0.154728470238132
HSC-2,24180125,3.69212808406266
CAMA-1,9877608,5.870182576067418
WM115,135423438,3.926483426744841
KMS-26,46943432,-1.993034671230462
Calu-6,26596,-4.0671398242119965
CMK,6610216,4.646052839283286
OVK18,54618164,4.037525377716131
TF-1,8515,2.99414039942182
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
KLE,3689413,-1.503166424361693
Hs 746.T,3689413,-1.6439550226846966
DMS 53,9936388,-3.9040655164911686
23132/87,9936388,-5.399700035064151
Rh30,6505803,0.7803145928661782
IST-Mes1,439501,-2.4971864822052767
NCI-H838,135875424,4.377927908580301
SW1417,11485656,1.9814975690953165
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
NCI-H226,135423438,1.8109443416998463
NCI-H2286,148198,-0.7964524113963312
SKM-1,36462,-0.9664350566951958
SNU-466,JQ-1-carboplatin (1-1 mol-mol),1.650577111038187
HCC95,9936388,-4.9854278423381135
Ri-1,10296883,1.1182456491009578
769-P,148198,-2.315494485063685
NCI-H747,107985,-4.6715942201014125
P12-Ichikawa,6610216,3.76430503895136
TF-1,12003241,-0.8942649772523563
HCC4006,10296883,4.182376901779113
BT 139,439501,-2.1565169223075062
SNU-1196,JQ-1-carboplatin (1-1 mol-mol),5.1757669603807015
Yamato-SS,JQ-1-carboplatin (1-1 mol-mol),0.686256399915639
MCAS,5460769,1.176961037581758
RPMI-6666,6610216,4.196045243172535
GCT,3689413,-2.349685112754086
Mel JuSo,439501,-1.0789226024470335
MKN7,36462,2.3552750815740326
VMRC-RCW,3689413,-0.2709078941714827
NCI-H1693,9903786,3.776760773308461
42-MG-BA,135875424,2.570592080360526
Becker,135875424,4.35709039626534
BT 422,36462,4.524557226357963
NCI-H929,6610216,4.64058383232424
SK-MES-1,26596,-0.6489352140411898
HCC1954,159324,3.165805717384629
SK-MM-2,8515,4.243303565094017
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
SIG-M5,409805,3.8770489658245344
LoVo,135875424,3.182508442374063
IGR-39,26596,-2.1240544281705955
K029AX,168313200,4.408216364227678
A3/Kawakami,11485656,1.2537678238706411
UO-31,44491742,3.8837342350027377
Hs 888.Lu,168313200,5.703757640857178
SK-LU-1,54618164,4.502535850506955
IGR-39,409805,3.9681890781996314
IGR-37,148198,-3.2890285430700064
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
CJM [Human melanoma],selumetinib-GDC-0941 (4-1 mol-mol),2.04616975422909
NCI-H1915,107985,-3.9185583163314064
EoL-1,11485656,-6.598388814450544
KYO-1,54618164,4.4035881094936125
EJM,168313200,3.7804211641471097
Ishikawa (Heraklio) 02 ER-,11485656,3.3351822196084937
SK-ES-1,168313200,1.7624238003073756
BT 172,26596,1.567138444115151
Yamato-SS,168313200,3.0262035577149717
SU-DHL-1,107985,-3.306496987383706
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
NCI-H1838,6505803,1.6268298993788928
JHOM-1,135875424,4.80614919695595
HT-1080,135423438,3.624839631641402
HCC2108,11485656,2.4652137706419137
LUDLU-1,9903786,3.064378057627616
CAL-51,54618164,4.021329289838694
CJM [Human melanoma],107985,-2.937279558730933
SK-MEL-3,409805,5.886045786440892
JHH-1,10296883,4.130591139989607
Mel JuSo,107985,-2.9458205931229897
OCI-Ly3,107985,-6.510642065564684
MeWo,54618164,4.010085322974807
A-549,6610216,4.4512033607640475
MOLT-3,49836020,4.359982480668932
A-549,9936388,1.4749208650316612
NCI-H2052,3689413,-1.081433417665549
G-292 clone A141B1,12003241,-1.351842997684689
KYSE-520,selumetinib-GDC-0941 (4-1 mol-mol),2.0690481757247037
KMRC-2,135875424,4.786513298485674
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
DND-41,24180125,1.0570161695352558
SUP-B15,3689413,-0.2664359486303652
HuH-28,6610216,3.8460491643808727
RERF-LC-A1,12003241,-0.839480669213789
RPMI-8402,159324,-4.775028439509436
OE33,6610216,4.3835431989355635
Hs 729.T,36462,1.157787126399629
MOLM-6,11485656,1.973328141098863
ONS-76,12003241,-1.3579895274230906
F-36P,409805,3.912389253799608
WM1799,8515,5.251103222363271
HD-MY-Z,409805,3.913878546925476
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
NCI-H1869,11485656,1.8296978789565703
JHUEM-2,107985,-3.927953160479623
T98G,9903786,3.9737183240681153
MOR/CPR,26596,-0.9539590783160214
TE-14,36462,2.704845630868705
Mono-Mac-1,12003241,-3.167077714646063
KP-4,9936388,-5.247407210845399
Hep 3B2.1-7,6505803,-0.5491843508320539
TCCSUP,148198,-2.229154528716237
Mel JuSo,26596,-0.7227371785697827
JIMT-1,148198,-2.4064236907207786
MOLT-13,12003241,-0.6419644689091649
Hs 578T,5460769,5.961368196562113
SUP-T1,5460769,2.284635628978783
EN,3689413,2.688418705808367
PE/CA-PJ15,6610216,4.602296752882169
JM-1,24180125,1.1035620934920058
Kasumi-2,10296883,1.6134498936175832
SYO-1,5460769,-0.8579503639796162
NCI-H661,36462,2.012090600363037
CAL-51,44491742,5.152478206660974
Li-7,12003241,-1.919504874807884
COLO 678,135875424,4.367651695561652
BC-3C,44491742,3.863176048034213
KYM-1,36462,0.7671444744551638
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
PC-3,439501,-3.5165301870607903
8-MG-BA,135875424,3.2007214055219144
G-292 clone A141B1,9936388,-5.3493608745804515
HuP-T3,6505803,1.3238670991795596
NCI-H1975,135875424,3.5608641934024843
HEC-1-A,9927531,4.872071430147468
MDA-MB-231,168313200,3.9490295578631778
CHP-126,46943432,1.4569747849475687
HDLM-2,148198,-3.3078190571311925
KYO-1,3689413,-0.0705408923087068
HCC827,24180125,3.832444407587902
COLO 829,148198,-3.4268778382536715
SNU-761,135423438,1.615583061665389
SK-BR-3,54618164,4.481980343250785
GI-1,11485656,2.981503140786654
NCI-H1693,selumetinib-GDC-0941 (4-1 mol-mol),1.7777896818074843
LoVo,44493528,4.114958638118981
NCI-H28,selumetinib-GDC-0941 (4-1 mol-mol),0.00452428337889
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
L-363,46943432,0.9900841118632197
NCI-H1693,3689413,-3.280819080207211
SCC-4,11485656,2.4110004255244153
WT2-iPS,135875424,4.320167330318722
ONCO-DG-1,44491742,4.983213967285157
COLO 205,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404403717614667
HCC1833,36462,3.6976539288717927
B-CPAP,9903786,2.2781712830719316
BICR 6,135875424,4.583907142773698
SU-DHL-8,11485656,1.738295367016229
IGR-1,148124,0.9085011917115766
ACHN,6610216,4.543816334940376
Hs 944.T,5460769,2.3296902245035995
NCI-H1105,44493528,4.252977962816797
JHUEM-3,3689413,-0.6367758327679763
Rh30,135398744,6.322590827161508
NCI-H2170,168313200,2.9481522397603452
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
NB1,9936388,-7.943927579353001
BICR 22,135875424,4.925705128316808
JMSU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3740828564312233
SF126,24180125,3.7130980524835233
HOP-92,6505803,0.7885009521193799
NCI-H460,6610216,4.838717363885395
KP-4,439501,-3.618807292682963
LS1034,135875424,4.8820481204382995
DMS 53,11485656,2.0694415183010317
RPMI-8226,selumetinib-GDC-0941 (4-1 mol-mol),1.6638240545531544
IGR-1,26596,-0.0620943147126713
LC-1/sq-SF,12003241,1.312627912595186
IGR-1,439501,-2.7516642734120307
B-CPAP,54618164,4.142992093020013
SNU-16,5460769,1.4244737217539871
CGTH-W-1,148198,-3.7862022669488
EBC-1,11485656,1.836879581205612
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
TF-1,6505803,0.7719508977741311
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
P3HR-1,36462,4.280628122452117
JJN-3,148198,-4.237204763630457
HCC95,44491742,3.8054910800445994
JHUEM-2,46943432,1.9094756808376605
Lu-99,409805,5.898617863060202
Caov-3,10296883,4.16431215306168
KE-39,409805,5.860910954246773
Karpas-422,409805,3.3322180704918876
DMS 53,9927531,3.323341915494568
CAL-85-1,36462,2.3184829377165657
SNU-81,26596,-2.2143193215677925
WM115,9903786,3.894434750277636
NCI-H358,9903786,1.2866771615699664
U2OS,selumetinib-GDC-0941 (4-1 mol-mol),1.8236240565324096
A4/Fukuda,11485656,1.5130746228374388
SUP-HD1,11485656,1.8294636044245336
SUP-T1,11485656,1.1772627696716973
NCI-H446,54618164,3.912679414201531
KYSE-30,9936388,2.2895828136918785
UM-UC-1,409805,5.7723907546588835
BT 164,24180125,3.8792207003051984
GSS,5460769,0.9437954326098514
KYSE-30,12003241,-0.1095696990749684
HCT 15,9903786,1.9585182501172609
NB4,148198,-3.6503523996612617
NU-DHL-1,9927531,5.134600574788464
Kelly,selumetinib-GDC-0941 (4-1 mol-mol),2.978588327990176
Granta-519,12003241,-2.1147517064841925
A-375,5460769,3.311565919469283
LNCaP clone FGC,10296883,3.861229612453215
8-MG-BA,54618164,4.752985073629535
SW1710,107985,-3.4300855672934447
LS411N,9903786,3.6806866285220017
NUGC-3,6505803,-1.151304908691564
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
NCI-H2087,JQ-1-carboplatin (1-1 mol-mol),-1.3930122272626189
IGROV-1,44491742,4.406671418311328
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
TE-6,439501,-2.719069941795036
SK-N-MC,44493528,4.172598643795567
SK-N-DZ,6505803,0.8525676742203174
NCI-H2110,135875424,4.423682476800295
NCI-H841,6505803,-2.206212090567919
Malme-3M,168313200,1.6999895311998603
OAW28,6610216,3.9661844518771185
HCC95,36462,3.279798214232864
SK-MEL-31,24180125,2.52832402517647
CMK,8515,3.756463629168832
Panc 03.27,8515,4.616547975522318
MOLM-6,6505803,0.3209765108224145
DMS 454,10296883,3.765531757081873
SNU-1,11485656,1.6687756600657273
Namalwa,12003241,-3.0032452893334596
NCI-H1581,54639024,4.478978545564096
Calu-3,135875424,4.098138876247088
HuH-1,135875424,4.883016404001769
Panc 05.04,439501,0.2716766298535532
A3/Kawakami,148124,-4.427555036012123
ECC12,selumetinib-GDC-0941 (4-1 mol-mol),2.781694050737888
KMRC-1,168313200,3.9547474801247455
A-375,36462,2.2806967665334894
HEC-1-B,439501,-2.327113074925545
IGR-39,49836020,4.439074954514643
CAL-51,36462,0.7338920585832341
JVM-2,159324,0.4301215701176792
NCI-H358,135423438,2.3856947945666587
NCI-H322,11485656,1.7917980555041009
OCI-AML-2,148198,-4.39978868082379
PC-3,11485656,3.836663422003702
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
MDA-MB-361,9903786,4.233301337396568
KP-4,135875424,3.69718795810946
Jurkat,107985,-3.461929084789121
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
Hs 294T,44491742,3.9125649468331383
DMS 273,26596,-2.1961333269229173
KP-4,6505803,-3.0608028116863464
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
Rh18,107985,-2.133985516239094
U-251MG,107985,-0.8094709308100292
YD-15,5460769,-2.912025087128814
SaOS-2,439501,-2.8243657156627724
A2058,6505803,-1.8574702030952697
WM115,148124,-1.9357807696466565
BL-41,9936388,3.270630647985179
SF539,107985,-2.833720447652478
LUDLU-1,46943432,3.590400948954701
MV4-11,26596,-2.2629821538239576
TE 617.T,49836020,3.775264114601375
NCI-H2172,107985,-3.1793632305275836
TE-8,26596,-1.186583847807299
RERF-LC-MS,6610216,4.063402980130349
NCI-H889,439501,-2.793088249368423
MPP 89,8515,4.682001144094345
Namalwa,6610216,4.155862937962793
JMSU-1,JQ-1-carboplatin (1-1 mol-mol),2.6355388254924517
SNU-1033,3689413,-2.6391429266703015
HSC-4,54618164,4.183236352259565
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776
PK-59,6610216,4.292036954059538
SNU-1076,9903786,2.0917140595670585
ACHN,12003241,-1.5952093864502457
ES-2,3689413,-2.830682661734752
GB-1,selumetinib-GDC-0941 (4-1 mol-mol),1.0997063493321384
KMS-34,26596,-3.9045844155365304
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
MDA-MB-435S,159324,2.5157696151622413
SNU-449,44491742,3.9284370838515903
NCI-H2110,107985,-2.7030092125020713
SIG-M5,8515,3.548062021757778
SK-N-AS,44493528,4.35131115030736
UACC-62,168313200,3.7263380394473793
VMRC-LCD,46943432,3.939748255334783
NCI-H1650,9936388,1.5331586238984851
BICR 18,JQ-1-carboplatin (1-1 mol-mol),0.3768377986008463
BT 112,107985,-2.3005939746155244
SK-MEL-31,409805,6.337253307669649
U-CH1,12003241,2.634808409336574
IMR-32,6505803,0.9080588170181416
RD,6610216,4.20357872595554
JM-1,26596,-2.491901301923365
Hs 839.T,3689413,-2.374647409552807
NCI-H1373,44493528,4.762290588865201
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
SW620,6610216,4.2277666768570885
NCI-H28,8515,4.734021472875567
VCaP,9936388,1.4949429315009104
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
MCAS,439501,-1.7764971276715424
Panc 05.04,135875424,4.70222110000058
KYSE-450,6505803,0.925446652115482
RT-4,3689413,0.3652230576391069
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
SF126,26596,2.229943441766346
EB1,3689413,-2.432787849324627
JHUEM-3,11485656,2.0558841747808776
NCI-H647,107985,-3.43875812490285
CW-2,3689413,0.3628565855877684
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
TE-6,36462,3.471406428909744
AML-193,8515,4.304311331712035
GB-1,3689413,-2.42348697309168
NCI-H1373,439501,-1.5059395530242756
MHH-ES-1,8515,3.021519312968192
NCI-H1299,36462,2.6599488251356536
SUP-T11,439501,-2.327064015434822
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
IGR-39,24180125,3.339854178002294
KMS-18,6610216,3.94026464586725
NCI-H2122,159324,3.624644935210345
H-STS,6505803,0.5486553702983976
Hs 940.T,9903786,1.9949918440372123
VMRC-LCD,26596,-2.205960208364449
Tm87-16,9903786,3.2568482334104587
OE21,107985,-4.136076680497118
TOV-21G,409805,6.192744001897522
COLO 205,159324,2.8774722055154704
SF539,46943432,2.0271543904998746
EFE-184,159324,4.113973214034695
JHH-4,26596,-1.5147419870530787
NCI-H2122,3689413,3.5396747143031497
PK-59,3689413,-0.088836641292159
TE-10,26596,-0.9876255141372016
NCI-H1435,148198,-2.750299073281892
MES-SA,10296883,3.8748644308488864
SK-MEL-24,12003241,-2.7585414015303424
VMRC-RCZ,168313200,2.5099927309584924
MIA PaCa-2,49836020,4.16350045307359
BT 245,10296883,3.705541909006873
DMS 53,JQ-1-carboplatin (1-1 mol-mol),-0.3265365150884423
KP-N-SI9s,9936388,-6.7356563717129925
VCaP,9927531,5.412919809162458
B-CPAP,11485656,2.2559715729134204
Calu-6,selumetinib-GDC-0941 (4-1 mol-mol),1.8439594255895029
CJM [Human melanoma],5460769,2.7678000793867077
COLO 668,439501,-2.739607891151669
HCC95,selumetinib-GDC-0941 (4-1 mol-mol),2.25370960012268
KCL-22,54618164,4.521405657965437
HDLM-2,54618164,3.4787631819448546
EHEB,9936388,-5.642934540589324
Hs 578Bst,168313200,1.6109769305505062
RERF-LC-MS,439501,-1.3704502050640626
UACC-257,8515,5.269866695423634
NCI-H1793,409805,6.049600065269875
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
NCI-H522,10296883,3.751667506317718
CAL-85-1,6610216,4.177291709133228
FTC-133,409805,6.0297974484260655
Lu-65,148198,-3.5921377356072397
Mino,6610216,4.52250684011298
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
Lu-65,36462,1.7650112764581103
VMRC-RCW,selumetinib-GDC-0941 (4-1 mol-mol),3.3415688059991537
Hep 3B2.1-7,409805,6.120261984134354
NCI-H2081,6505803,1.279924414831301
SK-MM-2,12003241,0.4022958113963022
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483
JURL-MK1,54618164,4.131613316224029
HMCB,135875424,3.5183087899290686
MV4-11,46943432,-1.773964414014851
Hs 746.T,8515,4.584865642264335
NCI-H2342,44493528,4.387491480960399
Pfeiffer,5460769,3.50798965945468
CAL-54,9936388,2.642816339395173
NCI-H1373,selumetinib-GDC-0941 (4-1 mol-mol),2.438730896518944
NCC-StC-K140,6505803,1.225711680594439
CA46,148198,-5.7845042531785
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
COLO 201,6505803,-2.3014705342843365
DK-MG,6610216,4.502429110487552
NCI-H522,168313200,1.7984937800694238
T84,148198,-4.2219788227955855
2004,6505803,1.2288982510543929
A3/Kawakami,3689413,-2.523189913009787
Daudi,44493528,3.680262260756896
SW1417,148124,0.4370036719879761
SNU-719,46943432,1.63856313223
BT 271,409805,3.7832807554338186
EFO-21,54618164,4.387147520518085
MOR/CPR,439501,-2.2142939555112484
SH-10-TC,54618164,4.2209628595779005
KMRC-3,148198,-3.839919535883422
IMR-32,11485656,1.530549227150807
HLF,5460769,2.8126856105883355
OCI-AML-3,6610216,3.7243231461323463
BICR 31,54618164,5.999146696375086
BT 428,5460769,2.5146871392563845
NCI-H2110,409805,5.766269272797009
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
EoL-1,49836020,1.4161576765733714
SNU-1066,9936388,2.256482479661346
OVCAR-4,148198,-2.4399206848241852
SNU-119,12003241,-0.7435067493629696
MOLT-3,12003241,0.5652275410160802
Hs 936.T,24180125,3.7813502708248543
L-363,54618164,4.061988189817136
Hs 940.T,12003241,-1.8353600585061816
ALL-SIL,5460769,0.8731159867521163
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
HEL 92.1.7,9936388,-4.8155020562106525
COV434,24180125,1.5082438286662294
OV7,148198,-4.147703554410761
KYSE-410,26596,0.1189340940832646
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
KMRC-2,9936388,3.0990467374612813
TE-4,36462,2.757071429089849
SW48,148198,-2.7635683141359277
NCI-H2196,107985,-4.2483053233771875
A3/Kawakami,10296883,3.880092254870085
SK-N-MC,135875424,2.366794730604702
Hs 852.T,439501,-1.3990443453800825
Peer,6610216,2.802806144642803
Aska-SS,439501,-3.4608963825976686
SNU-46,148198,-1.481074148002998
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
HL-60,54618164,3.9340481964964336
Lu-99,46943432,2.664503794915281
OCI-Ly10,26596,-0.6290463214568307
BT 330,9936388,0.9619236718444248
BT 498,9927531,5.612738328284819
SUP-M2,12003241,0.982076040273681
BT 164,54618164,3.5882356128871913
CAL-51,36462,0.7338920585832341
A-549,159324,3.3469799601732366
Hs 746.T,9936388,2.9301322002426393
HCC38,409805,3.899400540305636
SNU-46,439501,-2.258414005891366
HCC95,159324,3.4223994590460594
SNU-899,selumetinib-GDC-0941 (4-1 mol-mol),0.9114020833269496
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
BT-20,148124,-6.2975852770754015
PL-21,159324,0.5268160005724882
YD-15,54618164,4.077612524706247
SW1990,9936388,2.7870062891486613
NU-DUL-1,159324,0.0667263038861609
HCC366,JQ-1-carboplatin (1-1 mol-mol),1.2821420815948563
Mino,54618164,3.08934752103197
SU-DHL-1,24180125,2.3898229933344193
TE 617.T,44493528,4.329408184341151
HEC-265,9903786,3.4431873939131536
LNCaP clone FGC,107985,-3.945098238572166
OCI-M1,11485656,1.896897846334656
RL95-2,26596,-0.9803054302492492
Hs 611.T,9903786,0.3508528062947837
SaOS-2,107985,-4.209612864808627
LOX-IMVI,12003241,-2.813518393614124
Kelly,44493528,4.323987981167799
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876
U-251MG,9903786,4.913889261363981
RL95-2,46943432,5.824295984202932
MeWo,12003241,-1.7569732997280945
CHP-126,11485656,2.087458763125066
KMRC-3,9936388,-1.673858974154645
COV362,135875424,4.673498463439342
Yamato-SS,439501,-2.9542074712794517
HLF,selumetinib-GDC-0941 (4-1 mol-mol),3.676368121214341
BT-12,10296883,3.911493297930768
OE19,10296883,4.248743663804576
NUGC-4,409805,5.054333560474846
Hs 746.T,36462,3.4545901563724075
GMS-10,409805,5.760322629357072
Mono-Mac-1,11485656,2.9972427080576836
DK-MG,54618164,4.452383351866673
COLO 792,8515,3.901097239936766
EN,6610216,4.3529410731248
NCI-H716,6610216,4.204233875034661
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
LC-1/sq-SF,selumetinib-GDC-0941 (4-1 mol-mol),2.9597977830319935
U-937,6610216,3.792475471520531
DND-41,26596,-1.3202555430270588
COV644,49836020,0.1306983764226103
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
NCI-H1373,8515,4.13419356342465
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
Karpas-422,10296883,3.4516705884612704
SK-ES-1,12003241,-1.52997414629941
NALM-6,148198,-4.9316309610595335
NMC-G1,24180125,3.2827632569676433
SIG-M5,439501,-3.273907668571148
8305C,9903786,1.7590562865334185
Ku812,54618164,2.681700331746246
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
Hs 940.T,135875424,6.668178474722678
T98G,107985,-3.0074244908782792
KO52,148124,-8.023122181205325
697,135875424,2.464322234177451
NCI-H810,9903786,3.328850282444774
COR-L279,135423438,1.6988524729087828
SNU-503,5460769,2.419581709530207
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
SNU-213,107985,-3.586157663071436
Caki-1,409805,6.67721906325642
TALL-1 [Human adult T-ALL],54618164,3.238906598306848
BT 172,168313200,1.6859469241493503
KLE,54618164,4.225211860569233
HCC2279,159324,2.7132779523720068
SR,6505803,-2.233743184339516
Hs 766T,107985,-4.370036602649094
OCI-Ly10,3689413,2.738747600587094
JHH-4,36462,2.924311920402553
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
OC 314,107985,-3.8109236792960863
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
HT-1197,9927531,4.678863685283018
P31/FUJ,6505803,0.2535639265329721
BT 239,11485656,1.6389778224376736
YAPC,159324,3.323857793241652
NCI-H2081,9927531,2.933726437844289
MES-SA,439501,-2.264210619464941
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
KHM-1B,44493528,1.720576936641076
COV434,36462,-0.4470127244502256
Sq-1,11485656,3.136931266066648
BL-70,3689413,-1.0284037004933524
OE21,168313200,2.14822822620211
COLO 684,9936388,-6.416738093665191
Daudi,3689413,-4.376822515219121
BHT-101,439501,-2.3771581779378828
SEM,11485656,1.8495119352561953
BT 231,54618164,4.074270092547043
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
Calu-3,6505803,0.3203856441914136
YAPC,54618164,4.31457100114165
NCI-H508,148198,-2.3107893902367116
BL-70,107985,-2.6237617688158044
RCC10RGB,409805,6.020159348453613
KO52,439501,-3.705469726802315
LS1034,10296883,3.964188114120739
HCT 15,439501,-2.431117301372995
SW1271,409805,4.993473873943069
MDST8,159324,4.143261975826356
NCI-H2023,5460769,4.150302713550692
SNU-478,12003241,-2.4220393479516025
HCT 116,439501,-2.291145672790816
MSTO-211H,107985,-3.699787970340743
NCI-H2291,54618164,5.760703880265436
SNU-478,8515,3.3464395121012847
NCI-H1395,10296883,4.692616973111803
T24,3689413,-0.672605759999641
2004,6610216,3.877124276480686
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
HCC44,9903786,0.5279756391305372
SIG-M5,JQ-1-carboplatin (1-1 mol-mol),-0.4990095627989978
BT 333,11485656,2.747933389336241
OAW28,409805,4.888216855585461
KP-4,36462,0.4570460544879974
PK-1,3689413,-0.025358625846968
MDA-MB-231,selumetinib-GDC-0941 (4-1 mol-mol),2.1561447118873383
SK-N-SH,9936388,-5.065644908322296
SK-ES-1,439501,-3.332679382402903
NCI-H1105,6505803,1.9416219535122128
TYK-nu,11485656,2.0591967948441665
NCI-H358,JQ-1-carboplatin (1-1 mol-mol),-0.0841702060243808
NCI-H1355,135423438,1.8845070459109623
HEY A8,12003241,-2.767500133031125
HPB-ALL,12003241,-0.6872291231969794
Kasumi-2,9903786,1.7296917357536032
TE-15,JQ-1-carboplatin (1-1 mol-mol),0.1114942232553469
L3.3,9936388,-5.444309252993802
A-204,9936388,1.1921952776349394
NCI-H1155,107985,-2.9332881194329694
GB-1,439501,-2.3945114258909532
MES-SA,JQ-1-carboplatin (1-1 mol-mol),4.437075394990418
BICR 16,168313200,3.664678330841195
OE21,11485656,1.707456262972337
RS4;11,36462,-2.0562478035325698
NCI-H1373,12003241,-0.7849764131433078
ACC-MESO-1,6505803,0.753585399472996
TE-6,44491742,4.129891650576595
NCI-H1568,36462,0.6787379731584755
KYM-1,8515,3.3441166604006014
Hs 888.T,6610216,2.876743996028597
LS411N,9936388,1.997277136132151
Jurkat,46943432,1.5147475299254256
Caki-2,11485656,3.849014723207123
HCC4006,148124,-6.171218423439735
TF-1,46943432,1.9785022897713067
HuP-T4,JQ-1-carboplatin (1-1 mol-mol),-0.0362149836695267
NCI-H1650,439501,-0.6894352308557807
OVK18,409805,4.876837954630626
NCI-H1581,135423438,0.6953694326358761
MHH-CALL-4,6505803,0.4342437692072871
FTC-238,135875424,3.1896552091997603
LOU-NH91,54618164,4.244208934703923
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
LXF 289,11485656,2.2610473771175847
JHH-4,8515,4.445321980402721
NCI-H322,9927531,5.259442104255536
BICR 18,36462,2.3233990494988856
CAS-1,36462,2.348698215891486
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
SYO-1,168313200,2.736095144850066
HCC1954,selumetinib-GDC-0941 (4-1 mol-mol),0.8258284821582321
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
IGR-37,54618164,4.309961080908924
KNS-81,9927531,4.88247851361275
COLO 205,409805,5.399830169026648
KYSE-510,44491742,4.7429938042096245
EM-2,26596,-2.2140652847735027
SNU-1041,9903786,3.9190312975923822
YH-13,409805,5.8043407056117395
A-253,439501,-2.336084390723404
RS4;11,26596,-3.6621242440749766
OCI-Ly19,selumetinib-GDC-0941 (4-1 mol-mol),-1.7363769217481064
NCI-H460,135875424,3.211754300989152
NCI-H838,3689413,-2.1672294024388106
SNG-M,54618164,4.091040607264855
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
SU.86.86,selumetinib-GDC-0941 (4-1 mol-mol),2.756391846899265
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
HT-144,44493528,4.6392793264326
TTC-709,135875424,2.6743897511272454
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
TE-10,148198,-2.165511242505793
VMRC-RCW,46943432,3.328394132724634
BICR 16,6505803,-1.4833128134740765
BT 245,44491742,4.161467905313556
Kelly,54618164,3.6776094025388586
COLO 320,44491742,4.01582606797262
HCC1833,409805,5.961157606825395
MHH-NB-11,12003241,-1.5354599516868075
Hs 944.T,26596,-1.3336328172357843
NCI-H2081,11485656,1.3595446454141742
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
KP-3,9936388,-3.794861235698215
SNU-213,9903786,2.2891232968098887
Peer,12003241,-2.4634872028083015
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457
TYK-nu,10296883,3.5391236676051583
HCC1588,6505803,-1.104009998130938
BT 330,12003241,-0.9920089469814386
SK-MEL-30,24180125,3.411770720439659
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
NU-DHL-1,9903786,2.0090459538270298
A4/Fukuda,6610216,3.4719570509087445
SK-MEL-5,6610216,3.979150432082891
DMS 114,107985,-3.855936859666903
MOLM-6,44493528,4.505995981059325
NCI-H1299,24180125,3.786842850309645
Rh30,6610216,4.152878640581398
J82,9936388,2.8537355622155536
TTC-709,6610216,4.616312272440149
OCI-Ly10,46943432,0.1939232888167296
VCaP,135875424,4.074355595909067
SHP-77,11485656,2.0449362643576854
MFE-296,selumetinib-GDC-0941 (4-1 mol-mol),2.628937371578258
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
PaTu 8988s,36462,3.2992976849858593
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
BICR 22,8515,4.348804794701894
G-402,10296883,4.070324886092359
BT 428,11485656,2.0550266467475407
HuP-T4,107985,-3.5574573773350995
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
KMS-26,9927531,3.4485802259646703
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
MCAS,44493528,4.628123206531076
AM-38,6505803,-3.272255667195971
KCL-22,12003241,-4.05956124354109
RL95-2,9903786,1.393609544351605
QGP-1,409805,3.7704201197308578
COLO 205,107985,-2.774548005987086
M059K,409805,3.7462715716608943
Hs 888.T,6505803,-0.3251966852868098
Rh30,148198,-2.9975267063849507
SK-UT-1,168313200,3.914325756565286
SNU-869,409805,5.023063229429615
RD,148124,-4.312204426791305
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
JHUEM-2,12003241,-3.1995756847172108
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
NCI-H2029,11485656,1.831867006041765
DU145,36462,1.0541002135373008
23132/87,159324,3.098408449311899
HCC1395,9936388,-7.459318644951684
U-937,409805,5.256471886219303
OVTOKO,107985,-3.799732923526536
PLC/PRF/5,3689413,0.4443196233363375
SW1088,135875424,2.929496932080149
U-118MG,12003241,-0.1852675851464418
NU-DUL-1,44491742,3.737315333639921
NU-DUL-1,9936388,-7.007510974926655
NCI-H1915,6610216,4.005015250332215
BHT-101,9936388,2.229649251743914
MPP 89,selumetinib-GDC-0941 (4-1 mol-mol),2.3167615576876734
BHY,73707440,3.8308297989049143
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
KMRC-1,44491742,6.09620831621162
NCI-H889,6505803,4.205027761053593
A3/Kawakami,135875424,3.019357204965879
PC-3,135398744,6.536880900821883
P31/FUJ,9903786,1.0734919883099745
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
TE-11,36462,0.9380758205359858
LCLC-97TM1,46943432,0.977611384475134
ST486,26596,-3.6953345637142063
TUHR10TKB,44491742,4.130919607533437
SNU-C2A,JQ-1-carboplatin (1-1 mol-mol),1.666650905200112
JHH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.7984148033328824
FU-OV-1,36462,2.321134275550796
OVCAR-8,168313200,4.004773853109795
HDLM-2,3689413,0.2567400255605154
EB1,107985,-4.010764763700101
Hs 578T,JQ-1-carboplatin (1-1 mol-mol),1.3034632234881312
RPMI-8402,49836020,4.366358527241826
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
TM-31,8515,4.489204846953569
JHH-2,135875424,3.057763367956565
NCI-H841,JQ-1-carboplatin (1-1 mol-mol),4.388076170034027
SW1710,3689413,-0.3418925228905715
HDLM-2,159324,1.0950285882033006
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
Hs 888.Lu,409805,5.27366905303051
Panc 03.27,54618164,4.198880096494509
NCI-H146,439501,-3.5641402563292393
CAL-54,26596,0.8562356828634801
BT 139,5460769,4.859801196456228
OV7,3689413,-5.087599218712134
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
COLO 678,12003241,-1.07618054300688
SNU-886,9903786,2.951492144984292
BT-12,24180125,2.7437053891950636
NCI-H810,36462,1.4290563558220155
HCC1833,12003241,-0.598038454038546
BT 145,148198,-5.145484796849837
SNU-1041,3689413,2.0809742429378133
LS1034,12003241,0.7423322156732435
A-498,148198,-1.0809020747576437
KE-97,12003241,-1.757079073884842
NCI-H2452,44493528,4.324080951064212
BT-16,24180125,2.577165097149746
YD-8,9936388,2.2646667902608724
BV-173,9903786,1.323242877126727
SNU-46,11485656,2.352857034894664
HuH-6,148198,-4.2090148459879275
BT 440,148198,-3.676636651938413
RERF-LC-MS,54618164,3.9158352593779377
JK-1,3689413,-0.5403816328590246
ECC10,11485656,1.639857171829123
U2OS,9903786,2.225601394928473
697,9903786,0.9408007056276604
MM1.S,46943432,0.8040935349772499
NCI-H2009,9936388,-6.076047204085024
OCI-AML-2,439501,-2.945157705835344
COLO 320,6610216,3.982135199873874
NCI-H1838,49836020,4.844484842212348
MEC-1,3689413,-2.5144055984412903
KP-3,409805,5.570202879037171
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
OE19,107985,-3.5723109607204084
KM12,6610216,4.513163589835474
KMRC-3,107985,-4.753608924350131
HOS,148124,-6.277253873597463
NCI-H2286,54618164,4.200940501836108
NCI-H526,9936388,-5.702236125397588
SK-MEL-1,54618164,4.203160521869226
NCI-H810,46943432,2.958355821936664
SK-ES-1,3689413,-2.1650070700779582
A2780,8515,1.754639935244518
UM-UC-3,6505803,-0.1078533908221657
Kasumi-1,439501,-2.487116457098306
IST-Mes1,135875424,5.039969018342982
NCI-H1341,9927531,3.217953728153189
OVISE,9903786,4.69480560533159
RS4;11,8515,2.057442259754831
NCI-H716,9903786,1.532038090064473
HGC-27,6505803,-2.0578617298265787
KNS-60,6610216,4.235845632004621
Panc 04.03,11485656,3.4698409381110435
SNU-869,6610216,4.335710435048634
MV4-11,439501,-2.384651174177473
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
OCI-Ly19,8515,3.292375544216499
SU.86.86,9927531,4.197811757313418
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
NCI-H358,36462,2.0858276419608166
RT-112,409805,3.4444606673833875
Li-7,54618164,3.841358647410796
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
NH-6,9903786,1.6690533510154009
BT 216,12003241,2.6409098560740243
NCI-H929,135875424,3.2591057623275006
RVH-421,6505803,-0.8379256184936457
Peer,44493528,3.441371603588331
BT 328,12003241,0.43959296828198
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
SNU-601,5460769,-0.8674559843471038
SW1417,36462,3.4260079153172596
8-MG-BA,10296883,4.312011375690635
HCC1143,159324,3.533344711636858
SiMa,9927531,3.724506882989752
HCC1588,135875424,4.102110498165806
SNU-668,11485656,2.3773285837214444
Kuramochi,9927531,6.027141313400392
NCI-H322,26596,-1.3562395131244265
NCI-H2172,9903786,4.970438346504575
AsPC-1,12003241,0.1897400127907629
SiMa,5460769,0.4503719492820418
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
TCC-Pan2,148198,-2.533769262654455
SUP-T1,12003241,-2.125139255884817
RCH-ACV,6610216,4.070722186568696
YD-10B,439501,-2.459950710231521
Capan-2,9927531,4.988385726182681
HEC-59,3689413,-1.7900495461220194
OE19,selumetinib-GDC-0941 (4-1 mol-mol),2.914512652837311
GOS-3,6610216,4.739620593848468
JHH-2,36462,3.020657700681576
Hs 766T,JQ-1-carboplatin (1-1 mol-mol),-0.2736789980960341
KP-N-YN,72199289,5.448053701160584
HEC-108,9903786,3.9980769668892706
NUGC-3,5460769,1.9333841225118369
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
EFO-21,12003241,-0.6894261883426276
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323
HOP-62,8515,4.458909571137292
PC-14,6610216,4.542252614030989
COV644,3689413,-1.4992872949818017
PK-59,6505803,-0.3559678115713951
SU-DHL-8,135875424,3.290196738895973
SW1271,44493528,4.286060334293371
NCI-H358,46943432,1.7093173589972348
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188
LMSU,135875424,4.495921610081383
Hs 852.T,409805,3.946655740773064
647V,9903786,2.919786568637495
Daoy,6610216,4.836083157079014
HCC-56,44491742,4.146730174017219
LMSU,148198,-4.18626130759339
PK-1,9903786,5.672212413868687
SW1088,135423438,1.6657015051140114
NCI-H460,9936388,2.3098343611543415
CAL-85-1,439501,-2.788056668623063
Panc 02.03,168313200,4.226618217059218
EM-2,36462,-1.2083602096213608
Fu97,JQ-1-carboplatin (1-1 mol-mol),0.0288153653540589
Panc 10.05,107985,-4.4512341948004535
DB,168313200,1.5488809827223406
IM95,selumetinib-GDC-0941 (4-1 mol-mol),-0.8100536248662729
MHH-ES-1,107985,-3.8860683176627098
HEC-6,409805,5.177200547925916
22Rv1,24180125,2.329727344285758
KP-2,107985,-3.092372796276895
42-MG-BA,8515,3.761157629466223
OCI-AML-5,5460769,2.0028479546764664
HuH-6,JQ-1-carboplatin (1-1 mol-mol),1.9936450141574449
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
FTC-238,54618164,3.8997014526037272
A-253,9903786,4.10726286628635
JHOS-2,36462,1.7385216355636115
HuT 78,148124,-4.9142161440271135
MDA-MB-415,54618164,4.2840965764331935
NCI-H522,107985,-4.282222583037789
COLO 680N,107985,-1.189155361561619
NCI-H647,135423438,3.3344215247990507
SW48,54618164,3.7830586534540616
CA46,44493528,3.81061502276679
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
ACHN,168313200,3.9781211738583977
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
A4/Fukuda,54618164,3.3817410387547575
NCI-H28,6610216,4.594899997318736
PF-382,135875424,3.2130182861195076
ALL-SIL,54618164,3.625474128679928
SNU-886,12003241,-3.694795257520175
RERF-LC-MS,36462,1.1230283698314445
JURL-MK1,24180125,3.1743291213422373
Mel JuSo,54618164,4.220783643811767
MCAS,3689413,-1.1400919247426515
SK-MEL-24,10296883,3.9886960310238178
SNU-216,36462,2.86106389441445
BT-12,49836020,2.972579306483729
OCI-Ly10,107985,-3.494379177576491
NCI-H292,9877608,5.923265260718527
YD-38,3689413,0.3954861349850884
BT 498,135875424,3.150429417088691
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
Panc 08.13,148198,-3.0939761234000867
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
Rh41,107985,-4.1063623944843695
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
OVCAR-8,409805,6.24723950775959
BT 286,439501,-3.2145304071914844
TE-15,107985,-3.356146031116269
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
WSU-DLCL2,36462,-1.1890066512244994
HMC-1-8,3689413,0.9110162890999955
SNU-119,409805,3.7561778624984585
TUHR4TKB,6505803,0.1183916105816245
RCH-ACV,12003241,-2.009657794147886
JHOC-5,148198,-2.0741521634031033
TF-1,9903786,1.2296708534399408
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
Tm87-16,5460769,0.8511670833811608
SUP-B15,12003241,-3.8836552178144848
JHOS-2,3689413,-2.497853898445669
H-STS,107985,-3.371812219101193
P31/FUJ,148198,-3.664233852608881
FaDu,135875424,3.054249321596862
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
253J-BV,44493528,5.814016422877873
FaDu,8515,5.401189505812741
NCI-H1299,9936388,-0.1781231784373126
DK-MG,439501,-2.8000262894493653
KCL-22,JQ-1-carboplatin (1-1 mol-mol),0.9961294088187655
C2BBe1,6505803,1.1561047092337646
SK-MEL-30,9936388,2.3653955391527575
SK-N-MC,168313200,3.837504051506091
MHH-ES-1,11485656,2.0026914663439648
BT 320,409805,6.1406982436622
Namalwa,24180125,2.5255693450157697
RKO,26596,-1.341584325458414
EKVX,54618164,3.934714976458277
RS4;11,409805,2.991806460925903
8-MG-BA,148198,-4.196871599679804
BICR 18,5460769,1.6305268231033057
IGR-37,3689413,2.8374772536506407
NCI-H2052,168313200,3.834081580136544
TYK-nu,168313200,2.5919880239615702
NCI-H441,selumetinib-GDC-0941 (4-1 mol-mol),1.6335298040025916
Hep 3B2.1-7,6610216,4.203161900181635
MFE-319,148198,-4.2483014049358685
TCC-Pan2,54618164,4.990459114460208
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
HPB-ALL,148198,-3.7758492829938857
BT 416,8515,1.3533271204830115
NCI-H716,135398744,6.457168364956761
LNCaP clone FGC,409805,5.792724487332009
NCO2,46943432,0.3319797897009531
OCI-M1,6610216,4.2941719628539925
LS1034,148124,-4.182223287132367
KMM-1,6610216,4.9199477821818
647V,8515,4.838859925138422
COR-L105,11485656,1.8131666015075352
Pfeiffer,9927531,3.43317918273791
WM793,6505803,-1.695252066312567
HuCC-T1,439501,-1.791859675505955
MFE-296,36462,0.8328013204585911
Calu-6,9936388,-7.509028566007479
MPP 89,44491742,4.112850541914658
TE-8,36462,2.1560218282432393
NCI-H1650,9903786,2.8320144189469385
MOLT-16,107985,-4.899451887345495
MFE-319,10296883,4.228563171543355
CJM [Human melanoma],148198,-2.9746080822797754
MM1.S,10296883,3.0108141042121246
KMS-27,8515,4.078018494843081
RKO,6610216,3.958403220086871
NCI-H1568,409805,3.8387714265583592
RPMI-8226,135398744,6.232374281438443
HCC2279,148198,-1.731390144529653
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
ONS-76,6505803,1.3937943977095182
CMK,135875424,3.145736210165476
KP-3,9903786,3.3194843074548843
SNU-878,9903786,2.6270705473192644
MKN1,409805,5.673588155962679
SK-CO-1,6505803,-2.970063061644963
VM-CUB-1,409805,4.766364955884477
Tm87-16,6505803,-2.793426888899639
TTC-709,148124,-6.07552333900772
U-118MG,148198,-4.8447991211514685
TTC-709,8515,2.8339402756906735
MV4-11,11485656,-4.658244572129019
HCC1500,9936388,-2.5304598124234365
DV-90,135423438,2.6619709505145637
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
VMRC-RCZ,selumetinib-GDC-0941 (4-1 mol-mol),2.964733367482892
LOU-NH91,409805,5.248055334811583
2004,9936388,0.7178208617873092
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
Mino,8515,3.2979107224105406
NCI-H1341,107985,-3.661657007936306
SNU-C2A,409805,4.9402914369912
HEY A8,54618164,4.2562410022928105
KMS-12-BM,6505803,-0.6027320108546551
TE-5,26596,-0.6674646083378311
MG-63,44491742,4.049642181579157
HT-1080,12003241,-0.8718791582683669
OCI-Ly3,12003241,-1.5890645032871102
SK-MEL-3,135875424,4.254537076795971
G-361,409805,5.8363569704148714
Ki-JK,439501,-2.4258748646441624
HCT 8,selumetinib-GDC-0941 (4-1 mol-mol),2.0495496026415307
PF-382,159324,-2.108239526563577
RS4;11,10296883,2.9468024036762483
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
CCK-81,10296883,3.3537849250565244
MHH-NB-11,26596,-2.2895666937918673
COLO 680N,44493528,4.52378169119992
T84,6610216,3.707288952645697
NCO2,148198,-4.272732589139003
NCI-H1092,168313200,1.6747772833697747
SK-MEL-5,10296883,3.4956550108222775
SNG-M,3689413,1.102237357506899
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
SW1710,8515,4.438897883446972
HCC1588,9936388,-4.959177530840856
SiMa,11485656,1.7152313811667237
SW1990,3689413,-1.271257676680656
NCI-H1355,148198,-3.013300378590096
NCI-H2172,159324,3.4766300457250416
KYSE-510,3689413,3.0228627584183565
MeWo,135875424,3.994936562823645
KE-37,6610216,4.08860835396977
TT2609-C02,6505803,-2.0944052734627565
TALL-1 [Human adult T-ALL],46943432,0.6516741568598718
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
HT115,12003241,-0.6699503648785873
HD-MY-Z,8515,3.657206097253692
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
BT 248,6505803,-0.8385222866943476
NCI-H526,46943432,1.817345748951115
NCI-H1435,9903786,1.8372314189682823
DMS 273,24180125,3.0640550148835812
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
8-MG-BA,JQ-1-carboplatin (1-1 mol-mol),3.7753986930145658
HPB-ALL,9927531,5.02886546731598
NCI-H1581,148198,-2.796222248008704
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
IM95,439501,-2.2673196662301933
MDA-MB-231,148198,-1.1637706942171424
GI-1,9927531,5.508249375264951
Jurkat,9936388,-5.914965617519404
SU-DHL-1,6505803,-0.92520479323989
Caov-3,36462,0.673348876480101
COR-L95,5460769,3.3963309413836815
HuP-T3,46943432,3.2592232125577665
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
SNU-1077,6610216,4.195845914467317
SK-MEL-3,44491742,3.867059457044452
MHH-CALL-4,10296883,2.742921338749494
HCC95,24180125,5.4375658391597215
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
COR-L105,135875424,4.584511127602178
SK-MEL-30,439501,-0.2056245952948021
Daudi,10296883,2.545577320776033
BT 147,135398744,6.518001641470466
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
Panc 10.05,3689413,0.9531263048130152
SH-4,44493528,4.462421273683891
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
BT 286,9903786,1.725049982792706
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
22Rv1,12003241,-0.1253815141985464
HT-1376,11485656,2.207084161817658
NCI-H1755,439501,-3.104182815210806
KMH-2,3689413,-1.7619354335242607
T24,9927531,4.8353414036700615
SK-HEP-1,409805,5.808157500863876
HCC1500,24180125,3.164669305988548
NCI-H2228,24180125,3.874762133754576
SK-UT-1,439501,-2.663904937582399
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
EFO-21,44493528,4.429307418549765
OCI-Ly19,36462,-1.4425476096855017
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
SNU-387,24180125,3.6779507392233017
KE-97,26596,-2.711610546447418
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
SU-DHL-8,3689413,-0.1983897447219186
IGR-1,9927531,6.184289140362073
NCI-H358,44493528,4.323169379797207
JHOM-1,148124,-4.470730490195969
SNU-1041,6610216,4.964227197665286
KYSE-140,439501,-2.2036133964389446
MOLT-13,46943432,0.575626036010324
NCI-H1755,159324,3.419106148632872
SH-10-TC,148198,-3.7737897444404993
HDLM-2,11485656,1.650668651442868
HuCC-T1,44493528,5.528865919674086
NCI-H1666,11485656,1.1104908410257284
IGR-37,9903786,4.593363058361211
PL-21,26596,-4.324956328818882
EM-2,8515,3.0626946322597495
Capan-2,107985,-3.8437908284665494
2004,46943432,1.6029430054361635
MM1.S,54618164,3.790511096311708
SUP-T1,26596,-4.2216278033342105
Hs 895.T,11485656,3.207979584674572
AML-193,168313200,1.5323685202636708
RT-112,11485656,1.7918654430987004
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
CHP-126,135875424,3.887160554276878
RPMI-8226,36462,0.6867842067888891
TE-9,12003241,-0.5375086976849406
SNU-61,12003241,0.1572719330395487
BT 164,36462,-0.9210275826088992
SNU-398,159324,0.2037987580554599
NCI-H1184,49836020,5.907287846852096
TUHR10TKB,9903786,1.579233705567475
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
P31/FUJ,24180125,3.650250525491935
RS4;11,12003241,-1.5224166820052676
SNU-886,26596,-1.4881272997493236
SNU-626,9903786,4.459436811322819
NB1,439501,-2.2993360738685604
HOP-92,12003241,-2.2936384439521156
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
LC-1/sq-SF,148198,-3.4004768458616086
HCC4006,9927531,5.0093588349321125
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
Rh41,selumetinib-GDC-0941 (4-1 mol-mol),-0.3258971504305004
BT 239,439501,-3.505235897057165
A3/Kawakami,JQ-1-carboplatin (1-1 mol-mol),-1.0104542056691184
CHP-126,54618164,6.478655654296826
NMC-G1,439501,-2.0387411188020024
NCI-H716,8515,1.647950101342266
BT 328,9903786,4.817171686681598
PK-1,9936388,-3.885789608116406
HeLa,11485656,1.8522393336584817
VM-CUB-1,44493528,4.312275176745317
TC-71,12003241,0.7010514965491693
NCI-H2085,3689413,-0.2448228197387998
SCC-9,6505803,-0.8932206272709824
MHH-NB-11,439501,-2.5352340677709404
EB1,36462,-1.26198957190765
HT-144,49836020,4.351286347642034
SK-MEL-24,439501,0.5144696508733063
COV362,9927531,5.782280660469085
BT 224,107985,-2.0427396938627993
Karpas-422,148198,-3.5709854147128843
MOLT-13,54618164,3.06844415075447
SCC-25,36462,4.497362805225712
OS-RC-2,6610216,4.858225947192859
CAL-148,JQ-1-carboplatin (1-1 mol-mol),1.5060433709656682
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
HEC-1-A,148124,-3.4679432039259392
MeWo,409805,5.880050900822264
MDA-MB-231,9936388,2.201115810933066
MIA PaCa-2,54618164,3.936263034196557
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
Ci-1,9927531,4.406404304601132
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
JM-1,107985,-4.195149425063274
COLO 680N,159324,3.5471149133283113
HEY A8,3689413,-2.2125181580464592
HT-55,24180125,3.3828154090857288
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
KMRC-20,44493528,4.509843443263092
NCI-H1734,9877608,5.725584045619203
WM115,10296883,3.9273376390568138
A-673,12003241,-2.2168793422392103
UO-31,135875424,2.695151327670827
769-P,26596,-0.9592747509105644
SK-N-AS,9936388,-8.947501416398147
L-1236,8515,4.228188725172905
SNU-245,3689413,-1.9631171858613183
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
TE-4,11485656,2.067320929780226
GMS-10,12003241,-0.439124949180571
GA-10,8515,2.077027098708472
CAL-51,12003241,-1.2189714227076325
SNU-601,107985,-3.781462063304301
BT 216,24180125,3.180911613417136
SW620,44493528,4.454828902160922
NCI-H889,11485656,2.9669952832356645
PLC/PRF/5,135875424,4.546560112708509
SNU-1,44493528,4.533433840242425
RERF-LC-Ad2,135875424,4.566580865948674
KM12,9903786,1.2751766913602836
HSC-2,168313200,3.029663410726755
NCI-H2342,135875424,4.000102704356125
COR-L51,26596,-2.461438053418328
SUP-M2,148198,-0.2011306598462228
Hs 888.T,26596,-1.257833689984314
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
KNS-81,3689413,2.13740937168454
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
IM95,148124,-7.38218571284071
SNU-5,5460769,1.0227075924286728
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
UO-31,JQ-1-carboplatin (1-1 mol-mol),1.475282337781019
HCT 8,9927531,4.796707314113722
NCI-H810,54618164,3.7149211791922543
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
SNU-668,3689413,0.4740443403911467
OAW42,439501,-3.627774271274344
LCLC-97TM1,3689413,0.1289764847745495
COR-L95,148198,-4.800055382400855
RKO,9936388,0.8183869926163714
SK-MEL-5,9936388,2.3503506475790816
HT-1197,JQ-1-carboplatin (1-1 mol-mol),3.4670046988259675
KYSE-510,12003241,-0.1961434673469709
SNU-182,159324,1.3333674502303892
SNU-899,5460769,1.25373521066823
Detroit 562,12003241,-1.0092858141729106
NCI-H1355,107985,-3.217493720542047
SNU-46,409805,6.019654456375195
BT 245,439501,-4.061461225365729
DLD-1,135423438,2.617658821195633
U2OS,135875424,4.905688284770679
Kasumi-1,148198,-3.174700681388165
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
ECC12,135423438,4.440785881559049
TE-15,26596,-3.7197158754991615
NCI-H211,135423438,1.3338851322165923
8305C,36462,2.9479443430205565
SNU-387,168313200,2.350990490549559
KNS-60,9927531,4.453206768801637
ZR-75-30,439501,0.5523338496996666
BT 444,439501,-3.015846554822595
UACC-257,107985,-2.6812388273080416
Capan-1,6610216,4.674579245931144
SET-2,168313200,1.9017333660597997
Namalwa,107985,-4.241523948583442
NCI-H838,46943432,5.187493822997753
BICR 16,12003241,-0.754422743943259
OVCAR-4,46943432,4.3382167265111935
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
SYO-1,439501,-5.087995993751375
SUP-B15,54618164,3.715480597582055
Panc 04.03,12003241,0.3752932920389255
YD-8,148198,-3.6074550947406863
DU145,5460769,5.167808415466422
OCI-Ly3,9903786,0.6513092256101434
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
TALL-1 [Human adult T-ALL],12003241,-0.6623785293924347
A2780,107985,-4.859396565896689
SNU-C4,9936388,-0.0983600900121806
SW579,selumetinib-GDC-0941 (4-1 mol-mol),1.5749080758485403
IM95,72199289,4.342442192219408
PE/CA-PJ15,3689413,2.6755130574722767
RERF-LC-MS,26596,-1.2372341703529914
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
SW1990,12003241,-1.6004272332343192
MeWo,439501,-2.203137437916754
Hs 688(A).T,selumetinib-GDC-0941 (4-1 mol-mol),3.4396417778201305
LoVo,9903786,0.6551100591729495
KP-2,439501,-0.3502086047975351
NCI-N87,107985,-3.2122311985508136
JHUEM-3,6610216,3.5445169404516763
HCC1806,409805,3.807575848238892
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
CGTH-W-1,24180125,4.136455430290878
NCI-H1581,44491742,3.702285088658523
A4/Fukuda,46943432,-0.0927442133672991
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
BT 416,12003241,-2.2907483254938774
Kasumi-1,6505803,0.4376823954906434
DU145,135875424,4.588838795967896
NCI-H1573,6505803,-1.6898584234465963
THP-1,135423438,1.568931663958045
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
BT 504,6505803,-4.714346364333315
KNS-62,439501,-2.644603626195061
T3M-10,selumetinib-GDC-0941 (4-1 mol-mol),0.2338392597437749
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
CCF-STTG1,409805,5.227575027972168
Hs 578T,9903786,3.085679401941195
NCI-H1650,107985,-2.270753589848381
IMR-32,409805,3.9011051007010216
EM-2,148198,-3.744081167157371
NCI-H1341,3689413,-3.76878307288409
LS180,11485656,2.0322073649322716
BT 187,8515,5.227478147693905
BT 340,148198,-3.6521537693808654
PaTu 8988t,36462,2.8739750906545263
CML-T1,148198,-3.9003291277504526
T3M-10,44491742,3.8541069254264566
VMRC-LCD,8515,3.6418627663613767
LP-1,135875424,2.677692696582144
MDA-MB-453,409805,5.496183153122164
KMS-20,24180125,1.3264637419284662
NCI-H747,54618164,4.351605428759409
JJN-3,135423438,1.720470314756554
TE-1,11485656,2.6145816655687746
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
JHUEM-1,107985,-5.021141551070729
SNU-398,409805,5.101188270824189
U-937,5460769,3.0065623514388298
A-375,24180125,3.577996774573621
YD-38,439501,-2.4363640234681347
KYSE-140,6505803,1.6434747535859726
DEL,selumetinib-GDC-0941 (4-1 mol-mol),2.6612594732504475
EM-2,44491742,3.7753697950117897
SNU-410,26596,4.2924060391829935
SNU-213,439501,-0.6838743591109449
SUP-M2,9927531,2.443296482682693
2004,8515,3.233137098345555
SNU-466,135875424,2.3489478767532868
HPAF-II,selumetinib-GDC-0941 (4-1 mol-mol),0.3156523393039555
OCI-Ly3,409805,3.465377623426226
SNU-213,44493528,4.322072480687394
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
HEC-6,36462,2.1560073537614293
JHH-5,6505803,-2.587639781058575
AN3-CA,148198,-4.708662281337999
KPL-1,409805,3.94742453602603
SNU-1214,6610216,3.72445074492986
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
BxPC-3,11485656,2.0481416814216375
CML-T1,46943432,2.522264418529326
TE-11,107985,-4.723022079982108
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
JVM-3,46943432,-0.4792671630818655
EPLC-272H,9936388,-6.231113427915417
SNU-1,JQ-1-carboplatin (1-1 mol-mol),-0.7235204219761906
P-STS,439501,-3.4977273473127632
HEC-151,10296883,3.675956149700743
MCF-7,36462,5.1077442019933725
IGR-39,148124,-4.6116706508158405
MKN74,148198,-2.653452729835883
BC-3C,439501,-3.6854661122428896
JHUEM-7,135875424,3.03961944002969
NCI-H1299,9936388,-0.1781231784373126
COV644,selumetinib-GDC-0941 (4-1 mol-mol),0.580143851486064
OE19,439501,0.2818425095827352
HEC-151,148198,-1.7915860378087891
F-36P,135423438,1.517615115973094
SF126,JQ-1-carboplatin (1-1 mol-mol),5.083897711074173
ST486,135875424,2.429416484956845
EM-2,12003241,-5.8745734353402534
BICR 31,9903786,2.10396775229317
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
GA-10,107985,-4.472986688211123
NCI-H650,54618164,4.229021786886974
LOX-IMVI,8515,4.202942492571131
BT 440,168313200,1.843181494702656
Karpas-620,8515,3.795596892904238
CCF-STTG1,6505803,-1.8344087076537687
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
SHP-77,26596,-1.5620029042215733
CCK-81,12003241,-0.505625792514721
TE 441.T,439501,-2.08185324910289
HCC1806,selumetinib-GDC-0941 (4-1 mol-mol),2.757254827906479
SCC-25,12003241,-2.271238083973026
YD-8,54618164,4.2297332581599525
HCC2279,6505803,3.133680214684758
CAL-27,107985,-3.8647010297285633
SK-OV-3,6610216,4.5015440272840275
Rh18,3689413,-2.3361578419795843
T24,selumetinib-GDC-0941 (4-1 mol-mol),2.57595628877945
NCI-H1092,11485656,1.8493866648869597
NCI-H1755,9936388,2.296070393599244
SNU-1,6610216,3.805786974362891
Hs 934.T,439501,-2.1837618207890808
WM793,5460769,5.840780592325561
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
SUP-HD1,9903786,1.2830576514216323
A-673,10296883,3.758044639987347
MKN45,3689413,3.361842209441358
NCI-H446,107985,-2.6399259174122145
VMRC-RCW,24180125,2.498362315316048
WM1799,12003241,-2.735191284404769
SNU-C5,6610216,4.499193869483049
KMRC-1,6505803,1.455434702084088
L-540,409805,4.181619305997671
MCAS,JQ-1-carboplatin (1-1 mol-mol),0.8866425431722468
COLO 668,409805,5.83951169667826
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
SNU-620,36462,1.92809998402212
HuP-T3,168313200,4.289513738947004
WM793,12003241,-0.659721194491695
23132/87,148198,-2.6574855185514816
NCI-H1915,168313200,1.9344190672197936
OCI-AML-5,9903786,1.179944382770948
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
Ci-1,9903786,3.745611899218518
TOV-112D,26596,-2.3004297516066927
NCI-H28,409805,5.138383267484091
A4/Fukuda,148198,-4.99238512913244
TUHR14TKB,JQ-1-carboplatin (1-1 mol-mol),-0.4661242690765318
WM793,9936388,1.3359302595984517
SCaBER,54618164,4.0199688029488705
8-MG-BA,49836020,-4.019161217996327
Rh41,6610216,3.3674197793498455
KO52,135875424,3.01966044425059
OCI-Ly19,439501,-4.390923092151438
RVH-421,107985,-3.4217512234536684
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
LK-2,11485656,1.8402967364166432
T98G,148198,-3.089381534593653
VMRC-RCZ,409805,6.1071177447924025
BT 271,9927531,5.398706995408204
HuH-28,JQ-1-carboplatin (1-1 mol-mol),1.577793116101398
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
BT 422,24180125,2.9257600434741384
NB1,6505803,-2.349165224527604
VMRC-RCW,12003241,-1.0941298808716429
Hs 578Bst,135875424,2.7019998595734327
NCI-H1869,9927531,5.985290716685452
Peer,36462,-0.261188902535988
SNU-201,135875424,3.4476242027363715
L-363,9936388,-7.043187460159181
NCI-H460,409805,5.4278006548731295
A4/Fukuda,168313200,2.9572494196719723
SNU-761,135875424,3.262050115513109
NCI-H1355,10296883,4.3250704024764115
EFO-21,8515,4.337691454144492
YD-15,148198,-2.3396960553231456
KHM-1B,148198,-5.169783546510426
HT,24180125,2.2044358325458004
DMS 79,9936388,0.9891135195416976
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
HCC44,6505803,-2.265511821723746
JM-1,6610216,3.7780643735318615
NCI-H446,24180125,2.4081916686313765
Hs 294T,148198,-2.1277510633920325
LK-2,8515,4.21224929070005
NCI-H23,148124,-7.582966161502026
SH-10-TC,9927531,5.280985634466932
EFO-21,168313200,3.134269131890617
KMS-18,JQ-1-carboplatin (1-1 mol-mol),0.042136194628161
OC 314,439501,-2.7228413581115105
BT-549,54618164,4.423974096662665
CGTH-W-1,9903786,1.99445591465905
HeLa,409805,3.8139652884767377
Hs 944.T,6610216,4.253321078848661
NCI-H1155,6610216,4.350100771446706
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
HCC1143,44493528,4.485488370266477
BFTC-909,12003241,-0.8371396827795129
VCaP,11485656,1.7583797003884982
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
JeKo-1,148198,-5.137467449260085
BT 422,3689413,0.8456322118691856
COLO 829,12003241,-1.833925982592443
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
KYO-1,9927531,4.747865514161547
NCI-H1155,9936388,-5.221468348115442
M-07e,439501,-3.111960923766982
IGR-1,409805,3.621837141721011
Hs 822.T,10296883,4.102512563950569
Mel Ho,135875424,3.73335713138188
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
SK-LMS-1,409805,6.056363964674445
AN3-CA,9903786,1.5268103297033566
NCI-H747,11485656,1.912245155570418
NCI-H1563,409805,5.970262971726849
SUP-T11,46943432,2.7244636388334658
BT 504,36462,3.8166909345932383
LS411N,6505803,-0.6536233604701492
VCaP,26596,0.7732068358688922
HSC-3,439501,-2.291291548686292
EJM,6610216,4.116260512201503
CAL-78,36462,2.4399344670231295
OPM-2,10296883,2.7550650350156474
NCI-H2171,6505803,-0.0596794204500112
JHH-1,54618164,3.8675979353658496
GDM-1,439501,-2.0864895468216846
IA-LM,9936388,2.150111055311291
TT2609-C02,44491742,4.381647170405731
EC-GI-10,5460769,0.497898829273519
HCC366,3689413,-0.7247636162337553
SK-ES-1,10296883,3.792538750425496
NCI-H460,11485656,2.6212830818798065
HCC202,12003241,0.4259304556953664
MOLM-13,11485656,-3.968420003132376
BT 232,168313200,1.7449359098138864
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
P12-Ichikawa,44493528,4.170368058365218
RL,409805,3.773572615684441
FaDu,10296883,4.258019240847728
BHY,44493528,4.130126082796934
Reh,148198,-5.109999259943676
SJSA-1,3689413,0.2987109884776379
FTC-238,8515,4.054693228356072
K029AX,selumetinib-GDC-0941 (4-1 mol-mol),-0.0187548496270864
NCI-H2110,49836020,-1.7351781152481929
OCUM-1,439501,-1.255627556410841
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
SK-CO-1,8515,5.207883928071115
KYSE-30,36462,2.847864502569603
NCI-H2171,135875424,2.950178944342904
RD-ES,36462,-0.4809008818897318
BT 482,11485656,2.703365491527676
TC-71,JQ-1-carboplatin (1-1 mol-mol),2.9266133797401617
MOLP-8,54618164,3.908946135671936
MDA-MB-231,8515,5.450664059005112
BT-20,135875424,4.4451352594965545
HCC2279,54618164,3.781364659048129
LOX-IMVI,107985,-4.647027352160178
HCC15,6610216,4.23435184261858
KE-39,44491742,3.945663107977575
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
SNG-M,10296883,3.727661706333134
BT 147,54618164,4.134127896254606
CAL-12T,6610216,4.273060683121512
NCI-H716,11485656,1.4384613287076216
MOLM-13,6610216,4.131122051839403
YH-13,8515,4.054803825976401
NCI-H2452,107985,-2.625758680845612
2004,54618164,4.090816099167248
SK-MM-2,46943432,0.6521165388255271
NCI-H1651,44491742,4.212944602241969
HEL 92.1.7,6505803,1.0440378201694858
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968
KMBC-2,3689413,-0.0193871140642154
SNU-C5,44491742,3.683316121476328
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
LOX-IMVI,135875424,4.258043031810949
NCI-N87,439501,-2.2970478950560715
NCI-H1339,439501,-1.6994812988125017
A101D,107985,-2.8849374617938928
BT-20,11485656,1.799713509383809
SNU-1,9927531,3.402077148066899
OE33,135875424,4.864853081585439
WM88,135875424,3.748879677238851
NCI-H1944,135875424,3.314930841291418
MOLM-13,159324,-0.2587959593058327
KMRC-1,6610216,4.1544949822147
WM115,12003241,-3.303596686294694
WSU-DLCL2,6610216,4.106084410539223
BT 416,9927531,5.009885250018842
KM12,135423438,-1.274556391505103
COR-L95,9936388,1.0197606854481494
MOTN-1,148198,-6.162698623617939
SNU-840,6505803,4.055722811765136
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
DEL,6505803,-2.9749849917390763
WM115,148198,-2.543343591950365
HPB-ALL,135875424,3.2013409363750474
DK-MG,5460769,1.2841485986218522
EFO-27,168313200,3.5651936579716277
HuH-6,135423438,1.011063885151324
A-204,6505803,-3.259421100625582
ALL-SIL,36462,-1.376242093473402
TE 617.T,10296883,3.758267174754907
UACC-62,439501,-0.4240195200695472
HuP-T3,36462,3.380707637397105
SNU-668,54618164,3.824849623749051
SCC-4,9903786,2.916722616299938
LS513,11485656,2.48053451645545
NCI-H520,36462,2.88085787375963
ESS-1,24180125,3.331979674522133
NCI-H460,9903786,4.057661845653794
BT 112,6610216,4.1837874586497765
SU-DHL-6,11485656,1.7981230616770194
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
SNU-5,439501,-2.355283147047071
Hs 729.T,135875424,4.346118730396158
Kelly,8515,3.705301466780827
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
HLF,148124,-4.484401267484706
LS123,135875424,3.499213265654359
OAW28,409805,4.888216855585461
MFE-319,6505803,1.682030282534213
SW579,49836020,3.73786460957764
BT 428,24180125,3.179416514721958
TUHR4TKB,3689413,-1.6587483895037962
HT-55,409805,6.000222439376886
GA-10,168313200,1.62244958697484
Ri-1,9927531,3.385054072969868
BICR 31,148124,2.7085675831815292
NCI-H1568,5460769,1.1324377767406906
NCI-H520,9927531,5.647411307076465
639V,9903786,3.738179934930431
VMRC-RCZ,12003241,-1.8843773680512867
D283 Med,9936388,-6.8022099816120605
ACC-MESO-1,6610216,4.642819431262072
SK-ES-1,9936388,-6.72300625347337
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
RS4;11,11485656,1.5968543308992733
OAW28,439501,-0.9322268226633188
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
2004,107985,-3.884773360661375
PSN1,11485656,1.8304064123419443
UACC-812,439501,-1.4243957864326813
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
COLO 205,6505803,-3.0495951977326774
THP-1,9903786,3.0926145703043852
NCI-H2141,9903786,2.15851319161548
CHP-126,JQ-1-carboplatin (1-1 mol-mol),1.0753028994481633
SK-MEL-2,439501,1.1166422747690987
NCI-H2085,409805,4.930961778179055
OCI-AML-2,159324,-1.1992485255240457
THP-1,54618164,3.674496857626057
BHT-101,11485656,2.812775629456312
Hs 578T,135875424,3.578631345262118
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942
KYSE-520,439501,-3.151478653175136
Hs 888.Lu,9903786,2.210543303670434
AGS,36462,4.1696288524979455
KMS-18,11485656,2.411593279183438
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
IGROV-1,54618164,4.2184521751950115
NCI-H2081,26596,-1.5856459484869678
CAS-1,3689413,-1.7594128574941137
MOLM-6,44491742,4.372818024610458
MHH-NB-11,6505803,-0.1977325958086978
CAL-148,159324,-1.9386881161550555
OCI-Ly19,JQ-1-carboplatin (1-1 mol-mol),0.1428825624230537
K-562,135423438,0.8826240773524879
AU565,24180125,2.1910645714042634
A3/Kawakami,168313200,2.7550323232462763
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
BT 444,409805,5.849288534866383
SNU-407,148198,-3.549575176870091
NCI-H1650,135875424,3.5061044557480865
HCC78,439501,-1.472903672264699
HuH-28,9936388,2.0438791197733632
BEN,6610216,5.086594972781992
BHT-101,46943432,2.878256091901955
IGROV-1,44491742,4.406671418311328
HDQ-P1,9927531,5.7159143296477115
KMS-20,135398744,7.132407790781497
NCI-H716,46943432,2.344580529763938
WT2-iPS,107985,-3.785373915846311
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
SNU-840,9903786,4.945950711370254
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
ECC12,11485656,3.0837599564309164
NCI-H446,JQ-1-carboplatin (1-1 mol-mol),0.8362654932665712
GOS-3,11485656,3.367022375162814
EN,168313200,3.9043181429935783
KP-2,10296883,4.2919996415348125
JHH-4,3689413,0.1617777803735524
NCI-H1623,36462,0.862958596391428
TE-9,409805,5.86939241633817
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
HCC95,439501,-2.2206191561813537
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
SNU-685,439501,-2.253643843124453
SNU-1105,148198,-2.088080435846721
KP-N-SI9s,9903786,1.8487391330719625
NCI-H2110,6610216,4.402528376622354
HCC2935,54618164,4.374064434375431
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
Hs 936.T,409805,5.094755228809154
NCI-H1838,135875424,4.369975669876832
SHP-77,54618164,3.947626272795489
SK-OV-3,3689413,0.6002437290843657
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
RPMI-7951,439501,-2.4869379045692313
SNU-16,6505803,-5.221093931145045
BT 179,selumetinib-GDC-0941 (4-1 mol-mol),2.518966795971957
HCC95,3689413,2.984270072976439
TT,135875424,4.193021061621861
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
KMS-11,135875424,3.01982766210033
AsPC-1,107985,-4.227741895863185
NCI-H2085,12003241,-2.8100927731995924
HSC-3,5460769,0.5796773846600773
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
NCI-H1105,44491742,3.93837449237457
JIMT-1,JQ-1-carboplatin (1-1 mol-mol),6.316159128553351
MIA PaCa-2,46943432,1.539225582233631
HEC-108,148198,-2.2464200337513587
Karpas-299,3689413,-1.6709269792656412
SNU-182,12003241,-2.036673656339672
SNU-878,5460769,2.876812490154217
JVM-3,9903786,0.2351218463531885
P12-Ichikawa,9903786,1.487769039842012
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
HuCC-T1,36462,2.236186722853638
MDA-MB-468,3689413,0.3907824455820104
EoL-1,135875424,2.3813180528282416
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
NCI-H508,12003241,-0.6008293317473488
MOLT-3,36462,0.822802174642417
SH-10-TC,6505803,1.0685090299796742
Hs 936.T,107985,-3.1215732689718028
OV-90,24180125,3.901301919914901
MIA PaCa-2,168313200,1.759366617697624
HeLa,12003241,1.4760559160729645
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
KG-1-C,46943432,5.204516853454411
BT 328,11485656,2.729036955069127
HCC2108,6505803,-0.7557590797286265
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991
BT 131,8515,4.487021263418678
F-36P,JQ-1-carboplatin (1-1 mol-mol),-0.2067996802850356
LS123,44491742,4.080361644542357
HT-29,3689413,-0.0079740382830798
SNU-308,JQ-1-carboplatin (1-1 mol-mol),5.335805605025179
HCC1937,24180125,2.538066880036907
SW1088,9936388,2.2762478176067504
NCI-H647,54618164,4.0719010175074475
NCC-StC-K140,46943432,0.3281345750011573
HT-144,11485656,1.9072618769680565
NCI-H1693,168313200,1.14369624115849
U-BLC1,JQ-1-carboplatin (1-1 mol-mol),2.2972315497002156
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
HuNS1,107985,-4.251008653839981
HCT 15,selumetinib-GDC-0941 (4-1 mol-mol),0.3162595465665505
NCI-H1734,148198,-1.222978862296857
LUDLU-1,JQ-1-carboplatin (1-1 mol-mol),0.2520834188708127
Panc 03.27,36462,1.4276751747001344
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
NCI-H2085,107985,-2.9768129287712957
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
KMS-20,135423438,1.13023072719564
HeLa,135875424,4.463353648372455
UM-UC-1,11485656,1.563439328929869
COLO 320,8515,3.7887210443451145
HOP-92,135875424,3.091462315962494
SNU-719,3689413,0.5380163789509392
F-36P,9903786,0.2788806994422486
KMS-18,3689413,0.1282967701093688
CAL-51,9877608,5.917079709597661
Jurkat,54639024,4.525209760597627
KYSE-180,26596,-0.879665743021705
NCI-H1573,159324,2.583464622792162
SNU-475,3689413,0.7678171361213897
AsPC-1,168313200,3.2842521999758523
Ku812,135423438,-2.2335088833738146
KALS-1,135423438,2.6558677077861783
CCF-STTG1,107985,-2.0025512814929525
SU-DHL-8,JQ-1-carboplatin (1-1 mol-mol),0.1071137470507251
BT 147,439501,-3.335486008920962
NUGC-3,439501,-0.8687930764506365
H-STS,3689413,-4.4758570940331515
TUHR10TKB,11485656,1.859700421768517
G-292 clone A141B1,24180125,3.760295361832437
Hs 822.T,6610216,4.486963526445925
SW1271,148198,-2.630785543453804
BT 159,selumetinib-GDC-0941 (4-1 mol-mol),1.265249520396083
Hs 822.T,3689413,-2.285857937794557
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
SF539,26596,-2.288089999638428
MHH-CALL-4,JQ-1-carboplatin (1-1 mol-mol),-0.223161875024046
Reh,439501,-2.4165922655956407
COLO 699,3689413,3.029151035827229
NCI-H2122,5460769,2.4268150631675067
42-MG-BA,9903786,3.3707760791071184
NCI-H2009,46943432,2.8478796444115835
HOS,135875424,3.0466328118467665
BT 440,24180125,3.8960542559338167
LS411N,6610216,4.962940577428159
TE 441.T,148198,-7.570550283496053
RPMI-8226,54618164,3.2179536432625206
TUHR10TKB,5460769,4.601270489376953
TE 441.T,409805,4.133178498098395
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
Kasumi-2,6610216,3.59110037414398
BICR 31,148198,-3.2373882564770513
NCI-H1563,54618164,4.2887374141786605
Hs 944.T,24180125,2.7195236908297247
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
GSS,44491742,4.082096433494501
RD,12003241,-0.8502341845781216
ECC10,8515,1.9738672443997605
DMS 454,44491742,3.21829880696891
VMRC-LCD,10296883,4.114131577263389
SUP-HD1,44493528,3.885514545819132
RD,148198,-4.957696360654166
KE-97,54618164,3.878126009924748
COLO 320,168313200,1.677967705893316
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
P12-Ichikawa,409805,3.706415090956248
TUHR10TKB,54618164,4.212884900845848
JURL-MK1,409805,3.64663874719319
A-375,409805,5.425302340535218
CHP-126,24180125,1.66827310880367
Rh30,JQ-1-carboplatin (1-1 mol-mol),0.2476583684107503
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
697,409805,3.1910228760525103
COLO 829,9927531,5.213552390265391
PL-21,9936388,-7.198492921849207
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
CAMA-1,439501,-1.1821357093397586
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
RERF-LC-A1,11485656,2.3794985324061217
HuP-T3,9903786,4.0743016574038915
253J-BV,9936388,1.8223967711781484
Hs 934.T,409805,5.721934448582198
MOLM-6,159324,-0.3631540608942797
HMC-1-8,135875424,3.5952222830478364
SF539,36462,1.0067932013019132
LOX-IMVI,168313200,4.329297638154407
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
SH-10-TC,107985,-2.836230887151265
HCC827,44491742,3.1413058075131746
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
SNU-878,46943432,1.577791022290007
VMRC-LCD,JQ-1-carboplatin (1-1 mol-mol),0.5789512547654533
SU.86.86,9903786,4.655147385880342
23132/87,3689413,0.7778055116853778
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
SW982,9903786,2.8939777098979333
EFO-27,6505803,0.9411407576336728
BT 172,8515,3.555586253309452
NCI-H526,36462,-0.2788107449556972
M059K,11485656,3.642862127299764
Li-7,439501,-2.4815602749889005
RERF-LC-A1,49836020,4.4326562717782005
HT-144,10296883,4.023256164305908
OCI-Ly19,11485656,1.5733827974679646
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
RS4;11,9903786,1.046136748247593
MIA PaCa-2,9936388,-9.05612896602556
Kasumi-2,44491742,3.800345149395397
NCI-H1105,409805,3.478082900897108
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
RT-4,9936388,-6.517969541343547
Daoy,JQ-1-carboplatin (1-1 mol-mol),4.339760854193934
GaMG,6610216,4.2952250564370456
EBC-1,12003241,0.7952037321943549
ALL-SIL,8515,1.9161675301812888
OCI-AML-3,44493528,4.354469059332478
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918
NCI-H1373,3689413,-0.1033910947263759
HL-60,44491742,3.945358906065035
NCI-H2110,11485656,1.6105476919050796
BT 224,135875424,2.9965213302921816
NCI-H2286,409805,5.54195525972207
U-CH1,11485656,3.664474394273293
SK-CO-1,148198,-1.1611262776602205
B-CPAP,6505803,1.185723298587951
Hs 611.T,46943432,2.371802595815265
NCI-H2196,148198,-4.10304845693827
NUGC-3,409805,4.126577550423276
COR-L51,5460769,2.8872461015254913
UACC-62,148198,-2.3489315937571016
EFO-27,36462,3.079082429258617
2004,10296883,3.635468664105464
ESS-1,26596,-1.5335330182559344
Detroit 562,selumetinib-GDC-0941 (4-1 mol-mol),2.228637480790017
BFTC-905,44491742,3.9351753124000073
HSC-2,10296883,3.989480591678073
TT2609-C02,107985,-2.9617370553841686
UO-31,107985,-3.731329066681621
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226
SNG-M,148198,-2.9777183458451324
CCF-STTG1,3689413,0.3028996084806184
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
K029AX,107985,-3.0173775457381917
EBC-1,107985,-3.983945161523554
YKG-1,107985,-2.4631339535317993
MPP 89,3689413,-2.191379674666751
HCC78,12003241,-1.0292430450952663
NCI-H322,148198,-4.812707384343781
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
PSN1,6610216,4.258794252853587
SU-DHL-10,44493528,4.09014780948348
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
DOV13,135875424,3.915299469104102
Calu-3,9936388,1.0811796684163033
Mono-Mac-1,6505803,-1.0735015571845192
MEC-1,44491742,3.700583986314622
COLO 699,selumetinib-GDC-0941 (4-1 mol-mol),0.865445033104183
23132/87,135875424,3.8304583590646897
8505C,49836020,5.7227071797800235
JHH-4,54618164,3.864214635175561
NCI-H1155,36462,0.801473469069013
JM-1,135875424,2.019666731209586
SYO-1,148124,3.7376682623632966
NCI-H2029,selumetinib-GDC-0941 (4-1 mol-mol),3.389084232117775
HCC1833,6610216,4.331535803824163
HL-60,107985,-4.705805511662373
HCT 116,selumetinib-GDC-0941 (4-1 mol-mol),2.1704161349367506
SCaBER,6610216,4.252046489021801
SNU-449,168313200,1.9091128501610053
LOU-NH91,3689413,0.742189593443008
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
OAW42,10296883,4.103500664094552
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194
KNS-42,3689413,-0.7849742988075888
CJM [Human melanoma],10296883,4.108453768620905
UACC-62,9903786,5.03427767143789
SK-N-MC,11485656,1.4655490415518024
TE-10,46943432,3.9363265037788087
SK-N-AS,409805,3.819858792673344
OE19,135875424,5.148848479100124
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
SNU-503,10296883,4.26792397433306
647V,10296883,3.904352101938312
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
Lu-99,8515,3.0709969622454008
DMS 273,36462,2.158918041886743
BT 245,26596,-1.3254238494846824
PK-59,9936388,2.2614163852650377
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
2004,135875424,2.8234839465542967
EFE-184,12003241,-0.5797348651994826
M-07e,107985,-5.456968892435315
Li-7,8515,3.090070672715684
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
NB4,5460769,1.5499271806248969
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
KMS-20,148124,-6.52302823792501
LXF 289,107985,-2.691798131563437
SK-N-BE(2),selumetinib-GDC-0941 (4-1 mol-mol),-2.409093744965772
OS-RC-2,44491742,4.539389041576503
DMS 114,selumetinib-GDC-0941 (4-1 mol-mol),1.847196257351989
OV56,409805,6.100421280710762
OPM-2,6610216,3.8953919440086575
ONS-76,409805,3.962852167855045
BT 179,11485656,3.2813483165810218
JHOS-2,6610216,4.585679605860104
HuH-28,135875424,3.694475868133385
Pfeiffer,135423438,1.688577361264551
NCI-H1650,9927531,5.159202312794284
Pfeiffer,6505803,0.5055759259934013
8305C,159324,2.7489494667199774
NB4,46943432,0.4478875833240771
SK-LU-1,439501,-0.3728808637534341
MFE-319,9903786,4.166499809230756
WM115,11485656,3.738489726762909
SW1271,24180125,2.511417012575286
Mel JuSo,3689413,1.1230560004280308
SK-MEL-28,10296883,3.852008110979885
TF-1,9927531,3.351583098746858
Panc 10.05,9936388,0.6007373562986975
OE21,5460769,0.0529032243874579
KMRC-2,439501,-1.138228475309333
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
KMS-26,26596,-2.3246210028506873
JURL-MK1,44493528,4.152814926042147
MDA-MB-453,9927531,3.885109165752666
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
NCI-H2452,36462,2.3648017756260327
LUDLU-1,44491742,3.9054426641243873
HEL 92.1.7,148198,-5.4580431363429645
8305C,9936388,-4.900292137873706
CML-T1,5460769,1.000954417912476
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
G-361,46943432,0.7031306283020791
Hs 888.Lu,49836020,4.832752015410737
SNU-C4,6505803,0.4157286441200272
NCI-H460,439501,-2.362377537788676
SNU-182,44493528,4.330541683560017
GB-1,159324,3.060378986435554
BV-173,8515,3.3679633726453027
KMRC-3,12003241,-2.293511180564156
HCC1833,49836020,-1.119955366422227
SF539,6505803,-2.26727491960267
SNU-620,49836020,5.484424750861699
NCI-H23,107985,-4.988280245499153
HuH-28,46943432,1.6312961638133356
MOLP-2,10296883,2.8483200317166935
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
42-MG-BA,148198,-6.365227331542155
Caki-1,168313200,4.325484294930164
MIA PaCa-2,6610216,4.225429520822784
UACC-62,12003241,-2.2941993438250865
PL-21,JQ-1-carboplatin (1-1 mol-mol),-0.1767086466705203
EM-2,107985,-4.199278116415869
RVH-421,439501,-0.8524727848852272
BICR 6,12003241,-1.5069556465481264
G-402,46943432,1.7574910832930757
HuT 78,10296883,2.429678266579514
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
NCC-StC-K140,409805,3.739861273702827
Hs 294T,36462,1.1730429194866945
CAL-29,12003241,-0.9586511485623302
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
786-O,selumetinib-GDC-0941 (4-1 mol-mol),2.324696492331355
MPP 89,JQ-1-carboplatin (1-1 mol-mol),2.0529863800316
SW982,24180125,3.159304808237073
YD-15,12003241,-1.418070390851184
MDA-MB-157,148124,-6.016678597172854
SK-N-MC,439501,-1.9559444468392349
MOLT-13,9936388,-7.171381917175865
NCI-H2081,8515,3.558797146048482
RL95-2,148198,-3.5486250738118654
JHH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.61874119121482
NCI-H1184,36462,-0.6681972686085113
NCI-H2087,159324,1.2033860013078608
DMS 454,135875424,4.8848557327736115
SNU-119,11485656,2.5966291939022192
NCI-H1869,168313200,3.875520299128645
NCI-H661,148198,-4.235070372495308
COLO 699,44493528,4.4403065738336345
PaTu 8988s,12003241,-0.9111494781164662
CAL-12T,12003241,-2.021983796416415
MCF-7,409805,3.9764139851355305
NCI-H2170,36462,1.2877330572705072
EFO-21,26596,2.967643494346353
PC-14,409805,5.400742947036561
CFPAC-1,54618164,4.158502253037373
SNU-C2A,54618164,3.882205124522901
TOV-112D,36462,-0.0852741805164054
KP-N-YN,5460769,4.0809724038992705
JHUEM-1,148198,-4.791795021050916
BT 422,135423438,1.9130848394222184
SNU-878,6505803,-0.5234937095696075
SUP-M2,54618164,3.710642593686204
NCI-H460,6505803,-0.4074860596498978
KYO-1,6505803,0.8445463549156219
Rh18,24180125,1.6950247634535058
GaMG,135423438,1.57749164646486
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
HSC-4,6610216,4.241818899552939
HEL 92.1.7,26596,-1.1995167561269164
COLO 699,44491742,4.375917041754564
SNU-1079,JQ-1-carboplatin (1-1 mol-mol),-1.464930217070614
SNU-601,JQ-1-carboplatin (1-1 mol-mol),1.969115182185286
JHUEM-3,46943432,2.585182446151882
SK-N-BE(2),9936388,-4.085977969956083
JHH-5,5460769,1.8419810692418657
WM88,5460769,5.637392858071443
Daoy,11485656,1.6776877831097698
NCI-H1581,54618164,3.710224728811778
MES-SA,9936388,2.5692609882827964
RKO,409805,3.580644131410829
SUP-B15,36462,-2.1786464367677567
SNU-620,44491742,4.13195678155616
NCI-H1105,JQ-1-carboplatin (1-1 mol-mol),2.500241308426971
BHT-101,36462,1.5384712003732817
BT 440,11485656,2.455280972559295
BT 239,135875424,2.359781873979594
COR-L95,6610216,4.601423414679649
HEC-59,409805,5.86459561757921
KYSE-70,159324,1.7590392520862297
RCH-ACV,6505803,0.7886152170301014
697,135423438,1.9125323106681824
DB,54618164,3.106803740802123
IGROV-1,26596,2.910298792762654
D283 Med,5460769,1.125938178392905
SNU-81,159324,-2.5700546068481502
RD,11485656,1.6123587927279353
KO52,148198,-6.726627358418003
SR,26596,-2.2070280953319283
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
HPB-ALL,6505803,2.1919107783283573
JIMT-1,3689413,-1.7375587293018775
RT-112,26596,-1.382463026117804
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
NCI-H1573,46943432,4.3322940998633985
OV-90,11485656,2.959062717330634
QGP-1,159324,3.569458401959675
NU-DHL-1,24180125,2.343403566122717
SUP-B15,9903786,1.6008803071908635
Peer,49836020,4.240424721025454
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
CAL-54,54618164,4.189782722036381
MV4-11,107985,-4.336594623751159
SNU-626,24180125,2.1450306590662636
KE-37,148198,-3.992364419056407
EB1,44491742,3.4704982889402545
TE-8,11485656,2.0537902737407348
CHP-212,9927531,5.318398541001747
TE-4,10296883,4.159951408110945
SK-N-DZ,135423438,2.1379059476501023
BT 482,439501,-3.1816156321337186
SF539,12003241,-2.026733754371074
KNS-60,10296883,3.392658915268081
JURL-MK1,135875424,3.956954247189128
DND-41,3689413,-2.0667644412480755
VCaP,10296883,3.8501012850712137
TE-8,54618164,4.10241796815657
NCI-H810,135398744,5.260119762115652
NCI-H2052,9936388,2.267249027506278
VMRC-LCD,168313200,3.7179740407892905
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
HOS,8515,4.704557853558991
Calu-1,135875424,4.2506874987837024
Daudi,409805,3.686040208403983
HMC-1-8,409805,4.767028573995512
MFE-319,6610216,4.57557190347099
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
EPLC-272H,10296883,4.153935511243516
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
Li-7,5460769,-0.8720138445783291
TE-11,10296883,3.918560367292528
SUP-HD1,107985,-2.650415887719213
T24,11485656,2.4283497682817945
HCC1806,9903786,3.5202039340354636
BFTC-905,36462,2.198737830407542
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
SET-2,24180125,3.520791323049292
MDA-MB-157,8515,2.4995790404865983
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
BICR 22,3689413,1.1307119933583345
NCI-H1650,10296883,4.859498077632093
JJN-3,135875424,2.965307149294294
COR-L95,168313200,1.9910859109269063
GCT,409805,6.004543979788198
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
SNU-410,159324,4.304183383322186
T84,12003241,-0.2889439900128532
SK-CO-1,9903786,1.8148473241522671
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
HL-60,12003241,-0.948434817183572
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
KMS-20,6610216,3.669058069013872
NCI-H1869,9903786,3.8309501172404734
SNU-899,9903786,2.4739971743095497
HL-60,8515,4.112946136291534
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
Calu-1,6610216,4.821045384716902
TUHR14TKB,6610216,3.9404746180356063
SUP-T1,6610216,3.659307734000498
OCI-AML-3,135423438,2.310750023126374
SNU-761,24180125,2.7199190915281326
ECC12,12003241,-0.4991552447723122
HH [Human lymphoma],49836020,3.7105679750249663
BT 320,9936388,1.7913306244505192
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
B-CPAP,6610216,4.017338863517876
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
NCI-H2141,36462,2.278510684114093
Peer,135398744,6.7016638444522325
BL-70,409805,3.720661860726631
NCI-H1755,selumetinib-GDC-0941 (4-1 mol-mol),0.8235666459967586
TUHR14TKB,148124,4.386073638804714
Panc 05.04,11485656,2.761392845467755
HCC1428,107985,-3.631274120999778
COR-L51,8515,1.8792206140077008
RERF-LC-MS,10296883,4.230661493555322
ST486,46943432,0.4282456426671725
SNU-1079,9903786,0.8372132722803839
BT 482,148198,-3.9999181754289097
SNU-503,6610216,4.10575364051366
F-36P,148124,-6.364948087395455
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
HEC-1-A,6610216,3.9875292357765137
HuP-T4,selumetinib-GDC-0941 (4-1 mol-mol),-0.95779192570868
JHH-5,44491742,3.8169087988503705
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
A3/Kawakami,5460769,1.7157310456182762
KMS-11,36462,1.092413370877101
SET-2,9903786,0.1058309934713531
Reh,168313200,2.040785396929617
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
Kelly,135875424,1.72735348015212
SNU-16,409805,3.8567661793390826
SCaBER,148198,-2.8787440610496806
MHH-CALL-3,9936388,-0.8161492964940873
GB-1,6505803,1.9427567614251149
HCC1806,148198,-2.202923064459824
PE/CA-PJ49,135875424,3.843300837205347
SK-MEL-5,8515,4.00227623893396
RS4;11,3689413,-2.3954384764538528
Granta-519,26596,-3.6955660538224784
Hs 578T,168313200,3.633474320966812
GSS,6610216,2.9495192814585542
BV-173,JQ-1-carboplatin (1-1 mol-mol),-0.3456077598653477
HCC1588,148198,-2.081842945352174
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
U-118MG,selumetinib-GDC-0941 (4-1 mol-mol),2.998678120294993
RVH-421,44491742,4.40169374936578
YD-8,36462,2.7241354710815
OE21,135875424,4.2322811376256
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
RKO,107985,-4.24085601271806
JIMT-1,159324,3.5615073929278016
HMC-1-8,159324,3.1611757337355844
TF-1,3689413,-2.3947116127493797
RKN,439501,-1.5558449248177562
SJSA-1,73707440,4.290448161515078
HOP-62,12003241,-2.147728480634193
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
HEC-251,5460769,6.090602801092177
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
MFE-319,3689413,0.3953423105508483
SK-N-BE(2),168313200,2.1741727294521933
BICR 6,26596,-1.5869658496484045
CHP-126,148198,-3.388805594241749
COLO 201,9936388,0.7010349840122784
CCF-STTG1,6610216,4.787403157480984
Panc 10.05,12003241,0.2449442349226892
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
NCI-H727,159324,3.364651085509472
BT 187,selumetinib-GDC-0941 (4-1 mol-mol),2.194213096235158
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
RPMI-7951,9903786,2.3675771120862485
RPMI-6666,49836020,4.712616665171358
SNU-C5,selumetinib-GDC-0941 (4-1 mol-mol),1.7590235463431136
PaTu 8902,409805,5.142449436796194
TE 617.T,148198,-5.570836708197065
PaTu 8902,54618164,4.284638344065584
JHUEM-3,12003241,-2.0090653802187197
KHM-1B,9903786,1.5275790345873377
SNU-1079,439501,-2.542024376307003
AMO1,439501,-2.703410930799938
EN,12003241,3.248318270429482
SK-N-MC,24180125,1.1647530142438975
MDA-MB-231,54618164,4.06902412063099
A-172,9903786,3.6235991814079545
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
HCC-56,5460769,4.347795399558133
Jurkat,3689413,-0.8866590036526504
NCI-H2170,8515,5.392751727081425
SW1417,168313200,4.158512973048199
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
SW579,8515,3.4248666995365085
GCT,12003241,-2.363961173456096
AML-193,135875424,2.8839431116482803
NCI-H2030,409805,6.26321786552448
MOLT-3,3689413,-1.814335700031944
PE/CA-PJ49,6610216,4.338624993526508
SU.86.86,148198,-1.8590332811796892
JMSU-1,5460769,-1.1957562952388658
BT 239,5460769,-1.3091160600101754
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
HSC-2,148124,-0.6160192527791234
GI-1,148124,-7.051514265549868
NCI-H1792,10296883,4.349504038438606
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
MHH-NB-11,159324,-2.228668051576579
NCI-H1944,24180125,3.7624051932211233
ECC12,3689413,0.1011873229267039
NCI-H1581,9903786,1.8918310652044057
SJSA-1,409805,4.702457052286149
LS180,49836020,0.6204023867713871
BT-12,36462,3.2397163088580103
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
MES-SA,36462,3.892924771749451
LOX-IMVI,5460769,1.2475955137176375
TUHR14TKB,135875424,2.9544471921358944
JM-1,5460769,0.6255065324989537
Mel Ho,26596,-0.5803801535189402
Yamato-SS,6505803,-0.8903036807486634
A3/Kawakami,9927531,2.786138883968946
G-402,11485656,-0.4595745654780468
NCI-H1734,6505803,-1.047831457511852
NCC-StC-K140,107985,-3.758364572200111
PL-21,8515,3.0959710718642044
MDA-MB-157,11485656,1.3019788320898549
A3/Kawakami,26596,-1.4802505010126563
KP-N-SI9s,11485656,2.178887968945585
ST486,54618164,2.876081696628776
BT 172,9927531,4.926572000473132
NB4,44493528,4.205501797319906
EC-GI-10,12003241,-1.9756752078564588
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
Hs 766T,5460769,5.317456208461946
TE-9,9936388,-5.179827441506514
Rh18,6505803,-0.099361262112988
Yamato-SS,10296883,4.303641626861945
COR-L95,135875424,3.0866900102445816
A-172,12003241,-1.0086398080644707
NCI-H520,168313200,1.818196575131949
HCC1419,44491742,3.720252057260251
HPAF-II,159324,5.40988875272192
COLO 792,24180125,3.327455807525018
Lu-99,JQ-1-carboplatin (1-1 mol-mol),0.8870442725111318
NCI-H1703,135423438,-3.3255405313096733
HuT 78,9927531,5.1568522769540674
NCI-H810,6610216,3.5606323089389993
SNU-503,12003241,-0.772187364196845
SW1990,168313200,2.994110056013303
KNS-60,135875424,4.390614396621118
NCI-H1666,439501,-0.7596014001034053
NB4,6505803,-1.6595544122287686
Caki-1,selumetinib-GDC-0941 (4-1 mol-mol),2.159609795753867
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
JHH-6,6610216,5.06991273615497
KP-4,24180125,3.869043701331771
HL-60,46943432,1.262475604488991
MHH-ES-1,9903786,1.586022951185602
Pfeiffer,8515,1.6662943389832352
SNU-407,12003241,-0.5168922712641052
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
SaOS-2,11485656,2.155652122560971
Panc 02.03,3689413,0.2165954212360822
KYSE-520,72199289,5.964996237473484
IM95,JQ-1-carboplatin (1-1 mol-mol),0.9463817139870012
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803
SU-DHL-6,439501,-2.4303946334698057
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
HCT 15,JQ-1-carboplatin (1-1 mol-mol),0.2733719637316636
HCC1428,44493528,4.080046839622648
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
HCC1500,409805,3.5957056987066407
SNU-1041,409805,6.796428886349938
PaTu 8988s,44493528,4.319224054149941
SK-MEL-28,409805,5.67996042379304
CCF-STTG1,9936388,2.748356806633847
CAS-1,148198,-2.1391789652686324
OCI-Ly19,26596,-2.6757237263114875
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
JHH-1,6610216,4.205222984762599
SUP-HD1,3689413,-2.4864416841895727
PaTu 8988t,11485656,1.82057121616084
YD-15,439501,-2.3800052899031985
ECC12,5460769,2.2219131741447913
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
SW48,26596,-2.356334812614481
HCC1419,9927531,5.21935192048334
Karpas-422,168313200,3.637067495296451
CCK-81,409805,5.180549735133195
KHM-1B,26596,-2.1296194509234576
HCC38,36462,1.0526574988311552
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
BT 187,9936388,1.2853309860246789
JJN-3,selumetinib-GDC-0941 (4-1 mol-mol),1.20099577342293
SK-MES-1,10296883,3.8789679823498178
Granta-519,5460769,2.1422187145203897
U-251MG,148198,-4.2062260455061535
SH-4,12003241,-2.3432697923698083
NCI-H1915,135875424,4.440187270311882
KMS-28BM,107985,-4.596587711336739
2004,12003241,-2.052412032835344
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
NCI-H2106,44493528,4.52361018349812
IGR-37,6610216,4.326761658529103
NCI-H661,26596,-0.5563822784391794
NCI-H1395,135875424,3.644181585171065
5637,9903786,1.5217427141278097
COV362,10296883,3.813835962370156
BT-474,6610216,3.6735786534145296
IGR-37,10296883,3.844591108282479
A4/Fukuda,9927531,3.7257201794253776
LXF 289,409805,5.2068809837223435
EFM-192A,168313200,2.8329755718004845
NH-6,6505803,1.7515572770987142
SH-10-TC,3689413,0.5157614607297105
HT-144,9927531,5.124270234210206
Hs 852.T,10296883,3.5270090388531883
ALL-SIL,159324,0.7144692186053382
U-251MG,44491742,4.097928635737581
NMC-G1,9927531,6.6210082677754984
U-937,9927531,3.434526864785126
IPC-298,11485656,2.382322261654795
647V,54618164,4.239215376560979
LoVo,49836020,1.6927786584323
MOLT-3,107985,-4.863339213865672
NCI-H1869,9936388,1.425696213804551
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
NALM-6,5460769,0.3419650871663187
Hs 852.T,49836020,3.510211812103559
HuH-6,12003241,-0.3879852820159472
PaTu 8988t,8515,4.36808886077581
A-204,49836020,-1.292663609986573
AML-193,26596,-1.9434141476174296
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
JHUEM-7,148198,-3.5780143567355336
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
SK-MEL-3,54618164,4.268913642051635
TE-14,148198,-4.134736941909179
BT 333,54618164,4.3182634129264805
SUIT-2,409805,6.22384099753819
HSC-2,11485656,1.6817242340457108
SU.86.86,135875424,4.152288157211863
SNG-M,46943432,3.1600160691323715
NCI-H2106,107985,-3.3293764267517645
UACC-257,135875424,5.07127694251911
DMS 454,11485656,2.8091900448674196
IGROV-1,36462,2.313632721410001
MDA-MB-435S,3689413,-2.4980053098555404
TALL-1 [Human adult T-ALL],44491742,3.807829450429648
IGROV-1,11485656,1.900409616013456
LK-2,JQ-1-carboplatin (1-1 mol-mol),4.1358496368308035
8305C,46943432,1.2980844168012595
PSN1,8515,3.9314106629194017
EC-GI-10,44491742,4.525033675313585
NCI-H1355,8515,3.3761756776550236
OC 314,148124,-5.275997135374238
EFO-21,6505803,0.6098596142059811
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
BT-12,54618164,4.2066066788639525
SNU-8,6610216,4.841964372920672
DEL,9927531,3.262771629290843
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
TOV-21G,135875424,3.093416550271537
SUP-B15,135875424,3.3386210567856462
HCC1143,409805,4.31745443409651
KYSE-30,54618164,4.68504508642832
LCLC-97TM1,6610216,4.478615539127516
CHP-212,168313200,1.911615856976856
NCI-H1341,409805,3.659332889741384
U-937,36462,-0.0459361343740989
KNS-60,6505803,0.337360479400098
KP-N-SI9s,5460769,-0.2609459312778176
NCI-H647,3689413,0.6953623673111984
IGROV-1,168313200,3.9938362637732983
MIA PaCa-2,11485656,1.8953661577719088
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
KP-N-YN,11485656,3.2850291914647345
HT-144,54618164,3.7938447611530943
NCI-H2228,49836020,2.091075397258879
BT 359,26596,-1.128901879166228
Kasumi-2,3689413,-2.6905586087263043
SNU-1214,9936388,-5.365264992891118
SNU-626,36462,1.8578593274486852
LS123,3689413,-2.2814901809462467
MDA-MB-468,36462,0.7713305657614911
BT 330,44491742,4.367748851083318
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
BICR 18,135875424,4.8231575753624645
SK-MEL-24,168313200,1.6999821233302863
KYSE-520,107985,-2.3636087010870392
BT 428,439501,-3.4900182991978936
Sq-1,54618164,3.699819225246008
YAPC,135398744,6.484368053683043
HCC366,8515,6.197083268003746
OCI-Ly19,54618164,3.8908263095875775
NCI-H441,9903786,3.5452366409305887
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
NCI-H2172,54618164,4.006615708933043
SNU-1066,selumetinib-GDC-0941 (4-1 mol-mol),1.622393970628324
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
SNU-308,6505803,-0.8731800664163156
BT-20,9903786,4.2067479925704925
COV434,409805,3.527199506174152
SW1990,135875424,4.251787213143329
Capan-1,135875424,5.030307204242131
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
EFE-184,selumetinib-GDC-0941 (4-1 mol-mol),4.957759622991816
KE-39,135875424,3.891762591841876
JVM-2,107985,-4.027941774492786
HCC202,6505803,-1.9707463625548352
NALM-6,73707440,6.057800002109687
YD-8,159324,3.1492291636894416
DMS 114,36462,2.3990046572200803
SK-HEP-1,10296883,4.4971190241998835
JL-1,9903786,5.3673726170242455
MOLM-6,46943432,0.7708727335506564
SNG-M,JQ-1-carboplatin (1-1 mol-mol),1.0442661112179723
SUP-T11,10296883,3.5958048269755114
BT-20,12003241,1.693784137841815
SNU-878,36462,1.024756404830259
CFPAC-1,46943432,3.316693908453427
NCI-H929,6505803,-1.240454682973536
MOLP-8,11485656,1.8270206697288176
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
JHOS-2,12003241,-0.473680569939606
T-47D,54618164,5.7219706086611515
L3.3,12003241,-0.3315333583144895
C2BBe1,107985,-4.460375093006492
HuCC-T1,54618164,4.328486254050945
ALL-SIL,9936388,-6.364749169872344
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
NCI-H28,159324,1.6675960977646165
SUP-T11,9903786,1.3476542683573176
NCI-H146,44491742,2.6808030102351323
MFE-319,107985,-2.7027086117071386
HCC827,107985,-2.5128100299546574
PSN1,9936388,-1.558535767626658
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
OVISE,12003241,-0.8183931153803442
BT 328,168313200,2.3539430397400523
MM1.S,159324,2.619931466693083
L-428,148198,-4.114855824463333
NCI-H1944,11485656,1.8149710014494984
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
EFE-184,439501,-0.6930526838136172
SK-MEL-1,9927531,4.509159168037888
SNB-75,3689413,0.0039373561000733
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
NCI-H1792,11485656,2.6862672312545586
OVCAR-4,selumetinib-GDC-0941 (4-1 mol-mol),3.050941054620586
A-673,9903786,1.5948741514342302
KMM-1,selumetinib-GDC-0941 (4-1 mol-mol),3.455450229836309
UM-UC-3,5460769,6.395850795756177
T-47D,168313200,4.207994200595196
TE-9,5460769,0.3621954570930285
Becker,44493528,4.387044567791122
Mel Ho,148198,-2.080740439053791
SNU-1105,11485656,2.972533962775767
YD-10B,5460769,-2.041920161211882
PL-21,54618164,3.670173179687308
PF-382,5460769,-0.5383889446594711
LOU-NH91,107985,-2.204555775629559
BHT-101,6610216,4.6700039739173205
U2OS,8515,2.063485731700501
KYSE-510,148198,-4.124050195334788
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
KMRC-2,6610216,4.281887950309424
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
SEM,9903786,1.5227669871926164
OVCAR-5,3689413,-2.1267579766056297
SR,409805,3.9177412417250137
MEC-1,11485656,1.7582938847723142
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
BT 248,8515,3.628450909279232
MOLT-13,6505803,0.7492781623920575
DND-41,6505803,0.5178331109157311
KMS-12-BM,44491742,3.489197811217823
RERF-LC-MS,5460769,5.094680634820597
Hs 944.T,409805,4.813634896528736
SNU-182,36462,2.799224357966921
KMS-34,10296883,3.0941719737889515
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
SNU-668,9903786,2.616887117986772
NCI-H1184,409805,3.865118912577075
ZR-75-30,9903786,5.791062866548605
786-O,5460769,2.250547826623791
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
COLO 678,JQ-1-carboplatin (1-1 mol-mol),3.427094237994177
Fu97,3689413,-0.2126169445323924
HCC78,54618164,4.731393746832609
BT 131,135875424,2.7884599516406094
NCI-H1693,44491742,3.504045241968317
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
LS513,selumetinib-GDC-0941 (4-1 mol-mol),-1.1553983681711826
Panc 03.27,148124,-5.205294633058992
CAL-27,9903786,1.9830233496778105
BT 164,5460769,1.5184738603275272
TYK-nu,135875424,3.095355061385467
COLO 792,44493528,4.179590114468014
BT 224,9927531,6.091778203420535
KMH-2,11485656,1.7580590050514375
TT2609-C02,409805,6.168536428430093
Karpas-299,6505803,-1.557594922161658
SNU-466,9936388,1.636304731108846
8-MG-BA,409805,5.835769808247416
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
BT 330,8515,4.407994026323292
NCI-H1792,26596,-3.036610435257371
SNU-423,54618164,4.040713940867877
42-MG-BA,6505803,-4.6954878984778885
PaTu 8988t,12003241,-0.7673639150441187
TE-5,107985,-4.713560731593774
BT-16,10296883,4.008579102599456
UACC-257,148124,4.26256127916897
MDA-MB-231,36462,3.2714270621849404
SNU-869,JQ-1-carboplatin (1-1 mol-mol),5.110674906782879
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
UO-31,8515,2.1346366627261304
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
HSC-2,135875424,3.0509908073629397
YD-10B,46943432,0.8427215449680024
TCC-Pan2,46943432,2.922417635476058
NCI-H1105,135875424,3.000418011762545
RKO,148198,-2.1467795088860875
NCI-H2081,6610216,3.784534117796005
KNS-62,11485656,3.204340501575354
DV-90,9903786,1.7610541097937376
BICR 31,3689413,0.760898743899782
Kasumi-2,409805,3.7279902229812114
Panc 03.27,6610216,4.487781163899809
A101D,selumetinib-GDC-0941 (4-1 mol-mol),0.5924729203046659
Mel Ho,8515,4.383639407664171
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
KG-1-C,selumetinib-GDC-0941 (4-1 mol-mol),0.970562535367186
KP-3,54618164,4.648325993327064
NCI-H2087,135875424,3.0815246928264575
BT 131,5460769,2.20262518629684
HCC366,54618164,4.237927167369724
F-36P,49836020,5.768901368593018
PK-1,9927531,5.928994406522703
NCI-H520,6610216,3.9954490147026647
PF-382,73707440,6.113676619987129
NCI-H1869,24180125,4.3941927227643145
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
FU-OV-1,439501,-0.5556149973103641
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
TOV-112D,44491742,4.330645914345901
IGROV-1,3689413,-0.3633634632064185
LCLC-103H,6610216,4.684441214447026
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
SK-MM-2,9903786,2.9629309693480983
Kasumi-2,12003241,-2.245419673861097
SNU-8,3689413,-3.353074674655615
DLD-1,5460769,4.378806727859053
Hs 888.T,135875424,5.931085085521744
KMS-34,24180125,3.4515242001705015
HCT 8,107985,-4.208540258416988
NCI-H2023,6610216,4.407320475070226
SW948,44491742,3.910317363967626
NCI-H661,5460769,1.0320957244219937
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
MEC-1,135875424,2.225432824256911
COV644,24180125,2.7546946002955024
LS513,6610216,4.305930787985114
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
NCI-H2009,5460769,1.3316086312624285
G-402,9927531,4.821419019473558
NCI-H2009,6505803,-0.1719772058921901
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
JHUEM-1,5460769,1.70749298340363
BT 216,135398744,6.476974321326381
EFO-27,6610216,4.772563131438148
U-118MG,148124,-4.102697038278307
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
Ri-1,46943432,0.5214586687647272
COLO 800,10296883,3.791440473177963
HDQ-P1,439501,-2.3169119812080794
BHY,44491742,4.864491079150181
HCC1395,54618164,3.623383383409561
FTC-133,107985,-2.14591043360211
BT 330,6610216,4.420410954018115
NU-DUL-1,3689413,-2.4087699464815664
NCI-H2171,107985,-3.896160678794096
SCC-4,135875424,3.69532319714556
KYSE-450,11485656,2.990129749938368
THP-1,44491742,3.722381012581274
U2OS,12003241,-1.2814871357228934
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
HCC1428,54618164,3.90789130284992
SNU-1196,439501,-2.3352671282254303
U266B1,54618164,4.486024855885345
NCI-H1395,9903786,3.8864807174358984
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
TE-1,selumetinib-GDC-0941 (4-1 mol-mol),3.018112465414828
SNU-245,11485656,2.4335561364098073
GCT,54618164,4.311053334920422
COV362,JQ-1-carboplatin (1-1 mol-mol),5.952007792704957
NCI-H23,5460769,-1.0672070635340756
HuCC-T1,159324,4.160356668133178
SK-N-SH,11485656,1.632835295559006
SHP-77,107985,-2.181807844458771
PE/CA-PJ15,9903786,2.2611792207171484
SF295,6610216,4.890664911877899
MDA-MB-435S,107985,-2.6395704161452973
NCI-H929,107985,-4.785949324647598
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
NCI-H1734,12003241,-3.2634619258307644
NCI-H2444,409805,4.152431794667637
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
HEC-108,107985,-3.7063937347849696
NOMO-1,9903786,1.612481289648159
MSTO-211H,54618164,3.0389284404004795
RPMI-8402,36462,-2.7936372470857473
NH-6,135875424,3.8228230929419182
BT 172,135875424,3.0485083904276933
RCH-ACV,49836020,-2.2684832321475774
TE-1,439501,-0.5334953492440002
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
HEC-265,JQ-1-carboplatin (1-1 mol-mol),0.3590363949507987
KCL-22,409805,3.899318616941848
GA-10,49836020,3.868484173874789
OVK18,selumetinib-GDC-0941 (4-1 mol-mol),1.2512103740452307
IGROV-1,107985,-2.8971910842184516
NCI-H524,12003241,-3.023793196266873
Panc 08.13,9903786,3.5519515597880646
CMK,36462,0.4830261270802425
SK-MES-1,49836020,5.814503877703118
PLC/PRF/5,6610216,3.842648408877997
KE-97,JQ-1-carboplatin (1-1 mol-mol),-0.8780333698313584
NCI-H1092,6610216,4.21553350442545
NCI-H2291,11485656,3.4201367707893424
LS180,44491742,4.531352051294965
COLO 800,11485656,3.591351165158368
NCI-H727,54618164,4.079418853402711
CAL-85-1,148124,-7.077964947486074
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
BT 359,409805,5.267313408202177
COV362,54618164,3.998980611100999
SNU-201,24180125,3.798087696111674
SUP-T11,6505803,1.7392273117289616
ChaGo-K-1,148124,-2.510637409875074
NCI-H2110,10296883,4.192584749950301
LCLC-97TM1,409805,4.11204743963536
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
HuH-28,54618164,3.756751318056744
NOMO-1,107985,-4.118574275669005
CMK,JQ-1-carboplatin (1-1 mol-mol),-0.2458956642529063
JHUEM-1,54618164,3.7597599948507217
CAL-29,9927531,5.397915625533194
LAMA-84,12003241,-5.010316876482206
JVM-2,26596,-2.43180743148247
BICR 18,6610216,4.848962680938815
NCI-H1869,12003241,-1.5114527115730307
MFE-296,148124,-4.488467363744148
SNU-16,JQ-1-carboplatin (1-1 mol-mol),-0.5947193789750925
RT-112,6505803,-1.2171367776544837
BV-173,44491742,2.039629297457472
SK-MEL-2,6610216,4.255505327986827
L-363,9903786,1.2649504106242235
TT2609-C02,135875424,5.0022625641084755
CAL-12T,49836020,4.6523718910669745
COLO 205,11485656,2.198859686609949
BICR 22,9903786,3.2901982519836213
OV-90,3689413,1.0666322744292105
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
RL95-2,24180125,2.972100845265481
TE-9,6610216,4.485470919587612
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
MKN7,9936388,1.0718801330101393
NCI-H1373,159324,3.0208465782791825
JHH-6,168313200,3.15578355324536
TALL-1 [Human adult T-ALL],135875424,3.2199979097840905
FaDu,selumetinib-GDC-0941 (4-1 mol-mol),1.0128048472171496
HEC-108,135875424,4.07561778301408
L-1236,107985,-2.039005405341846
HSC-4,409805,5.399675964474335
HT,selumetinib-GDC-0941 (4-1 mol-mol),2.035866243674196
SW982,11485656,3.4639453633875985
COLO 320,6505803,1.3976396139000618
WSU-DLCL2,44493528,4.16645945517617
NCO2,11485656,2.116269191877006
NCI-H2126,12003241,2.692479485403981
AM-38,439501,-2.2075146927882177
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
HCC1806,JQ-1-carboplatin (1-1 mol-mol),3.517828248057606
8-MG-BA,107985,-2.2660198800752793
KE-39,54618164,4.766262408385177
SK-N-MC,72199289,4.349528374595986
IST-Mes1,8515,4.272788297141445
HEC-6,5460769,3.976458521596205
SNU-869,135875424,4.845035654060252
BDCM,6505803,-1.085958720489184
SNU-489,12003241,-0.3449149032803904
CL-11,135875424,4.310840427091723
BT 139,135875424,2.659641868559938
JHUEM-2,439501,-3.5756847183572704
HCC1195,8515,4.9817766810597135
HEL 92.1.7,9903786,1.7249056875700772
NCI-H2170,12003241,-0.7011198558518746
2004,135398744,6.587609936981218
OCI-AML-5,135875424,2.7043595166369694
OCI-Ly10,10296883,3.528234094962338
MM1.S,3689413,-0.3922685663675629
M-07e,3689413,-2.11596462386005
TE-4,JQ-1-carboplatin (1-1 mol-mol),-0.4679949874900955
GSU,6610216,4.620250876462257
TOV-21G,selumetinib-GDC-0941 (4-1 mol-mol),3.592857274356158
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
KE-39,9927531,6.019185228760376
NCI-H322,36462,3.679003516443927
SW1990,5460769,2.4608974418371017
5637,3689413,-0.8929275995994026
Panc 04.03,439501,0.3022334331499904
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
PK-59,11485656,2.1797490126169823
GSU,9936388,1.1039291708072954
SU-DHL-10,36462,0.5230051322888742
BT-474,148198,-3.4060318714272984
COLO 205,44491742,4.914749097396915
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
BT 359,168313200,1.7683739360111177
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
VM-CUB-1,148198,-2.29434239766537
SW948,9903786,1.6902329933335576
BT 482,10296883,4.136673129402408
Kasumi-2,135398744,8.02054113805855
Mino,135398744,6.764750512167438
Rh41,12003241,-2.564539347057637
NCI-H2452,6610216,4.12804282735119
NCI-H1373,JQ-1-carboplatin (1-1 mol-mol),1.2259768292567783
LP-1,8515,3.897304365418543
NCI-H2171,44493528,3.677120674941258
COLO 741,49836020,-1.8257608892409716
NCI-H23,36462,-0.3281376255972362
CAL-51,11485656,2.6541256228973773
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
HuH-1,9936388,0.6905848957768463
NCI-H520,9903786,3.332228860924169
NCI-H2122,11485656,1.6231046249934602
HCC1833,9903786,4.187003338939228
EPLC-272H,107985,-2.872507953647575
ALL-SIL,44491742,3.700418914769662
VCaP,6610216,4.200351361755344
SK-N-DZ,selumetinib-GDC-0941 (4-1 mol-mol),1.1652159438027232
EPLC-272H,46943432,1.437902766779572
SNU-878,selumetinib-GDC-0941 (4-1 mol-mol),0.5330473997899833
WM793,159324,3.425736366761861
Karpas-620,6610216,5.001310944068096
OVTOKO,9903786,2.0414174754656544
SNU-1196,159324,3.4693899047563512
LS123,10296883,3.5438428207771495
KYM-1,12003241,1.54362271248318
SNU-626,49836020,-1.879821731308555
Daudi,9927531,3.2507934675389447
MKN7,439501,-1.6768390868463443
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
BT-20,168313200,2.4651891211897734
KATO III,6505803,3.725568714877732
COR-L105,439501,-1.395093001857319
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
NCI-H69,6610216,4.4991786369679
JM-1,135423438,1.5495237102322077
G-361,439501,-0.9249859922186838
CL-11,10296883,4.178438273202507
SNU-1077,6505803,4.592101417459953
TUHR14TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.1009270469043897
NCI-H2286,6610216,4.176129306068653
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
SNU-245,46943432,2.4309238019783095
SNU-201,148198,-1.525453793244306
SNU-16,9903786,1.405581496282783
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
SNU-216,24180125,5.748491941008621
SW1088,36462,2.5002786648987874
HCC1588,24180125,2.3655662504796493
HCT 15,6610216,4.137452944205724
HT-1197,44491742,3.769562948559888
OCI-Ly3,6610216,3.964539819675791
NCI-H146,44493528,1.3818057906729433
OC 314,46943432,2.002115523030698
BT 145,11485656,1.8093295586372804
KYSE-180,24180125,4.03262772641334
Daudi,36462,-1.782907247885185
NCI-H660,135875424,2.723331707113997
HH [Human lymphoma],439501,-4.820803116801483
SF126,12003241,-0.8562047407383144
SNU-620,selumetinib-GDC-0941 (4-1 mol-mol),-2.4786489689796554
JMSU-1,49836020,6.465700185404903
Karpas-299,148198,-2.4560718310367604
NCI-H1299,6610216,4.858778450336318
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
GCT,26596,-0.460153915776305
HCT 8,8515,5.054538260051568
HL-60,36462,-0.0073332403258697
AsPC-1,148198,-3.729188282050714
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206
JHUEM-7,36462,0.060815321002826
OVCAR-5,409805,6.058763261482215
G-401,8515,3.316277000480566
KYSE-510,6610216,4.6142103505031375
PE/CA-PJ49,10296883,4.094155197512124
Kuramochi,44491742,6.028956148879381
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
SK-MEL-30,148198,-1.6076704799075907
BT 239,24180125,1.280593014526314
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225
BT 428,9927531,4.812195201637174
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
SU-DHL-4,11485656,1.626108094127111
TALL-1 [Human adult T-ALL],159324,0.6712531731090338
HT-1197,409805,5.791869558181375
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
A-172,148124,-4.252719127564102
OCUM-1,24180125,3.1846560803491575
LoVo,148198,-1.1147075342847712
AsPC-1,148198,-3.729188282050714
WM266-4,148198,-3.639294781182272
IGR-39,439501,-2.7155182926460832
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
Hs 852.T,6610216,4.289282312349925
COLO 792,9936388,1.0587943491174894
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
CMK,409805,5.884748544483751
GOS-3,6505803,2.171469842265414
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
OV7,135875424,4.527719161863161
SNU-398,10296883,3.408276810721882
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
Li-7,6505803,-1.5573674441888958
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
YD-8,12003241,-1.7142863629727714
YD-10B,26596,-1.4003119054370567
EFE-184,44493528,4.48158845578013
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
NCI-H1703,54618164,3.5806376010346583
BFTC-909,6610216,4.898578232775107
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
HGC-27,11485656,1.9674233775632803
SCC-9,10296883,4.238304408621306
NCI-H520,26596,-1.7163548151943342
BT 330,135875424,2.80821579250056
LN-18,107985,-3.4646422995384283
SK-N-DZ,409805,3.6668852525503937
ECC10,439501,-2.678077063421273
HPB-ALL,409805,3.5963919308844283
Yamato-SS,9936388,1.5578978605453773
NCI-H446,26596,-3.841011502431018
UACC-62,44491742,4.3464910230211755
OVTOKO,3689413,-2.3162270386238735
SR,3689413,0.3714575249004426
HCC2279,3689413,-1.8306201481389968
GI-1,selumetinib-GDC-0941 (4-1 mol-mol),2.406121419892038
Peer,selumetinib-GDC-0941 (4-1 mol-mol),3.981609189515586
LS1034,9936388,-2.448497321625194
HuNS1,3689413,-2.2730227081216787
HuCC-T1,12003241,-1.0945393222434805
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
T84,3689413,-1.5299599275494418
HuG1-N,107985,-3.587499337326945
AsPC-1,135875424,4.124114476494282
Granta-519,49836020,3.8229564713378057
Caov-3,12003241,-2.5094220970195136
DLD-1,9927531,4.358823264887286
PL-21,9903786,1.6725311379491856
CL-11,135423438,1.6097510193323543
SNU-1214,439501,-2.3459859921965793
COLO 684,3689413,-2.2674920306130764
OVCAR-5,11485656,2.327604850531282
OAW28,148198,-3.8662210541116977
BT 232,6610216,3.928895495899257
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
EoL-1,5460769,1.0165285119643896
GMS-10,49836020,0.0918808601925
Calu-1,54618164,4.35336798848697
HCC1833,159324,2.7242134281125883
JHOS-2,10296883,4.146882384876985
PaTu 8988s,6505803,-2.1809975101024417
MDA-MB-468,24180125,2.6754361833338773
KYSE-150,9936388,0.0652021177968587
Lu-65,JQ-1-carboplatin (1-1 mol-mol),1.9478415319376168
SF268,54618164,4.349289633289385
Reh,selumetinib-GDC-0941 (4-1 mol-mol),2.2162895945823093
SF539,11485656,1.8649737443723855
ONCO-DG-1,5460769,1.9256836095204335
MCAS,26596,-1.466898780296629
COV434,11485656,1.9147698543097105
KMS-12-BM,36462,-0.0282673998252453
PL-21,3689413,-0.2817982428361766
Malme-3M,selumetinib-GDC-0941 (4-1 mol-mol),-2.272222861013609
KMBC-2,9903786,2.1846129600819353
SNU-719,6505803,-1.6348433064714072
Hs 852.T,24180125,3.655045721094024
JHUEM-7,168313200,3.430060131832228
LOX-IMVI,107985,-4.647027352160178
HGC-27,54618164,3.7690202033971416
697,5460769,1.383858776744359
SNU-668,9936388,1.544401750271857
YD-10B,44493528,3.7407231951864497
NCI-H1666,9927531,4.532813040549954
BT 286,168313200,1.66103693738852
SNU-1214,159324,0.6558856370223802
BT 286,135423438,1.7051552017965996
PF-382,46943432,0.0711232205860505
NCI-H358,9927531,4.779825407302033
PF-382,9903786,1.7632578420268197
LS123,439501,-0.5553663251516828
SK-N-SH,148198,-4.813749517608016
Calu-6,12003241,-0.728129558300084
SHP-77,148198,-3.620060060675933
BT 228,8515,3.7604007756554583
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
SNU-410,44491742,4.2778322604140815
HCC-56,107985,-4.037226887068548
HMCB,409805,5.980176460908731
SK-BR-3,11485656,1.9391537366026357
GP2d,10296883,2.4344246529088163
NCI-H2228,44491742,4.2440053782675555
CAL-29,5460769,2.8970816736671416
BT 131,148198,-4.140585549230615
AML-193,11485656,-1.7272529013303597
RL95-2,11485656,2.119003838335733
HEC-59,6610216,4.527816739997527
JHH-5,selumetinib-GDC-0941 (4-1 mol-mol),1.0650507170556407
Hs 766T,148198,-4.268636450980236
MOLM-13,26596,-2.2068545341754295
T98G,409805,5.844803307866975
MOLM-6,135875424,3.809731266515376
BT 504,3689413,0.2401102984502228
SF268,148124,-4.891183212360556
SNU-C1,selumetinib-GDC-0941 (4-1 mol-mol),-7.034120569721028
Rh41,5460769,3.320988700800296
KYSE-140,36462,3.8546995001877176
NCI-H2106,439501,-2.192418172555811
MeWo,9936388,-4.455184723751584
YAPC,107985,-3.02393363080246
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
MHH-NB-11,44491742,4.127844347820601
SK-MEL-3,6610216,4.385153925999174
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
DoHH2,159324,-2.321608210889596
KMS-34,3689413,-2.478307053017587
HCC1500,107985,-3.8501888791364034
CGTH-W-1,439501,-2.6325140773837012
MOTN-1,9903786,1.5262783813128549
BT 145,3689413,-2.1573583471040827
KYSE-140,9927531,4.387230999589902
BT 286,409805,3.8987037297039056
BT 482,135875424,3.0321936879214846
NCI-H1339,6505803,-2.1203038529931857
BV-173,36462,-3.0716079120235147
CCF-STTG1,6610216,4.787403157480984
SNU-C4,148198,-4.665423205896986
MOLP-2,73707440,4.42380771173
UM-UC-3,54618164,4.22166534814322
IGR-37,439501,-2.841973609481132
FTC-133,439501,-1.0725688155870328
NCI-H1355,135875424,3.7219654105807622
HCC2218,3689413,-1.7582350299108729
HuH-28,5460769,2.112533024093989
SW620,148198,-3.4206637711010455
SU-DHL-10,6505803,-0.3491248670962715
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
Panc 05.04,6505803,-2.723455605097511
DMS 53,439501,-4.4060490975057105
MKN7,12003241,0.0513011107794011
L-428,11485656,2.209073620058958
A-375,159324,3.1651524914786333
Peer,9903786,1.0379810938538272
COLO 668,selumetinib-GDC-0941 (4-1 mol-mol),1.3136339769423369
SW1417,10296883,4.30591793322403
OCI-AML-3,9927531,5.116735976562035
KMS-20,148198,-4.371887061655697
KHM-1B,24180125,1.7183751461282626
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
NCI-H1734,selumetinib-GDC-0941 (4-1 mol-mol),-0.5700124177299448
TE-8,6610216,4.316653592649421
L-363,10296883,3.350566136289887
UM-UC-3,148198,-2.7030111325228594
Hs 895.T,3689413,-2.343534689562226
NCI-H810,8515,3.5075433046865117
NCI-H520,12003241,-2.710304641181941
YKG-1,439501,-3.197548465236136
Raji,10296883,3.544688579045074
SK-OV-3,159324,5.082712026660022
786-O,409805,5.990992975175664
G-361,3689413,0.7888420983212308
NCI-H69,135875424,3.823328505000576
NCI-H1755,54618164,3.712374543898709
NCI-H446,6505803,2.330935427354621
Kasumi-2,6505803,-2.445084849944434
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
TE-1,159324,2.9187839778055795
SNU-1272,9936388,1.7321766128233604
KLE,135875424,3.394401628511705
NCI-N87,409805,4.5069551273823585
SW1417,3689413,1.8157284329768
PE/CA-PJ15,44493528,4.269836707696998
SNU-869,10296883,4.255396033988242
DV-90,8515,2.3844270200135615
L-363,135875424,3.938515519737711
SUP-HD1,26596,-3.617348161498389
BICR 16,26596,-0.6914049107649834
G-292 clone A141B1,148124,-4.342355625050856
OVSAHO,24180125,2.408510590249746
MES-SA,11485656,1.9187947649537451
KYSE-510,135875424,3.1467699489442182
A-253,6505803,0.0619140769446045
Becker,54618164,4.063586417108196
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
RKN,9936388,2.306220468641662
RERF-LC-A1,409805,5.788230095208666
A-172,135875424,4.966488760073994
CAL-51,26596,-1.4638590943230956
TM-31,9936388,3.1233644325895185
Hs 294T,409805,3.776693304184006
OCI-AML-3,46943432,-2.0174912276907637
OVCAR-8,9903786,3.64408364733759
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
HT,12003241,2.790793152125299
HCC2279,6610216,4.631099276458667
Pfeiffer,439501,-3.463410019597594
8505C,107985,-2.648849109047195
SU-DHL-10,9936388,-7.075176092444515
SNU-601,9936388,-4.393234947072901
A-549,107985,-1.903643524605076
KYSE-410,3689413,0.6720370091874901
MOLT-3,6610216,3.760595220298074
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866
OAW42,409805,5.898373871499896
FaDu,135423438,3.89304152437962
Becker,148124,-6.351335533141373
HEC-265,9936388,-5.092900256875076
KMS-26,5460769,1.6781754946124072
U2OS,24180125,2.6546755923389527
BT 164,6610216,4.359427405637071
LC-1/sq-SF,9936388,2.2105374849729036
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
TALL-1 [Human adult T-ALL],9927531,3.369458546084366
CFPAC-1,148198,-1.2933950729349923
Panc 02.03,10296883,4.297264305827386
MOLT-16,73707440,4.869509830184637
Panc 04.03,44491742,4.30815140156182
NCI-H716,135423438,0.7002351169719838
SCC-4,26596,-2.628163319920325
HCC1195,9903786,3.7437324544379487
Daoy,6505803,0.5477852544594343
RCH-ACV,44491742,3.725167954137364
YD-10B,6505803,-2.5898311798787774
DU145,44491742,3.929497920305024
HD-MY-Z,6610216,4.0359125052118685
KYSE-70,10296883,3.691258417269261
IGR-1,11485656,3.283043378063367
HEC-265,439501,-2.385481236661946
HCC78,3689413,0.9109498190296136
IGROV-1,12003241,-2.0122972114546904
MPP 89,148198,-3.0572841720054007
U-CH1,9936388,3.1396417887347017
NCI-H2228,107985,-3.27582791857513
JJN-3,8515,3.783800889557933
BC-3C,6610216,4.163400857926898
L-428,36462,-0.2610095506512102
J82,5460769,3.931927319993056
KYSE-140,6610216,4.474378770774551
SW48,9936388,-6.68623848822316
Hs 839.T,11485656,3.884634476915026
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
SEM,36462,-2.7360640601525845
M-07e,26596,-2.7882078019466725
DMS 79,8515,4.333974511399787
NCI-H441,54618164,4.199926300298215
RL95-2,12003241,-0.4521887729146946
SW48,5460769,-0.8804369809799648
NCI-H1105,9903786,2.2828684981562013
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
SNU-869,5460769,1.7157786407903552
SW48,3689413,2.066117060158584
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
RVH-421,12003241,-1.8374248826372317
OCI-Ly3,49836020,4.868556688555981
HT-55,6610216,4.122284728338665
SNU-1196,selumetinib-GDC-0941 (4-1 mol-mol),2.312847943895299
OAW42,135875424,4.816412015133948
Panc 04.03,9903786,4.611047286699123
CL-11,5460769,2.817673582837802
NCI-H1573,JQ-1-carboplatin (1-1 mol-mol),-0.275309697042944
A2058,11485656,1.8402668016957284
CGTH-W-1,12003241,-0.9249574155092228
GaMG,44491742,3.8685046453697383
MHH-ES-1,24180125,2.2198565259892775
M-07e,8515,3.3739706216827368
SNU-761,148198,-3.4808535079888494
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
Tm87-16,54618164,4.274519133447958
KMS-27,5460769,1.7009983096984826
Panc 08.13,46943432,1.4716775334108003
KYSE-450,3689413,-0.3124621453247139
JVM-2,439501,-2.3079985652377633
EoL-1,148198,-7.742780807176134
AM-38,11485656,3.1018952301837155
ACC-MESO-1,409805,5.492965963250371
KP-2,12003241,-1.0131753515014823
SK-MM-2,11485656,1.7777783316384888
MOLP-2,107985,-3.941416896107429
NCI-H1792,148198,-0.2067375055401052
NCI-H2030,107985,-3.4072882201526515
IPC-298,selumetinib-GDC-0941 (4-1 mol-mol),-1.1184200059628775
253J,159324,3.1278100403829696
Kelly,135398744,7.079466503802849
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
TCCSUP,409805,5.441662511172961
JHH-1,148198,-5.058972904251947
GA-10,10296883,2.032033381288912
LS513,54618164,4.0573753164291615
NCI-H1339,10296883,3.881669394748239
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
HCC1195,3689413,-0.7365828236328352
COLO 320,26596,0.3070863795461868
JHH-6,24180125,3.104630647099568
SNG-M,44493528,4.902033087695682
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
253J-BV,9903786,4.2891414604158395
MOLP-8,8515,3.727464051425151
BT 504,9903786,2.1257740171546717
HSC-2,439501,-2.499396675496898
SF539,44491742,4.105649274647132
LC-1/sq-SF,409805,5.500722861245553
AsPC-1,44493528,4.313387127964929
NCI-H211,9927531,3.644928626875117
SU-DHL-8,44493528,3.935387311306229
NCI-H1869,44493528,4.333760189181675
BICR 18,107985,-2.7131410229776916
HH [Human lymphoma],8515,3.942777456860918
RD,selumetinib-GDC-0941 (4-1 mol-mol),0.4291937329067764
GOS-3,9936388,2.12022290506738
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
HEC-251,6610216,4.488517337279306
SNU-478,159324,3.0477747725876645
HSC-3,9936388,1.0714511856923938
BT 145,9927531,3.3032194302925557
SNU-886,439501,-0.6078207224909147
SF268,10296883,3.944693282925585
AML-193,3689413,-0.2908308590674514
Rh30,135875424,2.415792825604233
ACC-MESO-1,148198,-2.036295291578454
NOMO-1,46943432,0.592792127892358
OUMS-23,49836020,3.7624735721332736
MES-SA,26596,0.3162950796632606
Panc 02.03,439501,0.4668648826805023
UO-31,36462,3.819646793717455
PaTu 8988s,148198,-4.140903608928441
TE-10,159324,2.9715130331129114
RPMI-8402,107985,-3.808655830164077
Panc 03.27,10296883,3.962678998629819
SW1353,9936388,-5.283221475424073
SNU-719,9903786,2.245774395512323
HPAC,11485656,1.4709930999197478
SK-N-DZ,44491742,3.9840069294663025
WM793,3689413,0.565505634508756
CFPAC-1,409805,5.9431710343838136
KYSE-510,36462,1.8586989227994473
Yamato-SS,5460769,4.640105648822845
NCI-H647,9903786,3.1378024767973827
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818
KYSE-520,9903786,4.522923988599173
JHOS-2,439501,-1.7810659698963345
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236
HEC-59,12003241,-0.4049011737939335
CHP-212,12003241,-2.3110623292084695
Capan-1,36462,2.302180393835448
PC-14,54618164,4.181975842638425
8-MG-BA,44493528,4.684736338919144
NCI-H1299,409805,5.9960995888447925
BHT-101,159324,4.240701145250969
Hs 688(A).T,6610216,4.587540345511735
TT2609-C02,26596,5.442135867718664
SNU-213,5460769,1.7717518807864931
NCI-H1734,8515,1.9897267358635304
Mono-Mac-1,44493528,3.807460562047893
COLO 800,135398744,6.478150217692287
HT-1197,148124,5.0758471047510625
OE19,6610216,4.442159691341868
Malme-3M,9936388,1.1290902894019168
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
SW1088,6610216,4.433022811362425
NCI-H838,44493528,4.484447335433128
KMBC-2,107985,-4.329865422149039
NCI-H23,135875424,3.011059427080452
U2OS,9936388,-2.745672898623292
G-401,3689413,-2.428789331956376
ONCO-DG-1,36462,2.81533551791567
SNU-761,107985,-2.3289505375357287
OAW42,3689413,0.5201903722679624
SNU-620,107985,-2.9200019324951483
SK-ES-1,11485656,2.2128952684348286
HGC-27,46943432,3.3342404916831825
HCC1500,439501,-1.4156205398968564
PE/CA-PJ49,3689413,1.6027869787622069
GB-1,107985,-1.5886789717003875
NCI-H1339,3689413,0.3064961832206241
HOP-62,44491742,4.640090000896823
OCI-AML-3,JQ-1-carboplatin (1-1 mol-mol),-1.7736109395797492
NCI-H520,168313200,1.818196575131949
HCC1171,439501,-1.4214133435338303
JHUEM-2,159324,-0.5047456010637043
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
LNCaP clone FGC,54618164,3.473617920574014
SK-N-BE(2),JQ-1-carboplatin (1-1 mol-mol),-0.9274219312218726
P3HR-1,168313200,4.175609839213621
CAL-51,6610216,4.7761200098267365
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
SIG-M5,44493528,4.118953354797346
MOLP-2,159324,4.04341209915365
CCF-STTG1,135875424,4.233748796461769
SNU-899,54618164,4.198848863293895
SNU-423,439501,-3.458666497477645
MHH-ES-1,159324,0.9353863537723508
CAL-54,439501,-3.2230187997856308
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
NCO2,6610216,3.0387992514470663
HCT 15,36462,1.5260279602132691
TCC-Pan2,5460769,4.19565263219897
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
HCC-56,9936388,-7.462492097738726
Daoy,148198,-1.968278269262657
H-STS,439501,-3.713409181758543
SHP-77,439501,-1.6083465101803276
Hs 934.T,6610216,4.346139991195847
OCI-AML-3,409805,3.723467633820993
KMS-11,168313200,1.7445720768361954
SK-MES-1,9903786,1.5074557756101594
UACC-62,11485656,3.7372530211489057
SNU-119,6610216,4.326307589827554
MOLM-13,44493528,3.9608078939228175
D283 Med,135875424,3.0041212409823053
COR-L95,8515,4.297389552329342
DOV13,36462,1.5210800303405427
ONS-76,135875424,3.856833286433643
ALL-SIL,11485656,1.390704841990788
AM-38,3689413,-2.9608439081613387
SU-DHL-8,54618164,3.0908319012602723
SIG-M5,168313200,2.70239683850215
BT 359,12003241,0.8363622600991807
COLO 792,selumetinib-GDC-0941 (4-1 mol-mol),-1.2874205422493403
EFM-192A,9927531,5.058042989735013
PE/CA-PJ15,10296883,4.07189179930938
RPMI-7951,3689413,-1.832371720912868
SNU-8,148198,-1.3128761791294046
EN,135875424,5.104378760772923
HCC366,107985,-3.089581015877287
EBC-1,44493528,4.198752101317416
HeLa,148198,-3.5416719655217976
SNB-75,6505803,-1.615420165549335
CL-11,JQ-1-carboplatin (1-1 mol-mol),-0.9371463412040694
NCI-H2286,439501,-0.7884333546830701
Hs 888.Lu,5460769,5.202141251599371
NCI-H1666,9903786,3.302889272478758
MOLT-13,135875424,3.0994865086023125
NCI-H2081,409805,3.646579192169883
TTC-709,36462,1.4655456556845978
OCI-Ly19,148198,-5.638964397793588
NU-DUL-1,409805,4.193403538182111
8505C,135423438,2.0572853298066036
L3.3,135398744,6.452563021638662
PE/CA-PJ49,148198,-3.4268639622300516
ZR-75-30,168313200,2.927725098790728
Ri-1,9903786,-0.2937603570790111
B-CPAP,107985,-3.233876642304658
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
NCI-H520,44493528,4.24259211168764
HEC-151,439501,-1.7100799573978192
HCC-56,135875424,5.1003791094232085
Calu-6,JQ-1-carboplatin (1-1 mol-mol),5.26702992417303
NCI-H1838,11485656,2.306632115850396
MDA-MB-415,3689413,0.9318118886316789
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
Hep 3B2.1-7,12003241,-1.3373877223864783
G-292 clone A141B1,6505803,0.1616313040376176
NCI-H2122,9903786,2.7991091527294216
BT 422,168313200,1.7894114416227225
AGS,6610216,4.185010509359766
G-401,6610216,3.9425308150709
SNU-423,107985,-4.181882942370829
HCC1143,439501,-0.7374061663212956
CHP-212,JQ-1-carboplatin (1-1 mol-mol),-0.8333787356849307
YAPC,9936388,2.1810367621372095
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
EFO-27,12003241,-1.7336155023360622
SJSA-1,135875424,4.854723891945684
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859
JHOC-5,36462,1.4237720157059233
TUHR14TKB,107985,-3.513276749954187
SK-N-BE(2),6505803,3.424835431725291
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
OVISE,409805,6.403340651497087
MOTN-1,24180125,1.1072514712604145
SW620,selumetinib-GDC-0941 (4-1 mol-mol),-0.6864895325025141
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152
IM95,10296883,2.4504094731139676
Hs 852.T,3689413,-1.1635573957116976
C2BBe1,24180125,3.074630364609225
JHUEM-7,44493528,4.303413387370261
Caov-3,49836020,-0.0609342715049496
HEC-1-A,3689413,-1.724337097738872
NCI-H1975,26596,-2.5930273814391196
SNU-C1,44491742,3.3879999967260717
BxPC-3,9936388,-5.112429278661846
HCC44,135423438,1.5851293275166212
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
BICR 31,11485656,2.9684140094972387
DMS 114,3689413,-0.1355634310043713
D283 Med,44493528,4.1397828788754465
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
SJSA-1,6505803,0.5726906025627778
SW620,135875424,2.207867824891832
BT 498,JQ-1-carboplatin (1-1 mol-mol),6.0311872836348535
EM-2,159324,-0.2491393012788013
MFE-296,3689413,0.1325691008190123
IST-Mes1,36462,4.9786696220654845
KMS-27,49836020,5.305149991763679
BT 248,439501,-2.3411963573363104
HT,11485656,2.2235968294792534
U-251MG,6505803,-1.162158161162463
697,54618164,3.6802056089192106
SNB-75,135875424,3.5358654963321556
BT 187,24180125,2.9040005790614183
NCI-H1568,44493528,4.1542795967274175
KU-19-19,159324,4.255883770522122
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
GP2d,44491742,5.750365262572418
ACC-MESO-1,3689413,0.4162012666414902
CW-2,9903786,2.9588284510461733
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
RPMI-8402,135875424,3.838035457399833
MHH-CALL-4,9903786,1.9013313990407976
TUHR14TKB,409805,6.116052032951237
ONS-76,44491742,4.314760532803232
TALL-1 [Human adult T-ALL],11485656,1.8418453381137807
HCT 15,9927531,3.5842922899079173
SYO-1,6610216,4.502442732113343
TF-1,6610216,3.918529921901587
OCI-M1,8515,3.8522238482171263
H-STS,12003241,-1.720451684377523
SBC-5,159324,3.4028835437957112
WM983B,6610216,4.015594712233716
SK-LMS-1,9927531,4.694028683387814
RD,JQ-1-carboplatin (1-1 mol-mol),1.5252268474537996
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
OCUM-1,12003241,-0.8918432074998596
BC-3C,10296883,3.936118595707102
Panc 10.05,24180125,2.67983729473107
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
TCC-Pan2,11485656,3.231735678762206
CAL-51,5460769,1.3780575552768597
SNU-1033,107985,-3.3872017086874924
LS180,107985,-4.080313435814333
HD-MY-Z,148198,-4.870979577806884
BT-16,148198,-6.229115557962731
HCC1806,54618164,4.175335893823892
ST486,3689413,-2.784671548878338
SNU-81,5460769,-2.0941921209529575
SW948,135875424,4.663257041681152
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
TCCSUP,159324,3.967918889169363
HEC-251,26596,-1.8718311463988424
NCI-H1339,409805,5.836206098158848
T98G,10296883,3.86323730718366
ONS-76,26596,0.1332187247782509
BV-173,5460769,1.1539249163538905
HCC2218,9936388,0.977315225187753
P31/FUJ,107985,-4.114404549725097
NCI-H446,12003241,-2.472170144252885
RKO,8515,4.32265921632429
Pfeiffer,44491742,3.3297086723950553
NCI-H211,11485656,1.3378939159503729
NCI-H1092,36462,1.746172568826328
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
NCI-H2286,10296883,4.1413309005393755
AU565,46943432,5.0196372017891555
TE-5,8515,4.767533818879323
K029AX,12003241,-1.6892437749493532
NCI-H196,107985,-2.614031076452801
Calu-3,107985,-4.172207821327108
HCC1438,11485656,3.297814060039802
BT 271,6610216,4.282258740589861
A3/Kawakami,9903786,0.9564213610990896
Mono-Mac-6,44493528,3.657931267862179
OV-90,54618164,4.104612796363699
COR-L47,26596,-5.5673450877852995
BT 271,54618164,3.681074149846346
SNU-8,26596,-0.6710039843025739
SNU-478,9927531,5.143977185818116
EB1,9903786,1.1512361945239595
IGR-39,44491742,4.786400321878876
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
NCI-H1155,selumetinib-GDC-0941 (4-1 mol-mol),2.5268470929641964
JHH-2,439501,-1.6705307194191004
HCT 116,5460769,4.292752734346336
LNCaP clone FGC,8515,4.149767079879017
Hs 746.T,11485656,1.8868493516636309
OCUM-1,26596,0.6196247278484265
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
HCC827,9936388,-1.46620375683839
SU-DHL-8,159324,-1.6239569487690224
MOTN-1,54618164,3.704812206069747
CHP-126,selumetinib-GDC-0941 (4-1 mol-mol),3.8559663060343
AU565,10296883,3.47614106437246
BT 239,6505803,-2.8170451599207733
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
NCI-H2452,9903786,2.1501841215173396
KMH-2,44493528,4.009016955634305
HEC-151,36462,3.471634124285656
SW579,44491742,3.723441369263322
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
P12-Ichikawa,JQ-1-carboplatin (1-1 mol-mol),-0.0557948647984977
HCC366,12003241,-0.2149977364985454
HT-1197,9903786,4.0222787047996915
AM-38,107985,-6.423033763358534
Caki-2,10296883,3.9921303819788574
HCC1143,6610216,3.638345017281011
SUP-T11,135875424,3.130261828756196
MDA-MB-453,107985,-4.386344018126506
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
SNU-216,8515,4.27176731188738
HEC-151,6610216,4.488226027984822
HCC2218,24180125,2.93475065656583
OVCAR-5,148198,-5.433409896244414
MG-63,12003241,-0.4675070550973023
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925
NCI-H1693,54618164,3.6996601744635726
NCI-H1915,5460769,1.211615003674484
MDA-MB-231,9903786,4.774872525437021
SK-ES-1,9927531,4.061932878113416
HCC1171,12003241,-1.936475523579036
CJM [Human melanoma],12003241,-0.9609981142913676
OCI-M1,54618164,3.810802357546973
HEC-265,5460769,4.34119097814152
EJM,49836020,4.362565190709962
HCC1500,5460769,5.1304942195737935
P12-Ichikawa,8515,3.077919808593495
TE-15,8515,2.4630178987516564
T3M-10,168313200,2.747390379796197
MOR/CPR,9903786,3.5279183844640305
MDA-MB-453,10296883,4.2989687155614735
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352
JHH-2,148124,-4.192242895506193
647V,135875424,4.107222785717565
MOLP-2,JQ-1-carboplatin (1-1 mol-mol),1.3158368386628676
EKVX,49836020,5.428301745137177
L-363,168313200,3.338476454499633
LCLC-97TM1,44493528,4.18527882332477
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
TOV-112D,135875424,3.733970966368142
A4/Fukuda,44491742,3.3943913096556444
NCI-N87,5460769,3.352422042402732
COV434,46943432,3.5633500403525447
ST486,148198,-7.753163237406848
L-428,9903786,1.2681458902985745
EHEB,12003241,-2.0597430880681062
SNB-75,selumetinib-GDC-0941 (4-1 mol-mol),0.9916175958844948
UO-31,26596,0.4742942530113579
PE/CA-PJ41 (clone D2),135875424,2.9357060771459245
JURL-MK1,6610216,3.8705017009241263
LC-1/sq-SF,JQ-1-carboplatin (1-1 mol-mol),2.338357576071754
CGTH-W-1,49836020,5.717814266829885
NCI-H650,135875424,4.813541263439062
OVCAR-8,148198,-5.019835125371004
HT-1080,168313200,2.6364388215014034
NU-DHL-1,6610216,3.849394820990355
LK-2,168313200,2.0373509363171283
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
Raji,6505803,2.919386850087895
SNU-245,44491742,4.301989616183203
NCI-H1869,10296883,4.447785026459559
LN-229,9936388,-1.4821904886179738
CAL-12T,439501,-3.605636550997873
A-673,439501,-3.092013019617277
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
NCI-H1623,148124,4.04127286799143
BC-3C,3689413,4.931170730107947
HL-60,6505803,0.5284927754579164
HuT 78,135875424,3.0458075465752694
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
LCLC-103H,148198,-1.3742012361346914
COV362,selumetinib-GDC-0941 (4-1 mol-mol),2.9953812620195066
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
SNU-C4,5460769,4.699419094889071
GI-1,135875424,4.168860245999812
LS513,3689413,-0.047571492296106
NCI-H1184,46943432,1.3653708283217592
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
KYSE-510,11485656,2.507694679939137
YKG-1,11485656,3.6397536658143865
SNU-601,148124,-5.099737761263376
CAS-1,6610216,4.732980040101764
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
G-361,107985,-3.212600988667039
NCI-H1694,44491742,4.026754305354829
HEC-251,9936388,-5.1528411757611465
U-251MG,36462,1.3694594348067
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
TT2609-C02,10296883,5.629000446872017
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
P12-Ichikawa,26596,-2.168612597742571
HDLM-2,12003241,-2.9289857152710344
BT 159,6610216,3.4275229189923864
HPAC,439501,-1.2049246371580666
A2780,10296883,3.5268945611299927
IGR-37,36462,1.327331458277256
Rh18,49836020,4.886485383707075
TE-8,9927531,4.6696791278322625
OAW28,148198,-3.8662210541116977
CML-T1,3689413,-2.671933251411637
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
A4/Fukuda,8515,2.244185004641864
T3M-10,54618164,3.850562433335668
NCI-H2286,135875424,2.580791603996685
AGS,135875424,4.083494996873591
769-P,135875424,4.650591407681101
HCC1195,9927531,5.131359962593503
SF539,135423438,0.8139499502196877
SF295,49836020,5.953375339581455
SW982,107985,-3.8739387991974303
Panc 04.03,36462,3.526332093717117
Aska-SS,135875424,5.860449274469886
U-937,JQ-1-carboplatin (1-1 mol-mol),3.049803202040864
Hep-G2,9936388,0.9252852669938214
HuT 78,8515,3.8606402282287657
NCI-H526,54618164,3.913888665030304
OV56,6610216,4.622532733616633
HCT 8,44491742,4.525976447408572
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
HCC4006,439501,-0.4255324495628316
NCI-H2023,6505803,-0.0935545329611447
A-172,44491742,3.879269865010821
SNU-182,135423438,0.1698643444011356
OCI-Ly3,9936388,-6.9188564775194035
T3M-10,9927531,5.241044178261577
BT 239,9936388,1.03619999927196
SNB-75,135423438,1.7474486526711988
SK-OV-3,36462,2.5052417836250496
BFTC-909,8515,4.73152093133166
GOS-3,10296883,4.354871301885758
LP-1,409805,3.155835706039454
TE-1,135875424,3.5778077934437658
TT,3689413,3.828584328493261
SU-DHL-1,439501,-2.3864560258185916
CAMA-1,54618164,4.317906672812886
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
NCI-H2170,107985,-2.7098434494469443
CAL-148,12003241,2.7249507328526015
NCI-H661,9903786,4.646166413465223
BV-173,3689413,-0.0500702145216063
NCI-H1734,439501,-2.4852115396408436
EoL-1,168313200,1.1681418802699055
SNU-216,54618164,4.432293411615551
SNU-761,409805,5.079172606794191
OS-RC-2,159324,5.727505196407322
Mono-Mac-1,9927531,4.461355065468675
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
G-292 clone A141B1,36462,2.8911125971985188
SK-N-BE(2),6610216,3.968848166238241
YD-10B,11485656,0.9298228362843758
HSC-2,44493528,4.3031885175258475
Panc 03.27,168313200,2.5506827880834075
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
BT 359,3689413,-0.0229882443129298
RT-4,6505803,-1.736360108528808
HDQ-P1,107985,-3.480538079364474
PF-382,44491742,5.368678247108403
OAW28,159324,2.7212056331712584
RT-112,8515,3.1628534284940866
JHOC-5,107985,-4.58395080292921
OE33,9903786,4.225835285233996
SUIT-2,9936388,2.2499280975506393
GSS,3689413,-0.0459197992618788
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
EFO-27,26596,4.577324640946523
ECC10,46943432,1.1549378530091958
COLO 684,11485656,1.9881024376461365
647V,26596,-2.3148144516989184
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
MOLP-8,168313200,3.062868142984741
OCI-Ly10,44491742,5.232515428740167
NUGC-3,36462,0.7786329645465295
HCC1428,JQ-1-carboplatin (1-1 mol-mol),1.63516660368819
CMK,44491742,6.009937952525146
WM983B,148124,-4.219347286004686
NCI-H211,107985,-4.531026670437544
SNU-1079,36462,1.5004158593347587
IGR-39,8515,5.35285474164026
COR-L51,11485656,1.4536828113034417
Becker,168313200,3.791120418398256
Granta-519,6505803,0.3707466177802866
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
TOV-112D,6610216,4.406532142355373
HSC-3,9903786,2.4966748748730025
G-402,54618164,3.969442190636606
GSS,8515,3.1387042874632396
IGR-39,12003241,-1.2962824425712205
T-47D,148198,-5.010352606662764
MEC-1,6505803,0.1083566885748684
KMS-21-BM,409805,3.562482933732855
NCI-H2106,54618164,3.710847397109672
WM115,24180125,3.7433275341391057
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
BT 172,54618164,4.156516720158305
PE/CA-PJ41 (clone D2),148198,-3.3597343554635652
VMRC-RCW,159324,3.6824970215019697
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
ChaGo-K-1,JQ-1-carboplatin (1-1 mol-mol),3.068818553236091
COLO 680N,selumetinib-GDC-0941 (4-1 mol-mol),2.523373252620712
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
PE/CA-PJ41 (clone D2),44493528,4.345645378925518
Calu-6,159324,1.441030904225
MOLP-8,135423438,1.7176055832456645
KP-2,selumetinib-GDC-0941 (4-1 mol-mol),0.2413129500799869
SK-CO-1,6610216,4.838209270425191
SBC-5,135875424,3.947045576812926
M-07e,9903786,0.8629482504426611
CMK,6505803,0.4799814546857159
OCI-M1,168313200,2.930152484546089
CCF-STTG1,148198,-4.129311374884182
MHH-CALL-4,46943432,0.4587577146987904
BxPC-3,9903786,2.126136875029704
NCI-H810,44493528,3.9330833724433294
BT 179,148198,-4.821830179812891
RPMI-8402,JQ-1-carboplatin (1-1 mol-mol),0.3952055511625851
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
TUHR10TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.6041094312427258
NCI-H1755,107985,-3.833306991653346
NU-DUL-1,5460769,0.0650786105857349
SNU-398,36462,3.0177530100723575
Ci-1,3689413,-2.5186366363641293
RPMI-6666,12003241,-3.2897330659592705
G-361,135398744,6.4148171061967645
TE-8,3689413,-1.695063922582594
SCC-25,44493528,4.171746510853467
MOLT-3,46943432,1.2471285566558974
NH-6,3689413,-2.319645843981955
NCI-H2009,36462,0.0033291412741449
KE-39,6610216,4.077734835238396
RD,26596,-1.141843302094684
SNU-503,107985,-1.4472392237999567
Rh30,107985,-3.1857089602300563
SYO-1,107985,-3.867738791331657
NCI-H650,12003241,-0.6460655528270789
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
RERF-LC-MS,6505803,-0.6931241555509828
NCI-H1373,9936388,2.083574695365507
P12-Ichikawa,44491742,4.234271740927445
SUP-B15,49836020,5.289684304949365
NCI-H1385,6610216,3.477667677691411
NCI-H292,12003241,-1.027467238096921
TE-6,9927531,3.995869764794834
A-549,8515,3.6622074868184464
REC-1,9936388,3.0128299108104306
KMS-28BM,44491742,3.645458914971546
Tm87-16,12003241,-0.0978800802816917
NCC-StC-K140,168313200,1.6105934418436303
SNU-387,9927531,5.201038765097566
SNU-410,3689413,1.1161257107979303
NCI-H2126,159324,3.545755917138017
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
MOLM-13,44491742,3.7695621371445975
MOLP-8,135398744,7.476327693514706
Rh41,44491742,3.4583513797459537
Hs 294T,6505803,0.4155965097555305
Ku812,148198,-4.150507844489635
RCH-ACV,8515,3.0347140209850973
CJM [Human melanoma],6505803,0.8455714648191155
MHH-NB-11,9936388,-5.109130573397568
MDA-MB-361,3689413,-1.8803084883549792
NCI-H292,3689413,1.7536313837601494
Peer,8515,2.413065162773513
CCK-81,44493528,2.4329753489883106
NCI-H1869,9903786,3.8309501172404734
SNU-5,107985,-4.4289140812757335
PSN1,44493528,4.302980688159976
SNU-626,9936388,2.473476131438239
DMS 53,10296883,3.680097664762246
CAMA-1,159324,3.8065405896449263
NCI-H1395,36462,4.192459813965937
NCI-H1693,11485656,1.8796712280136327
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
HuG1-N,439501,-1.480081510168686
SNU-489,3689413,0.2649172011332545
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
ES-2,439501,-2.264854435064497
A-375,11485656,2.720000014361131
CML-T1,36462,-1.7431711247812498
HCC1954,9936388,-7.1027886366654585
MKN7,3689413,-1.1623045029840038
SEM,168313200,1.52373638401344
U2OS,36462,0.572466421403533
MKN74,36462,3.612647213890312
GA-10,44491742,3.5610264108230365
HCC4006,409805,5.92416136943095
T24,6610216,4.48789546353662
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
HT-144,24180125,3.3475527139348524
BT 159,439501,-3.0773792715975685
SK-MEL-24,44491742,3.9511074387326337
IPC-298,107985,-3.141608665259132
647V,49836020,-1.4541135312501283
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477
LoVo,3689413,-0.0015328635235731
HCC1806,36462,2.6029103476346407
HCC827,5460769,2.7975928374001104
SK-N-MC,26596,-3.660625750775288
MOLP-8,135875424,3.0291075959050233
SNU-C5,135423438,1.6231432447945644
SKM-1,409805,3.7093603817382337
Hs 766T,6505803,-1.244402871615241
NCI-H1793,168313200,1.7961344835426234
SK-MES-1,54618164,3.771541214581354
OV-90,selumetinib-GDC-0941 (4-1 mol-mol),0.0279948147357564
NCI-H1693,9936388,1.0326729048127057
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
COV362,6610216,4.265894841411048
MDA-MB-361,107985,-3.5291292054176444
Ishikawa (Heraklio) 02 ER-,409805,6.059507379777802
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
TF-1,54618164,3.846409776212563
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
Ku812,135875424,4.708872885868404
NCI-H69,439501,-2.497311288560019
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
HPAC,36462,3.2094999713867103
SW948,148198,-4.802987893737634
SNU-886,6610216,4.570931249301276
SNU-16,439501,-4.306216522257499
SH-4,135423438,4.390344914590639
MKN1,3689413,-2.0686117581954537
DoHH2,3689413,-5.86508857802515
DU145,148124,-5.577110103227381
SNU-387,36462,3.501298082679132
SUP-T1,44493528,4.4942343110915655
LOX-IMVI,6505803,-1.7860593354464098
Rh41,8515,3.268186159654955
U-BLC1,107985,-3.242236083428716
U-118MG,439501,-2.7971615553970675
MPP 89,107985,-3.4631963812311892
MDA-MB-157,12003241,-1.4339892472843776
KYSE-150,439501,-2.052967446367251
Panc 02.03,6505803,-1.93196111296706
Kuramochi,36462,5.154140048373422
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
HEC-1-A,44491742,4.152626069309694
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
NCI-H2444,9927531,4.993346804303282
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
OE19,5460769,4.447133624333207
SNU-387,6505803,0.0715059334590081
RCC10RGB,6610216,4.531223922644925
FaDu,24180125,2.984010742515135
TE-6,135875424,3.6628772269399192
TE-1,24180125,3.0230127528664825
KYSE-450,135875424,4.8684130020868235
WM88,8515,4.23444504306986
NCI-H1915,10296883,3.8603336548286498
NCI-H2196,439501,-1.9043844138508108
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
TE 617.T,26596,-3.5782456619220246
TE-8,9903786,2.2578315560817432
Detroit 562,107985,-3.6999488288767313
LOU-NH91,439501,-1.197324809082114
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
BHT-101,3689413,0.1910629182476014
A-673,168313200,1.7801049656035806
SK-N-BE(2),44491742,3.960613770840922
HPAC,107985,-3.4399957064086677
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
Pfeiffer,3689413,-4.622184503253435
U-CH1,3689413,0.3133886953072482
UO-31,148124,-2.8322592718949178
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
IGR-39,168313200,3.552497438283597
RKN,44493528,4.408823872302737
MPP 89,26596,0.6612538021834572
5637,159324,1.920461519181454
NCI-H1155,JQ-1-carboplatin (1-1 mol-mol),0.0214289604046408
ONCO-DG-1,409805,5.221820983759216
Tm87-16,439501,-3.529895077478111
SF268,148198,-4.335293772909402
HD-MY-Z,148124,0.7380672872848864
MM1.S,9936388,-7.097218801181761
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
SNU-308,11485656,2.7823829895443657
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
253J,148198,-1.8697055950254904
NH-6,11485656,1.6969072995394532
DV-90,148124,-8.414781683507076
TCC-Pan2,3689413,-0.1350455546392483
SUIT-2,11485656,3.4408604141627763
NCI-H2126,9936388,-6.844961041738704
HEL,6505803,1.212867497705534
HT,3689413,-1.9551613931391472
KM12,selumetinib-GDC-0941 (4-1 mol-mol),1.4045070472454428
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
MKN74,44491742,4.321441779997771
NCI-H508,3689413,-2.320337530403156
OAW28,3689413,-1.4375749125930504
CAL-27,6505803,-0.9389361210216336
NCI-H1299,107985,-2.368506308925934
SNU-601,11485656,1.403357522956854
Caki-1,6610216,4.408834249020041
SK-N-MC,10296883,3.751405483484442
SNG-M,168313200,3.9899004151093416
NCI-H1355,159324,2.5006062648801413
MFE-296,24180125,3.541536211927579
MKN45,409805,6.427379029102213
EoL-1,10296883,0.2540444549811657
FU-OV-1,11485656,3.4521578130267336
SK-N-AS,49836020,4.951261339623108
DLD-1,9936388,-0.5378287493970375
Hep-G2,6610216,4.162282260552703
A-549,439501,-2.483005959928592
T24,44491742,4.439042191378119
MKN74,3689413,0.9993219534405752
TUHR10TKB,6610216,4.052125763672336
SNU-1033,6610216,4.08331616990365
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
639V,54618164,4.34294153821181
RS4;11,JQ-1-carboplatin (1-1 mol-mol),-0.1933675643740757
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
JVM-3,selumetinib-GDC-0941 (4-1 mol-mol),1.8327445847214063
LNCaP clone FGC,11485656,1.8681426570872277
HCC44,9936388,-7.032744443363015
SNU-1066,5460769,2.0075693464583817
LN-229,12003241,-0.983315383516156
IGR-37,44491742,4.84582247034579
KMH-2,9936388,-5.258192279265897
KYSE-180,6505803,-2.0087833017185264
SNU-5,3689413,0.3799296763624849
GI-1,24180125,3.248267375077655
NCI-H23,148198,-4.855451387960017
SNU-81,54618164,-0.3986435357924686
TE-15,12003241,-1.6215722433150963
SR,148198,-2.916135396785668
T3M-10,44493528,6.393646010300226
RD,36462,3.5531092488775213
NCI-H2452,3689413,1.184555113675537
PC-3,9927531,5.366538449676758
HLF,135875424,3.96007520843582
PK-45H,409805,3.737662637005359
KP-4,12003241,-0.2003950722684058
HEL,26596,-1.8679385890512872
M-07e,12003241,-1.0456216878354962
BCP-1,9936388,-5.382514367449052
DMS 114,9903786,5.060139909585821
NCI-H524,148198,-1.189369331000223
HCC1500,10296883,3.843895309810077
DoHH2,5460769,1.245270036002789
HCC366,439501,-0.4382794174763856
KP-N-SI9s,12003241,-1.3670670210068214
SK-LU-1,107985,-3.118655364766745
LK-2,148198,-4.1754104163119505
WSU-DLCL2,5460769,0.924781789272552
HCT 8,5460769,4.645297134954857
KE-39,54639024,4.382341904180532
J82,409805,5.742622843413684
U-118MG,5460769,3.4252823056372845
Hs 746.T,9903786,3.9786506562957857
NCI-H1703,6505803,-4.731386050574026
SCaBER,439501,-1.925365534311937
MHH-CALL-3,9903786,1.8198372830428096
CCK-81,439501,-0.4641982207624705
YD-10B,9936388,-5.330714776422858
SNU-1066,107985,-3.742344355961893
MDA-MB-453,46943432,1.9398007817238585
PL-21,6505803,-0.5329499578695445
MV4-11,JQ-1-carboplatin (1-1 mol-mol),-1.9845172656852084
NCI-H2170,6610216,4.450913676710835
NCI-H211,54618164,3.4322787963353747
OVSAHO,9936388,2.2943852117568944
NCI-H841,135875424,3.023154313740163
697,9927531,2.816043229727806
Rh18,12003241,-2.237967131461188
NCI-H1650,6505803,-1.2537158640702348
Hs 746.T,135875424,4.375354252450309
NCI-H2110,54618164,3.868151773731383
HCC1954,107985,-2.6910396839606743
RD,44491742,4.422595956491757
SW1353,5460769,4.513460705614206
NCC-StC-K140,9927531,5.259562635251384
NCI-H2106,159324,1.7207732882351374
IGR-1,10296883,3.2349676961668083
786-O,10296883,4.604694854621938
SK-HEP-1,54618164,4.274964046269975
OV56,5460769,1.208348663787762
OVISE,3689413,-2.3316050545360136
JK-1,9936388,-6.833225644440661
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
TE-14,5460769,2.4898485363417917
EJM,36462,0.7713020046102423
697,12003241,-3.737782369602395
ChaGo-K-1,135423438,3.972168514727344
TT2609-C02,36462,0.8008481405878352
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
OVISE,36462,4.611657944155446
BT 416,26596,-1.7367305778393065
OCI-AML-2,5460769,1.9036049524164391
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
769-P,54618164,4.26283597987166
SNU-886,3689413,-0.3695618539773043
NCI-H661,11485656,2.0326011859644075
SCC-4,409805,6.015616083217262
HCC38,54618164,4.35878231787182
NCI-H1651,9936388,-1.76189250621897
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
Hs 822.T,439501,-2.4556830232378712
CW-2,168313200,2.811372219498715
A3/Kawakami,12003241,0.0304416634107028
L3.3,5460769,1.7814582708772182
NCI-H1155,5460769,2.4022459790155413
SNU-423,6505803,0.7785757061169877
NCI-H2286,12003241,-2.840007028807547
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
TC-71,5460769,1.4458290097671247
OCUM-1,159324,3.056322890666483
NCI-H1355,11485656,1.9876880567524768
F-36P,439501,-3.1981830153040223
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
MKN7,9927531,4.538796074024755
Ku812,3689413,-1.935767376067546
TE 441.T,9936388,-8.412031296278057
HCC1954,439501,-2.308794181663851
FaDu,439501,-1.5866164776842138
PK-1,409805,3.919077042185541
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
ECC12,148198,-2.5550218392093624
DB,49836020,4.238014398783195
NCC-StC-K140,26596,-2.208339007847408
KYSE-520,9936388,1.4275069153979305
HGC-27,107985,-4.025909310335491
786-O,11485656,3.3310875403182423
Hs 895.T,9927531,5.651415148698969
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
SNU-738,9936388,-4.72034190751593
NCI-H2009,12003241,-1.6852069192913937
GDM-1,159324,-0.8409478858181092
KMS-11,3689413,-0.1519254071205927
JVM-2,9903786,-0.0734034903257133
COR-L47,36462,2.2585051399915934
J82,36462,1.6839056752253356
GOS-3,26596,5.630360863540023
HT,54618164,3.74446726264799
NCI-H292,5460769,0.0770188109309223
SK-MEL-2,107985,-2.782254692074657
LS123,107985,-4.283414364428649
Ci-1,6610216,5.011861477554625
PSN1,107985,-4.750149714277217
TE-11,JQ-1-carboplatin (1-1 mol-mol),3.4932129749903984
SW579,6505803,-3.37113602004837
F-36P,46943432,1.5782924322919043
TUHR4TKB,6610216,4.683546527875489
SNU-407,6610216,3.823355426817763
KNS-81,49836020,5.788020143086265
HCC2935,6505803,-3.078757042045483
SKM-1,46943432,0.4553858331231263
NCI-H522,6610216,4.154510920860766
NCI-H460,168313200,3.91056508525232
HCC1954,6610216,4.626340773067161
GMS-10,10296883,4.265684683390355
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
KM12,3689413,0.1387513220516042
U-CH1,409805,5.934012749257741
FaDu,54618164,4.2886892470468965
KYSE-150,168313200,3.874457481179803
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
BHY,3689413,1.273700268174745
KP-2,9936388,2.471423235540368
MEC-1,JQ-1-carboplatin (1-1 mol-mol),-0.5603049112570107
KM12,11485656,1.3721990605630514
SNU-869,12003241,1.357086277670327
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
UO-31,168313200,1.7728778067687565
NCI-H1651,54618164,4.3359415778445625
BT 333,409805,5.361000728406263
MPP 89,6505803,-0.6536237493754191
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
HT-1197,3689413,0.4105522735593818
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
LS411N,159324,3.2133975478450005
YH-13,3689413,-1.970237829798131
NCI-H1944,439501,-2.342776450648639
BT 131,36462,2.7060964215405043
639V,8515,4.442840674475755
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
SUP-T11,26596,-3.766256771827544
DEL,36462,-1.0094557701318494
BT 159,12003241,-1.7931625060077818
HCC1419,9936388,1.8369004896717465
A-375,5460769,3.311565919469283
WM88,409805,5.795816552441705
KYSE-150,selumetinib-GDC-0941 (4-1 mol-mol),2.603924706865474
GSS,26596,-1.5813697443428234
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
LCLC-97TM1,44491742,4.237702230509644
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
TE-10,6610216,4.592417655041801
IPC-298,54618164,4.245603036980359
JHH-2,9936388,-4.808151862711936
SNU-16,36462,0.5669347604291369
KMS-18,12003241,-1.9143210957947092
COV644,44491742,4.3354697105959055
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
HDLM-2,409805,3.613104828003659
NCI-H1299,409805,5.9960995888447925
SCC-9,168313200,4.072126418899639
WM266-4,6505803,-3.5137777685434384
NCI-H441,9936388,1.8164232394185744
CAL-33,44491742,3.945687581773722
NCI-H520,3689413,0.9100551461140616
MKN74,54618164,4.583505133133128
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
Panc 04.03,10296883,4.422301293811254
NUGC-4,439501,-0.6746997916086527
KALS-1,24180125,2.594623206570859
MHH-CALL-3,5460769,1.3871224464271157
TE-11,11485656,1.7659776894381034
HCC202,10296883,4.070733059674107
ZR-75-1,3689413,2.979171486892431
OE19,24180125,1.1253497268177255
JeKo-1,JQ-1-carboplatin (1-1 mol-mol),1.2993795236120171
SNU-387,3689413,-0.310852459101112
TCC-Pan2,selumetinib-GDC-0941 (4-1 mol-mol),0.1470991216405226
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
Hs 578T,409805,3.1145560968207806
DB,12003241,-2.5818700415802107
BT 239,168313200,1.5980864637494772
SW1271,8515,5.208985199998064
HEC-59,159324,3.11725748747758
NCI-H1395,3689413,-2.5246792207692073
HCC2279,36462,3.4584261364752544
IGR-37,107985,-4.09870344472461
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
HCC1588,409805,5.920497547047897
Hs 683,10296883,3.967060059444981
BT 145,5460769,1.52442130287449
JHOS-2,168313200,3.8439706585595017
Hep-G2,11485656,-0.7210069253709863
EPLC-272H,6610216,4.686916170256582
MOLP-2,135423438,1.6947558908608933
FU-OV-1,9903786,2.8592788804010936
GSS,46943432,0.9758869456663198
NCI-H520,9936388,-7.179601192363118
A-375,44493528,5.0092859091998205
JHOC-5,159324,2.904340852422458
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
SF539,8515,4.265018963639613
BT 482,3689413,0.1224003168777627
GI-1,36462,2.374062012412674
BT 147,6505803,-5.108349885338799
NUGC-4,12003241,-1.4802161759010128
SNG-M,6610216,4.501978621447079
NCI-H1339,36462,1.5499539192290197
NCI-H2029,10296883,4.228313124120171
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
SNU-620,148198,-2.4774771616722573
NCI-H1666,selumetinib-GDC-0941 (4-1 mol-mol),-1.4234011879049815
IA-LM,168313200,3.804941602819176
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
Mono-Mac-6,409805,4.403577666381438
PaTu 8988s,10296883,3.673245902839484
OCI-AML-2,8515,1.7413193486313066
BT 248,24180125,1.9773901044414168
SNU-C5,9903786,3.1730161972997517
BT 333,107985,-1.308331021854272
SUP-T1,9936388,-4.413014724970872
ES-2,JQ-1-carboplatin (1-1 mol-mol),4.854592360478168
RERF-LC-MS,44491742,4.380479941679622
SK-LMS-1,11485656,3.417878040932413
Karpas-620,3689413,-2.001578563648977
K-562,36462,1.3855340321895664
MeWo,6505803,3.0730315194784947
Panc 10.05,9927531,5.445272240057394
HD-MY-Z,6505803,-1.982363986131319
NCI-H358,107985,-4.0587779380967515
HCC1395,439501,-2.37120422712219
LCLC-97TM1,159324,3.194316902825419
Detroit 562,439501,-2.3410897293820003
786-O,9903786,3.782252181935989
DMS 53,selumetinib-GDC-0941 (4-1 mol-mol),1.3170486781657051
B-CPAP,159324,2.672075580393903
Caki-2,12003241,-1.799336945217181
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
NCI-H1105,selumetinib-GDC-0941 (4-1 mol-mol),2.7215813635503165
DMS 273,439501,-3.5888564067388633
BT 271,107985,-1.88483870994594
OCI-Ly3,8515,4.021036490140995
SCC-9,409805,5.497565328609373
CAL-27,36462,0.179567917898061
KMS-18,44491742,4.313842675965846
A-549,107985,-1.903643524605076
Hs 611.T,10296883,2.1070249605904574
SNU-478,54639024,4.476897438688029
PC-14,26596,-1.584314299248499
NCI-H2030,36462,2.530734561122129
BT 239,JQ-1-carboplatin (1-1 mol-mol),2.368101123229976
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
U-937,3689413,0.9938277330138956
NH-6,JQ-1-carboplatin (1-1 mol-mol),3.51966216446804
KE-39,159324,3.584614004631027
BT 286,9927531,5.383522650777723
JHUEM-3,409805,6.053062138585062
Lu-65,168313200,3.8994737452267945
PE/CA-PJ15,11485656,1.9220584297940355
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
NCI-H522,3689413,-4.273368850016072
23132/87,44491742,4.505625737535984
LCLC-97TM1,26596,-2.266692800551727
BICR 16,135875424,5.068625182385868
SW1353,36462,4.974473156128621
TTC-709,439501,-6.296451607950602
SK-N-FI,selumetinib-GDC-0941 (4-1 mol-mol),0.5932957788770222
Kuramochi,24180125,2.543134458262697
JMSU-1,44491742,4.046305015990271
A-673,26596,-3.820628112159822
HEL,24180125,3.3188099636510495
G-402,3689413,-2.398883611420732
BT 231,148124,-6.361454610291721
SCC-9,36462,2.4622585602605493
NCI-H1355,44491742,3.8267579721093905
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
SYO-1,3689413,0.2165411688819273
786-O,44493528,4.535672196429034
MOLT-3,26596,-3.757190091597864
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
Ki-JK,409805,3.598242312387121
BICR 56,6610216,5.354149970854336
GSU,11485656,2.5421521977711135
COLO 684,9903786,4.137443964220156
NCI-H1155,409805,6.377387432346561
IA-LM,10296883,4.25848729020474
BFTC-909,9927531,5.31835549136936
SF539,148124,-5.79726265481526
Lu-99,5460769,-0.1107532404571854
NCI-H889,JQ-1-carboplatin (1-1 mol-mol),5.709235070199913
SW1463,11485656,1.9271812519349985
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
NCI-H520,73707440,4.350001287035215
Mel Ho,5460769,6.181973204258103
DAN-G,5460769,3.6980093078585594
DU145,11485656,2.5427151524786993
SET-2,36462,0.7834835963268753
SF268,9936388,0.7736528995107874
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
A-549,9903786,1.8644448309659765
SW1353,24180125,2.9527880744197708
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
DMS 114,135875424,2.926439690209593
NCI-H446,36462,2.3080332043222587
MCAS,49836020,4.94613909678053
NCI-H2106,409805,4.639383577875326
BT 179,26596,-0.8233770737136159
HT-144,selumetinib-GDC-0941 (4-1 mol-mol),0.3357004293629391
HEY A8,9936388,2.7984735931283153
A2780,6505803,-1.803583295606165
CAL-78,6505803,-0.7223654000652794
KMS-21-BM,9877608,6.031837359251096
KMS-26,3689413,-5.054030253725733
SNU-C4,3689413,0.8564713625003593
COLO 699,36462,3.424891097483833
YKG-1,148124,-3.4477323343219637
KNS-62,409805,6.135262881771345
UACC-62,9936388,3.097569174421774
T98G,6505803,0.2412993690877728
NCI-H2110,6505803,-2.3425437188382587
KCL-22,selumetinib-GDC-0941 (4-1 mol-mol),1.6879768271667388
SNU-466,54618164,3.7908148329760585
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
SF295,5460769,2.0646753609737125
JeKo-1,10296883,3.632586939598192
MKN74,36462,3.612647213890312
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
OVCAR-4,6505803,2.147472746643062
SNU-869,8515,5.009412536897277
PE/CA-PJ49,148124,-8.481770349273331
KNS-42,439501,-0.277437282797495
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
NCI-H526,159324,2.2515086440464676
HD-MY-Z,135875424,4.008559842592383
TT,6505803,-1.545669685670545
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
BDCM,selumetinib-GDC-0941 (4-1 mol-mol),0.2374601063606183
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
U-CH1,6505803,-2.0509718148007408
NCI-H1869,107985,-2.86385536497776
NCI-H1563,11485656,2.498309340246036
NCI-H2081,135875424,3.067653141346589
BT-549,36462,2.0708174288882075
WM115,168313200,2.1363369230808593
TE-4,107985,-2.609556719332766
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
SNU-620,135875424,4.164173792833431
Rh41,148198,-4.585289739604842
Granta-519,9927531,4.885085469625254
DMS 454,6610216,3.227176343293299
BT 330,168313200,1.8051222028456737
SUP-B15,148198,-7.712554258926361
Yamato-SS,selumetinib-GDC-0941 (4-1 mol-mol),-1.5672740621691217
SNU-466,107985,-2.7437947575387196
DB,6610216,3.677102937964002
SW1710,148198,-2.170250492388752
2004,439501,-3.526370090236184
Rh18,JQ-1-carboplatin (1-1 mol-mol),2.2033827405363087
GaMG,10296883,3.750929990698749
COLO 800,6610216,4.2049381477581
LOX-IMVI,11485656,1.9351920109561
NCI-H2023,3689413,4.096769539099316
TOV-112D,6505803,2.1658799335254644
NCI-H1435,selumetinib-GDC-0941 (4-1 mol-mol),1.0023239879000474
Rh41,409805,3.496757496558559
Caov-3,9936388,-6.651302664748808
G-292 clone A141B1,135875424,3.061063292473857
DMS 273,6610216,4.172124776089646
OCI-Ly19,24180125,3.0993607004682007
LS411N,11485656,1.6093796612349578
HCC1428,9936388,2.06453548249226
HOP-62,168313200,1.5949515806080656
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
Kelly,3689413,-0.2906048821836837
KYSE-410,135875424,4.192963545953549
Kelly,11485656,1.664007289934324
LCLC-103H,12003241,-0.4608233539243975
SNU-449,11485656,3.58452534173841
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
SCaBER,JQ-1-carboplatin (1-1 mol-mol),1.2535925980177334
DOV13,148198,-3.763867663702191
G-401,148198,-4.717755806624399
Panc 04.03,9927531,5.313421559596226
HT-29,135875424,4.223622397781982
JL-1,135875424,5.193306419898844
GB-1,11485656,2.586323751918647
LCLC-97TM1,5460769,-2.8089441547625067
DU145,3689413,-1.3535401671184424
NCI-H2172,11485656,2.8163630892876212
HEL 92.1.7,148124,-2.207552768043412
NCI-H146,148198,-5.323171419653744
SK-N-DZ,439501,-4.085743704417651
LNCaP clone FGC,26596,-2.187376252798695
SNU-489,9903786,5.534401948294785
HCC1937,135875424,4.325388188219658
CAL-12T,36462,3.3360581602750647
HT-1376,9936388,2.4935299933788957
LK-2,44491742,3.8692951916642353
PC-3,135875424,4.657200452224415
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
NCI-H1734,5460769,-3.3513439751679983
AGS,24180125,3.82406888235565
KALS-1,107985,-2.955854025233171
DLD-1,6610216,5.046668272670703
MV4-11,159324,-2.593859532565249
IMR-32,JQ-1-carboplatin (1-1 mol-mol),0.0356823782644729
RVH-421,10296883,3.51018214130791
KMS-34,9927531,3.5487000216351277
Mel JuSo,10296883,4.305095904574399
HDLM-2,6505803,-0.3959336559510797
UM-UC-3,159324,3.5386000070846992
KMS-26,9936388,-7.293063549205381
MKN74,5460769,3.534639533895065
BT 330,10296883,4.249787142782667
SUIT-2,9936388,2.2499280975506393
BT 139,10296883,4.347610797549644
U-118MG,11485656,3.079828371250999
LP-1,26596,-1.5638632087078823
NCI-H2087,439501,-1.341118756842812
U-251MG,135875424,2.6316918837604613
KATO III,6610216,4.590153428005395
KE-39,9936388,1.1689372039333712
Hs 683,6610216,4.167851340670154
Granta-519,148198,-4.763660659469611
NCI-H522,11485656,1.866098793785005
DU4475,9903786,2.594571624962549
JJN-3,148124,-5.493027063423673
SNU-899,107985,-2.968304260034228
SU-DHL-8,24180125,1.326767036294653
SNU-16,6610216,3.5792098675105075
SK-N-AS,26596,-3.589406361417691
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
HEC-1-B,24180125,3.5721659894435556
GSS,135875424,3.760188013536636
NCI-H661,135875424,2.4725937826628006
G-401,9903786,2.8038927126182327
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
OCI-Ly10,JQ-1-carboplatin (1-1 mol-mol),0.3162452949317643
CAL-85-1,3689413,-0.0998650254858705
NCI-H520,12003241,-2.710304641181941
MES-SA,168313200,-2.8250067617566836
SNU-16,46943432,1.3599248800373205
JMSU-1,135875424,3.6629437314109703
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
MDA-MB-453,26596,-1.0726693130426117
COLO 668,6505803,-1.9386091565051409
SaOS-2,9927531,5.410264314347966
SW1573,24180125,4.83914798243841
BT 340,9927531,6.379921104021661
HT,6610216,4.522772185536218
DB,44493528,3.818238435779709
HEC-151,107985,-5.149498087919081
EM-2,JQ-1-carboplatin (1-1 mol-mol),-1.2961188335461022
NCI-H1623,9903786,3.0418604220511436
OCI-AML-3,6505803,-0.781782964907092
TE 617.T,9903786,3.301651498076641
Capan-2,9936388,2.515101489111694
ChaGo-K-1,6505803,0.7391022920837463
NCI-H810,6505803,1.3479141255635732
LMSU,44491742,4.063120482610564
KMS-11,159324,0.4321441091396028
HMC-1-8,148198,-2.948355719333101
Fu97,11485656,0.7885414844371695
HD-MY-Z,44491742,3.754375539988437
MCF-7,3689413,0.894647662863142
NCI-H1792,9903786,2.6645651408291227
8305C,5460769,5.099577444912903
TF-1,135875424,3.0732861246211005
SNU-503,JQ-1-carboplatin (1-1 mol-mol),0.9047504626214904
BT 271,3689413,-0.1683301005825848
KYSE-180,54618164,4.682866725736199
KYSE-140,409805,5.981415467159753
TALL-1 [Human adult T-ALL],3689413,-2.1948693605087577
769-P,36462,4.933051347758078
BFTC-909,6505803,-2.7076869289136147
EoL-1,439501,-3.7702491221703145
P31/FUJ,49836020,4.674155414221834
GA-10,6505803,-0.6934451176376895
42-MG-BA,36462,2.13247023966883
Hs 895.T,107985,-2.292353641464491
BT 330,107985,-2.041993977074398
HCT 8,10296883,4.100696094904368
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
JHOM-1,107985,-3.070831769435884
SK-BR-3,24180125,2.453332615132994
NCI-H1734,54618164,3.6379129162989807
TYK-nu,6610216,3.505675319704899
HSC-2,148198,-4.582461911697906
COR-L51,9927531,4.484495617917877
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
LN-229,9927531,7.375456166440614
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
KYSE-70,11485656,2.2230455690794404
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
TCCSUP,44493528,4.420877523389051
MOLM-13,9927531,3.44947203831576
NCI-H647,135875424,4.395312958272854
EM-2,9903786,1.526711348749508
HT-1376,6505803,-1.649820321739373
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
CAL-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.559817490656083
SW948,24180125,1.460789729891403
G-402,9903786,2.6546356785146084
T-47D,5460769,6.397053715460356
DV-90,148198,-5.605719832518081
MeWo,148198,-4.218734376362087
HeLa,26596,-2.0330393314508868
Hs 888.T,168313200,1.7807079224736295
KM12,26596,0.910782273652732
CAL-29,36462,1.6491569604201617
SUP-HD1,JQ-1-carboplatin (1-1 mol-mol),1.2897139290826176
BT-16,JQ-1-carboplatin (1-1 mol-mol),4.438873165062089
SNG-M,9936388,-6.347266548904431
Lu-65,6610216,3.857091251569688
JHH-6,107985,-2.694167531262161
L-428,8515,4.11039212024018
KMS-21-BM,46943432,-0.8221930725706761
SU-DHL-1,44493528,3.922242735424854
Hs 729.T,439501,-2.5302940667967695
DB,148198,-4.69635746988682
RMG-I,159324,2.9156763368001477
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978
WSU-DLCL2,148198,-3.6374417896025513
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
Sq-1,439501,0.4738250943054584
NCI-H2085,135875424,2.7505706963719243
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
OAW28,5460769,4.044755256654475
OVCAR-8,49836020,4.475611867400311
Pfeiffer,135875424,2.9223731979657206
RPMI-7951,36462,0.7881901219926554
SW1990,10296883,4.2503704087411025
KE-97,6505803,-0.1313893221516437
NCI-H1793,9927531,3.368036257397712
CAL-27,12003241,-1.271388336497811
KYSE-520,5460769,2.8497133103495713
TE-6,6505803,-2.104083305056956
SW48,6505803,-3.5264924347891897
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
ST486,44491742,3.1941323124879393
FTC-238,107985,-3.0403846548585336
COLO 201,10296883,3.948039741906064
AN3-CA,24180125,3.116324501416526
NCI-H2170,9936388,-3.7757464775618104
MEC-1,36462,-0.6422980977317088
SCC-4,46943432,2.425809878502144
EC-GI-10,8515,2.8034116636933137
HCC1195,36462,3.037174861907391
MKN74,3689413,0.9993219534405752
SNU-175,439501,-1.724461019506839
SNU-878,11485656,1.7316943988807143
OV7,11485656,2.0479156787278257
HT-1376,49836020,5.287165459832521
HCC2218,439501,-2.1463275405716495
Panc 02.03,148198,-4.053337817942692
Jurkat,JQ-1-carboplatin (1-1 mol-mol),0.5557917412854158
HCC1428,409805,3.849465032491537
Lu-65,9903786,2.0553359532496875
KNS-60,135423438,1.647918923583617
NCI-H520,24180125,2.1608136415253334
GCT,JQ-1-carboplatin (1-1 mol-mol),4.70217217207532
OVCAR-4,439501,-2.2754472098367855
NCI-H747,148198,-4.03542032091069
KE-37,73707440,6.056087509809561
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
HCC2935,11485656,3.30580870934939
OCUM-1,9936388,0.7309150474030258
HEC-59,135875424,3.434837292372321
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
KYSE-150,6505803,-1.1236376275824325
SNU-423,135875424,3.328445896940313
HT115,8515,3.1218327177521563
SNU-16,44491742,2.438228727906927
SNU-1272,3689413,0.1489687776606243
JHUEM-7,46943432,1.400588495445252
MOTN-1,168313200,1.7556194121014388
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
SW1271,11485656,2.5257448561020053
HT-29,selumetinib-GDC-0941 (4-1 mol-mol),2.4520768151927976
HEC-6,JQ-1-carboplatin (1-1 mol-mol),1.897969075910313
WM1799,148198,-2.113504584612542
Rh41,49836020,4.456584836146854
TE-4,439501,-1.5576935303532289
Lu-65,5460769,3.7972822070130494
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
GDM-1,135875424,3.346620494935451
Kuramochi,selumetinib-GDC-0941 (4-1 mol-mol),1.9620820620986936
KYSE-150,54618164,4.276823128617318
CHP-126,168313200,3.8336822443812686
YH-13,439501,-2.216859157731525
RVH-421,44493528,5.192740669556376
SW1710,36462,2.141494652685398
NCI-H1666,8515,2.2563145228126578
MM1.S,36462,-0.6145210813224762
NCI-H2087,168313200,1.7599184921468192
ZR-75-30,9927531,5.796828878545894
IGR-37,24180125,4.183476947530839
Ki-JK,6610216,3.665629915437924
NCI-N87,24180125,2.059368273959215
SU-DHL-10,24180125,2.65939444404047
Ki-JK,9903786,1.8002187553993072
NCI-H526,26596,-1.5534394961181943
SUP-T11,36462,-0.1109472671926892
Hs 683,9927531,5.316569157291169
NCI-H889,24180125,3.2522529388237804
AM-38,409805,-6.133052721162316
TE-14,11485656,2.3244152057135934
NCI-H1838,159324,3.097235526410686
HCC1954,5460769,3.202561874283659
A2058,46943432,5.180107767391253
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
SK-N-FI,54618164,3.861588841514918
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
HEC-1-A,409805,5.215124771693611
OVTOKO,8515,3.900067758648506
SNU-61,3689413,-2.128463404187725
SNU-8,11485656,2.474151094807621
NCI-H69,JQ-1-carboplatin (1-1 mol-mol),4.253677409086092
HMC-1-8,107985,-3.647060266664553
HT,107985,-2.427751220028882
SEM,3689413,-0.1393923728957227
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
MDA-MB-231,135875424,3.845545280720972
NCI-H727,12003241,-0.657143782776601
HuH-6,9936388,0.7826739866684046
BHY,6505803,-1.0358392928215592
BT-20,409805,3.857390251652358
BICR 56,12003241,-1.3308187474558526
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
HGC-27,5460769,1.1785967516378393
TE-11,6505803,-1.6927698953047237
COV362,9903786,6.486394788749974
OCI-AML-5,168313200,3.898123624233607
HCC366,9903786,2.568010100247165
NCI-H889,107985,-3.661574603852329
NCI-H1581,107985,-3.1807375781204192
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
NH-6,24180125,1.2366902198749954
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
NCI-H1373,11485656,2.0239924132240117
NALM-6,159324,-2.145978270745669
HuH-1,107985,-3.042398448679546
SK-N-AS,9927531,4.866192814831014
KE-39,11485656,2.227722528153515
HuP-T4,24180125,3.5257576180586976
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876
Mel Ho,11485656,2.770512917812994
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
NCI-H2126,9903786,3.129084376626642
BT 340,168313200,2.246218713505307
SNU-423,12003241,-1.4382544514663564
BL-70,46943432,1.6957346866180731
RT-112,5460769,3.4890381868117712
U-BLC1,168313200,1.5998883228525755
A-549,36462,3.3558444938413707
HuCC-T1,9927531,3.6522633748640487
LN-229,44491742,4.497083507897472
COLO 201,148198,-3.731044907420304
KE-37,439501,-2.40992471859013
NCI-H508,159324,3.293159228488628
NCI-H508,107985,-2.9102482212123126
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
Hs 936.T,9903786,5.166198075920313
HCT 15,148198,-4.831487376237021
SNU-668,12003241,-0.9113554646183494
BT 145,409805,4.038584920935172
A-204,10296883,3.4330765827623617
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
HCC38,12003241,1.828137629090711
A2058,148198,-2.943445139558103
SK-N-DZ,3689413,-4.934308383981231
Reh,5460769,-1.7090111602799842
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
DEL,159324,1.0301611989714654
5637,8515,2.6197871304529805
DMS 454,409805,6.063702183445294
OCI-AML-2,3689413,-0.7025216224577658
RPMI-7951,24180125,2.9670273769283506
BT 232,135875424,3.043961791838538
ZR-75-1,9936388,2.1610264064405977
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
ACHN,8515,3.990371766776524
MOLT-13,26596,-2.4111257577546565
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
RPMI-8226,11485656,0.7927893823334488
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
LN-229,409805,3.62654797699027
BT 145,10296883,3.987169762001794
YKG-1,148198,-3.345136621371903
RERF-LC-Ad2,168313200,4.3712795765743255
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
LCLC-103H,5460769,4.406822689547097
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
NCI-H1435,11485656,2.194016648354146
DU4475,26596,-2.6903175915045305
HEC-251,12003241,0.0135079560064688
SR,46943432,1.3532913979077017
RERF-LC-A1,9936388,-6.729312283369553
CAL-29,11485656,2.151813126384455
HCC44,JQ-1-carboplatin (1-1 mol-mol),-0.5327946699204261
SNU-C1,5460769,4.252440714424883
EFE-184,44491742,4.212174395306579
253J-BV,6610216,4.421938005073567
KATO III,3689413,2.9835896213027673
KNS-62,9927531,5.413841173671558
NCI-H508,11485656,2.212922909681824
KMS-28BM,24180125,1.7269497251160733
KNS-62,3689413,1.1853258222695242
HEC-1-B,159324,3.407433154532503
NCI-H1155,9927531,3.8709301895195023
SW1417,12003241,-2.0835943723769184
Kasumi-1,9903786,0.9129411943023928
PC-3,148198,-4.170321827302026
NCI-H292,107985,-2.5053359043606043
LOX-IMVI,135875424,4.258043031810949
FaDu,44493528,4.321653522203767
Hs 746.T,148124,-1.248919853815242
NCI-H647,409805,3.845998553182997
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
BICR 16,409805,3.7207804084193734
MDA-MB-468,selumetinib-GDC-0941 (4-1 mol-mol),2.2484170521033437
HEL,12003241,-0.3954740832299299
KHM-1B,135875424,3.3101852288443276
GCT,148124,-5.863408209006589
PaTu 8988t,54618164,4.622822732421989
BHY,9936388,1.458207941803915
KP-2,36462,3.367817386344384
BT 164,409805,3.8898564349489297
HT-55,9903786,2.6159451586769156
SNU-216,439501,-2.844909600692544
NU-DHL-1,3689413,-2.5727806443741836
OPM-2,44491742,3.727542800888903
SK-N-DZ,8515,4.2154161677755395
KYSE-180,6610216,4.857625528938267
OAW28,44493528,4.631141764792384
HCC1195,11485656,3.140969914915027
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
OAW28,10296883,4.314409366833216
A-253,107985,-4.608002410712629
DB,9927531,3.16097275010185
AN3-CA,10296883,3.730893077527662
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
G-402,26596,-0.4180942485240064
PL-21,135875424,3.3109880797567595
OCI-AML-2,107985,-4.717077032009498
Mel Ho,107985,-3.7981321235534855
CAL-120,439501,-2.2295565318957955
Rh41,44493528,3.718016939158044
Kasumi-2,46943432,0.9724659287269805
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
CGTH-W-1,5460769,2.937857230001596
BT-12,5460769,4.230264663253868
Lu-65,3689413,-0.1410308041132627
KP-N-SI9s,148198,-2.8651089609704283
U-BLC1,24180125,2.445144330165959
SW579,5460769,2.5889118142562197
KMS-21-BM,135875424,2.842121058769458
RKO,168313200,3.1169425006108455
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
KYO-1,24180125,3.3810336987775353
DAN-G,44491742,4.1375495021288
TTC-709,26596,-1.3495496110855745
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
NCI-H441,439501,1.4166866147967416
NCI-H1373,135398744,6.356905852078599
NCI-H69,24180125,1.624121163280204
NCI-H1105,36462,-0.2485041709419367
TALL-1 [Human adult T-ALL],439501,-2.6089794339614256
Lu-99,6505803,-2.9740342250772644
HEC-6,selumetinib-GDC-0941 (4-1 mol-mol),2.6580781853062887
JHH-4,11485656,1.6774790555680354
Ci-1,11485656,1.9220141721466868
SK-N-MC,9903786,1.1605258193445984
Lu-65,44491742,4.485926174539046
NCI-H1693,10296883,3.9815475003033143
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644
TOV-112D,168313200,2.88692754776733
KMRC-1,36462,3.0698954920529324
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
HPAC,24180125,3.1939061719051196
Peer,5460769,2.3155061508829107
BHT-101,selumetinib-GDC-0941 (4-1 mol-mol),-0.4263486280129431
SNU-407,135875424,3.3406481823919627
HEC-6,159324,3.215977706316347
HOP-62,5460769,2.443615735481444
OV7,JQ-1-carboplatin (1-1 mol-mol),4.300342052298617
UACC-257,439501,-1.398087538451765
HCC38,11485656,1.880745325077396
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
SW1710,44493528,4.456885248291854
HCC2108,409805,5.256429084033282
NCI-H1869,5460769,3.405523512527605
SU-DHL-8,6505803,-0.9881094595359692
JeKo-1,5460769,3.2700758729193526
MOLM-6,54618164,3.463736162611532
IPC-298,9936388,2.329968749108903
HT-1080,selumetinib-GDC-0941 (4-1 mol-mol),1.1211488481166476
SK-HEP-1,135875424,4.97106166770821
Panc 04.03,168313200,2.993774278353398
HCC1588,26596,-1.1478060280369464
SNU-61,135875424,3.609444893060012
LS1034,148198,-4.061801759513543
Hs 294T,24180125,3.2444441745748125
BT 440,10296883,3.8375846267667777
NCI-H69,5460769,3.1019087351608037
JURL-MK1,12003241,-5.793080967465335
BT 147,11485656,1.8934022107121244
SK-CO-1,439501,-2.410857533331093
NCI-H322,9936388,3.3425282984485656
DAN-G,selumetinib-GDC-0941 (4-1 mol-mol),0.9464172392973902
SR,11485656,1.4152988007368743
Hs 852.T,12003241,-1.871479503201469
AsPC-1,107985,-4.227741895863185
NCI-H1355,36462,2.9773846720161696
SNU-1066,409805,6.103521485077888
RS4;11,73707440,6.471067447631978
NB4,107985,-4.9939102669296025
OCUM-1,8515,2.556079594629699
WM88,12003241,-2.725037582616198
KM12,36462,2.407887950750621
BHY,148198,-2.089764447227438
SW620,44491742,4.4130085164157125
NCI-H2122,135398744,6.485849720689022
NCI-H650,6505803,-0.3045816142319602
NALM-6,49836020,4.594148282336944
GCT,168313200,1.6460729886366328
MDA-MB-468,168313200,3.682580404252184
SW982,6505803,-2.367469745570856
Ku812,9903786,1.763683139425592
CMK,10296883,3.7802056460582385
SNU-1105,selumetinib-GDC-0941 (4-1 mol-mol),2.42350207909939
COV644,409805,2.9980382861104724
HCC15,135423438,2.37991378319322
NCI-H1694,5460769,2.288070088951681
OVCAR-8,135398744,6.524120777237468
BICR 18,44493528,4.352077883289458
COV362,148124,-5.7927287034799395
OCI-M1,148198,-4.87600979079706
COLO 800,3689413,2.0885075938315576
BCP-1,107985,-4.375939376714335
JHH-6,36462,3.378771444296558
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
OE33,44493528,4.497258048563181
COLO 320,3689413,-1.9916072658639432
ZR-75-1,selumetinib-GDC-0941 (4-1 mol-mol),1.5981380020167046
JURL-MK1,36462,0.5090018133918662
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
AN3-CA,439501,-3.229124904343767
HuCC-T1,107985,-8.637408805931722
WSU-DLCL2,9927531,3.1454575318264495
RERF-LC-Ad1,9936388,2.559895364863056
NCI-H1563,selumetinib-GDC-0941 (4-1 mol-mol),0.8971079477843085
MM1.S,8515,6.088299107521539
NH-6,10296883,3.372603292906397
WSU-DLCL2,8515,2.8703139987768687
SKM-1,6505803,-1.0817481083509812
HEC-1-A,107985,-3.1197912471628126
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
SNU-466,46943432,0.8744733602203646
CW-2,5460769,1.6725505189692909
OVK18,11485656,1.7406304929162535
KNS-60,439501,-2.666798913296539
5637,5460769,-1.549780285334619
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
KMBC-2,36462,2.9079010396533302
LUDLU-1,54618164,4.275975403884661
NCI-H2286,selumetinib-GDC-0941 (4-1 mol-mol),2.0876737367962495
LN-18,46943432,2.786473052677047
22Rv1,JQ-1-carboplatin (1-1 mol-mol),6.088896276058885
OC 314,148198,-4.2730667463972285
HOS,107985,-2.5585929292957466
G-402,135875424,3.4290798142647776
TE-6,JQ-1-carboplatin (1-1 mol-mol),3.92725328436462
SNU-478,6610216,4.6316446091950665
ACC-MESO-1,9936388,3.1205070846652374
PF-382,11485656,2.17330616168877
BxPC-3,439501,-2.27553783948146
COLO 829,135875424,4.104169116255948
RPMI-8402,73707440,5.61171543505587
NCI-H2141,439501,-3.4118873833208676
JURL-MK1,159324,0.068905787386541
HCC1395,9903786,3.009593050669707
CGTH-W-1,11485656,-0.4433767239008435
COLO 201,selumetinib-GDC-0941 (4-1 mol-mol),0.0601925657233566
CAMA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.627092897381015
HCC202,439501,-1.9855042257832605
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
DEL,8515,2.936663368218975
RERF-LC-Ad2,9936388,1.1598877099292195
HSC-2,44491742,4.345443441235533
RMG-I,11485656,3.2385452078002883
MES-SA,3689413,1.9720850460136523
RT-112,54618164,4.39788452790178
L-363,3689413,0.386026439105166
KU-19-19,6610216,4.876021689690227
SUP-M2,6610216,3.4046920555141
COLO 684,148198,-5.116040428924247
CHP-212,3689413,0.1952243777291655
NCI-H1666,9936388,0.7507462468701122
CAL-54,JQ-1-carboplatin (1-1 mol-mol),-0.1626654882984976
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
CJM [Human melanoma],168313200,4.263181152618082
KNS-60,3689413,0.5613903891454114
SNU-478,selumetinib-GDC-0941 (4-1 mol-mol),-0.9905008638696244
PaTu 8988t,9936388,-7.900053622036252
Lu-99,44491742,4.467729937048073
CHP-212,26596,-3.74720846369554
SK-N-SH,409805,5.798286026067844
PF-382,6610216,3.7963864090602737
SEM,46943432,-1.9096552724661455
NCI-H1694,36462,-0.7254541172270241
Daudi,135423438,1.6157885595086947
HOP-92,10296883,4.19032829919567
KHM-1B,73707440,5.196065246508486
23132/87,107985,-3.2177510998907572
UO-31,11485656,2.1661292847689944
BT 131,6610216,4.128330382659673
M059K,10296883,4.043900698661033
NCI-H2286,3689413,-2.1479799329428437
EKVX,selumetinib-GDC-0941 (4-1 mol-mol),0.6299385991814179
KYM-1,135423438,1.6984584998013297
DOV13,selumetinib-GDC-0941 (4-1 mol-mol),3.389057426499923
SNU-C2A,439501,-1.0520759407127591
ACC-MESO-1,11485656,3.7436435043406
HT-55,148198,-2.6616245414762996
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937
BICR 22,148198,-3.168643556299537
2004,409805,3.735032742542569
LN-229,439501,-1.7560244035844634
Kelly,JQ-1-carboplatin (1-1 mol-mol),1.229495862558611
OVCAR-4,JQ-1-carboplatin (1-1 mol-mol),1.400504619073484
SNU-840,9936388,2.507111845662591
HCC1569,409805,3.626117249430006
BT 416,107985,-3.986056469995941
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
Pfeiffer,12003241,-4.957665380544675
CAL-62,46943432,2.920213901722772
SNU-1033,439501,-2.7458935942411085
A4/Fukuda,135875424,2.943838777845953
SW1353,12003241,-1.0641088251163675
BICR 6,36462,2.804124260868763
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
COLO 684,44493528,4.258277772173305
Calu-3,148198,-3.0650277227090643
HCC2108,24180125,3.362517679132719
Aska-SS,6505803,-1.3133371843623132
LUDLU-1,12003241,-0.5957791848083803
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
U-937,135875424,3.4051518074460487
MFE-319,5460769,5.093824644165235
SUP-T1,44491742,3.5302085503569782
CCF-STTG1,148124,-4.009391944909006
ZR-75-30,9936388,2.0011388860463373
MV4-11,9936388,-6.825137915729416
MDA-MB-435S,44493528,4.3922375921749195
SF126,409805,6.434205859651259
L-428,3689413,-2.385530955592741
NCI-H1581,26596,-0.8859288398475073
NCI-H2126,11485656,1.628640715546943
AGS,9936388,-0.8886821418021683
SNU-410,8515,4.263852404046252
PK-1,12003241,-0.8622642153841519
VMRC-LCD,6610216,4.359775252992096
NCI-H2029,44491742,3.631304430303769
JIMT-1,107985,-0.7659824645781472
GCT,36462,0.8758989390460181
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
RERF-LC-A1,9927531,4.243256542635893
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
SNU-201,12003241,-1.0113776062533857
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
HuT 78,9903786,-0.2471360619469426
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
BT-20,10296883,4.2664147255542
RCH-ACV,107985,-4.015124921394137
JIMT-1,12003241,-0.563362100663344
SU-DHL-1,12003241,0.0778318253848937
OVK18,24180125,3.28014774472566
NUGC-3,24180125,1.117540206425308
L-428,54618164,4.086288112715587
PK-59,36462,2.3986313317590384
253J,12003241,-2.2004462353623775
F-36P,9936388,-5.085386931503238
Capan-2,11485656,2.4723123479129727
NCI-H2009,9903786,1.8298580590992315
SNU-1033,148198,-5.122632724392466
Panc 05.04,3689413,-0.0862100916213441
JMSU-1,148198,-4.3097725771524225
SW1116,12003241,0.0582707461824652
NCI-H2009,107985,-3.3237358160703843
SNU-1214,54639024,4.425030534008987
TE 441.T,26596,-1.4712296697044354
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
Capan-1,5460769,0.8848211247496085
Sq-1,9903786,4.063753255024067
CW-2,6610216,3.647526913375138
SK-CO-1,44493528,4.973545843770428
HEC-151,6505803,0.2052514279790806
KP-2,3689413,-1.979504715969029
SW1417,9903786,3.296338786408906
SNU-C1,148198,-4.322316579096634
PE/CA-PJ49,107985,-3.897981701971708
OPM-2,26596,-3.75281027154887
G-401,135423438,1.541142645334712
COR-L279,6610216,3.5048681579644527
MOLP-8,10296883,2.725727750190508
SNU-719,36462,4.921998623089754
DU4475,10296883,3.4957672338374204
PK-59,5460769,5.2141758944681635
769-P,409805,6.213929900185549
U-937,9936388,-6.425883937752082
YD-10B,159324,2.234202132974722
L-363,409805,4.62619872485341
L-363,26596,-1.5549208071756957
HeLa,36462,3.354174189337733
MV4-11,8515,0.673726443721711
BT 172,12003241,-0.4866452668331515
22Rv1,36462,1.0860894145139028
NALM-6,JQ-1-carboplatin (1-1 mol-mol),-1.4954941357174671
DU145,6505803,2.9308640693327126
NCI-H716,409805,5.889888908173006
KMS-12-BM,107985,-5.423573263916533
JJN-3,135398744,6.34309809291168
JHOC-5,6610216,4.845168251413124
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
SK-MEL-31,44491742,4.695235381351794
HT-55,159324,3.075227758970609
OAW42,148124,0.6602730639600906
Panc 02.03,107985,-4.238430695688479
NCI-H2172,9936388,1.8105409817982183
MEC-1,148198,-4.2599268822798955
SNU-423,168313200,4.217782003449994
KMS-21-BM,9927531,3.894276575541364
NCI-H23,9903786,3.588944874892838
HEC-1-B,148198,-2.293611900914974
SUP-HD1,24180125,2.93936623955847
HCC827,135875424,3.772761345205915
SCC-9,44491742,4.764074483400304
COV644,6610216,4.439145409391099
BICR 56,107985,-3.799758605055094
NCI-H1650,12003241,-2.181878019620055
A3/Kawakami,54618164,3.8685963187989225
EC-GI-10,36462,1.6275747220843164
KYSE-180,159324,3.323934124765763
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
NCI-H1975,46943432,1.534293146837258
SF268,5460769,2.7900829317628157
COV362,26596,-1.9019545485387068
COR-L88,439501,-1.6986263045412435
NCI-H810,26596,-3.4871956530659927
LMSU,11485656,2.410376154528579
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
HD-MY-Z,26596,0.1075810605234112
NMC-G1,107985,-11.863849928065331
Hs 746.T,168313200,2.2627857100827216
KE-37,26596,-2.2525665271951527
LOU-NH91,168313200,3.810508485111527
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
RKN,12003241,-0.3350096455718494
NCI-H2228,3689413,-0.2908814661872257
U-937,148198,-3.074403033711411
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
Hs 611.T,12003241,-4.3632527403619425
FU-OV-1,9936388,1.7648084748519457
TE-5,148198,-2.7916171681720567
Caov-3,107985,-4.513463353783752
SNU-C1,12003241,0.2452706417287593
BT 224,10296883,4.270908833872631
SYO-1,9903786,1.9235940661883033
NCI-H2291,36462,3.214514942555881
NCI-H2122,12003241,-0.1228144224546952
TE-14,135398744,6.394251875306054
HuG1-N,36462,3.53181824317366
IM95,148198,-3.3737610727905056
SW1573,12003241,-0.6702221198842615
HPAC,159324,2.927164212591678
Karpas-620,9936388,2.8279791192492088
JHOS-2,148198,-3.889513078207594
Peer,439501,-2.3355144214927614
SW948,439501,-2.1692174321648174
U-CH1,5460769,3.546164006563716
PK-45H,6610216,4.350521005102969
SH-4,11485656,1.4824886275930502
L-363,107985,-3.711160596536445
HCC1428,148124,4.22185803984092
CFPAC-1,3689413,3.8323467943354337
YD-15,8515,2.6919898843278105
42-MG-BA,3689413,-1.7117650747651572
HT,5460769,1.55908415219926
U266B1,168313200,3.7842669184175497
SNU-175,107985,-3.5287642870069136
SK-N-DZ,9927531,3.3336857807362392
NCI-H196,49836020,1.0558785681395022
JeKo-1,3689413,-2.4394197066593835
L-540,9903786,1.612072273929478
NCI-H1915,148124,-0.3136547815699751
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
Panc 08.13,JQ-1-carboplatin (1-1 mol-mol),-0.4380500096287519
SW948,6610216,4.184431800680971
MOLT-16,8515,3.1215342992263255
NCI-H1838,9927531,5.140983076545055
JHUEM-2,9903786,1.0264930895087971
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
KYSE-410,11485656,2.2435649092934775
L-363,11485656,1.816293106463241
KLE,9936388,-3.639802417260702
TE 617.T,3689413,-0.0312016851133043
TE 617.T,36462,-0.1303372273364364
RS4;11,135875424,3.0879856704694313
Hs 294T,12003241,-1.502620378279095
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
KMRC-20,44491742,5.411645351023098
SNU-620,3689413,0.413852643898191
JHH-6,9927531,5.6306250844291075
HT-55,12003241,-0.758438477023311
SNU-1041,12003241,-1.3076188477929267
UACC-257,3689413,2.9773275321267945
KMS-21-BM,8515,3.650954647618241
OVCAR-4,9936388,-2.136102412732439
PF-382,6505803,0.1218702134100329
KYSE-140,12003241,-0.6057431237522657
ST486,36462,0.4017650011004973
JJN-3,24180125,2.8642596708213537
SK-BR-3,5460769,4.927732708716518
Ri-1,44491742,3.935960320926185
Hs 683,168313200,1.8001064604931507
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
BT 231,26596,-1.8186756145502985
KMBC-2,49836020,0.1766293750985906
SNU-1105,409805,3.776970125526721
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
SNU-475,148124,2.975733678575542
PE/CA-PJ49,11485656,1.6473553373420289
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974
LS1034,168313200,1.9785972892481352
DK-MG,9903786,4.148261806293546
MeWo,JQ-1-carboplatin (1-1 mol-mol),2.4504069963497463
SNU-398,6610216,3.625261217273112
NCI-H1838,107985,-2.652915947627781
OVCAR-8,9936388,2.326713990957197
NCI-H647,5460769,0.6003032928308929
COLO 792,439501,-2.3600745539186994
SW982,36462,3.200595192366945
EFM-192A,54618164,3.960745971422569
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
NCI-H1092,135875424,3.039549904779009
A-375,6610216,4.632433700861142
MM1.S,44493528,4.254687888851587
RPMI-8226,10296883,3.535123167046786
Malme-3M,135875424,3.120735979829605
BT 131,selumetinib-GDC-0941 (4-1 mol-mol),2.219067508706083
SNU-C5,5460769,3.868586295292914
A2058,24180125,2.583620117292264
SNU-398,439501,-1.0670786880866563
NOMO-1,9936388,-6.523282887173488
BT 286,24180125,3.4057895340262445
OC 314,26596,-2.5716994048265964
TOV-112D,3689413,0.2430902307838531
Panc 05.04,409805,4.292025323230266
NCI-H1694,JQ-1-carboplatin (1-1 mol-mol),-0.7317263485639335
HCC366,44493528,4.3832061934270445
KP-4,11485656,2.2916969527324778
NCI-H441,11485656,2.293217978905633
SNU-387,148124,3.5836786309908515
U-BLC1,8515,3.4266677281329843
P31/FUJ,159324,1.227532336429348
EoL-1,9903786,-0.1437472034571408
MDA-MB-415,selumetinib-GDC-0941 (4-1 mol-mol),-0.0962287719038293
NCI-H650,107985,-3.1029215971931645
JHH-1,148124,-4.284532449604465
A2058,135875424,4.909286996355865
NCI-H69,107985,-6.066304384854357
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155
SU-DHL-10,11485656,2.298266624508031
TE-6,148198,-3.788482057513412
OCI-Ly19,107985,-4.415552151834645
OVK18,148198,-3.802684433582173
NCI-H1694,168313200,1.7110744795628887
U-BLC1,409805,3.947099920887272
A-204,6610216,3.86099530765105
SNU-1033,JQ-1-carboplatin (1-1 mol-mol),1.515968870431384
TE-10,12003241,-0.2960597839275556
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615
NCI-H441,107985,-3.286782170083998
BL-70,49836020,4.386780315181427
CAMA-1,409805,5.823044999026108
Hs 683,3689413,-0.4207741938701824
BEN,46943432,2.875871955716667
NU-DHL-1,8515,3.2734160853720105
U-BLC1,11485656,2.1961180988259086
A4/Fukuda,6505803,0.0348674492980193
HMCB,12003241,-2.4987094510650834
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142
MOLM-16,439501,-2.4166934958345476
NCI-H211,24180125,1.6586707471398143
Lu-65,11485656,2.4652445580433713
OVCAR-4,168313200,3.9529975480401784
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
KCL-22,9936388,-5.415966351243413
SNU-738,selumetinib-GDC-0941 (4-1 mol-mol),2.490499311064832
SK-MEL-3,10296883,3.7969706070865423
TC-71,107985,-3.2735823603491987
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
HuH-28,107985,-3.906817449798121
JHH-5,10296883,4.145444689794886
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
MHH-ES-1,54618164,3.950702257104535
HSC-3,49836020,-1.9036219787804456
CGTH-W-1,9936388,2.615768469717637
BT 286,49836020,4.709879888093613
WM115,6610216,3.675624927368402
SW982,6610216,5.052310120816527
COLO 680N,409805,5.020246083137369
EN,11485656,1.3924868534559591
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
NCI-H1184,6505803,-0.2982079096547607
WSU-DLCL2,24180125,1.7087294222704126
A3/Kawakami,36462,0.6765947493601843
HCC1954,36462,1.6698517772269752
KMS-11,26596,-4.4422678730324465
TE-15,44493528,4.216402167585121
KMS-20,9936388,-8.248983770505305
NCI-H2228,9903786,2.418550241736446
HEC-50B,9903786,4.880358665703779
JHOC-5,439501,-1.8314674512872349
NCI-H322,54618164,4.3212378685636015
NCI-H1869,148124,3.56569848819375
TE-15,54618164,4.596489817745785
VCaP,3689413,-1.1358537127375183
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
HT-55,54618164,4.13568733206581
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
COLO 741,24180125,2.98778240195572
EM-2,73707440,3.768751115811406
2004,26596,-1.025080107658215
NB4,26596,-4.43915063636903
NCI-H1944,26596,-1.3994203937624
HEY A8,409805,6.361022434808549
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
KE-39,3689413,-1.8420159541718293
Hs 683,439501,-3.4221859538690467
SW948,107985,-3.1361927230844255
SU-DHL-10,selumetinib-GDC-0941 (4-1 mol-mol),2.1131040208605576
SNU-1196,9903786,3.851159965091799
KYSE-180,439501,-1.6605779697575254
NCI-H2023,135875424,5.909688089564903
NCI-H929,3689413,-2.331613234092956
HD-MY-Z,9903786,3.5223384929798187
CAL-51,6505803,-1.1525670311484852
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
KU-19-19,3689413,0.155027117273248
NCI-H1623,135875424,3.67415188779786
TE-5,409805,3.5754851367478624
NUGC-4,159324,3.728787065585916
OE21,26596,-3.6158126221637823
A2780,24180125,2.723679145549484
LC-1/sq-SF,3689413,0.5159232922556106
MFE-296,6505803,0.2108940318796544
A-673,24180125,1.1732098097274752
BFTC-909,24180125,2.699370118217823
KNS-62,107985,-3.5303048241663664
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
Reh,135875424,2.5875056879374307
SCC-25,26596,-1.8912501387828335
BT-16,36462,3.135379230377269
COLO 800,5460769,0.4868245753357603
KYO-1,148198,-3.141944756892253
NCI-H28,26596,-2.2516218144459508
CL-11,3689413,0.4065181450870009
Panc 08.13,12003241,-0.6066963298008116
Kasumi-1,135398744,7.461687299190896
CCK-81,9936388,-6.1702645083973335
Panc 03.27,6505803,-2.205442615727637
A-375,9903786,2.3118659059614877
PaTu 8902,9903786,4.041497343746548
Kasumi-1,10296883,1.6176834941349487
KP-2,6610216,4.180671400196187
JHH-1,135875424,4.689279573138962
Rh18,439501,-2.3237711161162102
KMS-18,24180125,2.507330316138634
BT-474,24180125,2.5464678025826077
KMRC-2,10296883,4.145802538683136
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
A2780,148198,-4.120801514793353
NCI-H69,6505803,2.592784813804099
KNS-60,44491742,4.18434599527296
SK-MEL-3,8515,4.372397104094242
Hs 688(A).T,6505803,2.8960604198469206
8-MG-BA,24180125,3.2708550287441813
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
CAL-85-1,12003241,-1.401340141763049
NCI-H716,JQ-1-carboplatin (1-1 mol-mol),0.4768639572382123
HEC-1-A,36462,1.2405106229854406
KATO III,9936388,1.2982183156620934
G-401,107985,-4.394015959361378
NCI-H1666,148198,-1.1369965956899613
CAS-1,44491742,3.9814120844096386
SNU-1076,8515,3.922584555723145
Jurkat,26596,-2.6358007271857216
Sq-1,JQ-1-carboplatin (1-1 mol-mol),0.7735005611319609
HuT 78,107985,-4.626222476681204
NCI-H28,9936388,-6.07130459443066
G-402,148198,-5.197807449941822
PE/CA-PJ41 (clone D2),107985,-2.5138911601110254
NCI-H2196,6610216,4.474259778958852
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
Hep 3B2.1-7,9903786,2.792162090587101
ST486,9903786,1.7386739001111973
A101D,10296883,3.721128272051271
P12-Ichikawa,12003241,0.1281153302005317
SK-HEP-1,107985,-2.2891993358893856
BT-12,107985,-4.197722629937788
Hs 940.T,3689413,0.3650733663514719
HuH-6,54618164,3.300518310579967
TCC-Pan2,9936388,2.201514810862402
2004,44491742,4.273676019695118
GSU,409805,5.755802270178732
SNU-16,8515,1.85079439361957
A-549,6505803,-0.295425809550202
8505C,148198,-2.1728643040186237
MES-SA,135423438,4.43653608071916
639V,159324,3.6195466497834543
OE33,148198,-2.7707811749574196
SNU-410,9936388,2.1346646723856444
SW1710,6505803,1.2425561690078113
CMK,148124,-4.626446728846703
SNU-886,135398744,6.3424886084429435
NCI-H1694,3689413,-2.758320209596303
MDA-MB-415,24180125,2.3743547117086887
JHOS-2,107985,-4.307159387799739
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
KYSE-140,54618164,4.2081025861503285
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
BICR 22,11485656,1.7887481250962165
TOV-112D,107985,-3.748470845385748
HL-60,5460769,4.053430435515514
OE33,12003241,0.2230817721074321
BT 145,135875424,2.9417434414875374
KE-39,10296883,3.8123665461282545
NU-DHL-1,6505803,0.0102011938996583
MFE-296,9927531,4.364597960371392
8505C,12003241,-1.423942083306862
HCC38,26596,-1.4255018531390269
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
RL95-2,107985,-3.902206557331598
KMS-20,6505803,-0.2025622916563878
SW1573,409805,6.568626512075582
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
SNU-407,selumetinib-GDC-0941 (4-1 mol-mol),0.3272948267945177
HEC-265,54618164,4.75947982853325
SNU-81,6505803,-0.5044882096333503
KMM-1,3689413,1.9155128689282703
SW1783,44493528,4.220460910824872
NCI-H2030,12003241,-1.1383124397984303
SNU-182,439501,-3.0072363734756173
AsPC-1,6505803,-1.959385905579291
HEC-1-A,JQ-1-carboplatin (1-1 mol-mol),2.5106263332941308
L3.3,26596,-0.871586326159775
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
U-BLC1,135875424,3.992147868924357
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
MG-63,11485656,3.0709685561149076
MDA-MB-468,49836020,3.927183487044253
OCI-Ly10,49836020,3.5902164250425503
NCC-StC-K140,5460769,0.9709750837193912
HCC-56,439501,0.1637931010538502
NCI-H1650,3689413,-2.359636469082647
BEN,9936388,2.3760143279303096
SNU-685,3689413,-2.422498805139559
Kasumi-1,46943432,-1.29446682230788
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
OCI-AML-5,148198,-5.018972426044919
KMRC-1,148198,-3.0121915653316953
CMK,107985,-5.004387874790032
NCI-H1944,135423438,6.01931856981719
NCI-H1651,148198,-3.460824501598599
OVTOKO,9936388,2.2599066716722707
COLO 668,135423438,2.664391389217799
NCI-H2342,9903786,5.089610325302681
697,26596,-3.738264049294864
NCI-H1869,135875424,4.489996634847175
U266B1,3689413,0.1413723785410366
BT 359,10296883,4.315166062972002
Daoy,26596,-2.0962215675601024
CA46,11485656,1.2289823963881294
KP-N-YN,9927531,3.406811023385209
VMRC-RCZ,24180125,3.3518977322477084
SEM,9927531,4.847523560791686
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
NCI-H929,54639024,4.491044339124744
BT 286,6610216,4.050396966302166
RPMI-8402,135398744,6.9217830210823434
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
Hs 611.T,36462,-1.281964415022038
DND-41,JQ-1-carboplatin (1-1 mol-mol),-0.1344797725296377
RMG-I,3689413,-2.168245992738919
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
KYSE-70,44493528,4.735176242945038
Hs 683,8515,4.507985509607111
TE-10,54618164,3.9236183962160993
NCI-H661,439501,-2.903837615768139
GDM-1,168313200,1.9234507371216816
CAL-27,49836020,4.376742607272952
KYM-1,9927531,4.58392682790106
PaTu 8902,11485656,3.4031855994132663
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
NCI-H1623,6610216,4.306736710776884
LS1034,44491742,3.738346956467245
ECC12,107985,-2.5253216616442047
Hep 3B2.1-7,24180125,2.3898780520203164
NCI-H460,135875424,3.211754300989152
SU-DHL-1,54618164,3.660876980117255
NCI-H211,JQ-1-carboplatin (1-1 mol-mol),-0.6701581797936323
TE-9,135875424,3.7718205892374943
NCI-H747,9927531,5.010482166224782
SNU-738,46943432,4.250733302993981
FTC-133,6610216,5.488595178062795
D283 Med,148198,-7.782574988452476
CAL-148,54618164,3.890764234949744
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
GP2d,6610216,3.5205675124685025
HuG1-N,54618164,3.8770793996245345
COLO 829,36462,2.7479607822495504
RL,selumetinib-GDC-0941 (4-1 mol-mol),2.248792439261428
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
RKO,9903786,4.184024439899693
SK-MEL-24,11485656,3.6100646887708305
IST-Mes1,3689413,0.9013533734229402
SNB-75,9927531,5.402780165726325
CML-T1,135875424,3.5304182343940935
NCI-H2405,9936388,-0.650835223807707
HEC-1-A,11485656,2.952835409818289
OVCAR-8,6505803,-0.7401549831867192
LOX-IMVI,24180125,3.3051299487129415
KYSE-410,9927531,5.048506934315496
THP-1,439501,-2.363264407361294
RPMI-7951,9936388,-2.1957578683042205
TE-4,9903786,1.7247018760374746
KMRC-3,44491742,3.892317452433475
SNU-489,selumetinib-GDC-0941 (4-1 mol-mol),2.3199148187504592
MV4-11,5460769,0.4038466040082859
CHP-126,6610216,4.916438855673617
786-O,9936388,-0.7628994518050997
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
BHY,409805,3.5626332868001787
LOX-IMVI,148198,-2.445772941232649
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544
BT 333,5460769,4.50385990816769
Peer,6505803,-0.1877996402044426
253J,135875424,3.6390829141774934
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
PLC/PRF/5,9936388,3.289212143502143
EFE-184,54618164,4.291032253552879
TE-5,6505803,0.1996396814401048
JHOC-5,12003241,-1.1087899100302334
BFTC-905,12003241,-0.5086689742708943
NCI-H1573,8515,6.25434864786871
HEL,107985,-3.965696416470184
SNU-C1,44493528,4.07827245501809
BICR 22,409805,3.8456212820768214
NCI-H2126,439501,-1.6048735298353825
COLO 668,9936388,-5.811086467822447
CAL-29,44491742,3.7928020727090392
P12-Ichikawa,159324,0.3478252328600322
HCC38,135875424,3.1024594516018453
RL,9927531,3.353152417945259
SNU-1076,9936388,-5.0107279938232185
SW1271,135875424,3.8663800475620542
VMRC-RCZ,44491742,4.2386816825846285
NCI-H1568,12003241,-1.4870303892505918
AML-193,5460769,4.1891717596196205
SNU-869,148198,-3.291202366312453
D283 Med,9927531,3.2144716566788745
Hs 839.T,10296883,4.248587708803948
OV7,12003241,-1.6318982026296969
BT 428,409805,5.8133328152421395
NCI-H1623,168313200,4.911870039242249
HuH-28,148198,-2.021570879292896
MFE-296,6610216,4.401598246385061
HuT 78,36462,0.7819646320410331
NCI-H810,JQ-1-carboplatin (1-1 mol-mol),0.4173048947939034
LS123,148198,-1.1889670275766562
Hs 852.T,9903786,1.6008538749226255
BT 164,JQ-1-carboplatin (1-1 mol-mol),4.081532753647648
JHUEM-7,6505803,0.2461537124409258
HCC1419,44493528,4.295803201146447
TE-11,409805,3.950672349574134
J82,11485656,3.7122630536085137
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
OE19,11485656,2.020762016730455
TE-10,439501,-2.523220580930317
WM1799,5460769,2.2209273724490335
Hs 729.T,6610216,4.1475026688344
TUHR4TKB,159324,5.085866388829581
RPMI-8402,12003241,-0.4088888603650127
LN-18,JQ-1-carboplatin (1-1 mol-mol),2.2157134511008927
Hs 940.T,107985,-2.5873077806657796
SCC-9,24180125,3.671852734769843
SET-2,135423438,1.6244153608303664
NCI-H522,9927531,4.749051096908956
RCH-ACV,JQ-1-carboplatin (1-1 mol-mol),-0.5668300449210979
DK-MG,168313200,3.870853059576488
